ID;Sex;Age;BackgroundAndGeneration;MedicineGroupATC;Periods;PersonsWithDispensedMedicines_1;PersonsWithMedicinesRelative_2
0;Total male and female;10000;Total background and generation;Total;2006;11241725;67.54
1;Total male and female;10000;Total background and generation;Total;2007;11320680;67.86
2;Total male and female;10000;Total background and generation;Total;2008;11704500;69.83
3;Total male and female;10000;Total background and generation;Total;2009;11803505;70.09
4;Total male and female;10000;Total background and generation;Total;2010;11859005;70.05
5;Total male and female;10000;Total background and generation;Total;2011;11696090;68.74
6;Total male and female;10000;Total background and generation;Total;2012;11587020;67.85
7;Total male and female;10000;Total background and generation;Total;2013;11439885;66.78
8;Total male and female;10000;Total background and generation;Total;2014;11420305;66.4
9;Total male and female;10000;Total background and generation;Total;2015;11454920;66.26
10;Total male and female;10000;Total background and generation;Total;2016;11517975;66.24
11;Total male and female;10000;Total background and generation;Total;2017;11482350;65.65
12;Total male and female;10000;Total background and generation;Total;2018;11591535;65.87
13;Total male and female;10000;Total background and generation;Total;2019;11591365;65.4
14;Total male and female;10000;Total background and generation;Total;2020;11177900;62.8
15;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2006;3127780;18.79
16;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2007;3369155;20.2
17;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2008;3588285;21.41
18;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2009;3812715;22.64
19;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2010;4053230;23.94
20;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2011;4239530;24.92
21;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2012;3567995;20.89
22;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2013;3695510;21.57
23;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2014;3888135;22.61
24;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2015;4056530;23.47
25;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2016;4205595;24.19
26;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2017;4300740;24.59
27;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2018;4407310;25.04
28;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2019;4381755;24.72
29;Total male and female;10000;Total background and generation;A Alimentary tract and metabolism;2020;4314580;24.24
30;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2006;135560;0.81
31;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2007;145735;0.87
32;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2008;147900;0.88
33;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2009;149050;0.89
34;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2010;154710;0.91
35;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2011;96590;0.57
36;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2012;38160;0.22
37;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2013;37720;0.22
38;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2014;38925;0.23
39;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2015;38365;0.22
40;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2016;38155;0.22
41;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2017;36165;0.21
42;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2018;35780;0.2
43;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2019;43930;0.25
44;Total male and female;10000;Total background and generation;A01 Stomatological preparations;2020;45190;0.25
45;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2006;135560;0.81
46;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2007;145735;0.87
47;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2008;147900;0.88
48;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2009;149050;0.89
49;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2010;154710;0.91
50;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2011;96590;0.57
51;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2012;38160;0.22
52;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2013;37720;0.22
53;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2014;38925;0.23
54;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2015;38365;0.22
55;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2016;38155;0.22
56;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2017;36165;0.21
57;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2018;35780;0.2
58;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2019;43930;0.25
59;Total male and female;10000;Total background and generation;A01A Stomatological preparations;2020;45190;0.25
60;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2006;1717060;10.32
61;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2007;1932975;11.59
62;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2008;2153940;12.85
63;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2009;2355645;13.99
64;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2010;2558270;15.11
65;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2011;2746955;16.14
66;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2012;1822580;10.67
67;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2013;1917420;11.19
68;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2014;2025395;11.78
69;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2015;2103755;12.17
70;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2016;2176235;12.52
71;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2017;2204900;12.61
72;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2018;2230140;12.67
73;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2019;2265425;12.78
74;Total male and female;10000;Total background and generation;A02 Drugs for acid related disorders;2020;2271760;12.76
75;Total male and female;10000;Total background and generation;A02A Antacids;2006;3380;0.02
76;Total male and female;10000;Total background and generation;A02A Antacids;2007;1785;0.01
77;Total male and female;10000;Total background and generation;A02A Antacids;2008;970;0.01
78;Total male and female;10000;Total background and generation;A02A Antacids;2009;570;0.0
79;Total male and female;10000;Total background and generation;A02A Antacids;2010;495;0.0
80;Total male and female;10000;Total background and generation;A02A Antacids;2011;395;0.0
81;Total male and female;10000;Total background and generation;A02A Antacids;2012;305;0.0
82;Total male and female;10000;Total background and generation;A02A Antacids;2013;480;0.0
83;Total male and female;10000;Total background and generation;A02A Antacids;2014;290;0.0
84;Total male and female;10000;Total background and generation;A02A Antacids;2015;210;0.0
85;Total male and female;10000;Total background and generation;A02A Antacids;2016;185;0.0
86;Total male and female;10000;Total background and generation;A02A Antacids;2017;125;0.0
87;Total male and female;10000;Total background and generation;A02A Antacids;2018;85;0.0
88;Total male and female;10000;Total background and generation;A02A Antacids;2019;95;0.0
89;Total male and female;10000;Total background and generation;A02A Antacids;2020;85;0.0
90;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2006;1715100;10.31
91;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2007;1931970;11.58
92;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2008;2153395;12.85
93;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2009;2355320;13.99
94;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2010;2557990;15.11
95;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2011;2746750;16.14
96;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2012;1822400;10.67
97;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2013;1917165;11.19
98;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2014;2025265;11.78
99;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2015;2103665;12.17
100;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2016;2176150;12.51
101;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2017;2204845;12.61
102;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2018;2230105;12.67
103;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2019;2265380;12.78
104;Total male and female;10000;Total background and generation;A02B Drugs for peptic ulcer and gord;2020;2271720;12.76
105;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2006;0;0.0
106;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2007;0;0.0
107;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2008;0;0.0
108;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2009;0;0.0
109;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2010;0;0.0
110;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2011;0;0.0
111;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2012;0;0.0
112;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2013;0;0.0
113;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2014;0;0.0
114;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2015;0;0.0
115;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2016;0;0.0
116;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2017;0;0.0
117;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2018;0;0.0
118;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2019;0;0.0
119;Total male and female;10000;Total background and generation;A02X Oth. drugs for acid related disord.;2020;0;0.0
120;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2006;346270;2.08
121;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2007;361875;2.17
122;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2008;360570;2.15
123;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2009;366475;2.18
124;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2010;372355;2.2
125;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2011;382420;2.25
126;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2012;369020;2.16
127;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2013;348950;2.04
128;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2014;368575;2.14
129;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2015;406800;2.35
130;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2016;407125;2.34
131;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2017;400305;2.29
132;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2018;405705;2.31
133;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2019;391785;2.21
134;Total male and female;10000;Total background and generation;A03 Drugs for funct.gastrointest.disord.;2020;371205;2.09
135;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2006;129905;0.78
136;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2007;132655;0.8
137;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2008;131630;0.79
138;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2009;132045;0.78
139;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2010;131210;0.77
140;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2011;131325;0.77
141;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2012;128535;0.75
142;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2013;119550;0.7
143;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2014;117065;0.68
144;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2015;110675;0.64
145;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2016;107915;0.62
146;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2017;105930;0.61
147;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2018;104195;0.59
148;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2019;101390;0.57
149;Total male and female;10000;Total background and generation;A03A Drugs for functional bowel disord.;2020;94720;0.53
150;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2006;4250;0.03
151;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2007;4065;0.02
152;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2008;3865;0.02
153;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2009;3900;0.02
154;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2010;4265;0.03
155;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2011;4895;0.03
156;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2012;4600;0.03
157;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2013;4555;0.03
158;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2014;4800;0.03
159;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2015;4655;0.03
160;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2016;4940;0.03
161;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2017;4970;0.03
162;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2018;5070;0.03
163;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2019;5055;0.03
164;Total male and female;10000;Total background and generation;A03B Belladonna and derivatives, plain;2020;4530;0.03
165;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2006;0;0.0
166;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2007;0;0.0
167;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2008;0;0.0
168;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2009;0;0.0
169;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2010;0;0.0
170;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2011;0;0.0
171;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2012;0;0.0
172;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2013;0;0.0
173;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2014;0;0.0
174;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2015;0;0.0
175;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2016;0;0.0
176;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2017;0;0.0
177;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2018;0;0.0
178;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2019;0;0.0
179;Total male and female;10000;Total background and generation;A03C Antispasmodics with psycholeptics;2020;0;0.0
180;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2006;0;0.0
181;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2007;0;0.0
182;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2008;0;0.0
183;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2009;0;0.0
184;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2010;0;0.0
185;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2011;0;0.0
186;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2012;0;0.0
187;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2013;0;0.0
188;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2014;0;0.0
189;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2015;0;0.0
190;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2016;0;0.0
191;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2017;0;0.0
192;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2018;0;0.0
193;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2019;0;0.0
194;Total male and female;10000;Total background and generation;A03D Antispasmodics with analgesics;2020;0;0.0
195;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2006;0;0.0
196;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2007;0;0.0
197;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2008;0;0.0
198;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2009;0;0.0
199;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2010;0;0.0
200;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2011;0;0.0
201;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2012;0;0.0
202;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2013;0;0.0
203;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2014;0;0.0
204;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2015;0;0.0
205;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2016;0;0.0
206;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2017;0;0.0
207;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2018;0;0.0
208;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2019;0;0.0
209;Total male and female;10000;Total background and generation;A03E Antispasmodics and anticholinergics;2020;0;0.0
210;Total male and female;10000;Total background and generation;A03F Propulsives;2006;223060;1.34
211;Total male and female;10000;Total background and generation;A03F Propulsives;2007;236790;1.42
212;Total male and female;10000;Total background and generation;A03F Propulsives;2008;236685;1.41
213;Total male and female;10000;Total background and generation;A03F Propulsives;2009;242165;1.44
214;Total male and female;10000;Total background and generation;A03F Propulsives;2010;249015;1.47
215;Total male and female;10000;Total background and generation;A03F Propulsives;2011;258965;1.52
216;Total male and female;10000;Total background and generation;A03F Propulsives;2012;247900;1.45
217;Total male and female;10000;Total background and generation;A03F Propulsives;2013;235635;1.38
218;Total male and female;10000;Total background and generation;A03F Propulsives;2014;258230;1.5
219;Total male and female;10000;Total background and generation;A03F Propulsives;2015;304255;1.76
220;Total male and female;10000;Total background and generation;A03F Propulsives;2016;306805;1.76
221;Total male and female;10000;Total background and generation;A03F Propulsives;2017;301525;1.72
222;Total male and female;10000;Total background and generation;A03F Propulsives;2018;308350;1.75
223;Total male and female;10000;Total background and generation;A03F Propulsives;2019;296735;1.67
224;Total male and female;10000;Total background and generation;A03F Propulsives;2020;282425;1.59
225;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2006;35620;0.21
226;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2007;39910;0.24
227;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2008;42765;0.26
228;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2009;45555;0.27
229;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2010;48425;0.29
230;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2011;51960;0.31
231;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2012;52820;0.31
232;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2013;55085;0.32
233;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2014;56855;0.33
234;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2015;62365;0.36
235;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2016;67625;0.39
236;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2017;72455;0.41
237;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2018;83510;0.47
238;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2019;90095;0.51
239;Total male and female;10000;Total background and generation;A04 Antiemetics and antinauseants;2020;81110;0.46
240;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2006;35620;0.21
241;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2007;39910;0.24
242;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2008;42765;0.26
243;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2009;45555;0.27
244;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2010;48425;0.29
245;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2011;51960;0.31
246;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2012;52820;0.31
247;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2013;55085;0.32
248;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2014;56855;0.33
249;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2015;62365;0.36
250;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2016;67625;0.39
251;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2017;72455;0.41
252;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2018;83510;0.47
253;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2019;90095;0.51
254;Total male and female;10000;Total background and generation;A04A Antiemetics and antinauseants;2020;81110;0.46
255;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2006;8670;0.05
256;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2007;9370;0.06
257;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2008;9970;0.06
258;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2009;10665;0.06
259;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2010;11075;0.07
260;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2011;11615;0.07
261;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2012;12035;0.07
262;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2013;12800;0.07
263;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2014;13380;0.08
264;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2015;13890;0.08
265;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2016;14395;0.08
266;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2017;15030;0.09
267;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2018;15560;0.09
268;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2019;16140;0.09
269;Total male and female;10000;Total background and generation;A05 Bile and liver therapy;2020;15810;0.09
270;Total male and female;10000;Total background and generation;A05A Bile therapy;2006;8670;0.05
271;Total male and female;10000;Total background and generation;A05A Bile therapy;2007;9370;0.06
272;Total male and female;10000;Total background and generation;A05A Bile therapy;2008;9970;0.06
273;Total male and female;10000;Total background and generation;A05A Bile therapy;2009;10665;0.06
274;Total male and female;10000;Total background and generation;A05A Bile therapy;2010;11075;0.07
275;Total male and female;10000;Total background and generation;A05A Bile therapy;2011;11615;0.07
276;Total male and female;10000;Total background and generation;A05A Bile therapy;2012;12035;0.07
277;Total male and female;10000;Total background and generation;A05A Bile therapy;2013;12800;0.07
278;Total male and female;10000;Total background and generation;A05A Bile therapy;2014;13380;0.08
279;Total male and female;10000;Total background and generation;A05A Bile therapy;2015;13890;0.08
280;Total male and female;10000;Total background and generation;A05A Bile therapy;2016;14395;0.08
281;Total male and female;10000;Total background and generation;A05A Bile therapy;2017;15030;0.09
282;Total male and female;10000;Total background and generation;A05A Bile therapy;2018;15560;0.09
283;Total male and female;10000;Total background and generation;A05A Bile therapy;2019;16140;0.09
284;Total male and female;10000;Total background and generation;A05A Bile therapy;2020;15810;0.09
285;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2006;0;0.0
286;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2007;0;0.0
287;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2008;0;0.0
288;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2009;0;0.0
289;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2010;0;0.0
290;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2011;0;0.0
291;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2012;0;0.0
292;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2013;0;0.0
293;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2014;0;0.0
294;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2015;0;0.0
295;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2016;0;0.0
296;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2017;0;0.0
297;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2018;0;0.0
298;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2019;0;0.0
299;Total male and female;10000;Total background and generation;A05B Liver therapy, lipotropics;2020;0;0.0
300;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2006;0;0.0
301;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2007;0;0.0
302;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2008;0;0.0
303;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2009;0;0.0
304;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2010;0;0.0
305;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2011;0;0.0
306;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2012;0;0.0
307;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2013;0;0.0
308;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2014;0;0.0
309;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2015;0;0.0
310;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2016;0;0.0
311;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2017;0;0.0
312;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2018;0;0.0
313;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2019;0;0.0
314;Total male and female;10000;Total background and generation;A05C Bile therapy drugs and lipotropics;2020;0;0.0
315;Total male and female;10000;Total background and generation;A06 Laxatives;2006;787295;4.73
316;Total male and female;10000;Total background and generation;A06 Laxatives;2007;855930;5.13
317;Total male and female;10000;Total background and generation;A06 Laxatives;2008;909225;5.42
318;Total male and female;10000;Total background and generation;A06 Laxatives;2009;975410;5.79
319;Total male and female;10000;Total background and generation;A06 Laxatives;2010;1054600;6.23
320;Total male and female;10000;Total background and generation;A06 Laxatives;2011;1144755;6.73
321;Total male and female;10000;Total background and generation;A06 Laxatives;2012;1156485;6.77
322;Total male and female;10000;Total background and generation;A06 Laxatives;2013;1152965;6.73
323;Total male and female;10000;Total background and generation;A06 Laxatives;2014;1208195;7.02
324;Total male and female;10000;Total background and generation;A06 Laxatives;2015;1281735;7.41
325;Total male and female;10000;Total background and generation;A06 Laxatives;2016;1358175;7.81
326;Total male and female;10000;Total background and generation;A06 Laxatives;2017;1420150;8.12
327;Total male and female;10000;Total background and generation;A06 Laxatives;2018;1460285;8.3
328;Total male and female;10000;Total background and generation;A06 Laxatives;2019;1470760;8.3
329;Total male and female;10000;Total background and generation;A06 Laxatives;2020;1429265;8.03
330;Total male and female;10000;Total background and generation;A06A Laxatives;2006;787295;4.73
331;Total male and female;10000;Total background and generation;A06A Laxatives;2007;855930;5.13
332;Total male and female;10000;Total background and generation;A06A Laxatives;2008;909225;5.42
333;Total male and female;10000;Total background and generation;A06A Laxatives;2009;975410;5.79
334;Total male and female;10000;Total background and generation;A06A Laxatives;2010;1054600;6.23
335;Total male and female;10000;Total background and generation;A06A Laxatives;2011;1144755;6.73
336;Total male and female;10000;Total background and generation;A06A Laxatives;2012;1156485;6.77
337;Total male and female;10000;Total background and generation;A06A Laxatives;2013;1152965;6.73
338;Total male and female;10000;Total background and generation;A06A Laxatives;2014;1208195;7.02
339;Total male and female;10000;Total background and generation;A06A Laxatives;2015;1281735;7.41
340;Total male and female;10000;Total background and generation;A06A Laxatives;2016;1358175;7.81
341;Total male and female;10000;Total background and generation;A06A Laxatives;2017;1420150;8.12
342;Total male and female;10000;Total background and generation;A06A Laxatives;2018;1460285;8.3
343;Total male and female;10000;Total background and generation;A06A Laxatives;2019;1470760;8.3
344;Total male and female;10000;Total background and generation;A06A Laxatives;2020;1429265;8.03
345;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2006;244715;1.47
346;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2007;248600;1.49
347;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2008;247490;1.48
348;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2009;250155;1.49
349;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2010;252645;1.49
350;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2011;252055;1.48
351;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2012;244015;1.43
352;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2013;232415;1.36
353;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2014;229405;1.33
354;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2015;226470;1.31
355;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2016;225025;1.29
356;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2017;223065;1.28
357;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2018;225935;1.28
358;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2019;220265;1.24
359;Total male and female;10000;Total background and generation;A07 Anti diarr/intest/infl/infect.agents;2020;213835;1.2
360;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2006;115650;0.69
361;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2007;118095;0.71
362;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2008;122360;0.73
363;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2009;126130;0.75
364;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2010;130790;0.77
365;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2011;131815;0.77
366;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2012;129420;0.76
367;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2013;122850;0.72
368;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2014;121695;0.71
369;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2015;119970;0.69
370;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2016;117765;0.68
371;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2017;115215;0.66
372;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2018;116495;0.66
373;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2019;112660;0.64
374;Total male and female;10000;Total background and generation;A07A Intestinal antiinfectives;2020;107395;0.6
375;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2006;75;0.0
376;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2007;40;0.0
377;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2008;15;0.0
378;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2009;5;0.0
379;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2010;5;0.0
380;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2011;10;0.0
381;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2012;10;0.0
382;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2013;10;0.0
383;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2014;5;0.0
384;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2015;0;0.0
385;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2016;0;0.0
386;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2017;0;0.0
387;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2018;0;0.0
388;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2019;0;0.0
389;Total male and female;10000;Total background and generation;A07B Intestinal adsorbents;2020;0;0.0
390;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2006;295;0.0
391;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2007;220;0.0
392;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2008;10;0.0
393;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2009;15;0.0
394;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2010;10;0.0
395;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2011;10;0.0
396;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2012;5;0.0
397;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2013;5;0.0
398;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2014;5;0.0
399;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2015;5;0.0
400;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2016;5;0.0
401;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2017;5;0.0
402;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2018;5;0.0
403;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2019;5;0.0
404;Total male and female;10000;Total background and generation;A07C Electrolytes with carbohydrates;2020;5;0.0
405;Total male and female;10000;Total background and generation;A07D Antipropulsives;2006;60240;0.36
406;Total male and female;10000;Total background and generation;A07D Antipropulsives;2007;60845;0.36
407;Total male and female;10000;Total background and generation;A07D Antipropulsives;2008;55270;0.33
408;Total male and female;10000;Total background and generation;A07D Antipropulsives;2009;52560;0.31
409;Total male and female;10000;Total background and generation;A07D Antipropulsives;2010;50160;0.3
410;Total male and female;10000;Total background and generation;A07D Antipropulsives;2011;47680;0.28
411;Total male and female;10000;Total background and generation;A07D Antipropulsives;2012;41755;0.24
412;Total male and female;10000;Total background and generation;A07D Antipropulsives;2013;36335;0.21
413;Total male and female;10000;Total background and generation;A07D Antipropulsives;2014;32890;0.19
414;Total male and female;10000;Total background and generation;A07D Antipropulsives;2015;30995;0.18
415;Total male and female;10000;Total background and generation;A07D Antipropulsives;2016;30430;0.18
416;Total male and female;10000;Total background and generation;A07D Antipropulsives;2017;29775;0.17
417;Total male and female;10000;Total background and generation;A07D Antipropulsives;2018;29700;0.17
418;Total male and female;10000;Total background and generation;A07D Antipropulsives;2019;25310;0.14
419;Total male and female;10000;Total background and generation;A07D Antipropulsives;2020;23330;0.13
420;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2006;74225;0.45
421;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2007;75235;0.45
422;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2008;75320;0.45
423;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2009;76835;0.46
424;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2010;76960;0.45
425;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2011;77750;0.46
426;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2012;77620;0.45
427;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2013;77740;0.45
428;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2014;78960;0.46
429;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2015;79590;0.46
430;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2016;80950;0.47
431;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2017;82250;0.47
432;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2018;83970;0.48
433;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2019;86110;0.49
434;Total male and female;10000;Total background and generation;A07E Intestinal antiinflammatory agents;2020;87005;0.49
435;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2006;0;0.0
436;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2007;0;0.0
437;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2008;0;0.0
438;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2009;0;0.0
439;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2010;0;0.0
440;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2011;0;0.0
441;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2012;0;0.0
442;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2013;0;0.0
443;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2014;0;0.0
444;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2015;0;0.0
445;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2016;0;0.0
446;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2017;0;0.0
447;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2018;0;0.0
448;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2019;0;0.0
449;Total male and female;10000;Total background and generation;A07F Antidiarrheal microorganisms;2020;0;0.0
450;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2006;10;0.0
451;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2007;5;0.0
452;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2008;0;0.0
453;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2009;0;0.0
454;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2010;0;0.0
455;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2011;0;0.0
456;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2012;0;0.0
457;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2013;0;0.0
458;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2014;0;0.0
459;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2015;0;0.0
460;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2016;0;0.0
461;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2017;0;0.0
462;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2018;10;0.0
463;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2019;0;0.0
464;Total male and female;10000;Total background and generation;A07X Other antidiarrheals;2020;0;0.0
465;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2006;565;0.0
466;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2007;550;0.0
467;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2008;120;0.0
468;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2009;30;0.0
469;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2010;5;0.0
470;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2011;5;0.0
471;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2012;0;0.0
472;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2013;5;0.0
473;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2014;0;0.0
474;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2015;0;0.0
475;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2016;0;0.0
476;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2017;0;0.0
477;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2018;0;0.0
478;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2019;0;0.0
479;Total male and female;10000;Total background and generation;A08 Antiobesity prep. excl.diet products;2020;0;0.0
480;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2006;565;0.0
481;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2007;550;0.0
482;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2008;120;0.0
483;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2009;30;0.0
484;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2010;5;0.0
485;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2011;5;0.0
486;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2012;0;0.0
487;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2013;5;0.0
488;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2014;0;0.0
489;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2015;0;0.0
490;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2016;0;0.0
491;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2017;0;0.0
492;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2018;0;0.0
493;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2019;0;0.0
494;Total male and female;10000;Total background and generation;A08A Antiobesity prep.excl.diet products;2020;0;0.0
495;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2006;11705;0.07
496;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2007;11320;0.07
497;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2008;11180;0.07
498;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2009;11560;0.07
499;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2010;11780;0.07
500;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2011;12215;0.07
501;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2012;12915;0.08
502;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2013;14590;0.09
503;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2014;14045;0.08
504;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2015;14305;0.08
505;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2016;14935;0.09
506;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2017;15535;0.09
507;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2018;16365;0.09
508;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2019;17750;0.1
509;Total male and female;10000;Total background and generation;A09 Digestives, incl. enzymes;2020;18800;0.11
510;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2006;11705;0.07
511;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2007;11320;0.07
512;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2008;11180;0.07
513;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2009;11560;0.07
514;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2010;11780;0.07
515;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2011;12215;0.07
516;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2012;12915;0.08
517;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2013;14590;0.09
518;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2014;14045;0.08
519;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2015;14305;0.08
520;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2016;14935;0.09
521;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2017;15535;0.09
522;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2018;16365;0.09
523;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2019;17750;0.1
524;Total male and female;10000;Total background and generation;A09A Digestives, incl. enzymes;2020;18800;0.11
525;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2006;625695;3.76
526;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2007;651420;3.9
527;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2008;680020;4.06
528;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2009;712045;4.23
529;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2010;741685;4.38
530;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2011;765455;4.5
531;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2012;783065;4.59
532;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2013;794060;4.64
533;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2014;800765;4.66
534;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2015;806615;4.67
535;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2016;811955;4.67
536;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2017;816485;4.67
537;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2018;820640;4.66
538;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2019;824250;4.65
539;Total male and female;10000;Total background and generation;A10 Drugs used in diabetes;2020;827950;4.65
540;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2006;211745;1.27
541;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2007;222290;1.33
542;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2008;234505;1.4
543;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2009;244970;1.45
544;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2010;252920;1.49
545;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2011;259140;1.52
546;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2012;264535;1.55
547;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2013;269640;1.57
548;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2014;274600;1.6
549;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2015;278790;1.61
550;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2016;281715;1.62
551;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2017;284120;1.62
552;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2018;284150;1.61
553;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2019;283655;1.6
554;Total male and female;10000;Total background and generation;A10A Insulins and analogues;2020;283080;1.59
555;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2006;512555;3.08
556;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2007;537960;3.22
557;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2008;565225;3.37
558;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2009;599375;3.56
559;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2010;630600;3.72
560;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2011;654615;3.85
561;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2012;671660;3.93
562;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2013;682080;3.98
563;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2014;688240;4.0
564;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2015;693860;4.01
565;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2016;699425;4.02
566;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2017;704570;4.03
567;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2018;709685;4.03
568;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2019;715035;4.03
569;Total male and female;10000;Total background and generation;A10B Blood glucose lowering drugs, excl.;2020;718965;4.04
570;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2006;0;0.0
571;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2007;0;0.0
572;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2008;0;0.0
573;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2009;0;0.0
574;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2010;0;0.0
575;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2011;0;0.0
576;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2012;0;0.0
577;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2013;0;0.0
578;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2014;0;0.0
579;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2015;0;0.0
580;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2016;0;0.0
581;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2017;0;0.0
582;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2018;0;0.0
583;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2019;0;0.0
584;Total male and female;10000;Total background and generation;A10X Other drugs used in diabetes;2020;0;0.0
585;Total male and female;10000;Total background and generation;A11 Vitamins;2006;38285;0.23
586;Total male and female;10000;Total background and generation;A11 Vitamins;2007;42235;0.25
587;Total male and female;10000;Total background and generation;A11 Vitamins;2008;49270;0.29
588;Total male and female;10000;Total background and generation;A11 Vitamins;2009;61510;0.37
589;Total male and female;10000;Total background and generation;A11 Vitamins;2010;101740;0.6
590;Total male and female;10000;Total background and generation;A11 Vitamins;2011;174685;1.03
591;Total male and female;10000;Total background and generation;A11 Vitamins;2012;256440;1.5
592;Total male and female;10000;Total background and generation;A11 Vitamins;2013;454525;2.65
593;Total male and female;10000;Total background and generation;A11 Vitamins;2014;655155;3.81
594;Total male and female;10000;Total background and generation;A11 Vitamins;2015;793260;4.59
595;Total male and female;10000;Total background and generation;A11 Vitamins;2016;919340;5.29
596;Total male and female;10000;Total background and generation;A11 Vitamins;2017;1024175;5.86
597;Total male and female;10000;Total background and generation;A11 Vitamins;2018;1117085;6.35
598;Total male and female;10000;Total background and generation;A11 Vitamins;2019;965870;5.45
599;Total male and female;10000;Total background and generation;A11 Vitamins;2020;937365;5.27
600;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2006;0;0.0
601;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2007;0;0.0
602;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2008;0;0.0
603;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2009;0;0.0
604;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2010;0;0.0
605;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2011;0;0.0
606;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2012;10;0.0
607;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2013;0;0.0
608;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2014;5;0.0
609;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2015;5;0.0
610;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2016;0;0.0
611;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2017;0;0.0
612;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2018;0;0.0
613;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2019;0;0.0
614;Total male and female;10000;Total background and generation;A11A Multivitamins, combinations;2020;0;0.0
615;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2006;5;0.0
616;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2007;0;0.0
617;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2008;0;0.0
618;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2009;0;0.0
619;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2010;0;0.0
620;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2011;0;0.0
621;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2012;0;0.0
622;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2013;0;0.0
623;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2014;0;0.0
624;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2015;0;0.0
625;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2016;0;0.0
626;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2017;0;0.0
627;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2018;0;0.0
628;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2019;0;0.0
629;Total male and female;10000;Total background and generation;A11B Multivitamins, plain;2020;0;0.0
630;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2006;34585;0.21
631;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2007;39675;0.24
632;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2008;47355;0.28
633;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2009;60045;0.36
634;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2010;100220;0.59
635;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2011;172955;1.02
636;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2012;254770;1.49
637;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2013;453080;2.64
638;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2014;653745;3.8
639;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2015;792285;4.58
640;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2016;918325;5.28
641;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2017;1023305;5.85
642;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2018;1115980;6.34
643;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2019;964880;5.44
644;Total male and female;10000;Total background and generation;A11C Vit A and D, incl.combin.of the two;2020;936175;5.26
645;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2006;710;0.0
646;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2007;615;0.0
647;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2008;595;0.0
648;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2009;520;0.0
649;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2010;740;0.0
650;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2011;1190;0.01
651;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2012;1300;0.01
652;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2013;1260;0.01
653;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2014;1515;0.01
654;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2015;1115;0.01
655;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2016;1265;0.01
656;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2017;1125;0.01
657;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2018;1530;0.01
658;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2019;1360;0.01
659;Total male and female;10000;Total background and generation;A11D Vitamin B1,and with vit. B6 and B12;2020;1590;0.01
660;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2006;25;0.0
661;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2007;25;0.0
662;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2008;15;0.0
663;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2009;5;0.0
664;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2010;15;0.0
665;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2011;30;0.0
666;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2012;25;0.0
667;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2013;25;0.0
668;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2014;10;0.0
669;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2015;15;0.0
670;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2016;5;0.0
671;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2017;0;0.0
672;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2018;0;0.0
673;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2019;0;0.0
674;Total male and female;10000;Total background and generation;A11E Vitamin B-complex, incl. combinat.;2020;5;0.0
675;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2006;1335;0.01
676;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2007;1110;0.01
677;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2008;830;0.0
678;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2009;625;0.0
679;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2010;500;0.0
680;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2011;395;0.0
681;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2012;285;0.0
682;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2013;145;0.0
683;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2014;95;0.0
684;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2015;100;0.0
685;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2016;70;0.0
686;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2017;70;0.0
687;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2018;60;0.0
688;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2019;50;0.0
689;Total male and female;10000;Total background and generation;A11G Ascorbic acid (vitamin C) + combin.;2020;60;0.0
690;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2006;2120;0.01
691;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2007;1045;0.01
692;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2008;680;0.0
693;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2009;430;0.0
694;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2010;385;0.0
695;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2011;410;0.0
696;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2012;365;0.0
697;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2013;480;0.0
698;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2014;290;0.0
699;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2015;85;0.0
700;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2016;45;0.0
701;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2017;40;0.0
702;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2018;30;0.0
703;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2019;35;0.0
704;Total male and female;10000;Total background and generation;A11H Other plain vitamin preparations;2020;20;0.0
705;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2006;5;0.0
706;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2007;5;0.0
707;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2008;0;0.0
708;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2009;0;0.0
709;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2010;0;0.0
710;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2011;0;0.0
711;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2012;0;0.0
712;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2013;0;0.0
713;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2014;0;0.0
714;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2015;0;0.0
715;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2016;0;0.0
716;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2017;0;0.0
717;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2018;0;0.0
718;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2019;0;0.0
719;Total male and female;10000;Total background and generation;A11J Other vitamin products + combinat.;2020;0;0.0
720;Total male and female;10000;Total background and generation;A12 Mineral supplements;2006;275225;1.65
721;Total male and female;10000;Total background and generation;A12 Mineral supplements;2007;305225;1.83
722;Total male and female;10000;Total background and generation;A12 Mineral supplements;2008;330130;1.97
723;Total male and female;10000;Total background and generation;A12 Mineral supplements;2009;361090;2.14
724;Total male and female;10000;Total background and generation;A12 Mineral supplements;2010;406525;2.4
725;Total male and female;10000;Total background and generation;A12 Mineral supplements;2011;453420;2.66
726;Total male and female;10000;Total background and generation;A12 Mineral supplements;2012;493590;2.89
727;Total male and female;10000;Total background and generation;A12 Mineral supplements;2013;506885;2.96
728;Total male and female;10000;Total background and generation;A12 Mineral supplements;2014;517960;3.01
729;Total male and female;10000;Total background and generation;A12 Mineral supplements;2015;529605;3.06
730;Total male and female;10000;Total background and generation;A12 Mineral supplements;2016;545285;3.14
731;Total male and female;10000;Total background and generation;A12 Mineral supplements;2017;558115;3.19
732;Total male and female;10000;Total background and generation;A12 Mineral supplements;2018;575205;3.27
733;Total male and female;10000;Total background and generation;A12 Mineral supplements;2019;579325;3.27
734;Total male and female;10000;Total background and generation;A12 Mineral supplements;2020;580650;3.26
735;Total male and female;10000;Total background and generation;A12A Calcium;2006;245485;1.47
736;Total male and female;10000;Total background and generation;A12A Calcium;2007;275600;1.65
737;Total male and female;10000;Total background and generation;A12A Calcium;2008;299210;1.79
738;Total male and female;10000;Total background and generation;A12A Calcium;2009;331600;1.97
739;Total male and female;10000;Total background and generation;A12A Calcium;2010;378185;2.23
740;Total male and female;10000;Total background and generation;A12A Calcium;2011;425400;2.5
741;Total male and female;10000;Total background and generation;A12A Calcium;2012;466340;2.73
742;Total male and female;10000;Total background and generation;A12A Calcium;2013;480570;2.81
743;Total male and female;10000;Total background and generation;A12A Calcium;2014;492720;2.86
744;Total male and female;10000;Total background and generation;A12A Calcium;2015;504610;2.92
745;Total male and female;10000;Total background and generation;A12A Calcium;2016;520480;2.99
746;Total male and female;10000;Total background and generation;A12A Calcium;2017;532805;3.05
747;Total male and female;10000;Total background and generation;A12A Calcium;2018;549040;3.12
748;Total male and female;10000;Total background and generation;A12A Calcium;2019;552155;3.12
749;Total male and female;10000;Total background and generation;A12A Calcium;2020;552945;3.11
750;Total male and female;10000;Total background and generation;A12B Potassium;2006;32735;0.2
751;Total male and female;10000;Total background and generation;A12B Potassium;2007;33470;0.2
752;Total male and female;10000;Total background and generation;A12B Potassium;2008;35175;0.21
753;Total male and female;10000;Total background and generation;A12B Potassium;2009;34230;0.2
754;Total male and female;10000;Total background and generation;A12B Potassium;2010;33475;0.2
755;Total male and female;10000;Total background and generation;A12B Potassium;2011;33565;0.2
756;Total male and female;10000;Total background and generation;A12B Potassium;2012;33025;0.19
757;Total male and female;10000;Total background and generation;A12B Potassium;2013;31910;0.19
758;Total male and female;10000;Total background and generation;A12B Potassium;2014;30120;0.18
759;Total male and female;10000;Total background and generation;A12B Potassium;2015;29555;0.17
760;Total male and female;10000;Total background and generation;A12B Potassium;2016;29405;0.17
761;Total male and female;10000;Total background and generation;A12B Potassium;2017;29115;0.17
762;Total male and female;10000;Total background and generation;A12B Potassium;2018;29575;0.17
763;Total male and female;10000;Total background and generation;A12B Potassium;2019;29800;0.17
764;Total male and female;10000;Total background and generation;A12B Potassium;2020;29910;0.17
765;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2006;1480;0.01
766;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2007;985;0.01
767;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2008;1030;0.01
768;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2009;750;0.0
769;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2010;690;0.0
770;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2011;680;0.0
771;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2012;770;0.0
772;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2013;1275;0.01
773;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2014;2010;0.01
774;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2015;2205;0.01
775;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2016;2190;0.01
776;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2017;3235;0.02
777;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2018;4495;0.03
778;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2019;5630;0.03
779;Total male and female;10000;Total background and generation;A12C Other mineral supplements;2020;6635;0.04
780;Total male and female;10000;Total background and generation;A13 Tonics;2006;0;0.0
781;Total male and female;10000;Total background and generation;A13 Tonics;2007;0;0.0
782;Total male and female;10000;Total background and generation;A13 Tonics;2008;0;0.0
783;Total male and female;10000;Total background and generation;A13 Tonics;2009;0;0.0
784;Total male and female;10000;Total background and generation;A13 Tonics;2010;0;0.0
785;Total male and female;10000;Total background and generation;A13 Tonics;2011;0;0.0
786;Total male and female;10000;Total background and generation;A13 Tonics;2012;0;0.0
787;Total male and female;10000;Total background and generation;A13 Tonics;2013;0;0.0
788;Total male and female;10000;Total background and generation;A13 Tonics;2014;0;0.0
789;Total male and female;10000;Total background and generation;A13 Tonics;2015;0;0.0
790;Total male and female;10000;Total background and generation;A13 Tonics;2016;0;0.0
791;Total male and female;10000;Total background and generation;A13 Tonics;2017;0;0.0
792;Total male and female;10000;Total background and generation;A13 Tonics;2018;0;0.0
793;Total male and female;10000;Total background and generation;A13 Tonics;2019;0;0.0
794;Total male and female;10000;Total background and generation;A13 Tonics;2020;0;0.0
795;Total male and female;10000;Total background and generation;A13A Tonics;2006;0;0.0
796;Total male and female;10000;Total background and generation;A13A Tonics;2007;0;0.0
797;Total male and female;10000;Total background and generation;A13A Tonics;2008;0;0.0
798;Total male and female;10000;Total background and generation;A13A Tonics;2009;0;0.0
799;Total male and female;10000;Total background and generation;A13A Tonics;2010;0;0.0
800;Total male and female;10000;Total background and generation;A13A Tonics;2011;0;0.0
801;Total male and female;10000;Total background and generation;A13A Tonics;2012;0;0.0
802;Total male and female;10000;Total background and generation;A13A Tonics;2013;0;0.0
803;Total male and female;10000;Total background and generation;A13A Tonics;2014;0;0.0
804;Total male and female;10000;Total background and generation;A13A Tonics;2015;0;0.0
805;Total male and female;10000;Total background and generation;A13A Tonics;2016;0;0.0
806;Total male and female;10000;Total background and generation;A13A Tonics;2017;0;0.0
807;Total male and female;10000;Total background and generation;A13A Tonics;2018;0;0.0
808;Total male and female;10000;Total background and generation;A13A Tonics;2019;0;0.0
809;Total male and female;10000;Total background and generation;A13A Tonics;2020;0;0.0
810;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2006;895;0.01
811;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2007;740;0.0
812;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2008;600;0.0
813;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2009;550;0.0
814;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2010;530;0.0
815;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2011;470;0.0
816;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2012;415;0.0
817;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2013;415;0.0
818;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2014;570;0.0
819;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2015;515;0.0
820;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2016;500;0.0
821;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2017;450;0.0
822;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2018;420;0.0
823;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2019;445;0.0
824;Total male and female;10000;Total background and generation;A14 Anabolic agents for systemic use;2020;410;0.0
825;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2006;895;0.01
826;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2007;740;0.0
827;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2008;600;0.0
828;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2009;550;0.0
829;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2010;530;0.0
830;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2011;470;0.0
831;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2012;415;0.0
832;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2013;415;0.0
833;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2014;570;0.0
834;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2015;515;0.0
835;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2016;500;0.0
836;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2017;450;0.0
837;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2018;420;0.0
838;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2019;445;0.0
839;Total male and female;10000;Total background and generation;A14A Anabolic steroids;2020;410;0.0
840;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2006;0;0.0
841;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2007;0;0.0
842;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2008;0;0.0
843;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2009;0;0.0
844;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2010;0;0.0
845;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2011;0;0.0
846;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2012;0;0.0
847;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2013;0;0.0
848;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2014;0;0.0
849;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2015;0;0.0
850;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2016;0;0.0
851;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2017;0;0.0
852;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2018;0;0.0
853;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2019;0;0.0
854;Total male and female;10000;Total background and generation;A14B Other anabolic agents;2020;0;0.0
855;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2006;0;0.0
856;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2007;0;0.0
857;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2008;0;0.0
858;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2009;0;0.0
859;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2010;0;0.0
860;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2011;0;0.0
861;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2012;0;0.0
862;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2013;0;0.0
863;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2014;0;0.0
864;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2015;0;0.0
865;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2016;0;0.0
866;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2017;0;0.0
867;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2018;0;0.0
868;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2019;0;0.0
869;Total male and female;10000;Total background and generation;A15 Appetite stimulants;2020;0;0.0
870;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2006;5680;0.03
871;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2007;5715;0.03
872;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2008;5600;0.03
873;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2009;5600;0.03
874;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2010;5755;0.03
875;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2011;5425;0.03
876;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2012;5280;0.03
877;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2013;4315;0.03
878;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2014;3925;0.02
879;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2015;3625;0.02
880;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2016;3475;0.02
881;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2017;3405;0.02
882;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2018;3320;0.02
883;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2019;3240;0.02
884;Total male and female;10000;Total background and generation;A16 Other aliment.tract/metabol.products;2020;3110;0.02
885;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2006;5680;0.03
886;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2007;5715;0.03
887;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2008;5600;0.03
888;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2009;5600;0.03
889;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2010;5755;0.03
890;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2011;5425;0.03
891;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2012;5280;0.03
892;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2013;4315;0.03
893;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2014;3925;0.02
894;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2015;3625;0.02
895;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2016;3475;0.02
896;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2017;3405;0.02
897;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2018;3320;0.02
898;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2019;3240;0.02
899;Total male and female;10000;Total background and generation;A16A Oth.aliment.tract and metabol.prod.;2020;3110;0.02
900;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2006;1731810;10.41
901;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2007;1786335;10.71
902;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2008;1839745;10.98
903;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2009;1899605;11.28
904;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2010;1954135;11.54
905;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2011;2006925;11.79
906;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2012;2039100;11.94
907;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2013;2061135;12.03
908;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2014;2096020;12.19
909;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2015;2132730;12.34
910;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2016;2188625;12.59
911;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2017;2231695;12.76
912;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2018;2274860;12.93
913;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2019;2305335;13.01
914;Total male and female;10000;Total background and generation;B Blood and blood forming organs;2020;2286375;12.85
915;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2006;1376340;8.27
916;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2007;1430535;8.57
917;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2008;1477225;8.81
918;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2009;1529605;9.08
919;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2010;1580995;9.34
920;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2011;1624605;9.55
921;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2012;1658195;9.71
922;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2013;1684335;9.83
923;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2014;1714125;9.97
924;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2015;1741485;10.07
925;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2016;1774235;10.2
926;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2017;1801310;10.3
927;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2018;1828125;10.39
928;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2019;1855590;10.47
929;Total male and female;10000;Total background and generation;B01 Antithrombotic agents;2020;1856665;10.43
930;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2006;1376340;8.27
931;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2007;1430535;8.57
932;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2008;1477225;8.81
933;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2009;1529605;9.08
934;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2010;1580995;9.34
935;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2011;1624605;9.55
936;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2012;1658195;9.71
937;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2013;1684335;9.83
938;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2014;1714125;9.97
939;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2015;1741485;10.07
940;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2016;1774235;10.2
941;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2017;1801310;10.3
942;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2018;1828125;10.39
943;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2019;1855590;10.47
944;Total male and female;10000;Total background and generation;B01A Antithrombotic agents;2020;1856665;10.43
945;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2006;31250;0.19
946;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2007;32965;0.2
947;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2008;33300;0.2
948;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2009;33210;0.2
949;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2010;31045;0.18
950;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2011;31100;0.18
951;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2012;32050;0.19
952;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2013;34265;0.2
953;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2014;42760;0.25
954;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2015;47790;0.28
955;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2016;44290;0.25
956;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2017;43605;0.25
957;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2018;46650;0.27
958;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2019;44235;0.25
959;Total male and female;10000;Total background and generation;B02 Antihemorrhagics;2020;44025;0.25
960;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2006;13545;0.08
961;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2007;14070;0.08
962;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2008;14415;0.09
963;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2009;14895;0.09
964;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2010;15295;0.09
965;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2011;15955;0.09
966;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2012;15935;0.09
967;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2013;16100;0.09
968;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2014;16410;0.1
969;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2015;17200;0.1
970;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2016;18825;0.11
971;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2017;20505;0.12
972;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2018;23550;0.13
973;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2019;25840;0.15
974;Total male and female;10000;Total background and generation;B02A Antifibrinolytics;2020;27905;0.16
975;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2006;17795;0.11
976;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2007;18985;0.11
977;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2008;18990;0.11
978;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2009;18415;0.11
979;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2010;15840;0.09
980;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2011;15230;0.09
981;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2012;16210;0.09
982;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2013;18290;0.11
983;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2014;26480;0.15
984;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2015;30745;0.18
985;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2016;25650;0.15
986;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2017;23340;0.13
987;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2018;23330;0.13
988;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2019;18615;0.11
989;Total male and female;10000;Total background and generation;B02B Vitamin k and other hemostatics;2020;16405;0.09
990;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2006;456275;2.74
991;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2007;461155;2.76
992;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2008;473365;2.82
993;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2009;487445;2.89
994;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2010;492845;2.91
995;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2011;507780;2.98
996;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2012;509125;2.98
997;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2013;505345;2.95
998;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2014;512970;2.98
999;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2015;525735;3.04
1000;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2016;553935;3.19
1001;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2017;572300;3.27
1002;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2018;590555;3.36
1003;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2019;593345;3.35
1004;Total male and female;10000;Total background and generation;B03 Antianemic preparations;2020;568455;3.19
1005;Total male and female;10000;Total background and generation;B03A Iron preparations;2006;276130;1.66
1006;Total male and female;10000;Total background and generation;B03A Iron preparations;2007;273225;1.64
1007;Total male and female;10000;Total background and generation;B03A Iron preparations;2008;276655;1.65
1008;Total male and female;10000;Total background and generation;B03A Iron preparations;2009;277015;1.64
1009;Total male and female;10000;Total background and generation;B03A Iron preparations;2010;272335;1.61
1010;Total male and female;10000;Total background and generation;B03A Iron preparations;2011;274690;1.61
1011;Total male and female;10000;Total background and generation;B03A Iron preparations;2012;263105;1.54
1012;Total male and female;10000;Total background and generation;B03A Iron preparations;2013;251465;1.47
1013;Total male and female;10000;Total background and generation;B03A Iron preparations;2014;245580;1.43
1014;Total male and female;10000;Total background and generation;B03A Iron preparations;2015;248105;1.44
1015;Total male and female;10000;Total background and generation;B03A Iron preparations;2016;257200;1.48
1016;Total male and female;10000;Total background and generation;B03A Iron preparations;2017;269625;1.54
1017;Total male and female;10000;Total background and generation;B03A Iron preparations;2018;282570;1.61
1018;Total male and female;10000;Total background and generation;B03A Iron preparations;2019;292250;1.65
1019;Total male and female;10000;Total background and generation;B03A Iron preparations;2020;282185;1.59
1020;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2006;199675;1.2
1021;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2007;205750;1.23
1022;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2008;214925;1.28
1023;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2009;229835;1.36
1024;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2010;239810;1.42
1025;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2011;252030;1.48
1026;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2012;263850;1.54
1027;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2013;270255;1.58
1028;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2014;284580;1.65
1029;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2015;296445;1.71
1030;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2016;318750;1.83
1031;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2017;325990;1.86
1032;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2018;332115;1.89
1033;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2019;323560;1.83
1034;Total male and female;10000;Total background and generation;B03B Vitamin B12 and folic acid;2020;306495;1.72
1035;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2006;22270;0.13
1036;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2007;24795;0.15
1037;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2008;25065;0.15
1038;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2009;25255;0.15
1039;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2010;24210;0.14
1040;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2011;23730;0.14
1041;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2012;22770;0.13
1042;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2013;21260;0.12
1043;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2014;19670;0.11
1044;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2015;17980;0.1
1045;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2016;16405;0.09
1046;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2017;15535;0.09
1047;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2018;15270;0.09
1048;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2019;15345;0.09
1049;Total male and female;10000;Total background and generation;B03X Other antianemic preparations;2020;14880;0.08
1050;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2006;38760;0.23
1051;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2007;38090;0.23
1052;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2008;36115;0.22
1053;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2009;36350;0.22
1054;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2010;40915;0.24
1055;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2011;41960;0.25
1056;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2012;39730;0.23
1057;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2013;39865;0.23
1058;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2014;39475;0.23
1059;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2015;39280;0.23
1060;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2016;40920;0.24
1061;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2017;42075;0.24
1062;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2018;42595;0.24
1063;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2019;44390;0.25
1064;Total male and female;10000;Total background and generation;B05 Blood substitutes / perfus.solutions;2020;45770;0.26
1065;Total male and female;10000;Total background and generation;B05A Blood and related products;2006;10;0.0
1066;Total male and female;10000;Total background and generation;B05A Blood and related products;2007;15;0.0
1067;Total male and female;10000;Total background and generation;B05A Blood and related products;2008;10;0.0
1068;Total male and female;10000;Total background and generation;B05A Blood and related products;2009;15;0.0
1069;Total male and female;10000;Total background and generation;B05A Blood and related products;2010;15;0.0
1070;Total male and female;10000;Total background and generation;B05A Blood and related products;2011;15;0.0
1071;Total male and female;10000;Total background and generation;B05A Blood and related products;2012;10;0.0
1072;Total male and female;10000;Total background and generation;B05A Blood and related products;2013;10;0.0
1073;Total male and female;10000;Total background and generation;B05A Blood and related products;2014;5;0.0
1074;Total male and female;10000;Total background and generation;B05A Blood and related products;2015;10;0.0
1075;Total male and female;10000;Total background and generation;B05A Blood and related products;2016;10;0.0
1076;Total male and female;10000;Total background and generation;B05A Blood and related products;2017;10;0.0
1077;Total male and female;10000;Total background and generation;B05A Blood and related products;2018;10;0.0
1078;Total male and female;10000;Total background and generation;B05A Blood and related products;2019;10;0.0
1079;Total male and female;10000;Total background and generation;B05A Blood and related products;2020;15;0.0
1080;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2006;31095;0.19
1081;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2007;32830;0.2
1082;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2008;33365;0.2
1083;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2009;34090;0.2
1084;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2010;38525;0.23
1085;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2011;40230;0.24
1086;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2012;39185;0.23
1087;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2013;39315;0.23
1088;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2014;38980;0.23
1089;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2015;39110;0.23
1090;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2016;40760;0.23
1091;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2017;41915;0.24
1092;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2018;41600;0.24
1093;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2019;42935;0.24
1094;Total male and female;10000;Total background and generation;B05B Intravenous solutions;2020;44255;0.25
1095;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2006;8445;0.05
1096;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2007;5810;0.03
1097;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2008;3055;0.02
1098;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2009;2520;0.01
1099;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2010;2665;0.02
1100;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2011;1940;0.01
1101;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2012;580;0.0
1102;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2013;535;0.0
1103;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2014;490;0.0
1104;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2015;105;0.0
1105;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2016;85;0.0
1106;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2017;90;0.0
1107;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2018;65;0.0
1108;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2019;55;0.0
1109;Total male and female;10000;Total background and generation;B05C Irrigating solutions;2020;45;0.0
1110;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2006;5;0.0
1111;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2007;0;0.0
1112;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2008;0;0.0
1113;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2009;0;0.0
1114;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2010;0;0.0
1115;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2011;0;0.0
1116;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2012;0;0.0
1117;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2013;0;0.0
1118;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2014;0;0.0
1119;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2015;0;0.0
1120;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2016;0;0.0
1121;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2017;0;0.0
1122;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2018;0;0.0
1123;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2019;0;0.0
1124;Total male and female;10000;Total background and generation;B05D Peritoneal dialytics;2020;0;0.0
1125;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2006;290;0.0
1126;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2007;250;0.0
1127;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2008;235;0.0
1128;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2009;315;0.0
1129;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2010;365;0.0
1130;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2011;385;0.0
1131;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2012;375;0.0
1132;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2013;450;0.0
1133;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2014;425;0.0
1134;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2015;425;0.0
1135;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2016;455;0.0
1136;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2017;455;0.0
1137;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2018;1600;0.01
1138;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2019;2200;0.01
1139;Total male and female;10000;Total background and generation;B05X Intravenous solution additives;2020;2255;0.01
1140;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2006;0;0.0
1141;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2007;0;0.0
1142;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2008;0;0.0
1143;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2009;0;0.0
1144;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2010;0;0.0
1145;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2011;0;0.0
1146;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2012;0;0.0
1147;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2013;0;0.0
1148;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2014;0;0.0
1149;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2015;0;0.0
1150;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2016;0;0.0
1151;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2017;0;0.0
1152;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2018;0;0.0
1153;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2019;0;0.0
1154;Total male and female;10000;Total background and generation;B05Z Hemodialytics and hemofiltrates;2020;0;0.0
1155;Total male and female;10000;Total background and generation;B06 Other hematological agents;2006;15;0.0
1156;Total male and female;10000;Total background and generation;B06 Other hematological agents;2007;10;0.0
1157;Total male and female;10000;Total background and generation;B06 Other hematological agents;2008;10;0.0
1158;Total male and female;10000;Total background and generation;B06 Other hematological agents;2009;5;0.0
1159;Total male and female;10000;Total background and generation;B06 Other hematological agents;2010;5;0.0
1160;Total male and female;10000;Total background and generation;B06 Other hematological agents;2011;5;0.0
1161;Total male and female;10000;Total background and generation;B06 Other hematological agents;2012;115;0.0
1162;Total male and female;10000;Total background and generation;B06 Other hematological agents;2013;115;0.0
1163;Total male and female;10000;Total background and generation;B06 Other hematological agents;2014;115;0.0
1164;Total male and female;10000;Total background and generation;B06 Other hematological agents;2015;120;0.0
1165;Total male and female;10000;Total background and generation;B06 Other hematological agents;2016;135;0.0
1166;Total male and female;10000;Total background and generation;B06 Other hematological agents;2017;150;0.0
1167;Total male and female;10000;Total background and generation;B06 Other hematological agents;2018;195;0.0
1168;Total male and female;10000;Total background and generation;B06 Other hematological agents;2019;200;0.0
1169;Total male and female;10000;Total background and generation;B06 Other hematological agents;2020;220;0.0
1170;Total male and female;10000;Total background and generation;B06A Other hematological agents;2006;15;0.0
1171;Total male and female;10000;Total background and generation;B06A Other hematological agents;2007;10;0.0
1172;Total male and female;10000;Total background and generation;B06A Other hematological agents;2008;10;0.0
1173;Total male and female;10000;Total background and generation;B06A Other hematological agents;2009;5;0.0
1174;Total male and female;10000;Total background and generation;B06A Other hematological agents;2010;5;0.0
1175;Total male and female;10000;Total background and generation;B06A Other hematological agents;2011;5;0.0
1176;Total male and female;10000;Total background and generation;B06A Other hematological agents;2012;115;0.0
1177;Total male and female;10000;Total background and generation;B06A Other hematological agents;2013;115;0.0
1178;Total male and female;10000;Total background and generation;B06A Other hematological agents;2014;115;0.0
1179;Total male and female;10000;Total background and generation;B06A Other hematological agents;2015;120;0.0
1180;Total male and female;10000;Total background and generation;B06A Other hematological agents;2016;135;0.0
1181;Total male and female;10000;Total background and generation;B06A Other hematological agents;2017;145;0.0
1182;Total male and female;10000;Total background and generation;B06A Other hematological agents;2018;170;0.0
1183;Total male and female;10000;Total background and generation;B06A Other hematological agents;2019;180;0.0
1184;Total male and female;10000;Total background and generation;B06A Other hematological agents;2020;195;0.0
1185;Total male and female;10000;Total background and generation;C Cardiovascular system;2006;3154925;18.96
1186;Total male and female;10000;Total background and generation;C Cardiovascular system;2007;3261710;19.55
1187;Total male and female;10000;Total background and generation;C Cardiovascular system;2008;3362625;20.06
1188;Total male and female;10000;Total background and generation;C Cardiovascular system;2009;3466485;20.58
1189;Total male and female;10000;Total background and generation;C Cardiovascular system;2010;3557850;21.01
1190;Total male and female;10000;Total background and generation;C Cardiovascular system;2011;3649550;21.45
1191;Total male and female;10000;Total background and generation;C Cardiovascular system;2012;3710115;21.72
1192;Total male and female;10000;Total background and generation;C Cardiovascular system;2013;3724925;21.74
1193;Total male and female;10000;Total background and generation;C Cardiovascular system;2014;3680385;21.4
1194;Total male and female;10000;Total background and generation;C Cardiovascular system;2015;3696415;21.38
1195;Total male and female;10000;Total background and generation;C Cardiovascular system;2016;3726205;21.43
1196;Total male and female;10000;Total background and generation;C Cardiovascular system;2017;3759870;21.5
1197;Total male and female;10000;Total background and generation;C Cardiovascular system;2018;3775960;21.46
1198;Total male and female;10000;Total background and generation;C Cardiovascular system;2019;3796785;21.42
1199;Total male and female;10000;Total background and generation;C Cardiovascular system;2020;3770105;21.18
1200;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2006;478875;2.88
1201;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2007;476565;2.86
1202;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2008;470195;2.81
1203;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2009;474350;2.82
1204;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2010;474755;2.8
1205;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2011;482195;2.83
1206;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2012;464780;2.72
1207;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2013;460710;2.69
1208;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2014;455360;2.65
1209;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2015;447930;2.59
1210;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2016;447270;2.57
1211;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2017;451385;2.58
1212;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2018;456045;2.59
1213;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2019;441830;2.49
1214;Total male and female;10000;Total background and generation;C01 Cardiac therapy;2020;438585;2.46
1215;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2006;113240;0.68
1216;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2007;109985;0.66
1217;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2008;107465;0.64
1218;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2009;105230;0.62
1219;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2010;103500;0.61
1220;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2011;101515;0.6
1221;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2012;99570;0.58
1222;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2013;96360;0.56
1223;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2014;93355;0.54
1224;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2015;91345;0.53
1225;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2016;88605;0.51
1226;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2017;86810;0.5
1227;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2018;85540;0.49
1228;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2019;83825;0.47
1229;Total male and female;10000;Total background and generation;C01A Cardiac glycosides;2020;81685;0.46
1230;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2006;66345;0.4
1231;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2007;68535;0.41
1232;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2008;70255;0.42
1233;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2009;71720;0.43
1234;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2010;73155;0.43
1235;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2011;74010;0.43
1236;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2012;74160;0.43
1237;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2013;73685;0.43
1238;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2014;73965;0.43
1239;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2015;74145;0.43
1240;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2016;73230;0.42
1241;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2017;72815;0.42
1242;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2018;72065;0.41
1243;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2019;71275;0.4
1244;Total male and female;10000;Total background and generation;C01B Antiarrhythmics, class I and III;2020;69585;0.39
1245;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2006;20725;0.12
1246;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2007;23280;0.14
1247;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2008;26035;0.16
1248;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2009;30495;0.18
1249;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2010;28890;0.17
1250;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2011;36505;0.21
1251;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2012;34155;0.2
1252;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2013;37430;0.22
1253;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2014;38180;0.22
1254;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2015;42495;0.25
1255;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2016;41790;0.24
1256;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2017;49290;0.28
1257;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2018;52605;0.3
1258;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2019;53345;0.3
1259;Total male and female;10000;Total background and generation;C01C Cardiac stimulants excl. glycosides;2020;52795;0.3
1260;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2006;321885;1.93
1261;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2007;316050;1.89
1262;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2008;305110;1.82
1263;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2009;303845;1.8
1264;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2010;304310;1.8
1265;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2011;303470;1.78
1266;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2012;287085;1.68
1267;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2013;281310;1.64
1268;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2014;275345;1.6
1269;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2015;262995;1.52
1270;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2016;264600;1.52
1271;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2017;262150;1.5
1272;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2018;264445;1.5
1273;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2019;250030;1.41
1274;Total male and female;10000;Total background and generation;C01D Vasodilators used in card. diseases;2020;249605;1.4
1275;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2006;135;0.0
1276;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2007;485;0.0
1277;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2008;1750;0.01
1278;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2009;2770;0.02
1279;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2010;4495;0.03
1280;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2011;6010;0.04
1281;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2012;6950;0.04
1282;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2013;7710;0.04
1283;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2014;8910;0.05
1284;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2015;9370;0.05
1285;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2016;10080;0.06
1286;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2017;10420;0.06
1287;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2018;10935;0.06
1288;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2019;11265;0.06
1289;Total male and female;10000;Total background and generation;C01E Other cardiac preparations;2020;11935;0.07
1290;Total male and female;10000;Total background and generation;C02 Antihypertensives;2006;58535;0.35
1291;Total male and female;10000;Total background and generation;C02 Antihypertensives;2007;59690;0.36
1292;Total male and female;10000;Total background and generation;C02 Antihypertensives;2008;59490;0.35
1293;Total male and female;10000;Total background and generation;C02 Antihypertensives;2009;59360;0.35
1294;Total male and female;10000;Total background and generation;C02 Antihypertensives;2010;59730;0.35
1295;Total male and female;10000;Total background and generation;C02 Antihypertensives;2011;60000;0.35
1296;Total male and female;10000;Total background and generation;C02 Antihypertensives;2012;60105;0.35
1297;Total male and female;10000;Total background and generation;C02 Antihypertensives;2013;58330;0.34
1298;Total male and female;10000;Total background and generation;C02 Antihypertensives;2014;57315;0.33
1299;Total male and female;10000;Total background and generation;C02 Antihypertensives;2015;56330;0.33
1300;Total male and female;10000;Total background and generation;C02 Antihypertensives;2016;56015;0.32
1301;Total male and female;10000;Total background and generation;C02 Antihypertensives;2017;55830;0.32
1302;Total male and female;10000;Total background and generation;C02 Antihypertensives;2018;55360;0.31
1303;Total male and female;10000;Total background and generation;C02 Antihypertensives;2019;57025;0.32
1304;Total male and female;10000;Total background and generation;C02 Antihypertensives;2020;56590;0.32
1305;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2006;13710;0.08
1306;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2007;13640;0.08
1307;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2008;13735;0.08
1308;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2009;13640;0.08
1309;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2010;13415;0.08
1310;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2011;12970;0.08
1311;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2012;12295;0.07
1312;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2013;11265;0.07
1313;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2014;10780;0.06
1314;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2015;9970;0.06
1315;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2016;9910;0.06
1316;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2017;9730;0.06
1317;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2018;9795;0.06
1318;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2019;10555;0.06
1319;Total male and female;10000;Total background and generation;C02A Antiadren.agents, centrally acting;2020;10755;0.06
1320;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2006;0;0.0
1321;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2007;0;0.0
1322;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2008;0;0.0
1323;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2009;0;0.0
1324;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2010;0;0.0
1325;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2011;0;0.0
1326;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2012;0;0.0
1327;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2013;0;0.0
1328;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2014;0;0.0
1329;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2015;0;0.0
1330;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2016;0;0.0
1331;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2017;0;0.0
1332;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2018;0;0.0
1333;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2019;0;0.0
1334;Total male and female;10000;Total background and generation;C02B Antiadren.agents, ganglion-blocking;2020;0;0.0
1335;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2006;39580;0.24
1336;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2007;40885;0.25
1337;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2008;40625;0.24
1338;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2009;40800;0.24
1339;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2010;41410;0.24
1340;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2011;42455;0.25
1341;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2012;43540;0.25
1342;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2013;43015;0.25
1343;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2014;42615;0.25
1344;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2015;42575;0.25
1345;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2016;42415;0.24
1346;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2017;42465;0.24
1347;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2018;42190;0.24
1348;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2019;43360;0.24
1349;Total male and female;10000;Total background and generation;C02C Antiadren.agents, peripher. acting;2020;42830;0.24
1350;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2006;1370;0.01
1351;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2007;1365;0.01
1352;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2008;1370;0.01
1353;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2009;1370;0.01
1354;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2010;1405;0.01
1355;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2011;1405;0.01
1356;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2012;1290;0.01
1357;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2013;1365;0.01
1358;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2014;1435;0.01
1359;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2015;1420;0.01
1360;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2016;1420;0.01
1361;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2017;1385;0.01
1362;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2018;1310;0.01
1363;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2019;1030;0.01
1364;Total male and female;10000;Total background and generation;C02D Arteriolar smooth muscle agents;2020;1010;0.01
1365;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2006;4985;0.03
1366;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2007;4865;0.03
1367;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2008;4770;0.03
1368;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2009;4515;0.03
1369;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2010;4440;0.03
1370;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2011;4165;0.02
1371;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2012;3935;0.02
1372;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2013;3605;0.02
1373;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2014;3425;0.02
1374;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2015;3280;0.02
1375;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2016;3145;0.02
1376;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2017;3065;0.02
1377;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2018;2910;0.02
1378;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2019;2865;0.02
1379;Total male and female;10000;Total background and generation;C02K Other antihypertensives;2020;2780;0.02
1380;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2006;0;0.0
1381;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2007;0;0.0
1382;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2008;0;0.0
1383;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2009;0;0.0
1384;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2010;0;0.0
1385;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2011;0;0.0
1386;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2012;0;0.0
1387;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2013;0;0.0
1388;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2014;0;0.0
1389;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2015;0;0.0
1390;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2016;0;0.0
1391;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2017;0;0.0
1392;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2018;0;0.0
1393;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2019;0;0.0
1394;Total male and female;10000;Total background and generation;C02L Antihypertensives/diuretics combin.;2020;0;0.0
1395;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2006;0;0.0
1396;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2007;0;0.0
1397;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2008;0;0.0
1398;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2009;0;0.0
1399;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2010;0;0.0
1400;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2011;0;0.0
1401;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2012;0;0.0
1402;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2013;0;0.0
1403;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2014;0;0.0
1404;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2015;0;0.0
1405;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2016;0;0.0
1406;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2017;0;0.0
1407;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2018;0;0.0
1408;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2019;0;0.0
1409;Total male and female;10000;Total background and generation;C02N Combinations of antihypertensives..;2020;0;0.0
1410;Total male and female;10000;Total background and generation;C03 Diuretics;2006;1042225;6.26
1411;Total male and female;10000;Total background and generation;C03 Diuretics;2007;1057160;6.34
1412;Total male and female;10000;Total background and generation;C03 Diuretics;2008;1089175;6.5
1413;Total male and female;10000;Total background and generation;C03 Diuretics;2009;1112475;6.61
1414;Total male and female;10000;Total background and generation;C03 Diuretics;2010;1139310;6.73
1415;Total male and female;10000;Total background and generation;C03 Diuretics;2011;1157105;6.8
1416;Total male and female;10000;Total background and generation;C03 Diuretics;2012;1165710;6.83
1417;Total male and female;10000;Total background and generation;C03 Diuretics;2013;1151600;6.72
1418;Total male and female;10000;Total background and generation;C03 Diuretics;2014;1148145;6.68
1419;Total male and female;10000;Total background and generation;C03 Diuretics;2015;1144110;6.62
1420;Total male and female;10000;Total background and generation;C03 Diuretics;2016;1142335;6.57
1421;Total male and female;10000;Total background and generation;C03 Diuretics;2017;1135545;6.49
1422;Total male and female;10000;Total background and generation;C03 Diuretics;2018;1149975;6.53
1423;Total male and female;10000;Total background and generation;C03 Diuretics;2019;1165955;6.58
1424;Total male and female;10000;Total background and generation;C03 Diuretics;2020;1100280;6.18
1425;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2006;422545;2.54
1426;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2007;457705;2.74
1427;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2008;500455;2.99
1428;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2009;535325;3.18
1429;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2010;567705;3.35
1430;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2011;593255;3.49
1431;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2012;611345;3.58
1432;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2013;611625;3.57
1433;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2014;617555;3.59
1434;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2015;620585;3.59
1435;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2016;627490;3.61
1436;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2017;647455;3.7
1437;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2018;657700;3.74
1438;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2019;671860;3.79
1439;Total male and female;10000;Total background and generation;C03A Low-ceiling diuretics, thiazides;2020;611665;3.44
1440;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2006;100355;0.6
1441;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2007;92870;0.56
1442;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2008;86440;0.52
1443;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2009;80310;0.48
1444;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2010;81835;0.48
1445;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2011;81895;0.48
1446;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2012;80275;0.47
1447;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2013;77905;0.45
1448;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2014;77165;0.45
1449;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2015;75165;0.43
1450;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2016;72855;0.42
1451;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2017;70655;0.4
1452;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2018;71380;0.41
1453;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2019;74460;0.42
1454;Total male and female;10000;Total background and generation;C03B Low-ceiling diuret.,excl. thiazides;2020;69605;0.39
1455;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2006;409335;2.46
1456;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2007;403560;2.42
1457;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2008;408200;2.44
1458;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2009;410235;2.44
1459;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2010;411040;2.43
1460;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2011;407775;2.4
1461;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2012;402960;2.36
1462;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2013;393895;2.3
1463;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2014;390145;2.27
1464;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2015;386355;2.24
1465;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2016;381175;2.19
1466;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2017;375330;2.15
1467;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2018;371785;2.11
1468;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2019;366285;2.07
1469;Total male and female;10000;Total background and generation;C03C High-ceiling diuretics;2020;358805;2.02
1470;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2006;119240;0.72
1471;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2007;122310;0.73
1472;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2008;125470;0.75
1473;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2009;127945;0.76
1474;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2010;131005;0.77
1475;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2011;134420;0.79
1476;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2012;137735;0.81
1477;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2013;141265;0.82
1478;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2014;150410;0.87
1479;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2015;154440;0.89
1480;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2016;158860;0.91
1481;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2017;180710;1.03
1482;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2018;173840;0.99
1483;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2019;175270;0.99
1484;Total male and female;10000;Total background and generation;C03D Potassium-sparing agents;2020;180235;1.01
1485;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2006;141440;0.85
1486;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2007;130125;0.78
1487;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2008;120265;0.72
1488;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2009;110115;0.65
1489;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2010;100345;0.59
1490;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2011;91275;0.54
1491;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2012;83465;0.49
1492;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2013;75425;0.44
1493;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2014;67580;0.39
1494;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2015;59305;0.34
1495;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2016;53710;0.31
1496;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2017;47405;0.27
1497;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2018;41160;0.23
1498;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2019;36400;0.21
1499;Total male and female;10000;Total background and generation;C03E Diuretics/potassium-sparing agents;2020;32380;0.18
1500;Total male and female;10000;Total background and generation;C03X Other diuretics;2006;0;0.0
1501;Total male and female;10000;Total background and generation;C03X Other diuretics;2007;0;0.0
1502;Total male and female;10000;Total background and generation;C03X Other diuretics;2008;0;0.0
1503;Total male and female;10000;Total background and generation;C03X Other diuretics;2009;0;0.0
1504;Total male and female;10000;Total background and generation;C03X Other diuretics;2010;0;0.0
1505;Total male and female;10000;Total background and generation;C03X Other diuretics;2011;0;0.0
1506;Total male and female;10000;Total background and generation;C03X Other diuretics;2012;0;0.0
1507;Total male and female;10000;Total background and generation;C03X Other diuretics;2013;0;0.0
1508;Total male and female;10000;Total background and generation;C03X Other diuretics;2014;0;0.0
1509;Total male and female;10000;Total background and generation;C03X Other diuretics;2015;0;0.0
1510;Total male and female;10000;Total background and generation;C03X Other diuretics;2016;0;0.0
1511;Total male and female;10000;Total background and generation;C03X Other diuretics;2017;0;0.0
1512;Total male and female;10000;Total background and generation;C03X Other diuretics;2018;0;0.0
1513;Total male and female;10000;Total background and generation;C03X Other diuretics;2019;170;0.0
1514;Total male and female;10000;Total background and generation;C03X Other diuretics;2020;175;0.0
1515;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2006;5460;0.03
1516;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2007;4690;0.03
1517;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2008;4120;0.02
1518;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2009;3585;0.02
1519;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2010;3315;0.02
1520;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2011;2940;0.02
1521;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2012;2100;0.01
1522;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2013;1835;0.01
1523;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2014;1555;0.01
1524;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2015;1365;0.01
1525;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2016;1635;0.01
1526;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2017;1700;0.01
1527;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2018;1445;0.01
1528;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2019;1380;0.01
1529;Total male and female;10000;Total background and generation;C04 Peripheral vasodilators;2020;1255;0.01
1530;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2006;5460;0.03
1531;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2007;4690;0.03
1532;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2008;4120;0.02
1533;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2009;3585;0.02
1534;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2010;3315;0.02
1535;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2011;2940;0.02
1536;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2012;2100;0.01
1537;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2013;1835;0.01
1538;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2014;1555;0.01
1539;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2015;1365;0.01
1540;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2016;1635;0.01
1541;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2017;1700;0.01
1542;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2018;1445;0.01
1543;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2019;1380;0.01
1544;Total male and female;10000;Total background and generation;C04A Peripheral vasodilators;2020;1255;0.01
1545;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2006;141060;0.85
1546;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2007;152580;0.91
1547;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2008;179425;1.07
1548;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2009;185845;1.1
1549;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2010;191330;1.13
1550;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2011;198285;1.17
1551;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2012;195750;1.15
1552;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2013;185010;1.08
1553;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2014;77920;0.45
1554;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2015;56020;0.32
1555;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2016;53015;0.3
1556;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2017;52420;0.3
1557;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2018;51010;0.29
1558;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2019;53355;0.3
1559;Total male and female;10000;Total background and generation;C05 Vasoprotectives;2020;48680;0.27
1560;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2006;140520;0.84
1561;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2007;152240;0.91
1562;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2008;179365;1.07
1563;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2009;185805;1.1
1564;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2010;191295;1.13
1565;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2011;198230;1.16
1566;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2012;195745;1.15
1567;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2013;184980;1.08
1568;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2014;77910;0.45
1569;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2015;56020;0.32
1570;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2016;53010;0.3
1571;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2017;52420;0.3
1572;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2018;51010;0.29
1573;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2019;53355;0.3
1574;Total male and female;10000;Total background and generation;C05A Topic agents hemorrh./anal fissures;2020;48680;0.27
1575;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2006;405;0.0
1576;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2007;240;0.0
1577;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2008;45;0.0
1578;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2009;30;0.0
1579;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2010;35;0.0
1580;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2011;45;0.0
1581;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2012;5;0.0
1582;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2013;20;0.0
1583;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2014;5;0.0
1584;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2015;0;0.0
1585;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2016;0;0.0
1586;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2017;0;0.0
1587;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2018;0;0.0
1588;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2019;0;0.0
1589;Total male and female;10000;Total background and generation;C05B Antivaricose therapy;2020;0;0.0
1590;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2006;180;0.0
1591;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2007;125;0.0
1592;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2008;20;0.0
1593;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2009;15;0.0
1594;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2010;5;0.0
1595;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2011;10;0.0
1596;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2012;5;0.0
1597;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2013;10;0.0
1598;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2014;5;0.0
1599;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2015;0;0.0
1600;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2016;0;0.0
1601;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2017;0;0.0
1602;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2018;0;0.0
1603;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2019;0;0.0
1604;Total male and female;10000;Total background and generation;C05C Capillary stabilizing agents;2020;0;0.0
1605;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2006;1433880;8.62
1606;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2007;1492440;8.95
1607;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2008;1545520;9.22
1608;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2009;1596715;9.48
1609;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2010;1638410;9.68
1610;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2011;1673040;9.83
1611;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2012;1678670;9.83
1612;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2013;1661600;9.7
1613;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2014;1649925;9.59
1614;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2015;1635795;9.46
1615;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2016;1625885;9.35
1616;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2017;1615525;9.24
1617;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2018;1598470;9.08
1618;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2019;1586535;8.95
1619;Total male and female;10000;Total background and generation;C07 Beta blocking agents;2020;1553230;8.73
1620;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2006;1371010;8.24
1621;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2007;1430525;8.57
1622;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2008;1483930;8.85
1623;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2009;1535540;9.12
1624;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2010;1578745;9.32
1625;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2011;1615415;9.49
1626;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2012;1623850;9.51
1627;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2013;1610535;9.4
1628;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2014;1602655;9.32
1629;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2015;1592275;9.21
1630;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2016;1585855;9.12
1631;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2017;1578655;9.03
1632;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2018;1564845;8.89
1633;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2019;1556885;8.78
1634;Total male and female;10000;Total background and generation;C07A Beta blocking agents;2020;1528410;8.59
1635;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2006;39305;0.24
1636;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2007;42280;0.25
1637;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2008;42210;0.25
1638;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2009;43585;0.26
1639;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2010;44120;0.26
1640;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2011;43850;0.26
1641;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2012;42330;0.25
1642;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2013;39595;0.23
1643;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2014;37180;0.22
1644;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2015;34995;0.2
1645;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2016;32800;0.19
1646;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2017;30615;0.18
1647;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2018;28380;0.16
1648;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2019;25920;0.15
1649;Total male and female;10000;Total background and generation;C07B Beta blocking agents and thiazides;2020;23200;0.13
1650;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2006;39430;0.24
1651;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2007;35835;0.21
1652;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2008;32555;0.19
1653;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2009;29430;0.17
1654;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2010;26490;0.16
1655;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2011;23705;0.14
1656;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2012;21060;0.12
1657;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2013;18835;0.11
1658;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2014;16615;0.1
1659;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2015;14770;0.09
1660;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2016;13150;0.08
1661;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2017;11615;0.07
1662;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2018;10215;0.06
1663;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2019;8995;0.05
1664;Total male and female;10000;Total background and generation;C07C Beta block.agents / other diuretics;2020;7810;0.04
1665;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2006;0;0.0
1666;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2007;0;0.0
1667;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2008;0;0.0
1668;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2009;0;0.0
1669;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2010;0;0.0
1670;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2011;0;0.0
1671;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2012;0;0.0
1672;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2013;0;0.0
1673;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2014;0;0.0
1674;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2015;0;0.0
1675;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2016;0;0.0
1676;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2017;0;0.0
1677;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2018;0;0.0
1678;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2019;0;0.0
1679;Total male and female;10000;Total background and generation;C07D Beta block./thiazides/other diuret.;2020;0;0.0
1680;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2006;0;0.0
1681;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2007;0;0.0
1682;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2008;0;0.0
1683;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2009;0;0.0
1684;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2010;0;0.0
1685;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2011;0;0.0
1686;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2012;0;0.0
1687;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2013;0;0.0
1688;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2014;0;0.0
1689;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2015;0;0.0
1690;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2016;0;0.0
1691;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2017;0;0.0
1692;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2018;0;0.0
1693;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2019;0;0.0
1694;Total male and female;10000;Total background and generation;C07E Beta blocking agents / vasodilators;2020;0;0.0
1695;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2006;0;0.0
1696;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2007;0;0.0
1697;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2008;0;0.0
1698;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2009;0;0.0
1699;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2010;0;0.0
1700;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2011;0;0.0
1701;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2012;0;0.0
1702;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2013;0;0.0
1703;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2014;0;0.0
1704;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2015;0;0.0
1705;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2016;0;0.0
1706;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2017;0;0.0
1707;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2018;0;0.0
1708;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2019;0;0.0
1709;Total male and female;10000;Total background and generation;C07F Beta block./other antihypertensives;2020;0;0.0
1710;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2006;611675;3.68
1711;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2007;635475;3.81
1712;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2008;661820;3.95
1713;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2009;689645;4.1
1714;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2010;717025;4.24
1715;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2011;744680;4.38
1716;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2012;782795;4.58
1717;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2013;808050;4.72
1718;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2014;834545;4.85
1719;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2015;865470;5.01
1720;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2016;898795;5.17
1721;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2017;929725;5.32
1722;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2018;960680;5.46
1723;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2019;1008015;5.69
1724;Total male and female;10000;Total background and generation;C08 Calcium channel blockers;2020;1033555;5.81
1725;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2006;484390;2.91
1726;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2007;512680;3.07
1727;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2008;542765;3.24
1728;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2009;573810;3.41
1729;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2010;603555;3.56
1730;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2011;634160;3.73
1731;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2012;674740;3.95
1732;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2013;702950;4.1
1733;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2014;730810;4.25
1734;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2015;762420;4.41
1735;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2016;796165;4.58
1736;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2017;827585;4.73
1737;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2018;858305;4.88
1738;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2019;904605;5.1
1739;Total male and female;10000;Total background and generation;C08C Sel.calcium ch.block.mnly.vascular;2020;930125;5.23
1740;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2006;134555;0.81
1741;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2007;129675;0.78
1742;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2008;125945;0.75
1743;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2009;122730;0.73
1744;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2010;120120;0.71
1745;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2011;117235;0.69
1746;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2012;114670;0.67
1747;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2013;111730;0.65
1748;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2014;110330;0.64
1749;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2015;109555;0.63
1750;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2016;109375;0.63
1751;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2017;108750;0.62
1752;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2018;109515;0.62
1753;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2019;111145;0.63
1754;Total male and female;10000;Total background and generation;C08D Sel.calcium ch.block.direct cardiac;2020;111640;0.63
1755;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2006;0;0.0
1756;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2007;0;0.0
1757;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2008;0;0.0
1758;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2009;0;0.0
1759;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2010;0;0.0
1760;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2011;0;0.0
1761;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2012;0;0.0
1762;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2013;0;0.0
1763;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2014;0;0.0
1764;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2015;0;0.0
1765;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2016;0;0.0
1766;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2017;0;0.0
1767;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2018;0;0.0
1768;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2019;0;0.0
1769;Total male and female;10000;Total background and generation;C08E Non-sel. calcium channel blockers;2020;0;0.0
1770;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2006;0;0.0
1771;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2007;0;0.0
1772;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2008;0;0.0
1773;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2009;0;0.0
1774;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2010;0;0.0
1775;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2011;0;0.0
1776;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2012;0;0.0
1777;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2013;0;0.0
1778;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2014;115;0.0
1779;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2015;270;0.0
1780;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2016;375;0.0
1781;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2017;455;0.0
1782;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2018;515;0.0
1783;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2019;630;0.0
1784;Total male and female;10000;Total background and generation;C08G Calcium channel blockers/diuretics;2020;595;0.0
1785;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2006;1432340;8.61
1786;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2007;1538660;9.22
1787;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2008;1633705;9.75
1788;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2009;1717925;10.2
1789;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2010;1792645;10.59
1790;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2011;1863265;10.95
1791;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2012;1919840;11.24
1792;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2013;1940795;11.33
1793;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2014;1961380;11.4
1794;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2015;1978690;11.45
1795;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2016;1995845;11.48
1796;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2017;2008275;11.48
1797;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2018;2015715;11.45
1798;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2019;2026740;11.44
1799;Total male and female;10000;Total background and generation;C09 Agents on renin-angiotensin system;2020;2019220;11.34
1800;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2006;766275;4.6
1801;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2007;800770;4.8
1802;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2008;833810;4.97
1803;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2009;859580;5.1
1804;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2010;888275;5.25
1805;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2011;917470;5.39
1806;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2012;947170;5.55
1807;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2013;958655;5.6
1808;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2014;976690;5.68
1809;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2015;993230;5.75
1810;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2016;1007905;5.8
1811;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2017;1019265;5.83
1812;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2018;1036405;5.89
1813;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2019;1064900;6.01
1814;Total male and female;10000;Total background and generation;C09A Ace inhibitors, plain;2020;1061490;5.96
1815;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2006;134500;0.81
1816;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2007;143140;0.86
1817;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2008;150615;0.9
1818;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2009;155065;0.92
1819;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2010;157890;0.93
1820;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2011;159855;0.94
1821;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2012;160040;0.94
1822;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2013;155385;0.91
1823;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2014;152655;0.89
1824;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2015;148550;0.86
1825;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2016;143620;0.83
1826;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2017;139285;0.8
1827;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2018;133845;0.76
1828;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2019;127265;0.72
1829;Total male and female;10000;Total background and generation;C09B Ace inhibitors, combinations;2020;114235;0.64
1830;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2006;482300;2.9
1831;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2007;520285;3.12
1832;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2008;553875;3.3
1833;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2009;579250;3.44
1834;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2010;599380;3.54
1835;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2011;620110;3.64
1836;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2012;637325;3.73
1837;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2013;643245;3.75
1838;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2014;649905;3.78
1839;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2015;653825;3.78
1840;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2016;662175;3.81
1841;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2017;671600;3.84
1842;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2018;701280;3.98
1843;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2019;743190;4.19
1844;Total male and female;10000;Total background and generation;C09C Angiotensin II antagonists, plain;2020;711740;4.0
1845;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2006;205290;1.23
1846;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2007;236950;1.42
1847;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2008;264170;1.58
1848;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2009;286440;1.7
1849;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2010;302800;1.79
1850;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2011;315080;1.85
1851;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2012;320135;1.87
1852;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2013;311805;1.82
1853;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2014;306430;1.78
1854;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2015;297215;1.72
1855;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2016;289155;1.66
1856;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2017;284325;1.63
1857;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2018;278955;1.59
1858;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2019;247490;1.4
1859;Total male and female;10000;Total background and generation;C09D Angiotensin II antagonists, combin.;2020;229425;1.29
1860;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2006;0;0.0
1861;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2007;0;0.0
1862;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2008;2290;0.01
1863;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2009;7655;0.05
1864;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2010;13590;0.08
1865;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2011;18355;0.11
1866;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2012;16360;0.1
1867;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2013;13090;0.08
1868;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2014;11275;0.07
1869;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2015;10080;0.06
1870;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2016;9155;0.05
1871;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2017;8335;0.05
1872;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2018;7655;0.04
1873;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2019;7065;0.04
1874;Total male and female;10000;Total background and generation;C09X Other renin angiotensin syst.agents;2020;6445;0.04
1875;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2006;1352985;8.13
1876;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2007;1450735;8.7
1877;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2008;1487545;8.87
1878;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2009;1572380;9.34
1879;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2010;1654385;9.77
1880;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2011;1739625;10.22
1881;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2012;1825630;10.69
1882;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2013;1872765;10.93
1883;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2014;1920855;11.17
1884;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2015;1960520;11.34
1885;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2016;1999520;11.5
1886;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2017;2039865;11.66
1887;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2018;2059870;11.7
1888;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2019;2065775;11.66
1889;Total male and female;10000;Total background and generation;C10 Lipid modifying agents;2020;2033600;11.43
1890;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2006;1341815;8.06
1891;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2007;1429880;8.57
1892;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2008;1458740;8.7
1893;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2009;1541270;9.15
1894;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2010;1620610;9.57
1895;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2011;1703840;10.01
1896;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2012;1787850;10.47
1897;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2013;1834705;10.71
1898;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2014;1884300;10.96
1899;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2015;1925870;11.14
1900;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2016;1965355;11.3
1901;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2017;2007920;11.48
1902;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2018;2028325;11.53
1903;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2019;2036560;11.49
1904;Total male and female;10000;Total background and generation;C10A Lipid modifying agents, plain;2020;2009085;11.29
1905;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2006;22850;0.14
1906;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2007;35695;0.21
1907;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2008;39285;0.23
1908;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2009;39575;0.23
1909;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2010;41345;0.24
1910;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2011;43580;0.26
1911;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2012;45930;0.27
1912;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2013;46005;0.27
1913;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2014;43780;0.25
1914;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2015;41735;0.24
1915;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2016;41740;0.24
1916;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2017;42600;0.24
1917;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2018;41345;0.23
1918;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2019;39375;0.22
1919;Total male and female;10000;Total background and generation;C10B Lipid modifying agents,combinations;2020;30585;0.17
1920;Total male and female;10000;Total background and generation;D Dermatologicals;2006;3330965;20.01
1921;Total male and female;10000;Total background and generation;D Dermatologicals;2007;3411135;20.45
1922;Total male and female;10000;Total background and generation;D Dermatologicals;2008;3423740;20.43
1923;Total male and female;10000;Total background and generation;D Dermatologicals;2009;3484025;20.69
1924;Total male and female;10000;Total background and generation;D Dermatologicals;2010;3584105;21.17
1925;Total male and female;10000;Total background and generation;D Dermatologicals;2011;3582755;21.06
1926;Total male and female;10000;Total background and generation;D Dermatologicals;2012;3553160;20.8
1927;Total male and female;10000;Total background and generation;D Dermatologicals;2013;3502545;20.45
1928;Total male and female;10000;Total background and generation;D Dermatologicals;2014;3529460;20.52
1929;Total male and female;10000;Total background and generation;D Dermatologicals;2015;3439220;19.9
1930;Total male and female;10000;Total background and generation;D Dermatologicals;2016;3439315;19.78
1931;Total male and female;10000;Total background and generation;D Dermatologicals;2017;3396195;19.42
1932;Total male and female;10000;Total background and generation;D Dermatologicals;2018;3453005;19.62
1933;Total male and female;10000;Total background and generation;D Dermatologicals;2019;3421260;19.3
1934;Total male and female;10000;Total background and generation;D Dermatologicals;2020;3198920;17.97
1935;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2006;510180;3.07
1936;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2007;503835;3.02
1937;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2008;488505;2.91
1938;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2009;498660;2.96
1939;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2010;524260;3.1
1940;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2011;534575;3.14
1941;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2012;534035;3.13
1942;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2013;502480;2.93
1943;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2014;555390;3.23
1944;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2015;531090;3.07
1945;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2016;509140;2.93
1946;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2017;549190;3.14
1947;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2018;902335;5.13
1948;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2019;870530;4.91
1949;Total male and female;10000;Total background and generation;D01 Antifungals for dermatological use;2020;786800;4.42
1950;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2006;418385;2.51
1951;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2007;418300;2.51
1952;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2008;404455;2.41
1953;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2009;414920;2.46
1954;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2010;443120;2.62
1955;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2011;453410;2.66
1956;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2012;454050;2.66
1957;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2013;426545;2.49
1958;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2014;482630;2.81
1959;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2015;458050;2.65
1960;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2016;436620;2.51
1961;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2017;479065;2.74
1962;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2018;838245;4.76
1963;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2019;807940;4.56
1964;Total male and female;10000;Total background and generation;D01A Antifungals for topical use;2020;733105;4.12
1965;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2006;106460;0.64
1966;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2007;99185;0.59
1967;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2008;97840;0.58
1968;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2009;97665;0.58
1969;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2010;95480;0.56
1970;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2011;95710;0.56
1971;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2012;94225;0.55
1972;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2013;89280;0.52
1973;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2014;87390;0.51
1974;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2015;87600;0.51
1975;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2016;85990;0.49
1976;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2017;84450;0.48
1977;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2018;84055;0.48
1978;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2019;81540;0.46
1979;Total male and female;10000;Total background and generation;D01B Antifungals for systemic use;2020;69760;0.39
1980;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2006;682135;4.1
1981;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2007;687195;4.12
1982;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2008;730150;4.36
1983;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2009;745935;4.43
1984;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2010;868280;5.13
1985;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2011;914615;5.38
1986;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2012;955840;5.6
1987;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2013;994475;5.81
1988;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2014;984190;5.72
1989;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2015;949625;5.49
1990;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2016;946965;5.45
1991;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2017;931240;5.32
1992;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2018;997235;5.67
1993;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2019;1012560;5.71
1994;Total male and female;10000;Total background and generation;D02 Emollients and protectives;2020;1006335;5.65
1995;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2006;637320;3.83
1996;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2007;648045;3.88
1997;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2008;688135;4.11
1998;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2009;707270;4.2
1999;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2010;832560;4.92
2000;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2011;884505;5.2
2001;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2012;927390;5.43
2002;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2013;969285;5.66
2003;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2014;962635;5.6
2004;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2015;949620;5.49
2005;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2016;946965;5.45
2006;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2017;931240;5.32
2007;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2018;997235;5.67
2008;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2019;1012560;5.71
2009;Total male and female;10000;Total background and generation;D02A Emollients and protectives;2020;1006335;5.65
2010;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2006;52500;0.32
2011;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2007;45735;0.27
2012;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2008;49335;0.29
2013;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2009;45450;0.27
2014;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2010;43590;0.26
2015;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2011;37510;0.22
2016;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2012;35705;0.21
2017;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2013;32050;0.19
2018;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2014;27700;0.16
2019;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2015;5;0.0
2020;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2016;0;0.0
2021;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2017;0;0.0
2022;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2018;0;0.0
2023;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2019;0;0.0
2024;Total male and female;10000;Total background and generation;D02B Protectives against uv-radiation;2020;0;0.0
2025;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2006;37420;0.22
2026;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2007;34070;0.2
2027;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2008;2940;0.02
2028;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2009;2105;0.01
2029;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2010;2065;0.01
2030;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2011;1870;0.01
2031;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2012;1565;0.01
2032;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2013;1950;0.01
2033;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2014;2150;0.01
2034;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2015;2235;0.01
2035;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2016;2105;0.01
2036;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2017;2165;0.01
2037;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2018;2125;0.01
2038;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2019;1870;0.01
2039;Total male and female;10000;Total background and generation;D03 Means for wounds & ulcers treatment;2020;1785;0.01
2040;Total male and female;10000;Total background and generation;D03A Cicatrizants;2006;34965;0.21
2041;Total male and female;10000;Total background and generation;D03A Cicatrizants;2007;31780;0.19
2042;Total male and female;10000;Total background and generation;D03A Cicatrizants;2008;995;0.01
2043;Total male and female;10000;Total background and generation;D03A Cicatrizants;2009;200;0.0
2044;Total male and female;10000;Total background and generation;D03A Cicatrizants;2010;120;0.0
2045;Total male and female;10000;Total background and generation;D03A Cicatrizants;2011;45;0.0
2046;Total male and female;10000;Total background and generation;D03A Cicatrizants;2012;5;0.0
2047;Total male and female;10000;Total background and generation;D03A Cicatrizants;2013;5;0.0
2048;Total male and female;10000;Total background and generation;D03A Cicatrizants;2014;5;0.0
2049;Total male and female;10000;Total background and generation;D03A Cicatrizants;2015;5;0.0
2050;Total male and female;10000;Total background and generation;D03A Cicatrizants;2016;0;0.0
2051;Total male and female;10000;Total background and generation;D03A Cicatrizants;2017;0;0.0
2052;Total male and female;10000;Total background and generation;D03A Cicatrizants;2018;0;0.0
2053;Total male and female;10000;Total background and generation;D03A Cicatrizants;2019;0;0.0
2054;Total male and female;10000;Total background and generation;D03A Cicatrizants;2020;0;0.0
2055;Total male and female;10000;Total background and generation;D03B Enzymes;2006;2465;0.01
2056;Total male and female;10000;Total background and generation;D03B Enzymes;2007;2300;0.01
2057;Total male and female;10000;Total background and generation;D03B Enzymes;2008;1945;0.01
2058;Total male and female;10000;Total background and generation;D03B Enzymes;2009;1910;0.01
2059;Total male and female;10000;Total background and generation;D03B Enzymes;2010;1950;0.01
2060;Total male and female;10000;Total background and generation;D03B Enzymes;2011;1825;0.01
2061;Total male and female;10000;Total background and generation;D03B Enzymes;2012;1560;0.01
2062;Total male and female;10000;Total background and generation;D03B Enzymes;2013;1425;0.01
2063;Total male and female;10000;Total background and generation;D03B Enzymes;2014;1420;0.01
2064;Total male and female;10000;Total background and generation;D03B Enzymes;2015;1505;0.01
2065;Total male and female;10000;Total background and generation;D03B Enzymes;2016;1315;0.01
2066;Total male and female;10000;Total background and generation;D03B Enzymes;2017;1255;0.01
2067;Total male and female;10000;Total background and generation;D03B Enzymes;2018;1250;0.01
2068;Total male and female;10000;Total background and generation;D03B Enzymes;2019;855;0.0
2069;Total male and female;10000;Total background and generation;D03B Enzymes;2020;820;0.0
2070;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2006;36525;0.22
2071;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2007;32520;0.19
2072;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2008;32275;0.19
2073;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2009;33565;0.2
2074;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2010;44075;0.26
2075;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2011;34720;0.2
2076;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2012;26860;0.16
2077;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2013;23470;0.14
2078;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2014;260;0.0
2079;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2015;85;0.0
2080;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2016;50;0.0
2081;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2017;25;0.0
2082;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2018;10;0.0
2083;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2019;10;0.0
2084;Total male and female;10000;Total background and generation;D04 Antipruritics,incl antesthetics ....;2020;10;0.0
2085;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2006;36525;0.22
2086;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2007;32520;0.19
2087;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2008;32275;0.19
2088;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2009;33565;0.2
2089;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2010;44075;0.26
2090;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2011;34720;0.2
2091;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2012;26860;0.16
2092;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2013;23470;0.14
2093;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2014;260;0.0
2094;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2015;85;0.0
2095;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2016;50;0.0
2096;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2017;25;0.0
2097;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2018;10;0.0
2098;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2019;10;0.0
2099;Total male and female;10000;Total background and generation;D04A Antipruritics, incl antihistam. etc;2020;10;0.0
2100;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2006;68150;0.41
2101;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2007;69455;0.42
2102;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2008;70405;0.42
2103;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2009;75520;0.45
2104;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2010;84110;0.5
2105;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2011;90050;0.53
2106;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2012;88045;0.52
2107;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2013;87425;0.51
2108;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2014;86915;0.51
2109;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2015;84385;0.49
2110;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2016;84750;0.49
2111;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2017;88960;0.51
2112;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2018;87530;0.5
2113;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2019;90615;0.51
2114;Total male and female;10000;Total background and generation;D05 Antipsoriatics;2020;87355;0.49
2115;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2006;64880;0.39
2116;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2007;65925;0.4
2117;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2008;66730;0.4
2118;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2009;71725;0.43
2119;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2010;79370;0.47
2120;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2011;84595;0.5
2121;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2012;82395;0.48
2122;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2013;81440;0.48
2123;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2014;79530;0.46
2124;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2015;76615;0.44
2125;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2016;76900;0.44
2126;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2017;81750;0.47
2127;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2018;80485;0.46
2128;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2019;83950;0.47
2129;Total male and female;10000;Total background and generation;D05A Antipsoriatics for topical use;2020;81215;0.46
2130;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2006;4750;0.03
2131;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2007;4995;0.03
2132;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2008;5155;0.03
2133;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2009;5300;0.03
2134;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2010;6655;0.04
2135;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2011;7855;0.05
2136;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2012;8395;0.05
2137;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2013;8960;0.05
2138;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2014;11035;0.06
2139;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2015;11495;0.07
2140;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2016;11475;0.07
2141;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2017;11215;0.06
2142;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2018;10955;0.06
2143;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2019;10535;0.06
2144;Total male and female;10000;Total background and generation;D05B Antipsoriatics for systemic use;2020;9300;0.05
2145;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2006;705880;4.24
2146;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2007;707370;4.24
2147;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2008;722640;4.31
2148;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2009;747405;4.44
2149;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2010;764075;4.51
2150;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2011;769350;4.52
2151;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2012;763410;4.47
2152;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2013;756180;4.41
2153;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2014;766090;4.45
2154;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2015;764110;4.42
2155;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2016;788450;4.53
2156;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2017;784230;4.48
2157;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2018;806125;4.58
2158;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2019;789150;4.45
2159;Total male and female;10000;Total background and generation;D06 Antibiotics.. for dermatological use;2020;685760;3.85
2160;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2006;580925;3.49
2161;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2007;571430;3.43
2162;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2008;576020;3.44
2163;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2009;593025;3.52
2164;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2010;605280;3.58
2165;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2011;605415;3.56
2166;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2012;600975;3.52
2167;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2013;594910;3.47
2168;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2014;596185;3.47
2169;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2015;599135;3.47
2170;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2016;625295;3.6
2171;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2017;627485;3.59
2172;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2018;657035;3.73
2173;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2019;643930;3.63
2174;Total male and female;10000;Total background and generation;D06A Antibiotics for topical use;2020;561060;3.15
2175;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2006;138430;0.83
2176;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2007;150415;0.9
2177;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2008;162650;0.97
2178;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2009;170940;1.02
2179;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2010;176060;1.04
2180;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2011;181690;1.07
2181;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2012;179440;1.05
2182;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2013;178390;1.04
2183;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2014;188110;1.09
2184;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2015;182500;1.06
2185;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2016;180630;1.04
2186;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2017;173695;0.99
2187;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2018;165520;0.94
2188;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2019;160780;0.91
2189;Total male and female;10000;Total background and generation;D06B Chemotherapeutics for topical use;2020;136790;0.77
2190;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2006;0;0.0
2191;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2007;0;0.0
2192;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2008;0;0.0
2193;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2009;0;0.0
2194;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2010;0;0.0
2195;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2011;0;0.0
2196;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2012;0;0.0
2197;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2013;0;0.0
2198;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2014;0;0.0
2199;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2015;0;0.0
2200;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2016;0;0.0
2201;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2017;0;0.0
2202;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2018;0;0.0
2203;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2019;0;0.0
2204;Total male and female;10000;Total background and generation;D06C Antibiotics/chemotherapeutics, comb;2020;0;0.0
2205;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2006;2029840;12.2
2206;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2007;2100455;12.59
2207;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2008;2123725;12.67
2208;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2009;2156945;12.81
2209;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2010;2186430;12.91
2210;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2011;2172700;12.77
2211;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2012;2143395;12.55
2212;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2013;2109460;12.31
2213;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2014;2152280;12.51
2214;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2015;2149125;12.43
2215;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2016;2160360;12.42
2216;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2017;2107695;12.05
2217;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2018;1815250;10.31
2218;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2019;1802110;10.17
2219;Total male and female;10000;Total background and generation;D07 Dermatological corticosteroids;2020;1708795;9.6
2220;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2006;1593870;9.58
2221;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2007;1645575;9.86
2222;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2008;1671635;9.97
2223;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2009;1694615;10.06
2224;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2010;1733170;10.24
2225;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2011;1723690;10.13
2226;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2012;1710705;10.02
2227;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2013;1698980;9.92
2228;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2014;1711310;9.95
2229;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2015;1752850;10.14
2230;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2016;1792960;10.31
2231;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2017;1791285;10.24
2232;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2018;1790600;10.17
2233;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2019;1779425;10.04
2234;Total male and female;10000;Total background and generation;D07A Corticosteroids, plain;2020;1687520;9.48
2235;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2006;2465;0.01
2236;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2007;660;0.0
2237;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2008;25;0.0
2238;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2009;5;0.0
2239;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2010;5;0.0
2240;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2011;0;0.0
2241;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2012;0;0.0
2242;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2013;0;0.0
2243;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2014;0;0.0
2244;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2015;0;0.0
2245;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2016;0;0.0
2246;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2017;0;0.0
2247;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2018;0;0.0
2248;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2019;0;0.0
2249;Total male and female;10000;Total background and generation;D07B Corticosteroids with antiseptics;2020;0;0.0
2250;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2006;8860;0.05
2251;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2007;2060;0.01
2252;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2008;45;0.0
2253;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2009;5;0.0
2254;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2010;0;0.0
2255;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2011;0;0.0
2256;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2012;0;0.0
2257;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2013;610;0.0
2258;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2014;56775;0.33
2259;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2015;33760;0.2
2260;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2016;765;0.0
2261;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2017;0;0.0
2262;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2018;5;0.0
2263;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2019;0;0.0
2264;Total male and female;10000;Total background and generation;D07C Corticosteroids with antibiotics;2020;0;0.0
2265;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2006;584530;3.51
2266;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2007;618030;3.7
2267;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2008;618255;3.69
2268;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2009;631210;3.75
2269;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2010;621585;3.67
2270;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2011;614445;3.61
2271;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2012;590715;3.46
2272;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2013;559645;3.27
2273;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2014;564430;3.28
2274;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2015;529190;3.06
2275;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2016;516585;2.97
2276;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2017;452980;2.59
2277;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2018;46045;0.26
2278;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2019;43820;0.25
2279;Total male and female;10000;Total background and generation;D07X Corticosteroids, other combinations;2020;39290;0.22
2280;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2006;17360;0.1
2281;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2007;16235;0.1
2282;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2008;14280;0.09
2283;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2009;12655;0.08
2284;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2010;11925;0.07
2285;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2011;10195;0.06
2286;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2012;7255;0.04
2287;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2013;4135;0.02
2288;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2014;2250;0.01
2289;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2015;2265;0.01
2290;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2016;2360;0.01
2291;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2017;2255;0.01
2292;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2018;1790;0.01
2293;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2019;1695;0.01
2294;Total male and female;10000;Total background and generation;D08 Antiseptics and disinfectants;2020;1575;0.01
2295;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2006;17360;0.1
2296;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2007;16235;0.1
2297;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2008;14280;0.09
2298;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2009;12655;0.08
2299;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2010;11925;0.07
2300;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2011;10195;0.06
2301;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2012;7255;0.04
2302;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2013;4135;0.02
2303;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2014;2250;0.01
2304;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2015;2265;0.01
2305;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2016;2360;0.01
2306;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2017;2255;0.01
2307;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2018;1790;0.01
2308;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2019;1695;0.01
2309;Total male and female;10000;Total background and generation;D08A Antiseptics and disinfectants;2020;1575;0.01
2310;Total male and female;10000;Total background and generation;D09 Medicated dressings;2006;6530;0.04
2311;Total male and female;10000;Total background and generation;D09 Medicated dressings;2007;5935;0.04
2312;Total male and female;10000;Total background and generation;D09 Medicated dressings;2008;5210;0.03
2313;Total male and female;10000;Total background and generation;D09 Medicated dressings;2009;5315;0.03
2314;Total male and female;10000;Total background and generation;D09 Medicated dressings;2010;5385;0.03
2315;Total male and female;10000;Total background and generation;D09 Medicated dressings;2011;4735;0.03
2316;Total male and female;10000;Total background and generation;D09 Medicated dressings;2012;3810;0.02
2317;Total male and female;10000;Total background and generation;D09 Medicated dressings;2013;3380;0.02
2318;Total male and female;10000;Total background and generation;D09 Medicated dressings;2014;3210;0.02
2319;Total male and female;10000;Total background and generation;D09 Medicated dressings;2015;2730;0.02
2320;Total male and female;10000;Total background and generation;D09 Medicated dressings;2016;2635;0.02
2321;Total male and female;10000;Total background and generation;D09 Medicated dressings;2017;2535;0.01
2322;Total male and female;10000;Total background and generation;D09 Medicated dressings;2018;2300;0.01
2323;Total male and female;10000;Total background and generation;D09 Medicated dressings;2019;1770;0.01
2324;Total male and female;10000;Total background and generation;D09 Medicated dressings;2020;205;0.0
2325;Total male and female;10000;Total background and generation;D09A Medicated dressings;2006;6530;0.04
2326;Total male and female;10000;Total background and generation;D09A Medicated dressings;2007;5935;0.04
2327;Total male and female;10000;Total background and generation;D09A Medicated dressings;2008;5210;0.03
2328;Total male and female;10000;Total background and generation;D09A Medicated dressings;2009;5315;0.03
2329;Total male and female;10000;Total background and generation;D09A Medicated dressings;2010;5385;0.03
2330;Total male and female;10000;Total background and generation;D09A Medicated dressings;2011;4735;0.03
2331;Total male and female;10000;Total background and generation;D09A Medicated dressings;2012;3810;0.02
2332;Total male and female;10000;Total background and generation;D09A Medicated dressings;2013;3380;0.02
2333;Total male and female;10000;Total background and generation;D09A Medicated dressings;2014;3210;0.02
2334;Total male and female;10000;Total background and generation;D09A Medicated dressings;2015;2730;0.02
2335;Total male and female;10000;Total background and generation;D09A Medicated dressings;2016;2635;0.02
2336;Total male and female;10000;Total background and generation;D09A Medicated dressings;2017;2535;0.01
2337;Total male and female;10000;Total background and generation;D09A Medicated dressings;2018;2300;0.01
2338;Total male and female;10000;Total background and generation;D09A Medicated dressings;2019;1770;0.01
2339;Total male and female;10000;Total background and generation;D09A Medicated dressings;2020;205;0.0
2340;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2006;186935;1.12
2341;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2007;197985;1.19
2342;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2008;199525;1.19
2343;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2009;204590;1.21
2344;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2010;206950;1.22
2345;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2011;208125;1.22
2346;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2012;211850;1.24
2347;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2013;212155;1.24
2348;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2014;212930;1.24
2349;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2015;193400;1.12
2350;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2016;187670;1.08
2351;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2017;190695;1.09
2352;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2018;190500;1.08
2353;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2019;186935;1.05
2354;Total male and female;10000;Total background and generation;D10 Anti-acne preparations;2020;175095;0.98
2355;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2006;178970;1.08
2356;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2007;189190;1.13
2357;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2008;190175;1.13
2358;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2009;193970;1.15
2359;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2010;195165;1.15
2360;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2011;196640;1.16
2361;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2012;199630;1.17
2362;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2013;199530;1.16
2363;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2014;198390;1.15
2364;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2015;177715;1.03
2365;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2016;171190;0.98
2366;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2017;173205;0.99
2367;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2018;171685;0.98
2368;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2019;166340;0.94
2369;Total male and female;10000;Total background and generation;D10A Anti-acne preparations, topical use;2020;154645;0.87
2370;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2006;13030;0.08
2371;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2007;14405;0.09
2372;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2008;15410;0.09
2373;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2009;17475;0.1
2374;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2010;18840;0.11
2375;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2011;18060;0.11
2376;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2012;18975;0.11
2377;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2013;19780;0.12
2378;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2014;22350;0.13
2379;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2015;22925;0.13
2380;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2016;23685;0.14
2381;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2017;25425;0.15
2382;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2018;27280;0.16
2383;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2019;28810;0.16
2384;Total male and female;10000;Total background and generation;D10B Anti-acne preparations,systemic use;2020;28645;0.16
2385;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2006;144370;0.87
2386;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2007;154610;0.93
2387;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2008;148435;0.89
2388;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2009;149210;0.89
2389;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2010;153915;0.91
2390;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2011;144600;0.85
2391;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2012;130280;0.76
2392;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2013;126330;0.74
2393;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2014;127770;0.74
2394;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2015;117345;0.68
2395;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2016;115810;0.67
2396;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2017;112300;0.64
2397;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2018;126805;0.72
2398;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2019;140255;0.79
2399;Total male and female;10000;Total background and generation;D11 Other dermatological preparations;2020;141135;0.79
2400;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2006;144370;0.87
2401;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2007;154610;0.93
2402;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2008;148435;0.89
2403;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2009;149210;0.89
2404;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2010;153915;0.91
2405;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2011;144600;0.85
2406;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2012;130280;0.76
2407;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2013;126330;0.74
2408;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2014;127770;0.74
2409;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2015;117345;0.68
2410;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2016;115810;0.67
2411;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2017;112300;0.64
2412;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2018;126805;0.72
2413;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2019;140255;0.79
2414;Total male and female;10000;Total background and generation;D11A Other dermatological preparations;2020;141135;0.79
2415;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2006;2026590;12.18
2416;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2007;1532205;9.18
2417;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2008;2644430;15.78
2418;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2009;2659900;15.79
2419;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2010;2678280;15.82
2420;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2011;1703155;10.01
2421;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2012;1663225;9.74
2422;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2013;1412570;8.25
2423;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2014;1319970;7.67
2424;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2015;1294765;7.49
2425;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2016;1238305;7.12
2426;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2017;1258270;7.19
2427;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2018;1273150;7.23
2428;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2019;1288450;7.27
2429;Total male and female;10000;Total background and generation;G Genito urinary system and sex hormones;2020;1226645;6.89
2430;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2006;356455;2.14
2431;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2007;369025;2.21
2432;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2008;373305;2.23
2433;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2009;380810;2.26
2434;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2010;382460;2.26
2435;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2011;386165;2.27
2436;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2012;365150;2.14
2437;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2013;306035;1.79
2438;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2014;283480;1.65
2439;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2015;268140;1.55
2440;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2016;205180;1.18
2441;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2017;220825;1.26
2442;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2018;219945;1.25
2443;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2019;213705;1.21
2444;Total male and female;10000;Total background and generation;G01 Gynecological antiseptics/infectives;2020;199560;1.12
2445;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2006;356455;2.14
2446;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2007;369025;2.21
2447;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2008;373305;2.23
2448;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2009;380810;2.26
2449;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2010;382460;2.26
2450;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2011;386165;2.27
2451;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2012;365150;2.14
2452;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2013;306035;1.79
2453;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2014;283480;1.65
2454;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2015;268140;1.55
2455;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2016;205180;1.18
2456;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2017;220825;1.26
2457;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2018;219945;1.25
2458;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2019;213705;1.21
2459;Total male and female;10000;Total background and generation;G01A Antiinfectives/antisept.exc.cortico;2020;199560;1.12
2460;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2006;0;0.0
2461;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2007;0;0.0
2462;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2008;0;0.0
2463;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2009;0;0.0
2464;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2010;0;0.0
2465;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2011;0;0.0
2466;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2012;0;0.0
2467;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2013;0;0.0
2468;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2014;0;0.0
2469;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2015;0;0.0
2470;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2016;0;0.0
2471;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2017;0;0.0
2472;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2018;0;0.0
2473;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2019;0;0.0
2474;Total male and female;10000;Total background and generation;G01B Antiinfectives/antisept.inc.cortico;2020;0;0.0
2475;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2006;75810;0.46
2476;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2007;30245;0.18
2477;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2008;142895;0.85
2478;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2009;150420;0.89
2479;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2010;163465;0.97
2480;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2011;44505;0.26
2481;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2012;38820;0.23
2482;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2013;20280;0.12
2483;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2014;18055;0.1
2484;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2015;18260;0.11
2485;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2016;18835;0.11
2486;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2017;19980;0.11
2487;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2018;21640;0.12
2488;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2019;22260;0.13
2489;Total male and female;10000;Total background and generation;G02 Other gynecologicals;2020;23120;0.13
2490;Total male and female;10000;Total background and generation;G02A Oxytocics;2006;1425;0.01
2491;Total male and female;10000;Total background and generation;G02A Oxytocics;2007;255;0.0
2492;Total male and female;10000;Total background and generation;G02A Oxytocics;2008;70;0.0
2493;Total male and female;10000;Total background and generation;G02A Oxytocics;2009;35;0.0
2494;Total male and female;10000;Total background and generation;G02A Oxytocics;2010;20;0.0
2495;Total male and female;10000;Total background and generation;G02A Oxytocics;2011;15;0.0
2496;Total male and female;10000;Total background and generation;G02A Oxytocics;2012;5;0.0
2497;Total male and female;10000;Total background and generation;G02A Oxytocics;2013;10;0.0
2498;Total male and female;10000;Total background and generation;G02A Oxytocics;2014;30;0.0
2499;Total male and female;10000;Total background and generation;G02A Oxytocics;2015;30;0.0
2500;Total male and female;10000;Total background and generation;G02A Oxytocics;2016;45;0.0
2501;Total male and female;10000;Total background and generation;G02A Oxytocics;2017;55;0.0
2502;Total male and female;10000;Total background and generation;G02A Oxytocics;2018;40;0.0
2503;Total male and female;10000;Total background and generation;G02A Oxytocics;2019;55;0.0
2504;Total male and female;10000;Total background and generation;G02A Oxytocics;2020;65;0.0
2505;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2006;64370;0.39
2506;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2007;19610;0.12
2507;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2008;133420;0.8
2508;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2009;141210;0.84
2509;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2010;154190;0.91
2510;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2011;34995;0.21
2511;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2012;29915;0.18
2512;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2013;11875;0.07
2513;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2014;9920;0.06
2514;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2015;10415;0.06
2515;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2016;11080;0.06
2516;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2017;12280;0.07
2517;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2018;13905;0.08
2518;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2019;14505;0.08
2519;Total male and female;10000;Total background and generation;G02B Contraceptives for topical use;2020;15625;0.09
2520;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2006;10545;0.06
2521;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2007;10465;0.06
2522;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2008;10170;0.06
2523;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2009;9915;0.06
2524;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2010;10065;0.06
2525;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2011;9620;0.06
2526;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2012;8990;0.05
2527;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2013;8405;0.05
2528;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2014;8115;0.05
2529;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2015;7820;0.05
2530;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2016;7715;0.04
2531;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2017;7655;0.04
2532;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2018;7705;0.04
2533;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2019;7705;0.04
2534;Total male and female;10000;Total background and generation;G02C Other gynecologicals;2020;7440;0.04
2535;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2006;1458325;8.76
2536;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2007;906415;5.43
2537;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2008;2028350;12.1
2538;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2009;2024315;12.02
2539;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2010;2013410;11.89
2540;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2011;991725;5.83
2541;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2012;958745;5.61
2542;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2013;744265;4.34
2543;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2014;653220;3.8
2544;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2015;630970;3.65
2545;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2016;624630;3.59
2546;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2017;626525;3.58
2547;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2018;635750;3.61
2548;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2019;646255;3.65
2549;Total male and female;10000;Total background and generation;G03 Sex hormones, modulators genit.syst.;2020;597300;3.36
2550;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2006;988325;5.94
2551;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2007;418000;2.51
2552;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2008;1600250;9.55
2553;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2009;1609655;9.56
2554;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2010;1609310;9.51
2555;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2011;555565;3.27
2556;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2012;534360;3.13
2557;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2013;382425;2.23
2558;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2014;379595;2.21
2559;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2015;374760;2.17
2560;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2016;366920;2.11
2561;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2017;364775;2.09
2562;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2018;364375;2.07
2563;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2019;367435;2.07
2564;Total male and female;10000;Total background and generation;G03A Hormonal contraceptives system. use;2020;346015;1.94
2565;Total male and female;10000;Total background and generation;G03B Androgens;2006;9280;0.06
2566;Total male and female;10000;Total background and generation;G03B Androgens;2007;9900;0.06
2567;Total male and female;10000;Total background and generation;G03B Androgens;2008;10550;0.06
2568;Total male and female;10000;Total background and generation;G03B Androgens;2009;11290;0.07
2569;Total male and female;10000;Total background and generation;G03B Androgens;2010;11830;0.07
2570;Total male and female;10000;Total background and generation;G03B Androgens;2011;12705;0.07
2571;Total male and female;10000;Total background and generation;G03B Androgens;2012;13660;0.08
2572;Total male and female;10000;Total background and generation;G03B Androgens;2013;14710;0.09
2573;Total male and female;10000;Total background and generation;G03B Androgens;2014;15075;0.09
2574;Total male and female;10000;Total background and generation;G03B Androgens;2015;15760;0.09
2575;Total male and female;10000;Total background and generation;G03B Androgens;2016;16690;0.1
2576;Total male and female;10000;Total background and generation;G03B Androgens;2017;17940;0.1
2577;Total male and female;10000;Total background and generation;G03B Androgens;2018;19085;0.11
2578;Total male and female;10000;Total background and generation;G03B Androgens;2019;20365;0.11
2579;Total male and female;10000;Total background and generation;G03B Androgens;2020;21255;0.12
2580;Total male and female;10000;Total background and generation;G03C Estrogens;2006;162195;0.97
2581;Total male and female;10000;Total background and generation;G03C Estrogens;2007;156670;0.94
2582;Total male and female;10000;Total background and generation;G03C Estrogens;2008;149430;0.89
2583;Total male and female;10000;Total background and generation;G03C Estrogens;2009;144795;0.86
2584;Total male and female;10000;Total background and generation;G03C Estrogens;2010;142090;0.84
2585;Total male and female;10000;Total background and generation;G03C Estrogens;2011;141650;0.83
2586;Total male and female;10000;Total background and generation;G03C Estrogens;2012;138080;0.81
2587;Total male and female;10000;Total background and generation;G03C Estrogens;2013;131825;0.77
2588;Total male and female;10000;Total background and generation;G03C Estrogens;2014;129000;0.75
2589;Total male and female;10000;Total background and generation;G03C Estrogens;2015;123510;0.71
2590;Total male and female;10000;Total background and generation;G03C Estrogens;2016;123390;0.71
2591;Total male and female;10000;Total background and generation;G03C Estrogens;2017;124520;0.71
2592;Total male and female;10000;Total background and generation;G03C Estrogens;2018;128275;0.73
2593;Total male and female;10000;Total background and generation;G03C Estrogens;2019;132475;0.75
2594;Total male and female;10000;Total background and generation;G03C Estrogens;2020;129155;0.73
2595;Total male and female;10000;Total background and generation;G03D Progestogens;2006;116675;0.7
2596;Total male and female;10000;Total background and generation;G03D Progestogens;2007;118785;0.71
2597;Total male and female;10000;Total background and generation;G03D Progestogens;2008;115430;0.69
2598;Total male and female;10000;Total background and generation;G03D Progestogens;2009;112695;0.67
2599;Total male and female;10000;Total background and generation;G03D Progestogens;2010;111225;0.66
2600;Total male and female;10000;Total background and generation;G03D Progestogens;2011;110850;0.65
2601;Total male and female;10000;Total background and generation;G03D Progestogens;2012;108795;0.64
2602;Total male and female;10000;Total background and generation;G03D Progestogens;2013;105385;0.62
2603;Total male and female;10000;Total background and generation;G03D Progestogens;2014;103860;0.6
2604;Total male and female;10000;Total background and generation;G03D Progestogens;2015;102915;0.6
2605;Total male and female;10000;Total background and generation;G03D Progestogens;2016;102580;0.59
2606;Total male and female;10000;Total background and generation;G03D Progestogens;2017;102925;0.59
2607;Total male and female;10000;Total background and generation;G03D Progestogens;2018;106795;0.61
2608;Total male and female;10000;Total background and generation;G03D Progestogens;2019;108270;0.61
2609;Total male and female;10000;Total background and generation;G03D Progestogens;2020;83475;0.47
2610;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2006;0;0.0
2611;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2007;0;0.0
2612;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2008;0;0.0
2613;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2009;0;0.0
2614;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2010;0;0.0
2615;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2011;0;0.0
2616;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2012;0;0.0
2617;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2013;0;0.0
2618;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2014;0;0.0
2619;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2015;0;0.0
2620;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2016;0;0.0
2621;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2017;0;0.0
2622;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2018;0;0.0
2623;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2019;0;0.0
2624;Total male and female;10000;Total background and generation;G03E Androgens / female sex hormon.comb.;2020;0;0.0
2625;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2006;27570;0.17
2626;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2007;25105;0.15
2627;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2008;23815;0.14
2628;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2009;23325;0.14
2629;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2010;22250;0.13
2630;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2011;22080;0.13
2631;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2012;21375;0.13
2632;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2013;21555;0.13
2633;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2014;22215;0.13
2634;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2015;21595;0.12
2635;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2016;22420;0.13
2636;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2017;24920;0.14
2637;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2018;30085;0.17
2638;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2019;33530;0.19
2639;Total male and female;10000;Total background and generation;G03F Progestogens / estrogens combinat.;2020;34320;0.19
2640;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2006;16025;0.1
2641;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2007;23880;0.14
2642;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2008;28560;0.17
2643;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2009;30710;0.18
2644;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2010;31705;0.19
2645;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2011;32255;0.19
2646;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2012;32275;0.19
2647;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2013;31695;0.19
2648;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2014;30;0.0
2649;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2015;5;0.0
2650;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2016;5;0.0
2651;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2017;10;0.0
2652;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2018;10;0.0
2653;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2019;10;0.0
2654;Total male and female;10000;Total background and generation;G03G Gonadotropins/oth.ovulation stimul.;2020;10;0.0
2655;Total male and female;10000;Total background and generation;G03H Antiandrogens;2006;198840;1.19
2656;Total male and female;10000;Total background and generation;G03H Antiandrogens;2007;195715;1.17
2657;Total male and female;10000;Total background and generation;G03H Antiandrogens;2008;189720;1.13
2658;Total male and female;10000;Total background and generation;G03H Antiandrogens;2009;181310;1.08
2659;Total male and female;10000;Total background and generation;G03H Antiandrogens;2010;174485;1.03
2660;Total male and female;10000;Total background and generation;G03H Antiandrogens;2011;167150;0.98
2661;Total male and female;10000;Total background and generation;G03H Antiandrogens;2012;160375;0.94
2662;Total male and female;10000;Total background and generation;G03H Antiandrogens;2013;104040;0.61
2663;Total male and female;10000;Total background and generation;G03H Antiandrogens;2014;17530;0.1
2664;Total male and female;10000;Total background and generation;G03H Antiandrogens;2015;5230;0.03
2665;Total male and female;10000;Total background and generation;G03H Antiandrogens;2016;5115;0.03
2666;Total male and female;10000;Total background and generation;G03H Antiandrogens;2017;5110;0.03
2667;Total male and female;10000;Total background and generation;G03H Antiandrogens;2018;5025;0.03
2668;Total male and female;10000;Total background and generation;G03H Antiandrogens;2019;5035;0.03
2669;Total male and female;10000;Total background and generation;G03H Antiandrogens;2020;4725;0.03
2670;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2006;4550;0.03
2671;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2007;3985;0.02
2672;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2008;3530;0.02
2673;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2009;3135;0.02
2674;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2010;2815;0.02
2675;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2011;2420;0.01
2676;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2012;2125;0.01
2677;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2013;1835;0.01
2678;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2014;2605;0.02
2679;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2015;3155;0.02
2680;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2016;3965;0.02
2681;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2017;4490;0.03
2682;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2018;2190;0.01
2683;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2019;1710;0.01
2684;Total male and female;10000;Total background and generation;G03X Oth.sex horm./modulat.genital syst.;2020;1070;0.01
2685;Total male and female;10000;Total background and generation;G04 Urologicals;2006;297070;1.78
2686;Total male and female;10000;Total background and generation;G04 Urologicals;2007;323385;1.94
2687;Total male and female;10000;Total background and generation;G04 Urologicals;2008;341740;2.04
2688;Total male and female;10000;Total background and generation;G04 Urologicals;2009;352030;2.09
2689;Total male and female;10000;Total background and generation;G04 Urologicals;2010;374345;2.21
2690;Total male and female;10000;Total background and generation;G04 Urologicals;2011;397645;2.34
2691;Total male and female;10000;Total background and generation;G04 Urologicals;2012;410005;2.4
2692;Total male and female;10000;Total background and generation;G04 Urologicals;2013;416590;2.43
2693;Total male and female;10000;Total background and generation;G04 Urologicals;2014;428145;2.49
2694;Total male and female;10000;Total background and generation;G04 Urologicals;2015;435710;2.52
2695;Total male and female;10000;Total background and generation;G04 Urologicals;2016;438575;2.52
2696;Total male and female;10000;Total background and generation;G04 Urologicals;2017;442440;2.53
2697;Total male and female;10000;Total background and generation;G04 Urologicals;2018;449505;2.55
2698;Total male and female;10000;Total background and generation;G04 Urologicals;2019;459540;2.59
2699;Total male and female;10000;Total background and generation;G04 Urologicals;2020;457305;2.57
2700;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2006;100570;0.6
2701;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2007;108465;0.65
2702;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2008;111560;0.67
2703;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2009;109755;0.65
2704;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2010;119355;0.7
2705;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2011;128540;0.76
2706;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2012;130925;0.77
2707;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2013;130560;0.76
2708;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2014;136260;0.79
2709;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2015;139170;0.81
2710;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2016;141170;0.81
2711;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2017;146715;0.84
2712;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2018;149455;0.85
2713;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2019;154400;0.87
2714;Total male and female;10000;Total background and generation;G04B Oth.urologicals, inc.antispasmodics;2020;150065;0.84
2715;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2006;210760;1.27
2716;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2007;232035;1.39
2717;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2008;248620;1.48
2718;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2009;261715;1.55
2719;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2010;276910;1.64
2720;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2011;293425;1.72
2721;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2012;304185;1.78
2722;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2013;311750;1.82
2723;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2014;318690;1.85
2724;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2015;324570;1.88
2725;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2016;325845;1.87
2726;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2017;325750;1.86
2727;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2018;330775;1.88
2728;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2019;337435;1.9
2729;Total male and female;10000;Total background and generation;G04C Benign prostatic hypertrophy drugs;2020;338845;1.9
2730;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2006;941375;5.66
2731;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2007;987125;5.92
2732;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2008;1021120;6.09
2733;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2009;1063915;6.32
2734;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2010;1098105;6.49
2735;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2011;1141500;6.71
2736;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2012;1173485;6.87
2737;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2013;1203915;7.03
2738;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2014;1237205;7.19
2739;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2015;1290765;7.47
2740;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2016;1312495;7.55
2741;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2017;1333120;7.62
2742;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2018;1365730;7.76
2743;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2019;1392510;7.86
2744;Total male and female;10000;Total background and generation;H Systemic hormonal prep,ex.sex hormones;2020;1283080;7.21
2745;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2006;37050;0.22
2746;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2007;39270;0.24
2747;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2008;38475;0.23
2748;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2009;38995;0.23
2749;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2010;38850;0.23
2750;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2011;39455;0.23
2751;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2012;38535;0.23
2752;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2013;32670;0.19
2753;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2014;27160;0.16
2754;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2015;27455;0.16
2755;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2016;27430;0.16
2756;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2017;26970;0.15
2757;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2018;26310;0.15
2758;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2019;26065;0.15
2759;Total male and female;10000;Total background and generation;H01 Pituitary, hypothalamic hormones.;2020;22445;0.13
2760;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2006;4135;0.02
2761;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2007;4425;0.03
2762;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2008;4685;0.03
2763;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2009;5045;0.03
2764;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2010;5340;0.03
2765;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2011;5550;0.03
2766;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2012;5645;0.03
2767;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2013;390;0.0
2768;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2014;355;0.0
2769;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2015;380;0.0
2770;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2016;385;0.0
2771;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2017;370;0.0
2772;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2018;385;0.0
2773;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2019;380;0.0
2774;Total male and female;10000;Total background and generation;H01A Anterior pituitary lobe hormones.;2020;385;0.0
2775;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2006;30220;0.18
2776;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2007;31310;0.19
2777;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2008;29720;0.18
2778;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2009;29525;0.18
2779;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2010;28540;0.17
2780;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2011;28635;0.17
2781;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2012;27440;0.16
2782;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2013;26160;0.15
2783;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2014;23775;0.14
2784;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2015;23990;0.14
2785;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2016;23740;0.14
2786;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2017;23200;0.13
2787;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2018;22400;0.13
2788;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2019;22040;0.12
2789;Total male and female;10000;Total background and generation;H01B Posterior pituitary lobe hormones;2020;18385;0.1
2790;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2006;3315;0.02
2791;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2007;4230;0.03
2792;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2008;4840;0.03
2793;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2009;5240;0.03
2794;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2010;5820;0.03
2795;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2011;6175;0.04
2796;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2012;6375;0.04
2797;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2013;6405;0.04
2798;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2014;3310;0.02
2799;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2015;3380;0.02
2800;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2016;3595;0.02
2801;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2017;3680;0.02
2802;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2018;3800;0.02
2803;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2019;3935;0.02
2804;Total male and female;10000;Total background and generation;H01C Hypothalamic hormones;2020;3960;0.02
2805;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2006;604205;3.63
2806;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2007;631405;3.78
2807;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2008;651550;3.89
2808;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2009;678675;4.03
2809;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2010;698645;4.13
2810;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2011;723975;4.25
2811;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2012;739220;4.33
2812;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2013;760635;4.44
2813;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2014;789740;4.59
2814;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2015;833705;4.82
2815;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2016;842735;4.85
2816;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2017;854765;4.89
2817;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2018;878875;4.99
2818;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2019;894275;5.05
2819;Total male and female;10000;Total background and generation;H02 Corticosteroids for systemic use;2020;777390;4.37
2820;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2006;584640;3.51
2821;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2007;611560;3.67
2822;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2008;633305;3.78
2823;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2009;661670;3.93
2824;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2010;680235;4.02
2825;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2011;705535;4.15
2826;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2012;721765;4.23
2827;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2013;743930;4.34
2828;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2014;773255;4.5
2829;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2015;818295;4.73
2830;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2016;829170;4.77
2831;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2017;842830;4.82
2832;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2018;868115;4.93
2833;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2019;884125;4.99
2834;Total male and female;10000;Total background and generation;H02A Corticosteroids system.use, plain;2020;768835;4.32
2835;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2006;22645;0.14
2836;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2007;23060;0.14
2837;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2008;21890;0.13
2838;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2009;20275;0.12
2839;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2010;21720;0.13
2840;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2011;21980;0.13
2841;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2012;20880;0.12
2842;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2013;20195;0.12
2843;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2014;20000;0.12
2844;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2015;18965;0.11
2845;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2016;16870;0.1
2846;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2017;14995;0.09
2847;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2018;13660;0.08
2848;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2019;12945;0.07
2849;Total male and female;10000;Total background and generation;H02B Corticosteroids system.use, combi.;2020;10700;0.06
2850;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2006;0;0.0
2851;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2007;0;0.0
2852;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2008;0;0.0
2853;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2009;0;0.0
2854;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2010;0;0.0
2855;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2011;0;0.0
2856;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2012;0;0.0
2857;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2013;0;0.0
2858;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2014;0;0.0
2859;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2015;0;0.0
2860;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2016;0;0.0
2861;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2017;0;0.0
2862;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2018;0;0.0
2863;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2019;0;0.0
2864;Total male and female;10000;Total background and generation;H02C Antiadrenal preparations;2020;0;0.0
2865;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2006;320345;1.92
2866;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2007;338780;2.03
2867;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2008;355480;2.12
2868;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2009;372900;2.21
2869;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2010;390545;2.31
2870;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2011;410890;2.41
2871;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2012;430745;2.52
2872;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2013;447855;2.61
2873;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2014;460995;2.68
2874;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2015;473765;2.74
2875;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2016;488160;2.81
2876;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2017;500815;2.86
2877;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2018;511910;2.91
2878;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2019;523095;2.95
2879;Total male and female;10000;Total background and generation;H03 Thyroid therapy;2020;529730;2.98
2880;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2006;306045;1.84
2881;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2007;325240;1.95
2882;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2008;342270;2.04
2883;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2009;360080;2.14
2884;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2010;378295;2.23
2885;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2011;399100;2.35
2886;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2012;419090;2.45
2887;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2013;436545;2.55
2888;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2014;450025;2.62
2889;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2015;463330;2.68
2890;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2016;477850;2.75
2891;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2017;490135;2.8
2892;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2018;500535;2.84
2893;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2019;511380;2.89
2894;Total male and female;10000;Total background and generation;H03A Thyroid preparations;2020;517445;2.91
2895;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2006;29570;0.18
2896;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2007;28615;0.17
2897;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2008;27825;0.17
2898;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2009;26900;0.16
2899;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2010;25880;0.15
2900;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2011;24860;0.15
2901;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2012;24565;0.14
2902;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2013;23905;0.14
2903;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2014;22955;0.13
2904;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2015;22295;0.13
2905;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2016;22150;0.13
2906;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2017;22485;0.13
2907;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2018;22840;0.13
2908;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2019;22715;0.13
2909;Total male and female;10000;Total background and generation;H03B Antithyroid preparations;2020;22705;0.13
2910;Total male and female;10000;Total background and generation;H03C Iodine therapy;2006;220;0.0
2911;Total male and female;10000;Total background and generation;H03C Iodine therapy;2007;185;0.0
2912;Total male and female;10000;Total background and generation;H03C Iodine therapy;2008;110;0.0
2913;Total male and female;10000;Total background and generation;H03C Iodine therapy;2009;130;0.0
2914;Total male and female;10000;Total background and generation;H03C Iodine therapy;2010;175;0.0
2915;Total male and female;10000;Total background and generation;H03C Iodine therapy;2011;175;0.0
2916;Total male and female;10000;Total background and generation;H03C Iodine therapy;2012;155;0.0
2917;Total male and female;10000;Total background and generation;H03C Iodine therapy;2013;185;0.0
2918;Total male and female;10000;Total background and generation;H03C Iodine therapy;2014;225;0.0
2919;Total male and female;10000;Total background and generation;H03C Iodine therapy;2015;55;0.0
2920;Total male and female;10000;Total background and generation;H03C Iodine therapy;2016;0;0.0
2921;Total male and female;10000;Total background and generation;H03C Iodine therapy;2017;0;0.0
2922;Total male and female;10000;Total background and generation;H03C Iodine therapy;2018;0;0.0
2923;Total male and female;10000;Total background and generation;H03C Iodine therapy;2019;0;0.0
2924;Total male and female;10000;Total background and generation;H03C Iodine therapy;2020;0;0.0
2925;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2006;18690;0.11
2926;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2007;19910;0.12
2927;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2008;20245;0.12
2928;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2009;20790;0.12
2929;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2010;20485;0.12
2930;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2011;20745;0.12
2931;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2012;21525;0.13
2932;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2013;20470;0.12
2933;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2014;20010;0.12
2934;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2015;20800;0.12
2935;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2016;21130;0.12
2936;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2017;19630;0.11
2937;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2018;20580;0.12
2938;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2019;23015;0.13
2939;Total male and female;10000;Total background and generation;H04 Pancreatic hormones;2020;18735;0.11
2940;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2006;18690;0.11
2941;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2007;19910;0.12
2942;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2008;20245;0.12
2943;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2009;20790;0.12
2944;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2010;20485;0.12
2945;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2011;20745;0.12
2946;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2012;21525;0.13
2947;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2013;20470;0.12
2948;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2014;20010;0.12
2949;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2015;20800;0.12
2950;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2016;21130;0.12
2951;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2017;19630;0.11
2952;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2018;20580;0.12
2953;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2019;23015;0.13
2954;Total male and female;10000;Total background and generation;H04A Glycogenolytic hormones;2020;18735;0.11
2955;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2006;2090;0.01
2956;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2007;2680;0.02
2957;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2008;3385;0.02
2958;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2009;4105;0.02
2959;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2010;4670;0.03
2960;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2011;5270;0.03
2961;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2012;5620;0.03
2962;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2013;5855;0.03
2963;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2014;5990;0.03
2964;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2015;6320;0.04
2965;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2016;6680;0.04
2966;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2017;6940;0.04
2967;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2018;7385;0.04
2968;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2019;7980;0.05
2969;Total male and female;10000;Total background and generation;H05 Calcium homeostasis;2020;8270;0.05
2970;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2006;815;0.0
2971;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2007;975;0.01
2972;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2008;1260;0.01
2973;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2009;1390;0.01
2974;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2010;1515;0.01
2975;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2011;1595;0.01
2976;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2012;1505;0.01
2977;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2013;1480;0.01
2978;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2014;1470;0.01
2979;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2015;1470;0.01
2980;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2016;1450;0.01
2981;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2017;1565;0.01
2982;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2018;1865;0.01
2983;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2019;2265;0.01
2984;Total male and female;10000;Total background and generation;H05A Parathyroid hormones and analogues;2020;2400;0.01
2985;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2006;1280;0.01
2986;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2007;1705;0.01
2987;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2008;2130;0.01
2988;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2009;2720;0.02
2989;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2010;3165;0.02
2990;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2011;3675;0.02
2991;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2012;4115;0.02
2992;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2013;4375;0.03
2993;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2014;4525;0.03
2994;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2015;4855;0.03
2995;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2016;5235;0.03
2996;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2017;5375;0.03
2997;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2018;5520;0.03
2998;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2019;5715;0.03
2999;Total male and female;10000;Total background and generation;H05B Anti-parathyroid agents;2020;5870;0.03
3000;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2006;4079330;24.51
3001;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2007;4201850;25.19
3002;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2008;4213190;25.14
3003;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2009;4248850;25.23
3004;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2010;4157305;24.56
3005;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2011;4187745;24.61
3006;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2012;4094965;23.98
3007;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2013;3951965;23.07
3008;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2014;3829570;22.27
3009;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2015;3894010;22.53
3010;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2016;3819095;21.96
3011;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2017;3710520;21.21
3012;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2018;3746990;21.29
3013;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2019;3656985;20.63
3014;Total male and female;10000;Total background and generation;J General antiinfectives for system.use;2020;3122210;17.54
3015;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2006;3830515;23.02
3016;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2007;3953365;23.7
3017;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2008;3969815;23.68
3018;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2009;4008550;23.8
3019;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2010;3921010;23.16
3020;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2011;3950165;23.21
3021;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2012;3858025;22.59
3022;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2013;3721260;21.72
3023;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2014;3592800;20.89
3024;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2015;3661415;21.18
3025;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2016;3572570;20.55
3026;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2017;3464540;19.81
3027;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2018;3490450;19.83
3028;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2019;3397425;19.17
3029;Total male and female;10000;Total background and generation;J01 Antibacterials for systemic use;2020;2868275;16.12
3030;Total male and female;10000;Total background and generation;J01A Tetracyclines;2006;911180;5.47
3031;Total male and female;10000;Total background and generation;J01A Tetracyclines;2007;1001440;6.0
3032;Total male and female;10000;Total background and generation;J01A Tetracyclines;2008;1023925;6.11
3033;Total male and female;10000;Total background and generation;J01A Tetracyclines;2009;1024080;6.08
3034;Total male and female;10000;Total background and generation;J01A Tetracyclines;2010;991830;5.86
3035;Total male and female;10000;Total background and generation;J01A Tetracyclines;2011;938055;5.51
3036;Total male and female;10000;Total background and generation;J01A Tetracyclines;2012;874675;5.12
3037;Total male and female;10000;Total background and generation;J01A Tetracyclines;2013;791165;4.62
3038;Total male and female;10000;Total background and generation;J01A Tetracyclines;2014;718425;4.18
3039;Total male and female;10000;Total background and generation;J01A Tetracyclines;2015;734100;4.25
3040;Total male and female;10000;Total background and generation;J01A Tetracyclines;2016;656410;3.77
3041;Total male and female;10000;Total background and generation;J01A Tetracyclines;2017;615850;3.52
3042;Total male and female;10000;Total background and generation;J01A Tetracyclines;2018;593195;3.37
3043;Total male and female;10000;Total background and generation;J01A Tetracyclines;2019;539365;3.04
3044;Total male and female;10000;Total background and generation;J01A Tetracyclines;2020;378285;2.13
3045;Total male and female;10000;Total background and generation;J01B Amphenicols;2006;145;0.0
3046;Total male and female;10000;Total background and generation;J01B Amphenicols;2007;10;0.0
3047;Total male and female;10000;Total background and generation;J01B Amphenicols;2008;10;0.0
3048;Total male and female;10000;Total background and generation;J01B Amphenicols;2009;5;0.0
3049;Total male and female;10000;Total background and generation;J01B Amphenicols;2010;5;0.0
3050;Total male and female;10000;Total background and generation;J01B Amphenicols;2011;5;0.0
3051;Total male and female;10000;Total background and generation;J01B Amphenicols;2012;45;0.0
3052;Total male and female;10000;Total background and generation;J01B Amphenicols;2013;85;0.0
3053;Total male and female;10000;Total background and generation;J01B Amphenicols;2014;30;0.0
3054;Total male and female;10000;Total background and generation;J01B Amphenicols;2015;0;0.0
3055;Total male and female;10000;Total background and generation;J01B Amphenicols;2016;20;0.0
3056;Total male and female;10000;Total background and generation;J01B Amphenicols;2017;5;0.0
3057;Total male and female;10000;Total background and generation;J01B Amphenicols;2018;0;0.0
3058;Total male and female;10000;Total background and generation;J01B Amphenicols;2019;0;0.0
3059;Total male and female;10000;Total background and generation;J01B Amphenicols;2020;0;0.0
3060;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2006;2068355;12.43
3061;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2007;2119185;12.7
3062;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2008;2125650;12.68
3063;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2009;2164275;12.85
3064;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2010;2111090;12.47
3065;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2011;2166755;12.73
3066;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2012;2133590;12.49
3067;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2013;2081550;12.15
3068;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2014;1996610;11.61
3069;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2015;2059570;11.91
3070;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2016;2032905;11.69
3071;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2017;1953420;11.17
3072;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2018;1962895;11.15
3073;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2019;1939125;10.94
3074;Total male and female;10000;Total background and generation;J01C Beta-lactam antibact., penicillins;2020;1587880;8.92
3075;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2006;15830;0.1
3076;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2007;15070;0.09
3077;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2008;14040;0.08
3078;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2009;13795;0.08
3079;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2010;13965;0.08
3080;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2011;15335;0.09
3081;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2012;14475;0.08
3082;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2013;14035;0.08
3083;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2014;13825;0.08
3084;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2015;14480;0.08
3085;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2016;13485;0.08
3086;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2017;13625;0.08
3087;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2018;13810;0.08
3088;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2019;15705;0.09
3089;Total male and female;10000;Total background and generation;J01D Other beta-lactam antibacterials;2020;14570;0.08
3090;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2006;343670;2.06
3091;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2007;317550;1.9
3092;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2008;301050;1.8
3093;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2009;285065;1.69
3094;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2010;275580;1.63
3095;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2011;262815;1.54
3096;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2012;243890;1.43
3097;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2013;211400;1.23
3098;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2014;177770;1.03
3099;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2015;168495;0.97
3100;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2016;162770;0.94
3101;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2017;156540;0.9
3102;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2018;156035;0.89
3103;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2019;160795;0.91
3104;Total male and female;10000;Total background and generation;J01E Sulfonamides and trimethoprim;2020;150930;0.85
3105;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2006;737335;4.43
3106;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2007;745300;4.47
3107;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2008;718345;4.29
3108;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2009;705420;4.19
3109;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2010;673005;3.98
3110;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2011;688185;4.04
3111;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2012;671885;3.93
3112;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2013;602740;3.52
3113;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2014;558735;3.25
3114;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2015;563760;3.26
3115;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2016;532320;3.06
3116;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2017;512285;2.93
3117;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2018;531595;3.02
3118;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2019;507165;2.86
3119;Total male and female;10000;Total background and generation;J01F Macrolides,lincosamides,streptogr.;2020;390880;2.2
3120;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2006;1300;0.01
3121;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2007;1135;0.01
3122;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2008;1150;0.01
3123;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2009;1105;0.01
3124;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2010;1190;0.01
3125;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2011;1455;0.01
3126;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2012;1530;0.01
3127;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2013;1485;0.01
3128;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2014;1310;0.01
3129;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2015;1320;0.01
3130;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2016;1250;0.01
3131;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2017;1245;0.01
3132;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2018;1160;0.01
3133;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2019;1280;0.01
3134;Total male and female;10000;Total background and generation;J01G Aminoglycoside antibacterials;2020;1230;0.01
3135;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2006;389415;2.34
3136;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2007;408600;2.45
3137;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2008;398975;2.38
3138;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2009;397020;2.36
3139;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2010;391855;2.31
3140;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2011;377460;2.22
3141;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2012;361455;2.12
3142;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2013;347050;2.03
3143;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2014;356820;2.07
3144;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2015;351830;2.04
3145;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2016;341510;1.96
3146;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2017;339335;1.94
3147;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2018;337770;1.92
3148;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2019;311465;1.76
3149;Total male and female;10000;Total background and generation;J01M Quinolone antibacterials;2020;283810;1.59
3150;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2006;0;0.0
3151;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2007;0;0.0
3152;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2008;0;0.0
3153;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2009;0;0.0
3154;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2010;0;0.0
3155;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2011;0;0.0
3156;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2012;0;0.0
3157;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2013;0;0.0
3158;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2014;0;0.0
3159;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2015;0;0.0
3160;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2016;0;0.0
3161;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2017;0;0.0
3162;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2018;0;0.0
3163;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2019;0;0.0
3164;Total male and female;10000;Total background and generation;J01R Combinations of antibacterials;2020;0;0.0
3165;Total male and female;10000;Total background and generation;J01X Other antibacterials;2006;477760;2.87
3166;Total male and female;10000;Total background and generation;J01X Other antibacterials;2007;523795;3.14
3167;Total male and female;10000;Total background and generation;J01X Other antibacterials;2008;566315;3.38
3168;Total male and female;10000;Total background and generation;J01X Other antibacterials;2009;601220;3.57
3169;Total male and female;10000;Total background and generation;J01X Other antibacterials;2010;627495;3.71
3170;Total male and female;10000;Total background and generation;J01X Other antibacterials;2011;668170;3.93
3171;Total male and female;10000;Total background and generation;J01X Other antibacterials;2012;696980;4.08
3172;Total male and female;10000;Total background and generation;J01X Other antibacterials;2013;717390;4.19
3173;Total male and female;10000;Total background and generation;J01X Other antibacterials;2014;754925;4.39
3174;Total male and female;10000;Total background and generation;J01X Other antibacterials;2015;768865;4.45
3175;Total male and female;10000;Total background and generation;J01X Other antibacterials;2016;777600;4.47
3176;Total male and female;10000;Total background and generation;J01X Other antibacterials;2017;793155;4.53
3177;Total male and female;10000;Total background and generation;J01X Other antibacterials;2018;810310;4.6
3178;Total male and female;10000;Total background and generation;J01X Other antibacterials;2019;799820;4.51
3179;Total male and female;10000;Total background and generation;J01X Other antibacterials;2020;772185;4.34
3180;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2006;232000;1.39
3181;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2007;232490;1.39
3182;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2008;228385;1.36
3183;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2009;227810;1.35
3184;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2010;223565;1.32
3185;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2011;223225;1.31
3186;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2012;220015;1.29
3187;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2013;203040;1.19
3188;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2014;196935;1.15
3189;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2015;182620;1.06
3190;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2016;187360;1.08
3191;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2017;175085;1.0
3192;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2018;173790;0.99
3193;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2019;165420;0.93
3194;Total male and female;10000;Total background and generation;J02 Antimycotics for systemic use;2020;146175;0.82
3195;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2006;232000;1.39
3196;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2007;232490;1.39
3197;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2008;228385;1.36
3198;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2009;227810;1.35
3199;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2010;223565;1.32
3200;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2011;223225;1.31
3201;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2012;220015;1.29
3202;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2013;203040;1.19
3203;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2014;196935;1.15
3204;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2015;182620;1.06
3205;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2016;187360;1.08
3206;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2017;175085;1.0
3207;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2018;173790;0.99
3208;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2019;165420;0.93
3209;Total male and female;10000;Total background and generation;J02A Antimycotics for systemic use;2020;146175;0.82
3210;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2006;7855;0.05
3211;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2007;7905;0.05
3212;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2008;8170;0.05
3213;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2009;7965;0.05
3214;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2010;7905;0.05
3215;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2011;8150;0.05
3216;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2012;8355;0.05
3217;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2013;8055;0.05
3218;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2014;7945;0.05
3219;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2015;8285;0.05
3220;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2016;8895;0.05
3221;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2017;9170;0.05
3222;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2018;9190;0.05
3223;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2019;8995;0.05
3224;Total male and female;10000;Total background and generation;J04 Antimycobacterials;2020;7845;0.04
3225;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2006;6480;0.04
3226;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2007;6610;0.04
3227;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2008;6830;0.04
3228;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2009;6655;0.04
3229;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2010;6620;0.04
3230;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2011;6890;0.04
3231;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2012;7110;0.04
3232;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2013;6860;0.04
3233;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2014;6750;0.04
3234;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2015;7105;0.04
3235;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2016;7725;0.04
3236;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2017;8015;0.05
3237;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2018;7990;0.05
3238;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2019;7815;0.04
3239;Total male and female;10000;Total background and generation;J04A Drugs for treatment of tuberculosis;2020;6735;0.04
3240;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2006;1390;0.01
3241;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2007;1305;0.01
3242;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2008;1360;0.01
3243;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2009;1335;0.01
3244;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2010;1305;0.01
3245;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2011;1280;0.01
3246;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2012;1265;0.01
3247;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2013;1210;0.01
3248;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2014;1205;0.01
3249;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2015;1195;0.01
3250;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2016;1190;0.01
3251;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2017;1165;0.01
3252;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2018;1220;0.01
3253;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2019;1195;0.01
3254;Total male and female;10000;Total background and generation;J04B Drugs for treatment of lepra;2020;1120;0.01
3255;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2006;73085;0.44
3256;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2007;78950;0.47
3257;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2008;81440;0.49
3258;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2009;86475;0.51
3259;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2010;90580;0.54
3260;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2011;93555;0.55
3261;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2012;95805;0.56
3262;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2013;96115;0.56
3263;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2014;98630;0.57
3264;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2015;104485;0.6
3265;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2016;107665;0.62
3266;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2017;110260;0.63
3267;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2018;114840;0.65
3268;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2019;117670;0.66
3269;Total male and female;10000;Total background and generation;J05 Antivirals for systemic use;2020;113335;0.64
3270;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2006;73085;0.44
3271;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2007;78950;0.47
3272;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2008;81440;0.49
3273;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2009;86475;0.51
3274;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2010;90580;0.54
3275;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2011;93555;0.55
3276;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2012;95805;0.56
3277;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2013;96115;0.56
3278;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2014;98630;0.57
3279;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2015;104485;0.6
3280;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2016;107665;0.62
3281;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2017;110260;0.63
3282;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2018;114840;0.65
3283;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2019;117670;0.66
3284;Total male and female;10000;Total background and generation;J05A Direct acting antivirals;2020;113335;0.64
3285;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2006;9005;0.05
3286;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2007;9730;0.06
3287;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2008;6890;0.04
3288;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2009;6235;0.04
3289;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2010;5840;0.03
3290;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2011;5800;0.03
3291;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2012;5950;0.03
3292;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2013;5940;0.03
3293;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2014;6030;0.04
3294;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2015;5985;0.03
3295;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2016;5710;0.03
3296;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2017;5425;0.03
3297;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2018;5565;0.03
3298;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2019;6610;0.04
3299;Total male and female;10000;Total background and generation;J06 Immune sera and immunoglobulins;2020;11160;0.06
3300;Total male and female;10000;Total background and generation;J06A Immune sera;2006;0;0.0
3301;Total male and female;10000;Total background and generation;J06A Immune sera;2007;0;0.0
3302;Total male and female;10000;Total background and generation;J06A Immune sera;2008;0;0.0
3303;Total male and female;10000;Total background and generation;J06A Immune sera;2009;0;0.0
3304;Total male and female;10000;Total background and generation;J06A Immune sera;2010;0;0.0
3305;Total male and female;10000;Total background and generation;J06A Immune sera;2011;0;0.0
3306;Total male and female;10000;Total background and generation;J06A Immune sera;2012;0;0.0
3307;Total male and female;10000;Total background and generation;J06A Immune sera;2013;0;0.0
3308;Total male and female;10000;Total background and generation;J06A Immune sera;2014;0;0.0
3309;Total male and female;10000;Total background and generation;J06A Immune sera;2015;0;0.0
3310;Total male and female;10000;Total background and generation;J06A Immune sera;2016;0;0.0
3311;Total male and female;10000;Total background and generation;J06A Immune sera;2017;0;0.0
3312;Total male and female;10000;Total background and generation;J06A Immune sera;2018;0;0.0
3313;Total male and female;10000;Total background and generation;J06A Immune sera;2019;0;0.0
3314;Total male and female;10000;Total background and generation;J06A Immune sera;2020;0;0.0
3315;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2006;9005;0.05
3316;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2007;9730;0.06
3317;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2008;6890;0.04
3318;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2009;6235;0.04
3319;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2010;5840;0.03
3320;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2011;5800;0.03
3321;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2012;5950;0.03
3322;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2013;5940;0.03
3323;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2014;6030;0.04
3324;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2015;5985;0.03
3325;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2016;5710;0.03
3326;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2017;5425;0.03
3327;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2018;5565;0.03
3328;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2019;6610;0.04
3329;Total male and female;10000;Total background and generation;J06B Immunoglobulins;2020;11160;0.06
3330;Total male and female;10000;Total background and generation;J07 Vaccines;2006;124720;0.75
3331;Total male and female;10000;Total background and generation;J07 Vaccines;2007;127070;0.76
3332;Total male and female;10000;Total background and generation;J07 Vaccines;2008;126945;0.76
3333;Total male and female;10000;Total background and generation;J07 Vaccines;2009;120355;0.71
3334;Total male and female;10000;Total background and generation;J07 Vaccines;2010;113970;0.67
3335;Total male and female;10000;Total background and generation;J07 Vaccines;2011;114975;0.68
3336;Total male and female;10000;Total background and generation;J07 Vaccines;2012;111740;0.65
3337;Total male and female;10000;Total background and generation;J07 Vaccines;2013;113030;0.66
3338;Total male and female;10000;Total background and generation;J07 Vaccines;2014;120720;0.7
3339;Total male and female;10000;Total background and generation;J07 Vaccines;2015;123500;0.71
3340;Total male and female;10000;Total background and generation;J07 Vaccines;2016;132420;0.76
3341;Total male and female;10000;Total background and generation;J07 Vaccines;2017;136940;0.78
3342;Total male and female;10000;Total background and generation;J07 Vaccines;2018;150970;0.86
3343;Total male and female;10000;Total background and generation;J07 Vaccines;2019;158035;0.89
3344;Total male and female;10000;Total background and generation;J07 Vaccines;2020;154645;0.87
3345;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2006;91835;0.55
3346;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2007;96860;0.58
3347;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2008;98485;0.59
3348;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2009;102850;0.61
3349;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2010;99300;0.59
3350;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2011;102610;0.6
3351;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2012;101715;0.6
3352;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2013;105480;0.62
3353;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2014;114060;0.66
3354;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2015;117925;0.68
3355;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2016;127385;0.73
3356;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2017;132480;0.76
3357;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2018;144230;0.82
3358;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2019;150220;0.85
3359;Total male and female;10000;Total background and generation;J07A Bacterial vaccines;2020;150615;0.85
3360;Total male and female;10000;Total background and generation;J07B Viral vaccines;2006;30225;0.18
3361;Total male and female;10000;Total background and generation;J07B Viral vaccines;2007;26625;0.16
3362;Total male and female;10000;Total background and generation;J07B Viral vaccines;2008;26045;0.16
3363;Total male and female;10000;Total background and generation;J07B Viral vaccines;2009;16180;0.1
3364;Total male and female;10000;Total background and generation;J07B Viral vaccines;2010;13495;0.08
3365;Total male and female;10000;Total background and generation;J07B Viral vaccines;2011;11405;0.07
3366;Total male and female;10000;Total background and generation;J07B Viral vaccines;2012;9140;0.05
3367;Total male and female;10000;Total background and generation;J07B Viral vaccines;2013;6755;0.04
3368;Total male and female;10000;Total background and generation;J07B Viral vaccines;2014;6010;0.03
3369;Total male and female;10000;Total background and generation;J07B Viral vaccines;2015;5070;0.03
3370;Total male and female;10000;Total background and generation;J07B Viral vaccines;2016;4960;0.03
3371;Total male and female;10000;Total background and generation;J07B Viral vaccines;2017;4180;0.02
3372;Total male and female;10000;Total background and generation;J07B Viral vaccines;2018;4130;0.02
3373;Total male and female;10000;Total background and generation;J07B Viral vaccines;2019;4655;0.03
3374;Total male and female;10000;Total background and generation;J07B Viral vaccines;2020;3605;0.02
3375;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2006;9805;0.06
3376;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2007;7625;0.05
3377;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2008;6815;0.04
3378;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2009;4065;0.02
3379;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2010;3135;0.02
3380;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2011;2465;0.01
3381;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2012;2040;0.01
3382;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2013;1585;0.01
3383;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2014;1455;0.01
3384;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2015;1090;0.01
3385;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2016;405;0.0
3386;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2017;555;0.0
3387;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2018;2890;0.02
3388;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2019;3580;0.02
3389;Total male and female;10000;Total background and generation;J07C Bacterial and viral vaccines,combi.;2020;705;0.0
3390;Total male and female;10000;Total background and generation;J07X Other vaccines;2006;0;0.0
3391;Total male and female;10000;Total background and generation;J07X Other vaccines;2007;0;0.0
3392;Total male and female;10000;Total background and generation;J07X Other vaccines;2008;0;0.0
3393;Total male and female;10000;Total background and generation;J07X Other vaccines;2009;0;0.0
3394;Total male and female;10000;Total background and generation;J07X Other vaccines;2010;0;0.0
3395;Total male and female;10000;Total background and generation;J07X Other vaccines;2011;0;0.0
3396;Total male and female;10000;Total background and generation;J07X Other vaccines;2012;0;0.0
3397;Total male and female;10000;Total background and generation;J07X Other vaccines;2013;0;0.0
3398;Total male and female;10000;Total background and generation;J07X Other vaccines;2014;0;0.0
3399;Total male and female;10000;Total background and generation;J07X Other vaccines;2015;0;0.0
3400;Total male and female;10000;Total background and generation;J07X Other vaccines;2016;0;0.0
3401;Total male and female;10000;Total background and generation;J07X Other vaccines;2017;0;0.0
3402;Total male and female;10000;Total background and generation;J07X Other vaccines;2018;0;0.0
3403;Total male and female;10000;Total background and generation;J07X Other vaccines;2019;0;0.0
3404;Total male and female;10000;Total background and generation;J07X Other vaccines;2020;0;0.0
3405;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2006;203595;1.22
3406;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2007;222650;1.33
3407;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2008;240095;1.43
3408;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2009;259215;1.54
3409;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2010;277645;1.64
3410;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2011;294490;1.73
3411;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2012;291525;1.71
3412;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2013;294275;1.72
3413;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2014;295075;1.72
3414;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2015;281600;1.63
3415;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2016;293820;1.69
3416;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2017;300875;1.72
3417;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2018;312670;1.78
3418;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2019;330915;1.87
3419;Total male and female;10000;Total background and generation;L Antineoplastic and immunomodul. agents;2020;339820;1.91
3420;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2006;40455;0.24
3421;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2007;46705;0.28
3422;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2008;51670;0.31
3423;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2009;60795;0.36
3424;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2010;71180;0.42
3425;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2011;77995;0.46
3426;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2012;82015;0.48
3427;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2013;80830;0.47
3428;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2014;87970;0.51
3429;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2015;70115;0.41
3430;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2016;80285;0.46
3431;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2017;62060;0.35
3432;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2018;68660;0.39
3433;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2019;78085;0.44
3434;Total male and female;10000;Total background and generation;L01 Antineoplastic agents;2020;83850;0.47
3435;Total male and female;10000;Total background and generation;L01A Alkylating agents;2006;5330;0.03
3436;Total male and female;10000;Total background and generation;L01A Alkylating agents;2007;5415;0.03
3437;Total male and female;10000;Total background and generation;L01A Alkylating agents;2008;5325;0.03
3438;Total male and female;10000;Total background and generation;L01A Alkylating agents;2009;5245;0.03
3439;Total male and female;10000;Total background and generation;L01A Alkylating agents;2010;5360;0.03
3440;Total male and female;10000;Total background and generation;L01A Alkylating agents;2011;5365;0.03
3441;Total male and female;10000;Total background and generation;L01A Alkylating agents;2012;5405;0.03
3442;Total male and female;10000;Total background and generation;L01A Alkylating agents;2013;5255;0.03
3443;Total male and female;10000;Total background and generation;L01A Alkylating agents;2014;5460;0.03
3444;Total male and female;10000;Total background and generation;L01A Alkylating agents;2015;0;0.0
3445;Total male and female;10000;Total background and generation;L01A Alkylating agents;2016;0;0.0
3446;Total male and female;10000;Total background and generation;L01A Alkylating agents;2017;0;0.0
3447;Total male and female;10000;Total background and generation;L01A Alkylating agents;2018;0;0.0
3448;Total male and female;10000;Total background and generation;L01A Alkylating agents;2019;0;0.0
3449;Total male and female;10000;Total background and generation;L01A Alkylating agents;2020;0;0.0
3450;Total male and female;10000;Total background and generation;L01B Antimetabolites;2006;29885;0.18
3451;Total male and female;10000;Total background and generation;L01B Antimetabolites;2007;34800;0.21
3452;Total male and female;10000;Total background and generation;L01B Antimetabolites;2008;39145;0.23
3453;Total male and female;10000;Total background and generation;L01B Antimetabolites;2009;47845;0.28
3454;Total male and female;10000;Total background and generation;L01B Antimetabolites;2010;57630;0.34
3455;Total male and female;10000;Total background and generation;L01B Antimetabolites;2011;63575;0.37
3456;Total male and female;10000;Total background and generation;L01B Antimetabolites;2012;67395;0.39
3457;Total male and female;10000;Total background and generation;L01B Antimetabolites;2013;70365;0.41
3458;Total male and female;10000;Total background and generation;L01B Antimetabolites;2014;76720;0.45
3459;Total male and female;10000;Total background and generation;L01B Antimetabolites;2015;69965;0.4
3460;Total male and female;10000;Total background and generation;L01B Antimetabolites;2016;79930;0.46
3461;Total male and female;10000;Total background and generation;L01B Antimetabolites;2017;61605;0.35
3462;Total male and female;10000;Total background and generation;L01B Antimetabolites;2018;68120;0.39
3463;Total male and female;10000;Total background and generation;L01B Antimetabolites;2019;77430;0.44
3464;Total male and female;10000;Total background and generation;L01B Antimetabolites;2020;83115;0.47
3465;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2006;660;0.0
3466;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2007;615;0.0
3467;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2008;690;0.0
3468;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2009;620;0.0
3469;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2010;680;0.0
3470;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2011;710;0.0
3471;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2012;615;0.0
3472;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2013;630;0.0
3473;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2014;630;0.0
3474;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2015;0;0.0
3475;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2016;0;0.0
3476;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2017;0;0.0
3477;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2018;0;0.0
3478;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2019;0;0.0
3479;Total male and female;10000;Total background and generation;L01C Plant alkaloids/oth.natural product;2020;0;0.0
3480;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2006;25;0.0
3481;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2007;20;0.0
3482;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2008;10;0.0
3483;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2009;15;0.0
3484;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2010;15;0.0
3485;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2011;10;0.0
3486;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2012;20;0.0
3487;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2013;20;0.0
3488;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2014;10;0.0
3489;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2015;0;0.0
3490;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2016;0;0.0
3491;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2017;0;0.0
3492;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2018;0;0.0
3493;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2019;0;0.0
3494;Total male and female;10000;Total background and generation;L01D Cytoox.antibiotics/related substan;2020;0;0.0
3495;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2006;5360;0.03
3496;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2007;6810;0.04
3497;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2008;7515;0.04
3498;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2009;8125;0.05
3499;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2010;8700;0.05
3500;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2011;9565;0.06
3501;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2012;9870;0.06
3502;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2013;5620;0.03
3503;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2014;6270;0.04
3504;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2015;145;0.0
3505;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2016;360;0.0
3506;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2017;465;0.0
3507;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2018;555;0.0
3508;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2019;660;0.0
3509;Total male and female;10000;Total background and generation;L01X Other antineoplastic agents;2020;750;0.0
3510;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2006;71955;0.43
3511;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2007;77385;0.46
3512;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2008;81120;0.48
3513;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2009;85110;0.51
3514;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2010;89035;0.53
3515;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2011;92870;0.55
3516;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2012;95915;0.56
3517;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2013;96350;0.56
3518;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2014;86865;0.51
3519;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2015;86710;0.5
3520;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2016;88550;0.51
3521;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2017;89770;0.51
3522;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2018;91175;0.52
3523;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2019;93115;0.53
3524;Total male and female;10000;Total background and generation;L02 Endocrine therapy;2020;94785;0.53
3525;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2006;32345;0.19
3526;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2007;35820;0.21
3527;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2008;37825;0.23
3528;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2009;39065;0.23
3529;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2010;39965;0.24
3530;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2011;40715;0.24
3531;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2012;40930;0.24
3532;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2013;39665;0.23
3533;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2014;28640;0.17
3534;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2015;27875;0.16
3535;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2016;28775;0.17
3536;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2017;29645;0.17
3537;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2018;31360;0.18
3538;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2019;33245;0.19
3539;Total male and female;10000;Total background and generation;L02A Hormones and related agents;2020;35345;0.2
3540;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2006;49530;0.3
3541;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2007;51800;0.31
3542;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2008;53760;0.32
3543;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2009;57120;0.34
3544;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2010;60400;0.36
3545;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2011;63440;0.37
3546;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2012;66640;0.39
3547;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2013;67655;0.39
3548;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2014;68775;0.4
3549;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2015;69120;0.4
3550;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2016;70035;0.4
3551;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2017;70225;0.4
3552;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2018;69740;0.4
3553;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2019;70035;0.4
3554;Total male and female;10000;Total background and generation;L02B Hormone antagonists/related agents;2020;69410;0.39
3555;Total male and female;10000;Total background and generation;L03 Immunostimulants;2006;12960;0.08
3556;Total male and female;10000;Total background and generation;L03 Immunostimulants;2007;13910;0.08
3557;Total male and female;10000;Total background and generation;L03 Immunostimulants;2008;15100;0.09
3558;Total male and female;10000;Total background and generation;L03 Immunostimulants;2009;15990;0.09
3559;Total male and female;10000;Total background and generation;L03 Immunostimulants;2010;16380;0.1
3560;Total male and female;10000;Total background and generation;L03 Immunostimulants;2011;16945;0.1
3561;Total male and female;10000;Total background and generation;L03 Immunostimulants;2012;17710;0.1
3562;Total male and female;10000;Total background and generation;L03 Immunostimulants;2013;17610;0.1
3563;Total male and female;10000;Total background and generation;L03 Immunostimulants;2014;16380;0.1
3564;Total male and female;10000;Total background and generation;L03 Immunostimulants;2015;14910;0.09
3565;Total male and female;10000;Total background and generation;L03 Immunostimulants;2016;13370;0.08
3566;Total male and female;10000;Total background and generation;L03 Immunostimulants;2017;12400;0.07
3567;Total male and female;10000;Total background and generation;L03 Immunostimulants;2018;12940;0.07
3568;Total male and female;10000;Total background and generation;L03 Immunostimulants;2019;13555;0.08
3569;Total male and female;10000;Total background and generation;L03 Immunostimulants;2020;13275;0.07
3570;Total male and female;10000;Total background and generation;L03A Immunostimulants;2006;12960;0.08
3571;Total male and female;10000;Total background and generation;L03A Immunostimulants;2007;13910;0.08
3572;Total male and female;10000;Total background and generation;L03A Immunostimulants;2008;15100;0.09
3573;Total male and female;10000;Total background and generation;L03A Immunostimulants;2009;15990;0.09
3574;Total male and female;10000;Total background and generation;L03A Immunostimulants;2010;16380;0.1
3575;Total male and female;10000;Total background and generation;L03A Immunostimulants;2011;16945;0.1
3576;Total male and female;10000;Total background and generation;L03A Immunostimulants;2012;17710;0.1
3577;Total male and female;10000;Total background and generation;L03A Immunostimulants;2013;17610;0.1
3578;Total male and female;10000;Total background and generation;L03A Immunostimulants;2014;16380;0.1
3579;Total male and female;10000;Total background and generation;L03A Immunostimulants;2015;14910;0.09
3580;Total male and female;10000;Total background and generation;L03A Immunostimulants;2016;13370;0.08
3581;Total male and female;10000;Total background and generation;L03A Immunostimulants;2017;12400;0.07
3582;Total male and female;10000;Total background and generation;L03A Immunostimulants;2018;12940;0.07
3583;Total male and female;10000;Total background and generation;L03A Immunostimulants;2019;13555;0.08
3584;Total male and female;10000;Total background and generation;L03A Immunostimulants;2020;13275;0.07
3585;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2006;84435;0.51
3586;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2007;91890;0.55
3587;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2008;100535;0.6
3588;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2009;108835;0.65
3589;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2010;116995;0.69
3590;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2011;123875;0.73
3591;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2012;109980;0.64
3592;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2013;112775;0.66
3593;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2014;117655;0.68
3594;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2015;121310;0.7
3595;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2016;123885;0.71
3596;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2017;143720;0.82
3597;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2018;147405;0.84
3598;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2019;154680;0.87
3599;Total male and female;10000;Total background and generation;L04 Immunosuppressants;2020;156665;0.88
3600;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2006;84435;0.51
3601;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2007;91890;0.55
3602;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2008;100535;0.6
3603;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2009;108835;0.65
3604;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2010;116995;0.69
3605;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2011;123875;0.73
3606;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2012;109980;0.64
3607;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2013;112775;0.66
3608;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2014;117655;0.68
3609;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2015;121310;0.7
3610;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2016;123885;0.71
3611;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2017;143720;0.82
3612;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2018;147405;0.84
3613;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2019;154680;0.87
3614;Total male and female;10000;Total background and generation;L04A Immunosuppressants;2020;156665;0.88
3615;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2006;3024475;18.17
3616;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2007;3094730;18.55
3617;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2008;3106035;18.53
3618;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2009;3119055;18.52
3619;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2010;3127320;18.47
3620;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2011;3146505;18.49
3621;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2012;3052630;17.87
3622;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2013;2911940;17.0
3623;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2014;2852375;16.58
3624;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2015;2789835;16.14
3625;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2016;2731290;15.71
3626;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2017;2674340;15.29
3627;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2018;2627120;14.93
3628;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2019;2555340;14.42
3629;Total male and female;10000;Total background and generation;M Musculo-skeletal system;2020;2321380;13.04
3630;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2006;2812715;16.9
3631;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2007;2862500;17.16
3632;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2008;2858025;17.05
3633;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2009;2854440;16.95
3634;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2010;2844945;16.8
3635;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2011;2855190;16.78
3636;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2012;2750160;16.1
3637;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2013;2600980;15.18
3638;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2014;2535710;14.74
3639;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2015;2469855;14.29
3640;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2016;2405635;13.83
3641;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2017;2345315;13.41
3642;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2018;2294775;13.04
3643;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2019;2217290;12.51
3644;Total male and female;10000;Total background and generation;M01 Antiinflammatory/antirheumatic prod.;2020;1977385;11.11
3645;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2006;2812455;16.9
3646;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2007;2862280;17.16
3647;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2008;2857870;17.05
3648;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2009;2854315;16.95
3649;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2010;2844820;16.8
3650;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2011;2855085;16.78
3651;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2012;2750045;16.1
3652;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2013;2600895;15.18
3653;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2014;2535615;14.74
3654;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2015;2469770;14.29
3655;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2016;2405555;13.83
3656;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2017;2345220;13.41
3657;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2018;2294705;13.04
3658;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2019;2217220;12.51
3659;Total male and female;10000;Total background and generation;M01A Anti-inflammatory/-rheumatic prod.;2020;1977345;11.11
3660;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2006;0;0.0
3661;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2007;0;0.0
3662;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2008;0;0.0
3663;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2009;0;0.0
3664;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2010;0;0.0
3665;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2011;0;0.0
3666;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2012;0;0.0
3667;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2013;0;0.0
3668;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2014;0;0.0
3669;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2015;0;0.0
3670;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2016;0;0.0
3671;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2017;0;0.0
3672;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2018;0;0.0
3673;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2019;0;0.0
3674;Total male and female;10000;Total background and generation;M01B Anti-inflammatory/-rheumatic comb.;2020;0;0.0
3675;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2006;780;0.0
3676;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2007;615;0.0
3677;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2008;455;0.0
3678;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2009;325;0.0
3679;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2010;285;0.0
3680;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2011;255;0.0
3681;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2012;235;0.0
3682;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2013;185;0.0
3683;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2014;170;0.0
3684;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2015;175;0.0
3685;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2016;145;0.0
3686;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2017;150;0.0
3687;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2018;115;0.0
3688;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2019;105;0.0
3689;Total male and female;10000;Total background and generation;M01C Specific antirheumatic agents;2020;60;0.0
3690;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2006;7480;0.04
3691;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2007;7340;0.04
3692;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2008;6735;0.04
3693;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2009;6520;0.04
3694;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2010;8060;0.05
3695;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2011;4370;0.03
3696;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2012;1130;0.01
3697;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2013;765;0.0
3698;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2014;460;0.0
3699;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2015;350;0.0
3700;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2016;255;0.0
3701;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2017;175;0.0
3702;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2018;110;0.0
3703;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2019;85;0.0
3704;Total male and female;10000;Total background and generation;M02 Topical joint/muscular pain products;2020;70;0.0
3705;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2006;7480;0.04
3706;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2007;7340;0.04
3707;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2008;6735;0.04
3708;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2009;6520;0.04
3709;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2010;8060;0.05
3710;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2011;4370;0.03
3711;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2012;1130;0.01
3712;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2013;765;0.0
3713;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2014;460;0.0
3714;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2015;350;0.0
3715;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2016;255;0.0
3716;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2017;175;0.0
3717;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2018;110;0.0
3718;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2019;85;0.0
3719;Total male and female;10000;Total background and generation;M02A Joint and muscular pain top. prod.;2020;70;0.0
3720;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2006;16760;0.1
3721;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2007;17300;0.1
3722;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2008;17730;0.11
3723;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2009;18840;0.11
3724;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2010;20820;0.12
3725;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2011;22135;0.13
3726;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2012;22850;0.13
3727;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2013;24465;0.14
3728;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2014;25905;0.15
3729;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2015;26250;0.15
3730;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2016;27090;0.16
3731;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2017;27600;0.16
3732;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2018;26945;0.15
3733;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2019;27080;0.15
3734;Total male and female;10000;Total background and generation;M03 Muscle relaxants;2020;27515;0.15
3735;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2006;1175;0.01
3736;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2007;1350;0.01
3737;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2008;1435;0.01
3738;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2009;1660;0.01
3739;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2010;1960;0.01
3740;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2011;2120;0.01
3741;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2012;2475;0.01
3742;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2013;3070;0.02
3743;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2014;3645;0.02
3744;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2015;3765;0.02
3745;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2016;4455;0.03
3746;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2017;4870;0.03
3747;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2018;4565;0.03
3748;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2019;4775;0.03
3749;Total male and female;10000;Total background and generation;M03A Muscle relaxants, peripheral.acting;2020;5425;0.03
3750;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2006;15185;0.09
3751;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2007;15555;0.09
3752;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2008;15910;0.09
3753;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2009;16820;0.1
3754;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2010;18505;0.11
3755;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2011;19670;0.12
3756;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2012;20015;0.12
3757;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2013;21055;0.12
3758;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2014;21975;0.13
3759;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2015;22225;0.13
3760;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2016;22420;0.13
3761;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2017;22530;0.13
3762;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2018;22200;0.13
3763;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2019;22155;0.13
3764;Total male and female;10000;Total background and generation;M03B Muscle relaxants, centrally acting;2020;21980;0.12
3765;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2006;795;0.0
3766;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2007;780;0.0
3767;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2008;770;0.0
3768;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2009;760;0.0
3769;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2010;755;0.0
3770;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2011;760;0.0
3771;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2012;730;0.0
3772;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2013;730;0.0
3773;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2014;675;0.0
3774;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2015;645;0.0
3775;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2016;630;0.0
3776;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2017;575;0.0
3777;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2018;530;0.0
3778;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2019;505;0.0
3779;Total male and female;10000;Total background and generation;M03C Muscle relaxants, directly acting;2020;430;0.0
3780;Total male and female;10000;Total background and generation;M04 Antigout preparations;2006;106880;0.64
3781;Total male and female;10000;Total background and generation;M04 Antigout preparations;2007;113420;0.68
3782;Total male and female;10000;Total background and generation;M04 Antigout preparations;2008;123060;0.73
3783;Total male and female;10000;Total background and generation;M04 Antigout preparations;2009;132535;0.79
3784;Total male and female;10000;Total background and generation;M04 Antigout preparations;2010;141490;0.84
3785;Total male and female;10000;Total background and generation;M04 Antigout preparations;2011;149500;0.88
3786;Total male and female;10000;Total background and generation;M04 Antigout preparations;2012;158095;0.93
3787;Total male and female;10000;Total background and generation;M04 Antigout preparations;2013;166730;0.97
3788;Total male and female;10000;Total background and generation;M04 Antigout preparations;2014;175240;1.02
3789;Total male and female;10000;Total background and generation;M04 Antigout preparations;2015;182320;1.05
3790;Total male and female;10000;Total background and generation;M04 Antigout preparations;2016;190210;1.09
3791;Total male and female;10000;Total background and generation;M04 Antigout preparations;2017;195520;1.12
3792;Total male and female;10000;Total background and generation;M04 Antigout preparations;2018;201745;1.15
3793;Total male and female;10000;Total background and generation;M04 Antigout preparations;2019;205620;1.16
3794;Total male and female;10000;Total background and generation;M04 Antigout preparations;2020;207155;1.16
3795;Total male and female;10000;Total background and generation;M04A Antigout preparations;2006;106880;0.64
3796;Total male and female;10000;Total background and generation;M04A Antigout preparations;2007;113420;0.68
3797;Total male and female;10000;Total background and generation;M04A Antigout preparations;2008;123060;0.73
3798;Total male and female;10000;Total background and generation;M04A Antigout preparations;2009;132535;0.79
3799;Total male and female;10000;Total background and generation;M04A Antigout preparations;2010;141490;0.84
3800;Total male and female;10000;Total background and generation;M04A Antigout preparations;2011;149500;0.88
3801;Total male and female;10000;Total background and generation;M04A Antigout preparations;2012;158095;0.93
3802;Total male and female;10000;Total background and generation;M04A Antigout preparations;2013;166730;0.97
3803;Total male and female;10000;Total background and generation;M04A Antigout preparations;2014;175240;1.02
3804;Total male and female;10000;Total background and generation;M04A Antigout preparations;2015;182320;1.05
3805;Total male and female;10000;Total background and generation;M04A Antigout preparations;2016;190210;1.09
3806;Total male and female;10000;Total background and generation;M04A Antigout preparations;2017;195520;1.12
3807;Total male and female;10000;Total background and generation;M04A Antigout preparations;2018;201745;1.15
3808;Total male and female;10000;Total background and generation;M04A Antigout preparations;2019;205620;1.16
3809;Total male and female;10000;Total background and generation;M04A Antigout preparations;2020;207155;1.16
3810;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2006;229235;1.38
3811;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2007;247200;1.48
3812;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2008;256215;1.53
3813;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2009;265120;1.57
3814;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2010;270875;1.6
3815;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2011;270990;1.59
3816;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2012;269470;1.58
3817;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2013;260760;1.52
3818;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2014;250855;1.46
3819;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2015;242125;1.4
3820;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2016;234815;1.35
3821;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2017;228545;1.31
3822;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2018;223530;1.27
3823;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2019;223100;1.26
3824;Total male and female;10000;Total background and generation;M05 Drugs for treatment of bone diseases;2020;217685;1.22
3825;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2006;229235;1.38
3826;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2007;247200;1.48
3827;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2008;256215;1.53
3828;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2009;265120;1.57
3829;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2010;270875;1.6
3830;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2011;270990;1.59
3831;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2012;269470;1.58
3832;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2013;260760;1.52
3833;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2014;250855;1.46
3834;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2015;242125;1.4
3835;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2016;234815;1.35
3836;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2017;228545;1.31
3837;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2018;223530;1.27
3838;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2019;223100;1.26
3839;Total male and female;10000;Total background and generation;M05B Bone structure and mineralization .;2020;217685;1.22
3840;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2006;590;0.0
3841;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2007;395;0.0
3842;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2008;60;0.0
3843;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2009;25;0.0
3844;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2010;20;0.0
3845;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2011;10;0.0
3846;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2012;5;0.0
3847;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2013;25;0.0
3848;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2014;0;0.0
3849;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2015;5;0.0
3850;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2016;5;0.0
3851;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2017;0;0.0
3852;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2018;0;0.0
3853;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2019;0;0.0
3854;Total male and female;10000;Total background and generation;M09 Oth.drugs for musculo-skelet.disord.;2020;0;0.0
3855;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2006;590;0.0
3856;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2007;395;0.0
3857;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2008;60;0.0
3858;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2009;25;0.0
3859;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2010;20;0.0
3860;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2011;10;0.0
3861;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2012;5;0.0
3862;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2013;25;0.0
3863;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2014;0;0.0
3864;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2015;5;0.0
3865;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2016;5;0.0
3866;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2017;0;0.0
3867;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2018;0;0.0
3868;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2019;0;0.0
3869;Total male and female;10000;Total background and generation;M09A Oth.disord.musculoskelet.syst.drugs;2020;0;0.0
3870;Total male and female;10000;Total background and generation;N Nervous system;2006;3207825;19.27
3871;Total male and female;10000;Total background and generation;N Nervous system;2007;3345930;20.06
3872;Total male and female;10000;Total background and generation;N Nervous system;2008;3398070;20.27
3873;Total male and female;10000;Total background and generation;N Nervous system;2009;2658570;15.79
3874;Total male and female;10000;Total background and generation;N Nervous system;2010;2740535;16.19
3875;Total male and female;10000;Total background and generation;N Nervous system;2011;2877030;16.91
3876;Total male and female;10000;Total background and generation;N Nervous system;2012;2905670;17.01
3877;Total male and female;10000;Total background and generation;N Nervous system;2013;2744495;16.02
3878;Total male and female;10000;Total background and generation;N Nervous system;2014;2824490;16.42
3879;Total male and female;10000;Total background and generation;N Nervous system;2015;2885835;16.69
3880;Total male and female;10000;Total background and generation;N Nervous system;2016;2944630;16.93
3881;Total male and female;10000;Total background and generation;N Nervous system;2017;2975975;17.02
3882;Total male and female;10000;Total background and generation;N Nervous system;2018;3004155;17.07
3883;Total male and female;10000;Total background and generation;N Nervous system;2019;2893720;16.33
3884;Total male and female;10000;Total background and generation;N Nervous system;2020;2854540;16.04
3885;Total male and female;10000;Total background and generation;N01 Anesthetics;2006;177415;1.07
3886;Total male and female;10000;Total background and generation;N01 Anesthetics;2007;204400;1.23
3887;Total male and female;10000;Total background and generation;N01 Anesthetics;2008;196975;1.18
3888;Total male and female;10000;Total background and generation;N01 Anesthetics;2009;181835;1.08
3889;Total male and female;10000;Total background and generation;N01 Anesthetics;2010;190870;1.13
3890;Total male and female;10000;Total background and generation;N01 Anesthetics;2011;196505;1.15
3891;Total male and female;10000;Total background and generation;N01 Anesthetics;2012;203100;1.19
3892;Total male and female;10000;Total background and generation;N01 Anesthetics;2013;198985;1.16
3893;Total male and female;10000;Total background and generation;N01 Anesthetics;2014;223200;1.3
3894;Total male and female;10000;Total background and generation;N01 Anesthetics;2015;224070;1.3
3895;Total male and female;10000;Total background and generation;N01 Anesthetics;2016;219745;1.26
3896;Total male and female;10000;Total background and generation;N01 Anesthetics;2017;191265;1.09
3897;Total male and female;10000;Total background and generation;N01 Anesthetics;2018;197090;1.12
3898;Total male and female;10000;Total background and generation;N01 Anesthetics;2019;205125;1.16
3899;Total male and female;10000;Total background and generation;N01 Anesthetics;2020;190310;1.07
3900;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2006;2640;0.02
3901;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2007;2595;0.02
3902;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2008;2655;0.02
3903;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2009;2520;0.01
3904;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2010;2830;0.02
3905;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2011;1935;0.01
3906;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2012;1855;0.01
3907;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2013;2250;0.01
3908;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2014;2260;0.01
3909;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2015;2245;0.01
3910;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2016;2905;0.02
3911;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2017;4285;0.02
3912;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2018;4730;0.03
3913;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2019;5395;0.03
3914;Total male and female;10000;Total background and generation;N01A Anesthetics, general;2020;5745;0.03
3915;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2006;175320;1.05
3916;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2007;202010;1.21
3917;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2008;194635;1.16
3918;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2009;179565;1.07
3919;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2010;188305;1.11
3920;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2011;194710;1.14
3921;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2012;201470;1.18
3922;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2013;197365;1.15
3923;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2014;221715;1.29
3924;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2015;222555;1.29
3925;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2016;218200;1.25
3926;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2017;189585;1.08
3927;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2018;195345;1.11
3928;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2019;203390;1.15
3929;Total male and female;10000;Total background and generation;N01B Anesthetics, local;2020;188890;1.06
3930;Total male and female;10000;Total background and generation;N02 Analgesics;2006;1038690;6.24
3931;Total male and female;10000;Total background and generation;N02 Analgesics;2007;1113985;6.68
3932;Total male and female;10000;Total background and generation;N02 Analgesics;2008;1165040;6.95
3933;Total male and female;10000;Total background and generation;N02 Analgesics;2009;1224140;7.27
3934;Total male and female;10000;Total background and generation;N02 Analgesics;2010;1284115;7.58
3935;Total male and female;10000;Total background and generation;N02 Analgesics;2011;1361375;8.0
3936;Total male and female;10000;Total background and generation;N02 Analgesics;2012;1398535;8.19
3937;Total male and female;10000;Total background and generation;N02 Analgesics;2013;1145215;6.69
3938;Total male and female;10000;Total background and generation;N02 Analgesics;2014;1199070;6.97
3939;Total male and female;10000;Total background and generation;N02 Analgesics;2015;1256395;7.27
3940;Total male and female;10000;Total background and generation;N02 Analgesics;2016;1318480;7.58
3941;Total male and female;10000;Total background and generation;N02 Analgesics;2017;1377450;7.88
3942;Total male and female;10000;Total background and generation;N02 Analgesics;2018;1400435;7.96
3943;Total male and female;10000;Total background and generation;N02 Analgesics;2019;1201165;6.78
3944;Total male and female;10000;Total background and generation;N02 Analgesics;2020;1162135;6.53
3945;Total male and female;10000;Total background and generation;N02A Opioids;2006;595970;3.58
3946;Total male and female;10000;Total background and generation;N02A Opioids;2007;651730;3.91
3947;Total male and female;10000;Total background and generation;N02A Opioids;2008;697415;4.16
3948;Total male and female;10000;Total background and generation;N02A Opioids;2009;745095;4.42
3949;Total male and female;10000;Total background and generation;N02A Opioids;2010;805005;4.75
3950;Total male and female;10000;Total background and generation;N02A Opioids;2011;860135;5.05
3951;Total male and female;10000;Total background and generation;N02A Opioids;2012;898340;5.26
3952;Total male and female;10000;Total background and generation;N02A Opioids;2013;814210;4.75
3953;Total male and female;10000;Total background and generation;N02A Opioids;2014;863110;5.02
3954;Total male and female;10000;Total background and generation;N02A Opioids;2015;921765;5.33
3955;Total male and female;10000;Total background and generation;N02A Opioids;2016;975990;5.61
3956;Total male and female;10000;Total background and generation;N02A Opioids;2017;1027020;5.87
3957;Total male and female;10000;Total background and generation;N02A Opioids;2018;1030530;5.86
3958;Total male and female;10000;Total background and generation;N02A Opioids;2019;999700;5.64
3959;Total male and female;10000;Total background and generation;N02A Opioids;2020;966020;5.43
3960;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2006;316305;1.9
3961;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2007;335430;2.01
3962;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2008;345160;2.06
3963;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2009;363620;2.16
3964;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2010;370420;2.19
3965;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2011;402925;2.37
3966;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2012;417265;2.44
3967;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2013;194540;1.14
3968;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2014;218150;1.27
3969;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2015;242905;1.41
3970;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2016;270270;1.55
3971;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2017;294810;1.69
3972;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2018;330375;1.88
3973;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2019;5010;0.03
3974;Total male and female;10000;Total background and generation;N02B Other analgesics and antipyretics;2020;4510;0.03
3975;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2006;220270;1.32
3976;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2007;229415;1.38
3977;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2008;231460;1.38
3978;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2009;235645;1.4
3979;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2010;243755;1.44
3980;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2011;251335;1.48
3981;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2012;248115;1.45
3982;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2013;242790;1.42
3983;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2014;239930;1.39
3984;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2015;231880;1.34
3985;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2016;228970;1.32
3986;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2017;227060;1.3
3987;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2018;226570;1.29
3988;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2019;228280;1.29
3989;Total male and female;10000;Total background and generation;N02C Antimigraine preparations;2020;222140;1.25
3990;Total male and female;10000;Total background and generation;N03 Antiepileptics;2006;245220;1.47
3991;Total male and female;10000;Total background and generation;N03 Antiepileptics;2007;257800;1.55
3992;Total male and female;10000;Total background and generation;N03 Antiepileptics;2008;268835;1.6
3993;Total male and female;10000;Total background and generation;N03 Antiepileptics;2009;267565;1.59
3994;Total male and female;10000;Total background and generation;N03 Antiepileptics;2010;269660;1.59
3995;Total male and female;10000;Total background and generation;N03 Antiepileptics;2011;284290;1.67
3996;Total male and female;10000;Total background and generation;N03 Antiepileptics;2012;298345;1.75
3997;Total male and female;10000;Total background and generation;N03 Antiepileptics;2013;309175;1.8
3998;Total male and female;10000;Total background and generation;N03 Antiepileptics;2014;323740;1.88
3999;Total male and female;10000;Total background and generation;N03 Antiepileptics;2015;337415;1.95
4000;Total male and female;10000;Total background and generation;N03 Antiepileptics;2016;347535;2.0
4001;Total male and female;10000;Total background and generation;N03 Antiepileptics;2017;351860;2.01
4002;Total male and female;10000;Total background and generation;N03 Antiepileptics;2018;353225;2.01
4003;Total male and female;10000;Total background and generation;N03 Antiepileptics;2019;358755;2.02
4004;Total male and female;10000;Total background and generation;N03 Antiepileptics;2020;356490;2.0
4005;Total male and female;10000;Total background and generation;N03A Antiepileptics;2006;245220;1.47
4006;Total male and female;10000;Total background and generation;N03A Antiepileptics;2007;257800;1.55
4007;Total male and female;10000;Total background and generation;N03A Antiepileptics;2008;268835;1.6
4008;Total male and female;10000;Total background and generation;N03A Antiepileptics;2009;267565;1.59
4009;Total male and female;10000;Total background and generation;N03A Antiepileptics;2010;269660;1.59
4010;Total male and female;10000;Total background and generation;N03A Antiepileptics;2011;284290;1.67
4011;Total male and female;10000;Total background and generation;N03A Antiepileptics;2012;298345;1.75
4012;Total male and female;10000;Total background and generation;N03A Antiepileptics;2013;309175;1.8
4013;Total male and female;10000;Total background and generation;N03A Antiepileptics;2014;323740;1.88
4014;Total male and female;10000;Total background and generation;N03A Antiepileptics;2015;337415;1.95
4015;Total male and female;10000;Total background and generation;N03A Antiepileptics;2016;347535;2.0
4016;Total male and female;10000;Total background and generation;N03A Antiepileptics;2017;351860;2.01
4017;Total male and female;10000;Total background and generation;N03A Antiepileptics;2018;353225;2.01
4018;Total male and female;10000;Total background and generation;N03A Antiepileptics;2019;358755;2.02
4019;Total male and female;10000;Total background and generation;N03A Antiepileptics;2020;356490;2.0
4020;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2006;63500;0.38
4021;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2007;74700;0.45
4022;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2008;82725;0.49
4023;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2009;88515;0.53
4024;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2010;86720;0.51
4025;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2011;88575;0.52
4026;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2012;88730;0.52
4027;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2013;88700;0.52
4028;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2014;89785;0.52
4029;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2015;90950;0.53
4030;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2016;92035;0.53
4031;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2017;92435;0.53
4032;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2018;93395;0.53
4033;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2019;93915;0.53
4034;Total male and female;10000;Total background and generation;N04 Anti-parkinson drugs;2020;93845;0.53
4035;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2006;19230;0.12
4036;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2007;18815;0.11
4037;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2008;18055;0.11
4038;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2009;17315;0.1
4039;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2010;16900;0.1
4040;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2011;16650;0.1
4041;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2012;16445;0.1
4042;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2013;16025;0.09
4043;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2014;15480;0.09
4044;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2015;15190;0.09
4045;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2016;14745;0.08
4046;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2017;14275;0.08
4047;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2018;13980;0.08
4048;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2019;13250;0.07
4049;Total male and female;10000;Total background and generation;N04A Anticholinergic agents;2020;12880;0.07
4050;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2006;45790;0.28
4051;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2007;57400;0.34
4052;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2008;66150;0.39
4053;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2009;72535;0.43
4054;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2010;71045;0.42
4055;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2011;73080;0.43
4056;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2012;73365;0.43
4057;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2013;73675;0.43
4058;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2014;75285;0.44
4059;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2015;76735;0.44
4060;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2016;78220;0.45
4061;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2017;79035;0.45
4062;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2018;80330;0.46
4063;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2019;81490;0.46
4064;Total male and female;10000;Total background and generation;N04B Dopaminergic agents;2020;81735;0.46
4065;Total male and female;10000;Total background and generation;N05 Psycholeptics;2006;1852650;11.13
4066;Total male and female;10000;Total background and generation;N05 Psycholeptics;2007;1894905;11.36
4067;Total male and female;10000;Total background and generation;N05 Psycholeptics;2008;1890355;11.28
4068;Total male and female;10000;Total background and generation;N05 Psycholeptics;2009;549270;3.26
4069;Total male and female;10000;Total background and generation;N05 Psycholeptics;2010;573230;3.39
4070;Total male and female;10000;Total background and generation;N05 Psycholeptics;2011;606865;3.57
4071;Total male and female;10000;Total background and generation;N05 Psycholeptics;2012;612195;3.58
4072;Total male and female;10000;Total background and generation;N05 Psycholeptics;2013;604750;3.53
4073;Total male and female;10000;Total background and generation;N05 Psycholeptics;2014;623120;3.62
4074;Total male and female;10000;Total background and generation;N05 Psycholeptics;2015;640795;3.71
4075;Total male and female;10000;Total background and generation;N05 Psycholeptics;2016;656825;3.78
4076;Total male and female;10000;Total background and generation;N05 Psycholeptics;2017;674485;3.86
4077;Total male and female;10000;Total background and generation;N05 Psycholeptics;2018;691710;3.93
4078;Total male and female;10000;Total background and generation;N05 Psycholeptics;2019;700390;3.95
4079;Total male and female;10000;Total background and generation;N05 Psycholeptics;2020;705075;3.96
4080;Total male and female;10000;Total background and generation;N05A Antipsychotics;2006;232425;1.4
4081;Total male and female;10000;Total background and generation;N05A Antipsychotics;2007;244805;1.47
4082;Total male and female;10000;Total background and generation;N05A Antipsychotics;2008;251955;1.5
4083;Total male and female;10000;Total background and generation;N05A Antipsychotics;2009;258280;1.53
4084;Total male and female;10000;Total background and generation;N05A Antipsychotics;2010;268780;1.59
4085;Total male and female;10000;Total background and generation;N05A Antipsychotics;2011;279540;1.64
4086;Total male and female;10000;Total background and generation;N05A Antipsychotics;2012;286625;1.68
4087;Total male and female;10000;Total background and generation;N05A Antipsychotics;2013;293670;1.71
4088;Total male and female;10000;Total background and generation;N05A Antipsychotics;2014;305390;1.78
4089;Total male and female;10000;Total background and generation;N05A Antipsychotics;2015;314755;1.82
4090;Total male and female;10000;Total background and generation;N05A Antipsychotics;2016;320885;1.85
4091;Total male and female;10000;Total background and generation;N05A Antipsychotics;2017;326975;1.87
4092;Total male and female;10000;Total background and generation;N05A Antipsychotics;2018;337015;1.92
4093;Total male and female;10000;Total background and generation;N05A Antipsychotics;2019;343170;1.94
4094;Total male and female;10000;Total background and generation;N05A Antipsychotics;2020;354380;1.99
4095;Total male and female;10000;Total background and generation;N05B Anxiolytics;2006;1163235;6.99
4096;Total male and female;10000;Total background and generation;N05B Anxiolytics;2007;1184070;7.1
4097;Total male and female;10000;Total background and generation;N05B Anxiolytics;2008;1174575;7.01
4098;Total male and female;10000;Total background and generation;N05B Anxiolytics;2009;273590;1.62
4099;Total male and female;10000;Total background and generation;N05B Anxiolytics;2010;291815;1.72
4100;Total male and female;10000;Total background and generation;N05B Anxiolytics;2011;312625;1.84
4101;Total male and female;10000;Total background and generation;N05B Anxiolytics;2012;311605;1.82
4102;Total male and female;10000;Total background and generation;N05B Anxiolytics;2013;302300;1.76
4103;Total male and female;10000;Total background and generation;N05B Anxiolytics;2014;305920;1.78
4104;Total male and female;10000;Total background and generation;N05B Anxiolytics;2015;308915;1.79
4105;Total male and female;10000;Total background and generation;N05B Anxiolytics;2016;315165;1.81
4106;Total male and female;10000;Total background and generation;N05B Anxiolytics;2017;322760;1.85
4107;Total male and female;10000;Total background and generation;N05B Anxiolytics;2018;325150;1.85
4108;Total male and female;10000;Total background and generation;N05B Anxiolytics;2019;323240;1.82
4109;Total male and female;10000;Total background and generation;N05B Anxiolytics;2020;316815;1.78
4110;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2006;847170;5.09
4111;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2007;867425;5.2
4112;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2008;864605;5.16
4113;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2009;163955;0.97
4114;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2010;170780;1.01
4115;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2011;185080;1.09
4116;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2012;188015;1.1
4117;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2013;184575;1.08
4118;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2014;195565;1.14
4119;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2015;207540;1.2
4120;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2016;218180;1.25
4121;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2017;228695;1.31
4122;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2018;237430;1.35
4123;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2019;239585;1.35
4124;Total male and female;10000;Total background and generation;N05C Hypnotics and sedatives;2020;241660;1.36
4125;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2006;942170;5.66
4126;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2007;999390;5.99
4127;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2008;1029825;6.14
4128;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2009;1055950;6.27
4129;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2010;1089635;6.44
4130;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2011;1142260;6.71
4131;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2012;1162915;6.81
4132;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2013;1193310;6.97
4133;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2014;1220390;7.1
4134;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2015;1242070;7.19
4135;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2016;1248260;7.18
4136;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2017;1246920;7.13
4137;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2018;1260780;7.16
4138;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2019;1277350;7.21
4139;Total male and female;10000;Total background and generation;N06 Psychoanaleptics;2020;1269905;7.13
4140;Total male and female;10000;Total background and generation;N06A Antidepressants;2006;851935;5.12
4141;Total male and female;10000;Total background and generation;N06A Antidepressants;2007;892765;5.35
4142;Total male and female;10000;Total background and generation;N06A Antidepressants;2008;905190;5.4
4143;Total male and female;10000;Total background and generation;N06A Antidepressants;2009;912650;5.42
4144;Total male and female;10000;Total background and generation;N06A Antidepressants;2010;925470;5.47
4145;Total male and female;10000;Total background and generation;N06A Antidepressants;2011;960005;5.64
4146;Total male and female;10000;Total background and generation;N06A Antidepressants;2012;967230;5.66
4147;Total male and female;10000;Total background and generation;N06A Antidepressants;2013;988885;5.77
4148;Total male and female;10000;Total background and generation;N06A Antidepressants;2014;1005330;5.85
4149;Total male and female;10000;Total background and generation;N06A Antidepressants;2015;1023185;5.92
4150;Total male and female;10000;Total background and generation;N06A Antidepressants;2016;1028410;5.91
4151;Total male and female;10000;Total background and generation;N06A Antidepressants;2017;1030420;5.89
4152;Total male and female;10000;Total background and generation;N06A Antidepressants;2018;1046030;5.94
4153;Total male and female;10000;Total background and generation;N06A Antidepressants;2019;1058260;5.97
4154;Total male and female;10000;Total background and generation;N06A Antidepressants;2020;1048565;5.89
4155;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2006;78390;0.47
4156;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2007;95640;0.57
4157;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2008;112520;0.67
4158;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2009;130490;0.77
4159;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2010;152595;0.9
4160;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2011;172275;1.01
4161;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2012;186935;1.09
4162;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2013;199320;1.16
4163;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2014;213855;1.24
4164;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2015;220980;1.28
4165;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2016;225195;1.3
4166;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2017;225700;1.29
4167;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2018;227395;1.29
4168;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2019;234790;1.32
4169;Total male and female;10000;Total background and generation;N06B Psychostimul.,adhd agents,nootropic;2020;238670;1.34
4170;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2006;0;0.0
4171;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2007;0;0.0
4172;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2008;0;0.0
4173;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2009;0;0.0
4174;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2010;0;0.0
4175;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2011;0;0.0
4176;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2012;0;0.0
4177;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2013;0;0.0
4178;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2014;0;0.0
4179;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2015;0;0.0
4180;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2016;0;0.0
4181;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2017;0;0.0
4182;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2018;0;0.0
4183;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2019;0;0.0
4184;Total male and female;10000;Total background and generation;N06C Psycholeptics, -analeptics combin.;2020;0;0.0
4185;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2006;25380;0.15
4186;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2007;27725;0.17
4187;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2008;31870;0.19
4188;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2009;35130;0.21
4189;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2010;37340;0.22
4190;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2011;38330;0.23
4191;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2012;38320;0.22
4192;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2013;36475;0.21
4193;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2014;34265;0.2
4194;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2015;32240;0.19
4195;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2016;29700;0.17
4196;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2017;24860;0.14
4197;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2018;21670;0.12
4198;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2019;20475;0.12
4199;Total male and female;10000;Total background and generation;N06D Anti-dementia drugs;2020;19630;0.11
4200;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2006;150640;0.91
4201;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2007;153110;0.92
4202;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2008;150635;0.9
4203;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2009;149225;0.89
4204;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2010;149570;0.88
4205;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2011;181900;1.07
4206;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2012;143335;0.84
4207;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2013;164780;0.96
4208;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2014;155960;0.91
4209;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2015;155715;0.9
4210;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2016;162770;0.94
4211;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2017;162455;0.93
4212;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2018;141570;0.8
4213;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2019;135940;0.77
4214;Total male and female;10000;Total background and generation;N07 Other nervous system drugs;2020;143870;0.81
4215;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2006;8750;0.05
4216;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2007;8445;0.05
4217;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2008;7845;0.05
4218;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2009;7695;0.05
4219;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2010;7340;0.04
4220;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2011;7080;0.04
4221;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2012;6575;0.04
4222;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2013;6120;0.04
4223;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2014;6410;0.04
4224;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2015;6075;0.04
4225;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2016;5575;0.03
4226;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2017;5360;0.03
4227;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2018;5280;0.03
4228;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2019;6035;0.03
4229;Total male and female;10000;Total background and generation;N07A Parasympathomimetics;2020;6020;0.03
4230;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2006;22305;0.13
4231;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2007;24095;0.14
4232;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2008;25060;0.15
4233;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2009;25755;0.15
4234;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2010;26905;0.16
4235;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2011;60540;0.36
4236;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2012;27390;0.16
4237;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2013;56185;0.33
4238;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2014;49575;0.29
4239;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2015;53050;0.31
4240;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2016;62310;0.36
4241;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2017;66660;0.38
4242;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2018;51590;0.29
4243;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2019;53095;0.3
4244;Total male and female;10000;Total background and generation;N07B Drugs used in addictive disorders;2020;66025;0.37
4245;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2006;119125;0.72
4246;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2007;119910;0.72
4247;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2008;116965;0.7
4248;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2009;114935;0.68
4249;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2010;114340;0.68
4250;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2011;113520;0.67
4251;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2012;108165;0.63
4252;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2013;101435;0.59
4253;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2014;97825;0.57
4254;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2015;93415;0.54
4255;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2016;89800;0.52
4256;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2017;84390;0.48
4257;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2018;78510;0.45
4258;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2019;72765;0.41
4259;Total male and female;10000;Total background and generation;N07C Antivertigo preparations;2020;66960;0.38
4260;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2006;965;0.01
4261;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2007;1130;0.01
4262;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2008;1205;0.01
4263;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2009;1285;0.01
4264;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2010;1430;0.01
4265;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2011;1545;0.01
4266;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2012;1580;0.01
4267;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2013;1725;0.01
4268;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2014;2770;0.02
4269;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2015;3795;0.02
4270;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2016;5785;0.03
4271;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2017;6755;0.04
4272;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2018;6785;0.04
4273;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2019;4640;0.03
4274;Total male and female;10000;Total background and generation;N07X Other nervous system drugs;2020;5600;0.03
4275;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2006;180690;1.09
4276;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2007;181200;1.09
4277;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2008;185420;1.11
4278;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2009;190505;1.13
4279;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2010;197150;1.16
4280;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2011;205700;1.21
4281;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2012;206985;1.21
4282;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2013;204960;1.2
4283;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2014;211735;1.23
4284;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2015;205675;1.19
4285;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2016;202760;1.17
4286;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2017;202810;1.16
4287;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2018;202995;1.15
4288;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2019;203405;1.15
4289;Total male and female;10000;Total background and generation;P Antiparasitics,insecticides,repellents;2020;189355;1.06
4290;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2006;171060;1.03
4291;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2007;170670;1.02
4292;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2008;178715;1.07
4293;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2009;182470;1.08
4294;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2010;187365;1.11
4295;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2011;194490;1.14
4296;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2012;195225;1.14
4297;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2013;190885;1.11
4298;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2014;194090;1.13
4299;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2015;185255;1.07
4300;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2016;178430;1.03
4301;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2017;173305;0.99
4302;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2018;172165;0.98
4303;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2019;170360;0.96
4304;Total male and female;10000;Total background and generation;P01 Antiprotozoals;2020;153615;0.86
4305;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2006;136580;0.82
4306;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2007;144015;0.86
4307;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2008;147525;0.88
4308;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2009;151365;0.9
4309;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2010;153995;0.91
4310;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2011;158040;0.93
4311;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2012;156760;0.92
4312;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2013;149885;0.87
4313;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2014;150180;0.87
4314;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2015;139845;0.81
4315;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2016;132005;0.76
4316;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2017;125710;0.72
4317;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2018;124455;0.71
4318;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2019;120855;0.68
4319;Total male and female;10000;Total background and generation;P01A Amoebiasis / other protozoal dis.;2020;106440;0.6
4320;Total male and female;10000;Total background and generation;P01B Antimalarials;2006;34860;0.21
4321;Total male and female;10000;Total background and generation;P01B Antimalarials;2007;26880;0.16
4322;Total male and female;10000;Total background and generation;P01B Antimalarials;2008;31475;0.19
4323;Total male and female;10000;Total background and generation;P01B Antimalarials;2009;31400;0.19
4324;Total male and female;10000;Total background and generation;P01B Antimalarials;2010;33735;0.2
4325;Total male and female;10000;Total background and generation;P01B Antimalarials;2011;36785;0.22
4326;Total male and female;10000;Total background and generation;P01B Antimalarials;2012;38765;0.23
4327;Total male and female;10000;Total background and generation;P01B Antimalarials;2013;41315;0.24
4328;Total male and female;10000;Total background and generation;P01B Antimalarials;2014;44275;0.26
4329;Total male and female;10000;Total background and generation;P01B Antimalarials;2015;45715;0.26
4330;Total male and female;10000;Total background and generation;P01B Antimalarials;2016;46765;0.27
4331;Total male and female;10000;Total background and generation;P01B Antimalarials;2017;47925;0.27
4332;Total male and female;10000;Total background and generation;P01B Antimalarials;2018;48130;0.27
4333;Total male and female;10000;Total background and generation;P01B Antimalarials;2019;49915;0.28
4334;Total male and female;10000;Total background and generation;P01B Antimalarials;2020;47560;0.27
4335;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2006;110;0.0
4336;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2007;150;0.0
4337;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2008;160;0.0
4338;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2009;175;0.0
4339;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2010;185;0.0
4340;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2011;195;0.0
4341;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2012;210;0.0
4342;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2013;205;0.0
4343;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2014;205;0.0
4344;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2015;225;0.0
4345;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2016;200;0.0
4346;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2017;175;0.0
4347;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2018;105;0.0
4348;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2019;75;0.0
4349;Total male and female;10000;Total background and generation;P01C Leishmaniasis and trypanosomiasis;2020;70;0.0
4350;Total male and female;10000;Total background and generation;P02 Anthelmintics;2006;2140;0.01
4351;Total male and female;10000;Total background and generation;P02 Anthelmintics;2007;2185;0.01
4352;Total male and female;10000;Total background and generation;P02 Anthelmintics;2008;1905;0.01
4353;Total male and female;10000;Total background and generation;P02 Anthelmintics;2009;1810;0.01
4354;Total male and female;10000;Total background and generation;P02 Anthelmintics;2010;1745;0.01
4355;Total male and female;10000;Total background and generation;P02 Anthelmintics;2011;2015;0.01
4356;Total male and female;10000;Total background and generation;P02 Anthelmintics;2012;1570;0.01
4357;Total male and female;10000;Total background and generation;P02 Anthelmintics;2013;1500;0.01
4358;Total male and female;10000;Total background and generation;P02 Anthelmintics;2014;1350;0.01
4359;Total male and female;10000;Total background and generation;P02 Anthelmintics;2015;1330;0.01
4360;Total male and female;10000;Total background and generation;P02 Anthelmintics;2016;1450;0.01
4361;Total male and female;10000;Total background and generation;P02 Anthelmintics;2017;1475;0.01
4362;Total male and female;10000;Total background and generation;P02 Anthelmintics;2018;1655;0.01
4363;Total male and female;10000;Total background and generation;P02 Anthelmintics;2019;1640;0.01
4364;Total male and female;10000;Total background and generation;P02 Anthelmintics;2020;1320;0.01
4365;Total male and female;10000;Total background and generation;P02B Antitrematodals;2006;285;0.0
4366;Total male and female;10000;Total background and generation;P02B Antitrematodals;2007;365;0.0
4367;Total male and female;10000;Total background and generation;P02B Antitrematodals;2008;395;0.0
4368;Total male and female;10000;Total background and generation;P02B Antitrematodals;2009;465;0.0
4369;Total male and female;10000;Total background and generation;P02B Antitrematodals;2010;430;0.0
4370;Total male and female;10000;Total background and generation;P02B Antitrematodals;2011;435;0.0
4371;Total male and female;10000;Total background and generation;P02B Antitrematodals;2012;355;0.0
4372;Total male and female;10000;Total background and generation;P02B Antitrematodals;2013;365;0.0
4373;Total male and female;10000;Total background and generation;P02B Antitrematodals;2014;315;0.0
4374;Total male and female;10000;Total background and generation;P02B Antitrematodals;2015;305;0.0
4375;Total male and female;10000;Total background and generation;P02B Antitrematodals;2016;320;0.0
4376;Total male and female;10000;Total background and generation;P02B Antitrematodals;2017;325;0.0
4377;Total male and female;10000;Total background and generation;P02B Antitrematodals;2018;320;0.0
4378;Total male and female;10000;Total background and generation;P02B Antitrematodals;2019;300;0.0
4379;Total male and female;10000;Total background and generation;P02B Antitrematodals;2020;180;0.0
4380;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2006;650;0.0
4381;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2007;545;0.0
4382;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2008;330;0.0
4383;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2009;290;0.0
4384;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2010;250;0.0
4385;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2011;570;0.0
4386;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2012;325;0.0
4387;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2013;320;0.0
4388;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2014;270;0.0
4389;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2015;325;0.0
4390;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2016;350;0.0
4391;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2017;465;0.0
4392;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2018;465;0.0
4393;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2019;565;0.0
4394;Total male and female;10000;Total background and generation;P02C Antinematodal agents;2020;520;0.0
4395;Total male and female;10000;Total background and generation;P02D Anticestodals;2006;1225;0.01
4396;Total male and female;10000;Total background and generation;P02D Anticestodals;2007;1290;0.01
4397;Total male and female;10000;Total background and generation;P02D Anticestodals;2008;1195;0.01
4398;Total male and female;10000;Total background and generation;P02D Anticestodals;2009;1080;0.01
4399;Total male and female;10000;Total background and generation;P02D Anticestodals;2010;1080;0.01
4400;Total male and female;10000;Total background and generation;P02D Anticestodals;2011;1020;0.01
4401;Total male and female;10000;Total background and generation;P02D Anticestodals;2012;905;0.01
4402;Total male and female;10000;Total background and generation;P02D Anticestodals;2013;840;0.0
4403;Total male and female;10000;Total background and generation;P02D Anticestodals;2014;780;0.0
4404;Total male and female;10000;Total background and generation;P02D Anticestodals;2015;715;0.0
4405;Total male and female;10000;Total background and generation;P02D Anticestodals;2016;795;0.0
4406;Total male and female;10000;Total background and generation;P02D Anticestodals;2017;705;0.0
4407;Total male and female;10000;Total background and generation;P02D Anticestodals;2018;890;0.01
4408;Total male and female;10000;Total background and generation;P02D Anticestodals;2019;800;0.0
4409;Total male and female;10000;Total background and generation;P02D Anticestodals;2020;640;0.0
4410;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2006;7855;0.05
4411;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2007;8720;0.05
4412;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2008;5055;0.03
4413;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2009;6500;0.04
4414;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2010;8395;0.05
4415;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2011;9605;0.06
4416;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2012;10595;0.06
4417;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2013;13090;0.08
4418;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2014;16860;0.1
4419;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2015;19680;0.11
4420;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2016;23605;0.14
4421;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2017;28840;0.16
4422;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2018;29990;0.17
4423;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2019;32320;0.18
4424;Total male and female;10000;Total background and generation;P03 Ectoparasiticides, incl scabicide..;2020;35245;0.2
4425;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2006;7855;0.05
4426;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2007;8720;0.05
4427;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2008;5055;0.03
4428;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2009;6500;0.04
4429;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2010;8395;0.05
4430;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2011;9605;0.06
4431;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2012;10595;0.06
4432;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2013;13090;0.08
4433;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2014;16860;0.1
4434;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2015;19680;0.11
4435;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2016;23605;0.14
4436;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2017;28840;0.16
4437;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2018;29990;0.17
4438;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2019;32320;0.18
4439;Total male and female;10000;Total background and generation;P03A Ectoparasiticides, incl scabicides;2020;35245;0.2
4440;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2006;0;0.0
4441;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2007;0;0.0
4442;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2008;0;0.0
4443;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2009;0;0.0
4444;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2010;0;0.0
4445;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2011;0;0.0
4446;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2012;0;0.0
4447;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2013;0;0.0
4448;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2014;0;0.0
4449;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2015;0;0.0
4450;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2016;0;0.0
4451;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2017;0;0.0
4452;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2018;0;0.0
4453;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2019;0;0.0
4454;Total male and female;10000;Total background and generation;P03B Insecticides and repellents;2020;0;0.0
4455;Total male and female;10000;Total background and generation;R Respiratory system;2006;3195780;19.2
4456;Total male and female;10000;Total background and generation;R Respiratory system;2007;3397440;20.36
4457;Total male and female;10000;Total background and generation;R Respiratory system;2008;3442135;20.54
4458;Total male and female;10000;Total background and generation;R Respiratory system;2009;3580675;21.26
4459;Total male and female;10000;Total background and generation;R Respiratory system;2010;3555425;21.0
4460;Total male and female;10000;Total background and generation;R Respiratory system;2011;3639400;21.39
4461;Total male and female;10000;Total background and generation;R Respiratory system;2012;3564030;20.87
4462;Total male and female;10000;Total background and generation;R Respiratory system;2013;3536065;20.64
4463;Total male and female;10000;Total background and generation;R Respiratory system;2014;3503490;20.37
4464;Total male and female;10000;Total background and generation;R Respiratory system;2015;3583445;20.73
4465;Total male and female;10000;Total background and generation;R Respiratory system;2016;3626925;20.86
4466;Total male and female;10000;Total background and generation;R Respiratory system;2017;3557725;20.34
4467;Total male and female;10000;Total background and generation;R Respiratory system;2018;3670460;20.86
4468;Total male and female;10000;Total background and generation;R Respiratory system;2019;3669390;20.7
4469;Total male and female;10000;Total background and generation;R Respiratory system;2020;3370095;18.93
4470;Total male and female;10000;Total background and generation;R01 Nasal preparations;2006;1030230;6.19
4471;Total male and female;10000;Total background and generation;R01 Nasal preparations;2007;1130725;6.78
4472;Total male and female;10000;Total background and generation;R01 Nasal preparations;2008;1166985;6.96
4473;Total male and female;10000;Total background and generation;R01 Nasal preparations;2009;1246935;7.4
4474;Total male and female;10000;Total background and generation;R01 Nasal preparations;2010;1304255;7.7
4475;Total male and female;10000;Total background and generation;R01 Nasal preparations;2011;1348180;7.92
4476;Total male and female;10000;Total background and generation;R01 Nasal preparations;2012;1317390;7.71
4477;Total male and female;10000;Total background and generation;R01 Nasal preparations;2013;1318545;7.7
4478;Total male and female;10000;Total background and generation;R01 Nasal preparations;2014;1323475;7.69
4479;Total male and female;10000;Total background and generation;R01 Nasal preparations;2015;1352790;7.83
4480;Total male and female;10000;Total background and generation;R01 Nasal preparations;2016;1400910;8.06
4481;Total male and female;10000;Total background and generation;R01 Nasal preparations;2017;1392425;7.96
4482;Total male and female;10000;Total background and generation;R01 Nasal preparations;2018;1416850;8.05
4483;Total male and female;10000;Total background and generation;R01 Nasal preparations;2019;1454530;8.21
4484;Total male and female;10000;Total background and generation;R01 Nasal preparations;2020;1357715;7.63
4485;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2006;1030230;6.19
4486;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2007;1130725;6.78
4487;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2008;1166980;6.96
4488;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2009;1246935;7.4
4489;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2010;1304255;7.7
4490;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2011;1348180;7.92
4491;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2012;1317390;7.71
4492;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2013;1318545;7.7
4493;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2014;1323475;7.69
4494;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2015;1352790;7.83
4495;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2016;1400910;8.06
4496;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2017;1392425;7.96
4497;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2018;1416850;8.05
4498;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2019;1454530;8.21
4499;Total male and female;10000;Total background and generation;R01A Decongestants/nasal prep., topical.;2020;1357715;7.63
4500;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2006;5;0.0
4501;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2007;5;0.0
4502;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2008;5;0.0
4503;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2009;0;0.0
4504;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2010;0;0.0
4505;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2011;0;0.0
4506;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2012;0;0.0
4507;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2013;0;0.0
4508;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2014;0;0.0
4509;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2015;0;0.0
4510;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2016;0;0.0
4511;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2017;0;0.0
4512;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2018;0;0.0
4513;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2019;0;0.0
4514;Total male and female;10000;Total background and generation;R01B Nasal decongestants, systemic use;2020;0;0.0
4515;Total male and female;10000;Total background and generation;R02 Throat preparations;2006;7430;0.04
4516;Total male and female;10000;Total background and generation;R02 Throat preparations;2007;6905;0.04
4517;Total male and female;10000;Total background and generation;R02 Throat preparations;2008;5560;0.03
4518;Total male and female;10000;Total background and generation;R02 Throat preparations;2009;4485;0.03
4519;Total male and female;10000;Total background and generation;R02 Throat preparations;2010;3900;0.02
4520;Total male and female;10000;Total background and generation;R02 Throat preparations;2011;1390;0.01
4521;Total male and female;10000;Total background and generation;R02 Throat preparations;2012;0;0.0
4522;Total male and female;10000;Total background and generation;R02 Throat preparations;2013;0;0.0
4523;Total male and female;10000;Total background and generation;R02 Throat preparations;2014;0;0.0
4524;Total male and female;10000;Total background and generation;R02 Throat preparations;2015;0;0.0
4525;Total male and female;10000;Total background and generation;R02 Throat preparations;2016;0;0.0
4526;Total male and female;10000;Total background and generation;R02 Throat preparations;2017;0;0.0
4527;Total male and female;10000;Total background and generation;R02 Throat preparations;2018;0;0.0
4528;Total male and female;10000;Total background and generation;R02 Throat preparations;2019;0;0.0
4529;Total male and female;10000;Total background and generation;R02 Throat preparations;2020;0;0.0
4530;Total male and female;10000;Total background and generation;R02A Throat preparations;2006;7430;0.04
4531;Total male and female;10000;Total background and generation;R02A Throat preparations;2007;6905;0.04
4532;Total male and female;10000;Total background and generation;R02A Throat preparations;2008;5560;0.03
4533;Total male and female;10000;Total background and generation;R02A Throat preparations;2009;4485;0.03
4534;Total male and female;10000;Total background and generation;R02A Throat preparations;2010;3900;0.02
4535;Total male and female;10000;Total background and generation;R02A Throat preparations;2011;1390;0.01
4536;Total male and female;10000;Total background and generation;R02A Throat preparations;2012;0;0.0
4537;Total male and female;10000;Total background and generation;R02A Throat preparations;2013;0;0.0
4538;Total male and female;10000;Total background and generation;R02A Throat preparations;2014;0;0.0
4539;Total male and female;10000;Total background and generation;R02A Throat preparations;2015;0;0.0
4540;Total male and female;10000;Total background and generation;R02A Throat preparations;2016;0;0.0
4541;Total male and female;10000;Total background and generation;R02A Throat preparations;2017;0;0.0
4542;Total male and female;10000;Total background and generation;R02A Throat preparations;2018;0;0.0
4543;Total male and female;10000;Total background and generation;R02A Throat preparations;2019;0;0.0
4544;Total male and female;10000;Total background and generation;R02A Throat preparations;2020;0;0.0
4545;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2006;1397145;8.39
4546;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2007;1480665;8.88
4547;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2008;1479590;8.83
4548;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2009;1538550;9.14
4549;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2010;1539270;9.09
4550;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2011;1573245;9.25
4551;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2012;1555380;9.11
4552;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2013;1510110;8.82
4553;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2014;1516760;8.82
4554;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2015;1538120;8.9
4555;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2016;1537780;8.84
4556;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2017;1511700;8.64
4557;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2018;1526815;8.68
4558;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2019;1533695;8.65
4559;Total male and female;10000;Total background and generation;R03 Drugs for obstruct. airway diseases;2020;1459170;8.2
4560;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2006;1144885;6.88
4561;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2007;1226655;7.35
4562;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2008;1227185;7.32
4563;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2009;1284035;7.62
4564;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2010;1286990;7.6
4565;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2011;1322270;7.77
4566;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2012;1308355;7.66
4567;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2013;1272425;7.43
4568;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2014;1285300;7.47
4569;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2015;1309425;7.57
4570;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2016;1318810;7.58
4571;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2017;1297835;7.42
4572;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2018;1319190;7.5
4573;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2019;1331930;7.52
4574;Total male and female;10000;Total background and generation;R03A Adrenergics, inhalants;2020;1268040;7.12
4575;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2006;703045;4.22
4576;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2007;720100;4.32
4577;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2008;715505;4.27
4578;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2009;730580;4.34
4579;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2010;726465;4.29
4580;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2011;733630;4.31
4581;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2012;721745;4.23
4582;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2013;697575;4.07
4583;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2014;692420;4.03
4584;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2015;690565;3.99
4585;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2016;670115;3.85
4586;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2017;651720;3.73
4587;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2018;634070;3.6
4588;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2019;614190;3.47
4589;Total male and female;10000;Total background and generation;R03B Oth.obstruct.airway dis.drugs/inhal;2020;567385;3.19
4590;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2006;6295;0.04
4591;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2007;4610;0.03
4592;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2008;3395;0.02
4593;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2009;1830;0.01
4594;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2010;1435;0.01
4595;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2011;1145;0.01
4596;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2012;970;0.01
4597;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2013;735;0.0
4598;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2014;505;0.0
4599;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2015;415;0.0
4600;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2016;355;0.0
4601;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2017;290;0.0
4602;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2018;325;0.0
4603;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2019;220;0.0
4604;Total male and female;10000;Total background and generation;R03C Adrenergics for systemic use;2020;80;0.0
4605;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2006;66620;0.4
4606;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2007;70985;0.43
4607;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2008;70455;0.42
4608;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2009;69920;0.42
4609;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2010;69240;0.41
4610;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2011;70020;0.41
4611;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2012;67645;0.4
4612;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2013;62690;0.37
4613;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2014;59080;0.34
4614;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2015;56065;0.32
4615;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2016;54145;0.31
4616;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2017;52505;0.3
4617;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2018;51065;0.29
4618;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2019;50895;0.29
4619;Total male and female;10000;Total background and generation;R03D Oth.obstruct.airway diseas systemic;2020;48685;0.27
4620;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2006;582095;3.5
4621;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2007;658005;3.94
4622;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2008;672005;4.01
4623;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2009;689735;4.1
4624;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2010;592700;3.5
4625;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2011;611285;3.59
4626;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2012;594550;3.48
4627;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2013;607215;3.54
4628;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2014;575520;3.35
4629;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2015;641415;3.71
4630;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2016;621550;3.57
4631;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2017;586405;3.35
4632;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2018;658520;3.74
4633;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2019;626275;3.53
4634;Total male and female;10000;Total background and generation;R05 Cough and cold preparations;2020;396205;2.23
4635;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2006;45650;0.27
4636;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2007;55040;0.33
4637;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2008;53800;0.32
4638;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2009;50855;0.3
4639;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2010;1880;0.01
4640;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2011;1425;0.01
4641;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2012;1300;0.01
4642;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2013;1410;0.01
4643;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2014;1165;0.01
4644;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2015;1065;0.01
4645;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2016;1090;0.01
4646;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2017;995;0.01
4647;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2018;970;0.01
4648;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2019;970;0.01
4649;Total male and female;10000;Total background and generation;R05C Expectorants, ex.cough suppressants;2020;960;0.01
4650;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2006;541485;3.25
4651;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2007;609580;3.65
4652;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2008;624700;3.73
4653;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2009;645015;3.83
4654;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2010;590940;3.49
4655;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2011;609935;3.58
4656;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2012;593315;3.47
4657;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2013;605865;3.54
4658;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2014;574420;3.34
4659;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2015;640400;3.7
4660;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2016;620520;3.57
4661;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2017;585445;3.35
4662;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2018;657595;3.74
4663;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2019;625355;3.53
4664;Total male and female;10000;Total background and generation;R05D Cough suppressants, ex.expectorants;2020;395280;2.22
4665;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2006;0;0.0
4666;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2007;0;0.0
4667;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2008;0;0.0
4668;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2009;0;0.0
4669;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2010;0;0.0
4670;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2011;0;0.0
4671;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2012;0;0.0
4672;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2013;0;0.0
4673;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2014;0;0.0
4674;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2015;0;0.0
4675;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2016;0;0.0
4676;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2017;0;0.0
4677;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2018;0;0.0
4678;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2019;0;0.0
4679;Total male and female;10000;Total background and generation;R05F Cough suppressants and expectorants;2020;0;0.0
4680;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2006;60;0.0
4681;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2007;45;0.0
4682;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2008;10;0.0
4683;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2009;0;0.0
4684;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2010;0;0.0
4685;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2011;0;0.0
4686;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2012;0;0.0
4687;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2013;0;0.0
4688;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2014;0;0.0
4689;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2015;0;0.0
4690;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2016;0;0.0
4691;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2017;0;0.0
4692;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2018;0;0.0
4693;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2019;0;0.0
4694;Total male and female;10000;Total background and generation;R05X Other cold combination preparations;2020;0;0.0
4695;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2006;1151960;6.92
4696;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2007;1211015;7.26
4697;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2008;1216645;7.26
4698;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2009;1278535;7.59
4699;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2010;1263605;7.46
4700;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2011;1303595;7.66
4701;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2012;1245940;7.3
4702;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2013;1251745;7.31
4703;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2014;1246770;7.25
4704;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2015;1233105;7.13
4705;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2016;1284540;7.39
4706;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2017;1244915;7.12
4707;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2018;1314880;7.47
4708;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2019;1323905;7.47
4709;Total male and female;10000;Total background and generation;R06 Antihistamines for systemic use;2020;1313215;7.38
4710;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2006;1151960;6.92
4711;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2007;1211015;7.26
4712;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2008;1216645;7.26
4713;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2009;1278535;7.59
4714;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2010;1263605;7.46
4715;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2011;1303595;7.66
4716;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2012;1245940;7.3
4717;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2013;1251745;7.31
4718;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2014;1246770;7.25
4719;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2015;1233105;7.13
4720;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2016;1284540;7.39
4721;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2017;1244915;7.12
4722;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2018;1314880;7.47
4723;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2019;1323905;7.47
4724;Total male and female;10000;Total background and generation;R06A Antihistamines for systemic use;2020;1313215;7.38
4725;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2006;0;0.0
4726;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2007;0;0.0
4727;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2008;0;0.0
4728;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2009;0;0.0
4729;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2010;0;0.0
4730;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2011;0;0.0
4731;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2012;0;0.0
4732;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2013;0;0.0
4733;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2014;0;0.0
4734;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2015;40;0.0
4735;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2016;50;0.0
4736;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2017;470;0.0
4737;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2018;645;0.0
4738;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2019;770;0.0
4739;Total male and female;10000;Total background and generation;R07 Other respiratory system products;2020;760;0.0
4740;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2006;0;0.0
4741;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2007;0;0.0
4742;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2008;0;0.0
4743;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2009;0;0.0
4744;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2010;0;0.0
4745;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2011;0;0.0
4746;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2012;0;0.0
4747;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2013;0;0.0
4748;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2014;0;0.0
4749;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2015;40;0.0
4750;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2016;50;0.0
4751;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2017;470;0.0
4752;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2018;645;0.0
4753;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2019;770;0.0
4754;Total male and female;10000;Total background and generation;R07A Other respiratory system products;2020;760;0.0
4755;Total male and female;10000;Total background and generation;S Sensory organs;2006;2037250;12.24
4756;Total male and female;10000;Total background and generation;S Sensory organs;2007;2067495;12.39
4757;Total male and female;10000;Total background and generation;S Sensory organs;2008;2066260;12.33
4758;Total male and female;10000;Total background and generation;S Sensory organs;2009;2086930;12.39
4759;Total male and female;10000;Total background and generation;S Sensory organs;2010;2105430;12.44
4760;Total male and female;10000;Total background and generation;S Sensory organs;2011;2132495;12.53
4761;Total male and female;10000;Total background and generation;S Sensory organs;2012;2089375;12.23
4762;Total male and female;10000;Total background and generation;S Sensory organs;2013;2056760;12.01
4763;Total male and female;10000;Total background and generation;S Sensory organs;2014;2046450;11.9
4764;Total male and female;10000;Total background and generation;S Sensory organs;2015;2057790;11.9
4765;Total male and female;10000;Total background and generation;S Sensory organs;2016;2088895;12.01
4766;Total male and female;10000;Total background and generation;S Sensory organs;2017;2085315;11.92
4767;Total male and female;10000;Total background and generation;S Sensory organs;2018;2131120;12.11
4768;Total male and female;10000;Total background and generation;S Sensory organs;2019;2160225;12.19
4769;Total male and female;10000;Total background and generation;S Sensory organs;2020;2004965;11.26
4770;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2006;1613675;9.7
4771;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2007;1645675;9.86
4772;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2008;1648395;9.83
4773;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2009;1661660;9.87
4774;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2010;1669210;9.86
4775;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2011;1712515;10.06
4776;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2012;1675280;9.81
4777;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2013;1658600;9.68
4778;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2014;1645985;9.57
4779;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2015;1642760;9.5
4780;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2016;1673710;9.63
4781;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2017;1671535;9.56
4782;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2018;1718145;9.76
4783;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2019;1757185;9.91
4784;Total male and female;10000;Total background and generation;S01 Ophthalmologicals;2020;1676385;9.42
4785;Total male and female;10000;Total background and generation;S01A Antiinfectives;2006;731135;4.39
4786;Total male and female;10000;Total background and generation;S01A Antiinfectives;2007;725235;4.35
4787;Total male and female;10000;Total background and generation;S01A Antiinfectives;2008;706580;4.22
4788;Total male and female;10000;Total background and generation;S01A Antiinfectives;2009;699210;4.15
4789;Total male and female;10000;Total background and generation;S01A Antiinfectives;2010;691610;4.08
4790;Total male and female;10000;Total background and generation;S01A Antiinfectives;2011;699230;4.11
4791;Total male and female;10000;Total background and generation;S01A Antiinfectives;2012;667530;3.91
4792;Total male and female;10000;Total background and generation;S01A Antiinfectives;2013;635440;3.71
4793;Total male and female;10000;Total background and generation;S01A Antiinfectives;2014;615425;3.58
4794;Total male and female;10000;Total background and generation;S01A Antiinfectives;2015;603475;3.49
4795;Total male and female;10000;Total background and generation;S01A Antiinfectives;2016;587440;3.38
4796;Total male and female;10000;Total background and generation;S01A Antiinfectives;2017;586355;3.35
4797;Total male and female;10000;Total background and generation;S01A Antiinfectives;2018;567745;3.23
4798;Total male and female;10000;Total background and generation;S01A Antiinfectives;2019;571050;3.22
4799;Total male and female;10000;Total background and generation;S01A Antiinfectives;2020;518925;2.92
4800;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2006;192985;1.16
4801;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2007;204250;1.22
4802;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2008;218795;1.31
4803;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2009;222475;1.32
4804;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2010;223760;1.32
4805;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2011;227480;1.34
4806;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2012;227110;1.33
4807;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2013;223800;1.31
4808;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2014;224640;1.31
4809;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2015;224320;1.3
4810;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2016;228000;1.31
4811;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2017;229165;1.31
4812;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2018;234930;1.33
4813;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2019;243795;1.38
4814;Total male and female;10000;Total background and generation;S01B Antiinflammatory agents;2020;222710;1.25
4815;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2006;181690;1.09
4816;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2007;191515;1.15
4817;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2008;203195;1.21
4818;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2009;208835;1.24
4819;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2010;210100;1.24
4820;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2011;217675;1.28
4821;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2012;212800;1.25
4822;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2013;203390;1.19
4823;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2014;197205;1.15
4824;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2015;186865;1.08
4825;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2016;191980;1.1
4826;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2017;188210;1.08
4827;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2018;181210;1.03
4828;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2019;184040;1.04
4829;Total male and female;10000;Total background and generation;S01C Anti-inflammatory/-infectives comb.;2020;173835;0.98
4830;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2006;179655;1.08
4831;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2007;185250;1.11
4832;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2008;193615;1.16
4833;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2009;199190;1.18
4834;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2010;205185;1.21
4835;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2011;213555;1.26
4836;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2012;219205;1.28
4837;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2013;219330;1.28
4838;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2014;223335;1.3
4839;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2015;226145;1.31
4840;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2016;231210;1.33
4841;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2017;236900;1.35
4842;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2018;242280;1.38
4843;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2019;241100;1.36
4844;Total male and female;10000;Total background and generation;S01E Antiglaucoma preparations, miotics;2020;227910;1.28
4845;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2006;23190;0.14
4846;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2007;23550;0.14
4847;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2008;23520;0.14
4848;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2009;23715;0.14
4849;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2010;24350;0.14
4850;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2011;24000;0.14
4851;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2012;24025;0.14
4852;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2013;22215;0.13
4853;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2014;20940;0.12
4854;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2015;18940;0.11
4855;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2016;18730;0.11
4856;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2017;19235;0.11
4857;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2018;21430;0.12
4858;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2019;25420;0.14
4859;Total male and female;10000;Total background and generation;S01F Mydriatics and cycloplegics;2020;25125;0.14
4860;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2006;328920;1.98
4861;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2007;335045;2.01
4862;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2008;322160;1.92
4863;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2009;331545;1.97
4864;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2010;317925;1.88
4865;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2011;322390;1.89
4866;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2012;295700;1.73
4867;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2013;306750;1.79
4868;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2014;296115;1.72
4869;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2015;289700;1.68
4870;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2016;310330;1.78
4871;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2017;282550;1.62
4872;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2018;309175;1.76
4873;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2019;304330;1.72
4874;Total male and female;10000;Total background and generation;S01G Decongestants and antiallergics;2020;296915;1.67
4875;Total male and female;10000;Total background and generation;S01H Local anesthetics;2006;60;0.0
4876;Total male and female;10000;Total background and generation;S01H Local anesthetics;2007;35;0.0
4877;Total male and female;10000;Total background and generation;S01H Local anesthetics;2008;35;0.0
4878;Total male and female;10000;Total background and generation;S01H Local anesthetics;2009;15;0.0
4879;Total male and female;10000;Total background and generation;S01H Local anesthetics;2010;20;0.0
4880;Total male and female;10000;Total background and generation;S01H Local anesthetics;2011;20;0.0
4881;Total male and female;10000;Total background and generation;S01H Local anesthetics;2012;20;0.0
4882;Total male and female;10000;Total background and generation;S01H Local anesthetics;2013;15;0.0
4883;Total male and female;10000;Total background and generation;S01H Local anesthetics;2014;10;0.0
4884;Total male and female;10000;Total background and generation;S01H Local anesthetics;2015;10;0.0
4885;Total male and female;10000;Total background and generation;S01H Local anesthetics;2016;10;0.0
4886;Total male and female;10000;Total background and generation;S01H Local anesthetics;2017;5;0.0
4887;Total male and female;10000;Total background and generation;S01H Local anesthetics;2018;0;0.0
4888;Total male and female;10000;Total background and generation;S01H Local anesthetics;2019;0;0.0
4889;Total male and female;10000;Total background and generation;S01H Local anesthetics;2020;0;0.0
4890;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2006;105;0.0
4891;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2007;70;0.0
4892;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2008;130;0.0
4893;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2009;135;0.0
4894;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2010;15;0.0
4895;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2011;0;0.0
4896;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2012;0;0.0
4897;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2013;15;0.0
4898;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2014;5;0.0
4899;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2015;0;0.0
4900;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2016;0;0.0
4901;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2017;0;0.0
4902;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2018;0;0.0
4903;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2019;0;0.0
4904;Total male and female;10000;Total background and generation;S01J Diagnostic agents;2020;0;0.0
4905;Total male and female;10000;Total background and generation;S01K Surgical aids;2006;625;0.0
4906;Total male and female;10000;Total background and generation;S01K Surgical aids;2007;300;0.0
4907;Total male and female;10000;Total background and generation;S01K Surgical aids;2008;95;0.0
4908;Total male and female;10000;Total background and generation;S01K Surgical aids;2009;50;0.0
4909;Total male and female;10000;Total background and generation;S01K Surgical aids;2010;40;0.0
4910;Total male and female;10000;Total background and generation;S01K Surgical aids;2011;25;0.0
4911;Total male and female;10000;Total background and generation;S01K Surgical aids;2012;30;0.0
4912;Total male and female;10000;Total background and generation;S01K Surgical aids;2013;50;0.0
4913;Total male and female;10000;Total background and generation;S01K Surgical aids;2014;45;0.0
4914;Total male and female;10000;Total background and generation;S01K Surgical aids;2015;25;0.0
4915;Total male and female;10000;Total background and generation;S01K Surgical aids;2016;20;0.0
4916;Total male and female;10000;Total background and generation;S01K Surgical aids;2017;20;0.0
4917;Total male and female;10000;Total background and generation;S01K Surgical aids;2018;20;0.0
4918;Total male and female;10000;Total background and generation;S01K Surgical aids;2019;25;0.0
4919;Total male and female;10000;Total background and generation;S01K Surgical aids;2020;20;0.0
4920;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2006;0;0.0
4921;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2007;0;0.0
4922;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2008;0;0.0
4923;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2009;0;0.0
4924;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2010;0;0.0
4925;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2011;0;0.0
4926;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2012;0;0.0
4927;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2013;0;0.0
4928;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2014;0;0.0
4929;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2015;0;0.0
4930;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2016;0;0.0
4931;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2017;0;0.0
4932;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2018;0;0.0
4933;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2019;5;0.0
4934;Total male and female;10000;Total background and generation;S01L Ocular vascular disorder agents;2020;5;0.0
4935;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2006;416725;2.5
4936;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2007;453460;2.72
4937;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2008;481610;2.87
4938;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2009;478580;2.84
4939;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2010;509955;3.01
4940;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2011;548315;3.22
4941;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2012;567515;3.32
4942;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2013;574445;3.35
4943;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2014;587165;3.41
4944;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2015;597310;3.46
4945;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2016;624300;3.59
4946;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2017;647770;3.7
4947;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2018;686880;3.9
4948;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2019;727960;4.11
4949;Total male and female;10000;Total background and generation;S01X Other ophthalmologicals;2020;709850;3.99
4950;Total male and female;10000;Total background and generation;S02 Otologicals;2006;531625;3.19
4951;Total male and female;10000;Total background and generation;S02 Otologicals;2007;529830;3.18
4952;Total male and female;10000;Total background and generation;S02 Otologicals;2008;523405;3.12
4953;Total male and female;10000;Total background and generation;S02 Otologicals;2009;531815;3.16
4954;Total male and female;10000;Total background and generation;S02 Otologicals;2010;544860;3.22
4955;Total male and female;10000;Total background and generation;S02 Otologicals;2011;530025;3.11
4956;Total male and female;10000;Total background and generation;S02 Otologicals;2012;519185;3.04
4957;Total male and female;10000;Total background and generation;S02 Otologicals;2013;499565;2.92
4958;Total male and female;10000;Total background and generation;S02 Otologicals;2014;501985;2.92
4959;Total male and female;10000;Total background and generation;S02 Otologicals;2015;517970;3.0
4960;Total male and female;10000;Total background and generation;S02 Otologicals;2016;516315;2.97
4961;Total male and female;10000;Total background and generation;S02 Otologicals;2017;514985;2.94
4962;Total male and female;10000;Total background and generation;S02 Otologicals;2018;518660;2.95
4963;Total male and female;10000;Total background and generation;S02 Otologicals;2019;513260;2.9
4964;Total male and female;10000;Total background and generation;S02 Otologicals;2020;430965;2.42
4965;Total male and female;10000;Total background and generation;S02A Antiinfectives;2006;77135;0.46
4966;Total male and female;10000;Total background and generation;S02A Antiinfectives;2007;70550;0.42
4967;Total male and female;10000;Total background and generation;S02A Antiinfectives;2008;62825;0.37
4968;Total male and female;10000;Total background and generation;S02A Antiinfectives;2009;62400;0.37
4969;Total male and female;10000;Total background and generation;S02A Antiinfectives;2010;58735;0.35
4970;Total male and female;10000;Total background and generation;S02A Antiinfectives;2011;54150;0.32
4971;Total male and female;10000;Total background and generation;S02A Antiinfectives;2012;51195;0.3
4972;Total male and female;10000;Total background and generation;S02A Antiinfectives;2013;49015;0.29
4973;Total male and female;10000;Total background and generation;S02A Antiinfectives;2014;47925;0.28
4974;Total male and female;10000;Total background and generation;S02A Antiinfectives;2015;47695;0.28
4975;Total male and female;10000;Total background and generation;S02A Antiinfectives;2016;49270;0.28
4976;Total male and female;10000;Total background and generation;S02A Antiinfectives;2017;49365;0.28
4977;Total male and female;10000;Total background and generation;S02A Antiinfectives;2018;54805;0.31
4978;Total male and female;10000;Total background and generation;S02A Antiinfectives;2019;55215;0.31
4979;Total male and female;10000;Total background and generation;S02A Antiinfectives;2020;57105;0.32
4980;Total male and female;10000;Total background and generation;S02B Corticosteroids;2006;0;0.0
4981;Total male and female;10000;Total background and generation;S02B Corticosteroids;2007;0;0.0
4982;Total male and female;10000;Total background and generation;S02B Corticosteroids;2008;0;0.0
4983;Total male and female;10000;Total background and generation;S02B Corticosteroids;2009;0;0.0
4984;Total male and female;10000;Total background and generation;S02B Corticosteroids;2010;0;0.0
4985;Total male and female;10000;Total background and generation;S02B Corticosteroids;2011;0;0.0
4986;Total male and female;10000;Total background and generation;S02B Corticosteroids;2012;0;0.0
4987;Total male and female;10000;Total background and generation;S02B Corticosteroids;2013;0;0.0
4988;Total male and female;10000;Total background and generation;S02B Corticosteroids;2014;0;0.0
4989;Total male and female;10000;Total background and generation;S02B Corticosteroids;2015;0;0.0
4990;Total male and female;10000;Total background and generation;S02B Corticosteroids;2016;0;0.0
4991;Total male and female;10000;Total background and generation;S02B Corticosteroids;2017;0;0.0
4992;Total male and female;10000;Total background and generation;S02B Corticosteroids;2018;0;0.0
4993;Total male and female;10000;Total background and generation;S02B Corticosteroids;2019;0;0.0
4994;Total male and female;10000;Total background and generation;S02B Corticosteroids;2020;0;0.0
4995;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2006;482380;2.9
4996;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2007;485750;2.91
4997;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2008;484525;2.89
4998;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2009;492700;2.93
4999;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2010;508375;3.0
5000;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2011;496440;2.92
5001;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2012;487405;2.85
5002;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2013;468845;2.74
5003;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2014;472415;2.75
5004;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2015;488875;2.83
5005;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2016;487185;2.8
5006;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2017;486275;2.78
5007;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2018;487255;2.77
5008;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2019;481490;2.72
5009;Total male and female;10000;Total background and generation;S02C Corticosteroids/antiinfectives comb;2020;395665;2.22
5010;Total male and female;10000;Total background and generation;S02D Other otologicals;2006;325;0.0
5011;Total male and female;10000;Total background and generation;S02D Other otologicals;2007;155;0.0
5012;Total male and female;10000;Total background and generation;S02D Other otologicals;2008;10;0.0
5013;Total male and female;10000;Total background and generation;S02D Other otologicals;2009;10;0.0
5014;Total male and female;10000;Total background and generation;S02D Other otologicals;2010;0;0.0
5015;Total male and female;10000;Total background and generation;S02D Other otologicals;2011;0;0.0
5016;Total male and female;10000;Total background and generation;S02D Other otologicals;2012;0;0.0
5017;Total male and female;10000;Total background and generation;S02D Other otologicals;2013;10;0.0
5018;Total male and female;10000;Total background and generation;S02D Other otologicals;2014;0;0.0
5019;Total male and female;10000;Total background and generation;S02D Other otologicals;2015;0;0.0
5020;Total male and female;10000;Total background and generation;S02D Other otologicals;2016;0;0.0
5021;Total male and female;10000;Total background and generation;S02D Other otologicals;2017;0;0.0
5022;Total male and female;10000;Total background and generation;S02D Other otologicals;2018;0;0.0
5023;Total male and female;10000;Total background and generation;S02D Other otologicals;2019;0;0.0
5024;Total male and female;10000;Total background and generation;S02D Other otologicals;2020;0;0.0
5025;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2006;0;0.0
5026;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2007;0;0.0
5027;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2008;0;0.0
5028;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2009;0;0.0
5029;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2010;0;0.0
5030;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2011;0;0.0
5031;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2012;0;0.0
5032;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2013;0;0.0
5033;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2014;0;0.0
5034;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2015;0;0.0
5035;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2016;0;0.0
5036;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2017;0;0.0
5037;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2018;0;0.0
5038;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2019;0;0.0
5039;Total male and female;10000;Total background and generation;S03 Ophthalmological/otological prepar.;2020;0;0.0
5040;Total male and female;10000;Total background and generation;S03A Antiinfectives;2006;0;0.0
5041;Total male and female;10000;Total background and generation;S03A Antiinfectives;2007;0;0.0
5042;Total male and female;10000;Total background and generation;S03A Antiinfectives;2008;0;0.0
5043;Total male and female;10000;Total background and generation;S03A Antiinfectives;2009;0;0.0
5044;Total male and female;10000;Total background and generation;S03A Antiinfectives;2010;0;0.0
5045;Total male and female;10000;Total background and generation;S03A Antiinfectives;2011;0;0.0
5046;Total male and female;10000;Total background and generation;S03A Antiinfectives;2012;0;0.0
5047;Total male and female;10000;Total background and generation;S03A Antiinfectives;2013;0;0.0
5048;Total male and female;10000;Total background and generation;S03A Antiinfectives;2014;0;0.0
5049;Total male and female;10000;Total background and generation;S03A Antiinfectives;2015;0;0.0
5050;Total male and female;10000;Total background and generation;S03A Antiinfectives;2016;0;0.0
5051;Total male and female;10000;Total background and generation;S03A Antiinfectives;2017;0;0.0
5052;Total male and female;10000;Total background and generation;S03A Antiinfectives;2018;0;0.0
5053;Total male and female;10000;Total background and generation;S03A Antiinfectives;2019;0;0.0
5054;Total male and female;10000;Total background and generation;S03A Antiinfectives;2020;0;0.0
5055;Total male and female;10000;Total background and generation;S03B Corticosteroids;2006;0;0.0
5056;Total male and female;10000;Total background and generation;S03B Corticosteroids;2007;0;0.0
5057;Total male and female;10000;Total background and generation;S03B Corticosteroids;2008;0;0.0
5058;Total male and female;10000;Total background and generation;S03B Corticosteroids;2009;0;0.0
5059;Total male and female;10000;Total background and generation;S03B Corticosteroids;2010;0;0.0
5060;Total male and female;10000;Total background and generation;S03B Corticosteroids;2011;0;0.0
5061;Total male and female;10000;Total background and generation;S03B Corticosteroids;2012;0;0.0
5062;Total male and female;10000;Total background and generation;S03B Corticosteroids;2013;0;0.0
5063;Total male and female;10000;Total background and generation;S03B Corticosteroids;2014;0;0.0
5064;Total male and female;10000;Total background and generation;S03B Corticosteroids;2015;0;0.0
5065;Total male and female;10000;Total background and generation;S03B Corticosteroids;2016;0;0.0
5066;Total male and female;10000;Total background and generation;S03B Corticosteroids;2017;0;0.0
5067;Total male and female;10000;Total background and generation;S03B Corticosteroids;2018;0;0.0
5068;Total male and female;10000;Total background and generation;S03B Corticosteroids;2019;0;0.0
5069;Total male and female;10000;Total background and generation;S03B Corticosteroids;2020;0;0.0
5070;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2006;0;0.0
5071;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2007;0;0.0
5072;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2008;0;0.0
5073;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2009;0;0.0
5074;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2010;0;0.0
5075;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2011;0;0.0
5076;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2012;0;0.0
5077;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2013;0;0.0
5078;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2014;0;0.0
5079;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2015;0;0.0
5080;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2016;0;0.0
5081;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2017;0;0.0
5082;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2018;0;0.0
5083;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2019;0;0.0
5084;Total male and female;10000;Total background and generation;S03C Corticosteroids/antiinfectives comb;2020;0;0.0
5085;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2006;0;0.0
5086;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2007;0;0.0
5087;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2008;0;0.0
5088;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2009;0;0.0
5089;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2010;0;0.0
5090;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2011;0;0.0
5091;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2012;0;0.0
5092;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2013;0;0.0
5093;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2014;0;0.0
5094;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2015;0;0.0
5095;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2016;0;0.0
5096;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2017;0;0.0
5097;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2018;0;0.0
5098;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2019;0;0.0
5099;Total male and female;10000;Total background and generation;S03D Oth.ophthalmological/otological pr.;2020;0;0.0
5100;Total male and female;10000;Total background and generation;V Various;2006;63245;0.38
5101;Total male and female;10000;Total background and generation;V Various;2007;56430;0.34
5102;Total male and female;10000;Total background and generation;V Various;2008;54985;0.33
5103;Total male and female;10000;Total background and generation;V Various;2009;53290;0.32
5104;Total male and female;10000;Total background and generation;V Various;2010;50200;0.3
5105;Total male and female;10000;Total background and generation;V Various;2011;50165;0.29
5106;Total male and female;10000;Total background and generation;V Various;2012;49105;0.29
5107;Total male and female;10000;Total background and generation;V Various;2013;49960;0.29
5108;Total male and female;10000;Total background and generation;V Various;2014;40575;0.24
5109;Total male and female;10000;Total background and generation;V Various;2015;34515;0.2
5110;Total male and female;10000;Total background and generation;V Various;2016;34715;0.2
5111;Total male and female;10000;Total background and generation;V Various;2017;35140;0.2
5112;Total male and female;10000;Total background and generation;V Various;2018;36450;0.21
5113;Total male and female;10000;Total background and generation;V Various;2019;38840;0.22
5114;Total male and female;10000;Total background and generation;V Various;2020;40090;0.23
5115;Total male and female;10000;Total background and generation;V01 Allergens;2006;29190;0.18
5116;Total male and female;10000;Total background and generation;V01 Allergens;2007;33215;0.2
5117;Total male and female;10000;Total background and generation;V01 Allergens;2008;33210;0.2
5118;Total male and female;10000;Total background and generation;V01 Allergens;2009;33255;0.2
5119;Total male and female;10000;Total background and generation;V01 Allergens;2010;30140;0.18
5120;Total male and female;10000;Total background and generation;V01 Allergens;2011;29055;0.17
5121;Total male and female;10000;Total background and generation;V01 Allergens;2012;27105;0.16
5122;Total male and female;10000;Total background and generation;V01 Allergens;2013;23075;0.13
5123;Total male and female;10000;Total background and generation;V01 Allergens;2014;16115;0.09
5124;Total male and female;10000;Total background and generation;V01 Allergens;2015;11875;0.07
5125;Total male and female;10000;Total background and generation;V01 Allergens;2016;11595;0.07
5126;Total male and female;10000;Total background and generation;V01 Allergens;2017;12110;0.07
5127;Total male and female;10000;Total background and generation;V01 Allergens;2018;13870;0.08
5128;Total male and female;10000;Total background and generation;V01 Allergens;2019;15895;0.09
5129;Total male and female;10000;Total background and generation;V01 Allergens;2020;17535;0.1
5130;Total male and female;10000;Total background and generation;V01A Allergens;2006;29190;0.18
5131;Total male and female;10000;Total background and generation;V01A Allergens;2007;33215;0.2
5132;Total male and female;10000;Total background and generation;V01A Allergens;2008;33210;0.2
5133;Total male and female;10000;Total background and generation;V01A Allergens;2009;33255;0.2
5134;Total male and female;10000;Total background and generation;V01A Allergens;2010;30140;0.18
5135;Total male and female;10000;Total background and generation;V01A Allergens;2011;29055;0.17
5136;Total male and female;10000;Total background and generation;V01A Allergens;2012;27105;0.16
5137;Total male and female;10000;Total background and generation;V01A Allergens;2013;23075;0.13
5138;Total male and female;10000;Total background and generation;V01A Allergens;2014;16115;0.09
5139;Total male and female;10000;Total background and generation;V01A Allergens;2015;11875;0.07
5140;Total male and female;10000;Total background and generation;V01A Allergens;2016;11595;0.07
5141;Total male and female;10000;Total background and generation;V01A Allergens;2017;12110;0.07
5142;Total male and female;10000;Total background and generation;V01A Allergens;2018;13870;0.08
5143;Total male and female;10000;Total background and generation;V01A Allergens;2019;15895;0.09
5144;Total male and female;10000;Total background and generation;V01A Allergens;2020;17535;0.1
5145;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2006;12155;0.07
5146;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2007;12355;0.07
5147;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2008;13125;0.08
5148;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2009;13925;0.08
5149;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2010;14950;0.09
5150;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2011;15790;0.09
5151;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2012;15285;0.09
5152;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2013;15465;0.09
5153;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2014;16095;0.09
5154;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2015;15710;0.09
5155;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2016;15995;0.09
5156;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2017;16040;0.09
5157;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2018;16170;0.09
5158;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2019;16200;0.09
5159;Total male and female;10000;Total background and generation;V03 All other therapeutic products;2020;15810;0.09
5160;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2006;12155;0.07
5161;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2007;12355;0.07
5162;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2008;13125;0.08
5163;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2009;13925;0.08
5164;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2010;14950;0.09
5165;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2011;15790;0.09
5166;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2012;15285;0.09
5167;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2013;15465;0.09
5168;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2014;16095;0.09
5169;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2015;15700;0.09
5170;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2016;15975;0.09
5171;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2017;16040;0.09
5172;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2018;16170;0.09
5173;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2019;16200;0.09
5174;Total male and female;10000;Total background and generation;V03A All other therapeutic products;2020;15810;0.09
5175;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2006;540;0.0
5176;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2007;455;0.0
5177;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2008;615;0.0
5178;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2009;485;0.0
5179;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2010;590;0.0
5180;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2011;320;0.0
5181;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2012;590;0.0
5182;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2013;700;0.0
5183;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2014;775;0.0
5184;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2015;715;0.0
5185;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2016;660;0.0
5186;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2017;685;0.0
5187;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2018;635;0.0
5188;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2019;620;0.0
5189;Total male and female;10000;Total background and generation;V04 Diagnostic agents;2020;605;0.0
5190;Total male and female;10000;Total background and generation;V04B Urine tests;2006;0;0.0
5191;Total male and female;10000;Total background and generation;V04B Urine tests;2007;0;0.0
5192;Total male and female;10000;Total background and generation;V04B Urine tests;2008;0;0.0
5193;Total male and female;10000;Total background and generation;V04B Urine tests;2009;0;0.0
5194;Total male and female;10000;Total background and generation;V04B Urine tests;2010;0;0.0
5195;Total male and female;10000;Total background and generation;V04B Urine tests;2011;0;0.0
5196;Total male and female;10000;Total background and generation;V04B Urine tests;2012;0;0.0
5197;Total male and female;10000;Total background and generation;V04B Urine tests;2013;0;0.0
5198;Total male and female;10000;Total background and generation;V04B Urine tests;2014;0;0.0
5199;Total male and female;10000;Total background and generation;V04B Urine tests;2015;0;0.0
5200;Total male and female;10000;Total background and generation;V04B Urine tests;2016;0;0.0
5201;Total male and female;10000;Total background and generation;V04B Urine tests;2017;0;0.0
5202;Total male and female;10000;Total background and generation;V04B Urine tests;2018;0;0.0
5203;Total male and female;10000;Total background and generation;V04B Urine tests;2019;0;0.0
5204;Total male and female;10000;Total background and generation;V04B Urine tests;2020;0;0.0
5205;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2006;540;0.0
5206;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2007;455;0.0
5207;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2008;615;0.0
5208;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2009;485;0.0
5209;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2010;590;0.0
5210;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2011;320;0.0
5211;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2012;590;0.0
5212;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2013;700;0.0
5213;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2014;775;0.0
5214;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2015;715;0.0
5215;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2016;660;0.0
5216;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2017;685;0.0
5217;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2018;635;0.0
5218;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2019;620;0.0
5219;Total male and female;10000;Total background and generation;V04C Other diagnostic agents;2020;605;0.0
5220;Total male and female;10000;Total background and generation;V06 General nutrients;2006;225;0.0
5221;Total male and female;10000;Total background and generation;V06 General nutrients;2007;145;0.0
5222;Total male and female;10000;Total background and generation;V06 General nutrients;2008;105;0.0
5223;Total male and female;10000;Total background and generation;V06 General nutrients;2009;60;0.0
5224;Total male and female;10000;Total background and generation;V06 General nutrients;2010;45;0.0
5225;Total male and female;10000;Total background and generation;V06 General nutrients;2011;45;0.0
5226;Total male and female;10000;Total background and generation;V06 General nutrients;2012;40;0.0
5227;Total male and female;10000;Total background and generation;V06 General nutrients;2013;50;0.0
5228;Total male and female;10000;Total background and generation;V06 General nutrients;2014;45;0.0
5229;Total male and female;10000;Total background and generation;V06 General nutrients;2015;35;0.0
5230;Total male and female;10000;Total background and generation;V06 General nutrients;2016;35;0.0
5231;Total male and female;10000;Total background and generation;V06 General nutrients;2017;45;0.0
5232;Total male and female;10000;Total background and generation;V06 General nutrients;2018;25;0.0
5233;Total male and female;10000;Total background and generation;V06 General nutrients;2019;15;0.0
5234;Total male and female;10000;Total background and generation;V06 General nutrients;2020;15;0.0
5235;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2006;0;0.0
5236;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2007;0;0.0
5237;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2008;0;0.0
5238;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2009;0;0.0
5239;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2010;0;0.0
5240;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2011;0;0.0
5241;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2012;0;0.0
5242;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2013;0;0.0
5243;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2014;0;0.0
5244;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2015;0;0.0
5245;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2016;0;0.0
5246;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2017;0;0.0
5247;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2018;0;0.0
5248;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2019;0;0.0
5249;Total male and female;10000;Total background and generation;V06A Obesity treatment diet formulations;2020;0;0.0
5250;Total male and female;10000;Total background and generation;V06B Protein supplements;2006;0;0.0
5251;Total male and female;10000;Total background and generation;V06B Protein supplements;2007;0;0.0
5252;Total male and female;10000;Total background and generation;V06B Protein supplements;2008;0;0.0
5253;Total male and female;10000;Total background and generation;V06B Protein supplements;2009;0;0.0
5254;Total male and female;10000;Total background and generation;V06B Protein supplements;2010;0;0.0
5255;Total male and female;10000;Total background and generation;V06B Protein supplements;2011;0;0.0
5256;Total male and female;10000;Total background and generation;V06B Protein supplements;2012;0;0.0
5257;Total male and female;10000;Total background and generation;V06B Protein supplements;2013;0;0.0
5258;Total male and female;10000;Total background and generation;V06B Protein supplements;2014;0;0.0
5259;Total male and female;10000;Total background and generation;V06B Protein supplements;2015;0;0.0
5260;Total male and female;10000;Total background and generation;V06B Protein supplements;2016;0;0.0
5261;Total male and female;10000;Total background and generation;V06B Protein supplements;2017;0;0.0
5262;Total male and female;10000;Total background and generation;V06B Protein supplements;2018;0;0.0
5263;Total male and female;10000;Total background and generation;V06B Protein supplements;2019;0;0.0
5264;Total male and female;10000;Total background and generation;V06B Protein supplements;2020;0;0.0
5265;Total male and female;10000;Total background and generation;V06C Infant formulas;2006;0;0.0
5266;Total male and female;10000;Total background and generation;V06C Infant formulas;2007;0;0.0
5267;Total male and female;10000;Total background and generation;V06C Infant formulas;2008;0;0.0
5268;Total male and female;10000;Total background and generation;V06C Infant formulas;2009;0;0.0
5269;Total male and female;10000;Total background and generation;V06C Infant formulas;2010;0;0.0
5270;Total male and female;10000;Total background and generation;V06C Infant formulas;2011;0;0.0
5271;Total male and female;10000;Total background and generation;V06C Infant formulas;2012;0;0.0
5272;Total male and female;10000;Total background and generation;V06C Infant formulas;2013;0;0.0
5273;Total male and female;10000;Total background and generation;V06C Infant formulas;2014;0;0.0
5274;Total male and female;10000;Total background and generation;V06C Infant formulas;2015;0;0.0
5275;Total male and female;10000;Total background and generation;V06C Infant formulas;2016;0;0.0
5276;Total male and female;10000;Total background and generation;V06C Infant formulas;2017;0;0.0
5277;Total male and female;10000;Total background and generation;V06C Infant formulas;2018;0;0.0
5278;Total male and female;10000;Total background and generation;V06C Infant formulas;2019;0;0.0
5279;Total male and female;10000;Total background and generation;V06C Infant formulas;2020;0;0.0
5280;Total male and female;10000;Total background and generation;V06D Other nutrients;2006;225;0.0
5281;Total male and female;10000;Total background and generation;V06D Other nutrients;2007;145;0.0
5282;Total male and female;10000;Total background and generation;V06D Other nutrients;2008;105;0.0
5283;Total male and female;10000;Total background and generation;V06D Other nutrients;2009;60;0.0
5284;Total male and female;10000;Total background and generation;V06D Other nutrients;2010;45;0.0
5285;Total male and female;10000;Total background and generation;V06D Other nutrients;2011;45;0.0
5286;Total male and female;10000;Total background and generation;V06D Other nutrients;2012;40;0.0
5287;Total male and female;10000;Total background and generation;V06D Other nutrients;2013;50;0.0
5288;Total male and female;10000;Total background and generation;V06D Other nutrients;2014;45;0.0
5289;Total male and female;10000;Total background and generation;V06D Other nutrients;2015;35;0.0
5290;Total male and female;10000;Total background and generation;V06D Other nutrients;2016;35;0.0
5291;Total male and female;10000;Total background and generation;V06D Other nutrients;2017;45;0.0
5292;Total male and female;10000;Total background and generation;V06D Other nutrients;2018;25;0.0
5293;Total male and female;10000;Total background and generation;V06D Other nutrients;2019;15;0.0
5294;Total male and female;10000;Total background and generation;V06D Other nutrients;2020;15;0.0
5295;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2006;23120;0.14
5296;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2007;11130;0.07
5297;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2008;8835;0.05
5298;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2009;6275;0.04
5299;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2010;5235;0.03
5300;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2011;5405;0.03
5301;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2012;6940;0.04
5302;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2013;11940;0.07
5303;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2014;8580;0.05
5304;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2015;7040;0.04
5305;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2016;7215;0.04
5306;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2017;7105;0.04
5307;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2018;6460;0.04
5308;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2019;6835;0.04
5309;Total male and female;10000;Total background and generation;V07 All other non-therapeutic products;2020;6800;0.04
5310;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2006;23120;0.14
5311;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2007;11130;0.07
5312;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2008;8835;0.05
5313;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2009;6275;0.04
5314;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2010;5235;0.03
5315;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2011;5405;0.03
5316;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2012;6940;0.04
5317;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2013;11940;0.07
5318;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2014;8580;0.05
5319;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2015;7040;0.04
5320;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2016;7215;0.04
5321;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2017;7105;0.04
5322;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2018;6460;0.04
5323;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2019;6835;0.04
5324;Total male and female;10000;Total background and generation;V07A All other non-therapeutic products;2020;6800;0.04
5325;Total male and female;10000;Total background and generation;V08 Contrast media;2006;0;0.0
5326;Total male and female;10000;Total background and generation;V08 Contrast media;2007;0;0.0
5327;Total male and female;10000;Total background and generation;V08 Contrast media;2008;0;0.0
5328;Total male and female;10000;Total background and generation;V08 Contrast media;2009;5;0.0
5329;Total male and female;10000;Total background and generation;V08 Contrast media;2010;0;0.0
5330;Total male and female;10000;Total background and generation;V08 Contrast media;2011;0;0.0
5331;Total male and female;10000;Total background and generation;V08 Contrast media;2012;0;0.0
5332;Total male and female;10000;Total background and generation;V08 Contrast media;2013;0;0.0
5333;Total male and female;10000;Total background and generation;V08 Contrast media;2014;0;0.0
5334;Total male and female;10000;Total background and generation;V08 Contrast media;2015;0;0.0
5335;Total male and female;10000;Total background and generation;V08 Contrast media;2016;0;0.0
5336;Total male and female;10000;Total background and generation;V08 Contrast media;2017;0;0.0
5337;Total male and female;10000;Total background and generation;V08 Contrast media;2018;0;0.0
5338;Total male and female;10000;Total background and generation;V08 Contrast media;2019;0;0.0
5339;Total male and female;10000;Total background and generation;V08 Contrast media;2020;0;0.0
5340;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2006;0;0.0
5341;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2007;0;0.0
5342;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2008;0;0.0
5343;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2009;0;0.0
5344;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2010;0;0.0
5345;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2011;0;0.0
5346;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2012;0;0.0
5347;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2013;0;0.0
5348;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2014;0;0.0
5349;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2015;0;0.0
5350;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2016;0;0.0
5351;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2017;0;0.0
5352;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2018;0;0.0
5353;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2019;0;0.0
5354;Total male and female;10000;Total background and generation;V08A X-ray contrast media, iodinated;2020;0;0.0
5355;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2006;0;0.0
5356;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2007;0;0.0
5357;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2008;0;0.0
5358;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2009;0;0.0
5359;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2010;0;0.0
5360;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2011;0;0.0
5361;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2012;0;0.0
5362;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2013;0;0.0
5363;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2014;0;0.0
5364;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2015;0;0.0
5365;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2016;0;0.0
5366;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2017;0;0.0
5367;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2018;0;0.0
5368;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2019;0;0.0
5369;Total male and female;10000;Total background and generation;V08B X-ray contrast media, non-iodinated;2020;0;0.0
5370;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2006;0;0.0
5371;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2007;0;0.0
5372;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2008;0;0.0
5373;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2009;0;0.0
5374;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2010;0;0.0
5375;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2011;0;0.0
5376;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2012;0;0.0
5377;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2013;0;0.0
5378;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2014;0;0.0
5379;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2015;0;0.0
5380;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2016;0;0.0
5381;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2017;0;0.0
5382;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2018;0;0.0
5383;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2019;0;0.0
5384;Total male and female;10000;Total background and generation;V08C Contrats media magnetic reson.imag.;2020;0;0.0
5385;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2006;0;0.0
5386;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2007;0;0.0
5387;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2008;0;0.0
5388;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2009;0;0.0
5389;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2010;0;0.0
5390;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2011;0;0.0
5391;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2012;0;0.0
5392;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2013;0;0.0
5393;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2014;0;0.0
5394;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2015;0;0.0
5395;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2016;0;0.0
5396;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2017;0;0.0
5397;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2018;0;0.0
5398;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2019;0;0.0
5399;Total male and female;10000;Total background and generation;V08D Ultrasound contrast media;2020;0;0.0
5400;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2006;0;0.0
5401;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2007;0;0.0
5402;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2008;0;0.0
5403;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2009;0;0.0
5404;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2010;0;0.0
5405;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2011;0;0.0
5406;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2012;0;0.0
5407;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2013;0;0.0
5408;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2014;0;0.0
5409;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2015;0;0.0
5410;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2016;0;0.0
5411;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2017;0;0.0
5412;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2018;0;0.0
5413;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2019;0;0.0
5414;Total male and female;10000;Total background and generation;V09 Diagnostic radiopharmaceuticals;2020;0;0.0
5415;Total male and female;10000;Total background and generation;V09A Central nervous system;2006;0;0.0
5416;Total male and female;10000;Total background and generation;V09A Central nervous system;2007;0;0.0
5417;Total male and female;10000;Total background and generation;V09A Central nervous system;2008;0;0.0
5418;Total male and female;10000;Total background and generation;V09A Central nervous system;2009;0;0.0
5419;Total male and female;10000;Total background and generation;V09A Central nervous system;2010;0;0.0
5420;Total male and female;10000;Total background and generation;V09A Central nervous system;2011;0;0.0
5421;Total male and female;10000;Total background and generation;V09A Central nervous system;2012;0;0.0
5422;Total male and female;10000;Total background and generation;V09A Central nervous system;2013;0;0.0
5423;Total male and female;10000;Total background and generation;V09A Central nervous system;2014;0;0.0
5424;Total male and female;10000;Total background and generation;V09A Central nervous system;2015;0;0.0
5425;Total male and female;10000;Total background and generation;V09A Central nervous system;2016;0;0.0
5426;Total male and female;10000;Total background and generation;V09A Central nervous system;2017;0;0.0
5427;Total male and female;10000;Total background and generation;V09A Central nervous system;2018;0;0.0
5428;Total male and female;10000;Total background and generation;V09A Central nervous system;2019;0;0.0
5429;Total male and female;10000;Total background and generation;V09A Central nervous system;2020;0;0.0
5430;Total male and female;10000;Total background and generation;V09B Skeleton;2006;0;0.0
5431;Total male and female;10000;Total background and generation;V09B Skeleton;2007;0;0.0
5432;Total male and female;10000;Total background and generation;V09B Skeleton;2008;0;0.0
5433;Total male and female;10000;Total background and generation;V09B Skeleton;2009;0;0.0
5434;Total male and female;10000;Total background and generation;V09B Skeleton;2010;0;0.0
5435;Total male and female;10000;Total background and generation;V09B Skeleton;2011;0;0.0
5436;Total male and female;10000;Total background and generation;V09B Skeleton;2012;0;0.0
5437;Total male and female;10000;Total background and generation;V09B Skeleton;2013;0;0.0
5438;Total male and female;10000;Total background and generation;V09B Skeleton;2014;0;0.0
5439;Total male and female;10000;Total background and generation;V09B Skeleton;2015;0;0.0
5440;Total male and female;10000;Total background and generation;V09B Skeleton;2016;0;0.0
5441;Total male and female;10000;Total background and generation;V09B Skeleton;2017;0;0.0
5442;Total male and female;10000;Total background and generation;V09B Skeleton;2018;0;0.0
5443;Total male and female;10000;Total background and generation;V09B Skeleton;2019;0;0.0
5444;Total male and female;10000;Total background and generation;V09B Skeleton;2020;0;0.0
5445;Total male and female;10000;Total background and generation;V09C Renal system;2006;0;0.0
5446;Total male and female;10000;Total background and generation;V09C Renal system;2007;0;0.0
5447;Total male and female;10000;Total background and generation;V09C Renal system;2008;0;0.0
5448;Total male and female;10000;Total background and generation;V09C Renal system;2009;0;0.0
5449;Total male and female;10000;Total background and generation;V09C Renal system;2010;0;0.0
5450;Total male and female;10000;Total background and generation;V09C Renal system;2011;0;0.0
5451;Total male and female;10000;Total background and generation;V09C Renal system;2012;0;0.0
5452;Total male and female;10000;Total background and generation;V09C Renal system;2013;0;0.0
5453;Total male and female;10000;Total background and generation;V09C Renal system;2014;0;0.0
5454;Total male and female;10000;Total background and generation;V09C Renal system;2015;0;0.0
5455;Total male and female;10000;Total background and generation;V09C Renal system;2016;0;0.0
5456;Total male and female;10000;Total background and generation;V09C Renal system;2017;0;0.0
5457;Total male and female;10000;Total background and generation;V09C Renal system;2018;0;0.0
5458;Total male and female;10000;Total background and generation;V09C Renal system;2019;0;0.0
5459;Total male and female;10000;Total background and generation;V09C Renal system;2020;0;0.0
5460;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2006;0;0.0
5461;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2007;0;0.0
5462;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2008;0;0.0
5463;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2009;0;0.0
5464;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2010;0;0.0
5465;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2011;0;0.0
5466;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2012;0;0.0
5467;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2013;0;0.0
5468;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2014;0;0.0
5469;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2015;0;0.0
5470;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2016;0;0.0
5471;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2017;0;0.0
5472;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2018;0;0.0
5473;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2019;0;0.0
5474;Total male and female;10000;Total background and generation;V09D Hepatic reticulo endothelial system;2020;0;0.0
5475;Total male and female;10000;Total background and generation;V09E Respiratory system;2006;0;0.0
5476;Total male and female;10000;Total background and generation;V09E Respiratory system;2007;0;0.0
5477;Total male and female;10000;Total background and generation;V09E Respiratory system;2008;0;0.0
5478;Total male and female;10000;Total background and generation;V09E Respiratory system;2009;0;0.0
5479;Total male and female;10000;Total background and generation;V09E Respiratory system;2010;0;0.0
5480;Total male and female;10000;Total background and generation;V09E Respiratory system;2011;0;0.0
5481;Total male and female;10000;Total background and generation;V09E Respiratory system;2012;0;0.0
5482;Total male and female;10000;Total background and generation;V09E Respiratory system;2013;0;0.0
5483;Total male and female;10000;Total background and generation;V09E Respiratory system;2014;0;0.0
5484;Total male and female;10000;Total background and generation;V09E Respiratory system;2015;0;0.0
5485;Total male and female;10000;Total background and generation;V09E Respiratory system;2016;0;0.0
5486;Total male and female;10000;Total background and generation;V09E Respiratory system;2017;0;0.0
5487;Total male and female;10000;Total background and generation;V09E Respiratory system;2018;0;0.0
5488;Total male and female;10000;Total background and generation;V09E Respiratory system;2019;0;0.0
5489;Total male and female;10000;Total background and generation;V09E Respiratory system;2020;0;0.0
5490;Total male and female;10000;Total background and generation;V09F Thyroid;2006;0;0.0
5491;Total male and female;10000;Total background and generation;V09F Thyroid;2007;0;0.0
5492;Total male and female;10000;Total background and generation;V09F Thyroid;2008;0;0.0
5493;Total male and female;10000;Total background and generation;V09F Thyroid;2009;0;0.0
5494;Total male and female;10000;Total background and generation;V09F Thyroid;2010;0;0.0
5495;Total male and female;10000;Total background and generation;V09F Thyroid;2011;0;0.0
5496;Total male and female;10000;Total background and generation;V09F Thyroid;2012;0;0.0
5497;Total male and female;10000;Total background and generation;V09F Thyroid;2013;0;0.0
5498;Total male and female;10000;Total background and generation;V09F Thyroid;2014;0;0.0
5499;Total male and female;10000;Total background and generation;V09F Thyroid;2015;0;0.0
5500;Total male and female;10000;Total background and generation;V09F Thyroid;2016;0;0.0
5501;Total male and female;10000;Total background and generation;V09F Thyroid;2017;0;0.0
5502;Total male and female;10000;Total background and generation;V09F Thyroid;2018;0;0.0
5503;Total male and female;10000;Total background and generation;V09F Thyroid;2019;0;0.0
5504;Total male and female;10000;Total background and generation;V09F Thyroid;2020;0;0.0
5505;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2006;0;0.0
5506;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2007;0;0.0
5507;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2008;0;0.0
5508;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2009;0;0.0
5509;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2010;0;0.0
5510;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2011;0;0.0
5511;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2012;0;0.0
5512;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2013;0;0.0
5513;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2014;0;0.0
5514;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2015;0;0.0
5515;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2016;0;0.0
5516;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2017;0;0.0
5517;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2018;0;0.0
5518;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2019;0;0.0
5519;Total male and female;10000;Total background and generation;V09G Cardiovascular system;2020;0;0.0
5520;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2006;0;0.0
5521;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2007;0;0.0
5522;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2008;0;0.0
5523;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2009;0;0.0
5524;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2010;0;0.0
5525;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2011;0;0.0
5526;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2012;0;0.0
5527;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2013;0;0.0
5528;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2014;0;0.0
5529;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2015;0;0.0
5530;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2016;0;0.0
5531;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2017;0;0.0
5532;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2018;0;0.0
5533;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2019;0;0.0
5534;Total male and female;10000;Total background and generation;V09H Inflammation / infection detection;2020;0;0.0
5535;Total male and female;10000;Total background and generation;V09I Tumour detection;2006;0;0.0
5536;Total male and female;10000;Total background and generation;V09I Tumour detection;2007;0;0.0
5537;Total male and female;10000;Total background and generation;V09I Tumour detection;2008;0;0.0
5538;Total male and female;10000;Total background and generation;V09I Tumour detection;2009;0;0.0
5539;Total male and female;10000;Total background and generation;V09I Tumour detection;2010;0;0.0
5540;Total male and female;10000;Total background and generation;V09I Tumour detection;2011;0;0.0
5541;Total male and female;10000;Total background and generation;V09I Tumour detection;2012;0;0.0
5542;Total male and female;10000;Total background and generation;V09I Tumour detection;2013;0;0.0
5543;Total male and female;10000;Total background and generation;V09I Tumour detection;2014;0;0.0
5544;Total male and female;10000;Total background and generation;V09I Tumour detection;2015;0;0.0
5545;Total male and female;10000;Total background and generation;V09I Tumour detection;2016;0;0.0
5546;Total male and female;10000;Total background and generation;V09I Tumour detection;2017;0;0.0
5547;Total male and female;10000;Total background and generation;V09I Tumour detection;2018;0;0.0
5548;Total male and female;10000;Total background and generation;V09I Tumour detection;2019;0;0.0
5549;Total male and female;10000;Total background and generation;V09I Tumour detection;2020;0;0.0
5550;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2006;0;0.0
5551;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2007;0;0.0
5552;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2008;0;0.0
5553;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2009;0;0.0
5554;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2010;0;0.0
5555;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2011;0;0.0
5556;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2012;0;0.0
5557;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2013;0;0.0
5558;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2014;0;0.0
5559;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2015;0;0.0
5560;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2016;0;0.0
5561;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2017;0;0.0
5562;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2018;0;0.0
5563;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2019;0;0.0
5564;Total male and female;10000;Total background and generation;V09X Oth.diagnostic radiopharmaceuticals;2020;0;0.0
5565;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2006;0;0.0
5566;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2007;0;0.0
5567;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2008;0;0.0
5568;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2009;0;0.0
5569;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2010;0;0.0
5570;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2011;0;0.0
5571;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2012;0;0.0
5572;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2013;0;0.0
5573;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2014;0;0.0
5574;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2015;0;0.0
5575;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2016;0;0.0
5576;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2017;0;0.0
5577;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2018;0;0.0
5578;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2019;0;0.0
5579;Total male and female;10000;Total background and generation;V10 Therapeutic radiopharmaceuticals;2020;0;0.0
5580;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2006;0;0.0
5581;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2007;0;0.0
5582;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2008;0;0.0
5583;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2009;0;0.0
5584;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2010;0;0.0
5585;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2011;0;0.0
5586;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2012;0;0.0
5587;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2013;0;0.0
5588;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2014;0;0.0
5589;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2015;0;0.0
5590;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2016;0;0.0
5591;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2017;0;0.0
5592;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2018;0;0.0
5593;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2019;0;0.0
5594;Total male and female;10000;Total background and generation;V10A Antiinflammatory agents;2020;0;0.0
5595;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2006;0;0.0
5596;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2007;0;0.0
5597;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2008;0;0.0
5598;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2009;0;0.0
5599;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2010;0;0.0
5600;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2011;0;0.0
5601;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2012;0;0.0
5602;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2013;0;0.0
5603;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2014;0;0.0
5604;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2015;0;0.0
5605;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2016;0;0.0
5606;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2017;0;0.0
5607;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2018;0;0.0
5608;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2019;0;0.0
5609;Total male and female;10000;Total background and generation;V10B Pain palliation,bone seeking agents;2020;0;0.0
5610;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2006;0;0.0
5611;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2007;0;0.0
5612;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2008;0;0.0
5613;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2009;0;0.0
5614;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2010;0;0.0
5615;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2011;0;0.0
5616;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2012;0;0.0
5617;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2013;0;0.0
5618;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2014;0;0.0
5619;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2015;0;0.0
5620;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2016;0;0.0
5621;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2017;0;0.0
5622;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2018;0;0.0
5623;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2019;0;0.0
5624;Total male and female;10000;Total background and generation;V10X Oth. therapeutic radiopharmaceutic.;2020;0;0.0
5625;Total male and female;10000;Total background and generation;V20 Surgical dressings;2006;0;0.0
5626;Total male and female;10000;Total background and generation;V20 Surgical dressings;2007;0;0.0
5627;Total male and female;10000;Total background and generation;V20 Surgical dressings;2008;0;0.0
5628;Total male and female;10000;Total background and generation;V20 Surgical dressings;2009;0;0.0
5629;Total male and female;10000;Total background and generation;V20 Surgical dressings;2010;0;0.0
5630;Total male and female;10000;Total background and generation;V20 Surgical dressings;2011;0;0.0
5631;Total male and female;10000;Total background and generation;V20 Surgical dressings;2012;0;0.0
5632;Total male and female;10000;Total background and generation;V20 Surgical dressings;2013;0;0.0
5633;Total male and female;10000;Total background and generation;V20 Surgical dressings;2014;0;0.0
5634;Total male and female;10000;Total background and generation;V20 Surgical dressings;2015;0;0.0
5635;Total male and female;10000;Total background and generation;V20 Surgical dressings;2016;0;0.0
5636;Total male and female;10000;Total background and generation;V20 Surgical dressings;2017;0;0.0
5637;Total male and female;10000;Total background and generation;V20 Surgical dressings;2018;0;0.0
5638;Total male and female;10000;Total background and generation;V20 Surgical dressings;2019;0;0.0
5639;Total male and female;10000;Total background and generation;V20 Surgical dressings;2020;0;0.0
5640;Total male and female;10000;Total background and generation;Y Not filled in;2006;32735;0.2
5641;Total male and female;10000;Total background and generation;Y Not filled in;2007;52220;0.31
5642;Total male and female;10000;Total background and generation;Y Not filled in;2008;70840;0.42
5643;Total male and female;10000;Total background and generation;Y Not filled in;2009;91040;0.54
5644;Total male and female;10000;Total background and generation;Y Not filled in;2010;107905;0.64
5645;Total male and female;10000;Total background and generation;Y Not filled in;2011;122800;0.72
5646;Total male and female;10000;Total background and generation;Y Not filled in;2012;135785;0.8
5647;Total male and female;10000;Total background and generation;Y Not filled in;2013;144375;0.84
5648;Total male and female;10000;Total background and generation;Y Not filled in;2014;151835;0.88
5649;Total male and female;10000;Total background and generation;Y Not filled in;2015;156830;0.91
5650;Total male and female;10000;Total background and generation;Y Not filled in;2016;165710;0.95
5651;Total male and female;10000;Total background and generation;Y Not filled in;2017;175995;1.01
5652;Total male and female;10000;Total background and generation;Y Not filled in;2018;185075;1.05
5653;Total male and female;10000;Total background and generation;Y Not filled in;2019;189290;1.07
5654;Total male and female;10000;Total background and generation;Y Not filled in;2020;194640;1.09
5655;Total male and female;10000;Dutch background;Total;2006;9149390;68.5
5656;Total male and female;10000;Dutch background;Total;2007;9195430;68.85
5657;Total male and female;10000;Dutch background;Total;2008;9485215;70.99
5658;Total male and female;10000;Dutch background;Total;2009;9525470;71.25
5659;Total male and female;10000;Dutch background;Total;2010;9547895;71.33
5660;Total male and female;10000;Dutch background;Total;2011;9375000;69.99
5661;Total male and female;10000;Dutch background;Total;2012;9258375;69.11
5662;Total male and female;10000;Dutch background;Total;2013;9117095;68.07
5663;Total male and female;10000;Dutch background;Total;2014;9071725;67.73
5664;Total male and female;10000;Dutch background;Total;2015;9068000;67.72
5665;Total male and female;10000;Dutch background;Total;2016;9073880;67.81
5666;Total male and female;10000;Dutch background;Total;2017;9001520;67.31
5667;Total male and female;10000;Dutch background;Total;2018;9039225;67.66
5668;Total male and female;10000;Dutch background;Total;2019;8991185;67.37
5669;Total male and female;10000;Dutch background;Total;2020;8655015;64.9
5670;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2006;2513770;18.82
5671;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2007;2710410;20.29
5672;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2008;2883080;21.58
5673;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2009;3056500;22.86
5674;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2010;3240305;24.21
5675;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2011;3372015;25.17
5676;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2012;2826500;21.1
5677;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2013;2911200;21.74
5678;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2014;3047695;22.75
5679;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2015;3166470;23.65
5680;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2016;3265105;24.4
5681;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2017;3324365;24.86
5682;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2018;3386115;25.34
5683;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2019;3360760;25.18
5684;Total male and female;10000;Dutch background;A Alimentary tract and metabolism;2020;3309645;24.82
5685;Total male and female;10000;Dutch background;A01 Stomatological preparations;2006;112410;0.84
5686;Total male and female;10000;Dutch background;A01 Stomatological preparations;2007;120730;0.9
5687;Total male and female;10000;Dutch background;A01 Stomatological preparations;2008;122405;0.92
5688;Total male and female;10000;Dutch background;A01 Stomatological preparations;2009;122585;0.92
5689;Total male and female;10000;Dutch background;A01 Stomatological preparations;2010;127245;0.95
5690;Total male and female;10000;Dutch background;A01 Stomatological preparations;2011;79220;0.59
5691;Total male and female;10000;Dutch background;A01 Stomatological preparations;2012;30390;0.23
5692;Total male and female;10000;Dutch background;A01 Stomatological preparations;2013;30125;0.22
5693;Total male and female;10000;Dutch background;A01 Stomatological preparations;2014;31295;0.23
5694;Total male and female;10000;Dutch background;A01 Stomatological preparations;2015;31110;0.23
5695;Total male and female;10000;Dutch background;A01 Stomatological preparations;2016;31005;0.23
5696;Total male and female;10000;Dutch background;A01 Stomatological preparations;2017;29290;0.22
5697;Total male and female;10000;Dutch background;A01 Stomatological preparations;2018;28925;0.22
5698;Total male and female;10000;Dutch background;A01 Stomatological preparations;2019;35965;0.27
5699;Total male and female;10000;Dutch background;A01 Stomatological preparations;2020;36800;0.28
5700;Total male and female;10000;Dutch background;A01A Stomatological preparations;2006;112410;0.84
5701;Total male and female;10000;Dutch background;A01A Stomatological preparations;2007;120730;0.9
5702;Total male and female;10000;Dutch background;A01A Stomatological preparations;2008;122405;0.92
5703;Total male and female;10000;Dutch background;A01A Stomatological preparations;2009;122585;0.92
5704;Total male and female;10000;Dutch background;A01A Stomatological preparations;2010;127245;0.95
5705;Total male and female;10000;Dutch background;A01A Stomatological preparations;2011;79220;0.59
5706;Total male and female;10000;Dutch background;A01A Stomatological preparations;2012;30390;0.23
5707;Total male and female;10000;Dutch background;A01A Stomatological preparations;2013;30125;0.22
5708;Total male and female;10000;Dutch background;A01A Stomatological preparations;2014;31295;0.23
5709;Total male and female;10000;Dutch background;A01A Stomatological preparations;2015;31110;0.23
5710;Total male and female;10000;Dutch background;A01A Stomatological preparations;2016;31005;0.23
5711;Total male and female;10000;Dutch background;A01A Stomatological preparations;2017;29290;0.22
5712;Total male and female;10000;Dutch background;A01A Stomatological preparations;2018;28925;0.22
5713;Total male and female;10000;Dutch background;A01A Stomatological preparations;2019;35965;0.27
5714;Total male and female;10000;Dutch background;A01A Stomatological preparations;2020;36800;0.28
5715;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2006;1381770;10.35
5716;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2007;1557315;11.66
5717;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2008;1736080;12.99
5718;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2009;1897425;14.19
5719;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2010;2060110;15.39
5720;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2011;2208470;16.49
5721;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2012;1498450;11.19
5722;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2013;1576960;11.77
5723;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2014;1664445;12.43
5724;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2015;1726185;12.89
5725;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2016;1780840;13.31
5726;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2017;1796940;13.44
5727;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2018;1810355;13.55
5728;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2019;1832545;13.73
5729;Total male and female;10000;Dutch background;A02 Drugs for acid related disorders;2020;1834215;13.75
5730;Total male and female;10000;Dutch background;A02A Antacids;2006;2675;0.02
5731;Total male and female;10000;Dutch background;A02A Antacids;2007;1480;0.01
5732;Total male and female;10000;Dutch background;A02A Antacids;2008;775;0.01
5733;Total male and female;10000;Dutch background;A02A Antacids;2009;455;0.0
5734;Total male and female;10000;Dutch background;A02A Antacids;2010;395;0.0
5735;Total male and female;10000;Dutch background;A02A Antacids;2011;320;0.0
5736;Total male and female;10000;Dutch background;A02A Antacids;2012;240;0.0
5737;Total male and female;10000;Dutch background;A02A Antacids;2013;395;0.0
5738;Total male and female;10000;Dutch background;A02A Antacids;2014;235;0.0
5739;Total male and female;10000;Dutch background;A02A Antacids;2015;175;0.0
5740;Total male and female;10000;Dutch background;A02A Antacids;2016;160;0.0
5741;Total male and female;10000;Dutch background;A02A Antacids;2017;105;0.0
5742;Total male and female;10000;Dutch background;A02A Antacids;2018;70;0.0
5743;Total male and female;10000;Dutch background;A02A Antacids;2019;80;0.0
5744;Total male and female;10000;Dutch background;A02A Antacids;2020;75;0.0
5745;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2006;1380220;10.33
5746;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2007;1556480;11.65
5747;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2008;1735635;12.99
5748;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2009;1897165;14.19
5749;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2010;2059885;15.39
5750;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2011;2208305;16.49
5751;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2012;1498305;11.18
5752;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2013;1576750;11.77
5753;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2014;1664340;12.43
5754;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2015;1726110;12.89
5755;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2016;1780770;13.31
5756;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2017;1796895;13.44
5757;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2018;1810325;13.55
5758;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2019;1832505;13.73
5759;Total male and female;10000;Dutch background;A02B Drugs for peptic ulcer and gord;2020;1834180;13.75
5760;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2006;0;0.0
5761;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2007;0;0.0
5762;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2008;0;0.0
5763;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2009;0;0.0
5764;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2010;0;0.0
5765;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2011;0;0.0
5766;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2012;0;0.0
5767;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2013;0;0.0
5768;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2014;0;0.0
5769;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2015;0;0.0
5770;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2016;0;0.0
5771;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2017;0;0.0
5772;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2018;0;0.0
5773;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2019;0;0.0
5774;Total male and female;10000;Dutch background;A02X Oth. drugs for acid related disord.;2020;0;0.0
5775;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2006;272160;2.04
5776;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2007;283600;2.12
5777;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2008;283195;2.12
5778;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2009;287020;2.15
5779;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2010;292295;2.18
5780;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2011;300505;2.24
5781;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2012;290540;2.17
5782;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2013;275070;2.05
5783;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2014;286770;2.14
5784;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2015;312705;2.34
5785;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2016;310685;2.32
5786;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2017;304700;2.28
5787;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2018;306305;2.29
5788;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2019;294995;2.21
5789;Total male and female;10000;Dutch background;A03 Drugs for funct.gastrointest.disord.;2020;280235;2.1
5790;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2006;100040;0.75
5791;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2007;102100;0.76
5792;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2008;101605;0.76
5793;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2009;101790;0.76
5794;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2010;101090;0.76
5795;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2011;101385;0.76
5796;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2012;98825;0.74
5797;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2013;92120;0.69
5798;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2014;90015;0.67
5799;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2015;85115;0.64
5800;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2016;82825;0.62
5801;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2017;80930;0.61
5802;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2018;79270;0.59
5803;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2019;76835;0.58
5804;Total male and female;10000;Dutch background;A03A Drugs for functional bowel disord.;2020;71495;0.54
5805;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2006;3570;0.03
5806;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2007;3425;0.03
5807;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2008;3230;0.02
5808;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2009;3260;0.02
5809;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2010;3525;0.03
5810;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2011;4010;0.03
5811;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2012;3780;0.03
5812;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2013;3770;0.03
5813;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2014;3900;0.03
5814;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2015;3800;0.03
5815;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2016;3965;0.03
5816;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2017;3970;0.03
5817;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2018;3980;0.03
5818;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2019;3995;0.03
5819;Total male and female;10000;Dutch background;A03B Belladonna and derivatives, plain;2020;3555;0.03
5820;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2006;0;0.0
5821;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2007;0;0.0
5822;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2008;0;0.0
5823;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2009;0;0.0
5824;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2010;0;0.0
5825;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2011;0;0.0
5826;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2012;0;0.0
5827;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2013;0;0.0
5828;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2014;0;0.0
5829;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2015;0;0.0
5830;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2016;0;0.0
5831;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2017;0;0.0
5832;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2018;0;0.0
5833;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2019;0;0.0
5834;Total male and female;10000;Dutch background;A03C Antispasmodics with psycholeptics;2020;0;0.0
5835;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2006;0;0.0
5836;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2007;0;0.0
5837;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2008;0;0.0
5838;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2009;0;0.0
5839;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2010;0;0.0
5840;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2011;0;0.0
5841;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2012;0;0.0
5842;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2013;0;0.0
5843;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2014;0;0.0
5844;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2015;0;0.0
5845;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2016;0;0.0
5846;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2017;0;0.0
5847;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2018;0;0.0
5848;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2019;0;0.0
5849;Total male and female;10000;Dutch background;A03D Antispasmodics with analgesics;2020;0;0.0
5850;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2006;0;0.0
5851;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2007;0;0.0
5852;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2008;0;0.0
5853;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2009;0;0.0
5854;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2010;0;0.0
5855;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2011;0;0.0
5856;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2012;0;0.0
5857;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2013;0;0.0
5858;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2014;0;0.0
5859;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2015;0;0.0
5860;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2016;0;0.0
5861;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2017;0;0.0
5862;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2018;0;0.0
5863;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2019;0;0.0
5864;Total male and female;10000;Dutch background;A03E Antispasmodics and anticholinergics;2020;0;0.0
5865;Total male and female;10000;Dutch background;A03F Propulsives;2006;176965;1.32
5866;Total male and female;10000;Dutch background;A03F Propulsives;2007;187035;1.4
5867;Total male and female;10000;Dutch background;A03F Propulsives;2008;187335;1.4
5868;Total male and female;10000;Dutch background;A03F Propulsives;2009;190965;1.43
5869;Total male and female;10000;Dutch background;A03F Propulsives;2010;197105;1.47
5870;Total male and female;10000;Dutch background;A03F Propulsives;2011;205105;1.53
5871;Total male and female;10000;Dutch background;A03F Propulsives;2012;197300;1.47
5872;Total male and female;10000;Dutch background;A03F Propulsives;2013;187655;1.4
5873;Total male and female;10000;Dutch background;A03F Propulsives;2014;201685;1.51
5874;Total male and female;10000;Dutch background;A03F Propulsives;2015;233565;1.74
5875;Total male and female;10000;Dutch background;A03F Propulsives;2016;233415;1.74
5876;Total male and female;10000;Dutch background;A03F Propulsives;2017;228945;1.71
5877;Total male and female;10000;Dutch background;A03F Propulsives;2018;232095;1.74
5878;Total male and female;10000;Dutch background;A03F Propulsives;2019;222715;1.67
5879;Total male and female;10000;Dutch background;A03F Propulsives;2020;212970;1.6
5880;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2006;30900;0.23
5881;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2007;34505;0.26
5882;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2008;36910;0.28
5883;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2009;39245;0.29
5884;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2010;41695;0.31
5885;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2011;44580;0.33
5886;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2012;44500;0.33
5887;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2013;46045;0.34
5888;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2014;47455;0.35
5889;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2015;51630;0.39
5890;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2016;55145;0.41
5891;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2017;58660;0.44
5892;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2018;66310;0.5
5893;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2019;70425;0.53
5894;Total male and female;10000;Dutch background;A04 Antiemetics and antinauseants;2020;64320;0.48
5895;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2006;30900;0.23
5896;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2007;34505;0.26
5897;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2008;36910;0.28
5898;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2009;39245;0.29
5899;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2010;41695;0.31
5900;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2011;44580;0.33
5901;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2012;44500;0.33
5902;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2013;46045;0.34
5903;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2014;47455;0.35
5904;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2015;51630;0.39
5905;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2016;55145;0.41
5906;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2017;58660;0.44
5907;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2018;66310;0.5
5908;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2019;70425;0.53
5909;Total male and female;10000;Dutch background;A04A Antiemetics and antinauseants;2020;64320;0.48
5910;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2006;7100;0.05
5911;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2007;7645;0.06
5912;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2008;8120;0.06
5913;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2009;8725;0.07
5914;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2010;9020;0.07
5915;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2011;9325;0.07
5916;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2012;9630;0.07
5917;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2013;10185;0.08
5918;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2014;10545;0.08
5919;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2015;10885;0.08
5920;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2016;11240;0.08
5921;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2017;11700;0.09
5922;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2018;12035;0.09
5923;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2019;12425;0.09
5924;Total male and female;10000;Dutch background;A05 Bile and liver therapy;2020;12180;0.09
5925;Total male and female;10000;Dutch background;A05A Bile therapy;2006;7100;0.05
5926;Total male and female;10000;Dutch background;A05A Bile therapy;2007;7645;0.06
5927;Total male and female;10000;Dutch background;A05A Bile therapy;2008;8120;0.06
5928;Total male and female;10000;Dutch background;A05A Bile therapy;2009;8725;0.07
5929;Total male and female;10000;Dutch background;A05A Bile therapy;2010;9020;0.07
5930;Total male and female;10000;Dutch background;A05A Bile therapy;2011;9325;0.07
5931;Total male and female;10000;Dutch background;A05A Bile therapy;2012;9630;0.07
5932;Total male and female;10000;Dutch background;A05A Bile therapy;2013;10185;0.08
5933;Total male and female;10000;Dutch background;A05A Bile therapy;2014;10545;0.08
5934;Total male and female;10000;Dutch background;A05A Bile therapy;2015;10885;0.08
5935;Total male and female;10000;Dutch background;A05A Bile therapy;2016;11240;0.08
5936;Total male and female;10000;Dutch background;A05A Bile therapy;2017;11700;0.09
5937;Total male and female;10000;Dutch background;A05A Bile therapy;2018;12035;0.09
5938;Total male and female;10000;Dutch background;A05A Bile therapy;2019;12425;0.09
5939;Total male and female;10000;Dutch background;A05A Bile therapy;2020;12180;0.09
5940;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2006;0;0.0
5941;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2007;0;0.0
5942;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2008;0;0.0
5943;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2009;0;0.0
5944;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2010;0;0.0
5945;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2011;0;0.0
5946;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2012;0;0.0
5947;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2013;0;0.0
5948;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2014;0;0.0
5949;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2015;0;0.0
5950;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2016;0;0.0
5951;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2017;0;0.0
5952;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2018;0;0.0
5953;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2019;0;0.0
5954;Total male and female;10000;Dutch background;A05B Liver therapy, lipotropics;2020;0;0.0
5955;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2006;0;0.0
5956;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2007;0;0.0
5957;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2008;0;0.0
5958;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2009;0;0.0
5959;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2010;0;0.0
5960;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2011;0;0.0
5961;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2012;0;0.0
5962;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2013;0;0.0
5963;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2014;0;0.0
5964;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2015;0;0.0
5965;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2016;0;0.0
5966;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2017;0;0.0
5967;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2018;0;0.0
5968;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2019;0;0.0
5969;Total male and female;10000;Dutch background;A05C Bile therapy drugs and lipotropics;2020;0;0.0
5970;Total male and female;10000;Dutch background;A06 Laxatives;2006;635985;4.76
5971;Total male and female;10000;Dutch background;A06 Laxatives;2007;697400;5.22
5972;Total male and female;10000;Dutch background;A06 Laxatives;2008;739470;5.53
5973;Total male and female;10000;Dutch background;A06 Laxatives;2009;791780;5.92
5974;Total male and female;10000;Dutch background;A06 Laxatives;2010;853565;6.38
5975;Total male and female;10000;Dutch background;A06 Laxatives;2011;924100;6.9
5976;Total male and female;10000;Dutch background;A06 Laxatives;2012;932585;6.96
5977;Total male and female;10000;Dutch background;A06 Laxatives;2013;931820;6.96
5978;Total male and female;10000;Dutch background;A06 Laxatives;2014;979255;7.31
5979;Total male and female;10000;Dutch background;A06 Laxatives;2015;1037310;7.75
5980;Total male and female;10000;Dutch background;A06 Laxatives;2016;1096645;8.19
5981;Total male and female;10000;Dutch background;A06 Laxatives;2017;1143330;8.55
5982;Total male and female;10000;Dutch background;A06 Laxatives;2018;1170935;8.76
5983;Total male and female;10000;Dutch background;A06 Laxatives;2019;1174885;8.8
5984;Total male and female;10000;Dutch background;A06 Laxatives;2020;1138175;8.53
5985;Total male and female;10000;Dutch background;A06A Laxatives;2006;635985;4.76
5986;Total male and female;10000;Dutch background;A06A Laxatives;2007;697400;5.22
5987;Total male and female;10000;Dutch background;A06A Laxatives;2008;739470;5.53
5988;Total male and female;10000;Dutch background;A06A Laxatives;2009;791780;5.92
5989;Total male and female;10000;Dutch background;A06A Laxatives;2010;853565;6.38
5990;Total male and female;10000;Dutch background;A06A Laxatives;2011;924100;6.9
5991;Total male and female;10000;Dutch background;A06A Laxatives;2012;932585;6.96
5992;Total male and female;10000;Dutch background;A06A Laxatives;2013;931820;6.96
5993;Total male and female;10000;Dutch background;A06A Laxatives;2014;979255;7.31
5994;Total male and female;10000;Dutch background;A06A Laxatives;2015;1037310;7.75
5995;Total male and female;10000;Dutch background;A06A Laxatives;2016;1096645;8.19
5996;Total male and female;10000;Dutch background;A06A Laxatives;2017;1143330;8.55
5997;Total male and female;10000;Dutch background;A06A Laxatives;2018;1170935;8.76
5998;Total male and female;10000;Dutch background;A06A Laxatives;2019;1174885;8.8
5999;Total male and female;10000;Dutch background;A06A Laxatives;2020;1138175;8.53
6000;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2006;198230;1.48
6001;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2007;201030;1.51
6002;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2008;199945;1.5
6003;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2009;202325;1.51
6004;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2010;203780;1.52
6005;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2011;203515;1.52
6006;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2012;196590;1.47
6007;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2013;187605;1.4
6008;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2014;184450;1.38
6009;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2015;182170;1.36
6010;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2016;179925;1.34
6011;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2017;177970;1.33
6012;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2018;179550;1.34
6013;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2019;174975;1.31
6014;Total male and female;10000;Dutch background;A07 Anti diarr/intest/infl/infect.agents;2020;169520;1.27
6015;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2006;90685;0.68
6016;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2007;92535;0.69
6017;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2008;95950;0.72
6018;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2009;99060;0.74
6019;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2010;102205;0.76
6020;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2011;103315;0.77
6021;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2012;100935;0.75
6022;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2013;95925;0.72
6023;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2014;94550;0.71
6024;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2015;93435;0.7
6025;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2016;90815;0.68
6026;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2017;88620;0.66
6027;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2018;89220;0.67
6028;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2019;85875;0.64
6029;Total male and female;10000;Dutch background;A07A Intestinal antiinfectives;2020;81545;0.61
6030;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2006;65;0.0
6031;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2007;35;0.0
6032;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2008;10;0.0
6033;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2009;5;0.0
6034;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2010;5;0.0
6035;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2011;0;0.0
6036;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2012;5;0.0
6037;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2013;0;0.0
6038;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2014;0;0.0
6039;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2015;0;0.0
6040;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2016;0;0.0
6041;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2017;0;0.0
6042;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2018;0;0.0
6043;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2019;0;0.0
6044;Total male and female;10000;Dutch background;A07B Intestinal adsorbents;2020;0;0.0
6045;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2006;245;0.0
6046;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2007;195;0.0
6047;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2008;10;0.0
6048;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2009;10;0.0
6049;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2010;10;0.0
6050;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2011;5;0.0
6051;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2012;5;0.0
6052;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2013;5;0.0
6053;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2014;5;0.0
6054;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2015;5;0.0
6055;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2016;5;0.0
6056;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2017;5;0.0
6057;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2018;5;0.0
6058;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2019;5;0.0
6059;Total male and female;10000;Dutch background;A07C Electrolytes with carbohydrates;2020;5;0.0
6060;Total male and female;10000;Dutch background;A07D Antipropulsives;2006;48665;0.36
6061;Total male and female;10000;Dutch background;A07D Antipropulsives;2007;49020;0.37
6062;Total male and female;10000;Dutch background;A07D Antipropulsives;2008;44470;0.33
6063;Total male and female;10000;Dutch background;A07D Antipropulsives;2009;42445;0.32
6064;Total male and female;10000;Dutch background;A07D Antipropulsives;2010;40665;0.3
6065;Total male and female;10000;Dutch background;A07D Antipropulsives;2011;38900;0.29
6066;Total male and female;10000;Dutch background;A07D Antipropulsives;2012;34380;0.26
6067;Total male and female;10000;Dutch background;A07D Antipropulsives;2013;30235;0.23
6068;Total male and female;10000;Dutch background;A07D Antipropulsives;2014;27390;0.2
6069;Total male and female;10000;Dutch background;A07D Antipropulsives;2015;25760;0.19
6070;Total male and female;10000;Dutch background;A07D Antipropulsives;2016;25215;0.19
6071;Total male and female;10000;Dutch background;A07D Antipropulsives;2017;24750;0.19
6072;Total male and female;10000;Dutch background;A07D Antipropulsives;2018;24590;0.18
6073;Total male and female;10000;Dutch background;A07D Antipropulsives;2019;21535;0.16
6074;Total male and female;10000;Dutch background;A07D Antipropulsives;2020;20090;0.15
6075;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2006;63475;0.48
6076;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2007;64245;0.48
6077;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2008;64125;0.48
6078;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2009;65375;0.49
6079;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2010;65335;0.49
6080;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2011;65720;0.49
6081;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2012;65310;0.49
6082;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2013;65265;0.49
6083;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2014;66040;0.49
6084;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2015;66450;0.5
6085;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2016;67380;0.5
6086;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2017;68120;0.51
6087;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2018;69275;0.52
6088;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2019;70765;0.53
6089;Total male and female;10000;Dutch background;A07E Intestinal antiinflammatory agents;2020;71165;0.53
6090;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2006;0;0.0
6091;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2007;0;0.0
6092;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2008;0;0.0
6093;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2009;0;0.0
6094;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2010;0;0.0
6095;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2011;0;0.0
6096;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2012;0;0.0
6097;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2013;0;0.0
6098;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2014;0;0.0
6099;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2015;0;0.0
6100;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2016;0;0.0
6101;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2017;0;0.0
6102;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2018;0;0.0
6103;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2019;0;0.0
6104;Total male and female;10000;Dutch background;A07F Antidiarrheal microorganisms;2020;0;0.0
6105;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2006;10;0.0
6106;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2007;5;0.0
6107;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2008;0;0.0
6108;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2009;0;0.0
6109;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2010;0;0.0
6110;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2011;0;0.0
6111;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2012;0;0.0
6112;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2013;0;0.0
6113;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2014;0;0.0
6114;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2015;0;0.0
6115;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2016;0;0.0
6116;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2017;0;0.0
6117;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2018;10;0.0
6118;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2019;0;0.0
6119;Total male and female;10000;Dutch background;A07X Other antidiarrheals;2020;0;0.0
6120;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2006;465;0.0
6121;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2007;465;0.0
6122;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2008;95;0.0
6123;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2009;20;0.0
6124;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2010;0;0.0
6125;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2011;5;0.0
6126;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2012;0;0.0
6127;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2013;5;0.0
6128;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2014;0;0.0
6129;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2015;0;0.0
6130;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2016;0;0.0
6131;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2017;0;0.0
6132;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2018;0;0.0
6133;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2019;0;0.0
6134;Total male and female;10000;Dutch background;A08 Antiobesity prep. excl.diet products;2020;0;0.0
6135;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2006;465;0.0
6136;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2007;465;0.0
6137;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2008;95;0.0
6138;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2009;20;0.0
6139;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2010;0;0.0
6140;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2011;5;0.0
6141;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2012;0;0.0
6142;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2013;5;0.0
6143;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2014;0;0.0
6144;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2015;0;0.0
6145;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2016;0;0.0
6146;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2017;0;0.0
6147;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2018;0;0.0
6148;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2019;0;0.0
6149;Total male and female;10000;Dutch background;A08A Antiobesity prep.excl.diet products;2020;0;0.0
6150;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2006;9815;0.07
6151;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2007;9645;0.07
6152;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2008;9520;0.07
6153;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2009;9940;0.07
6154;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2010;10050;0.08
6155;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2011;10335;0.08
6156;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2012;10935;0.08
6157;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2013;11985;0.09
6158;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2014;11775;0.09
6159;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2015;12095;0.09
6160;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2016;12575;0.09
6161;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2017;13065;0.1
6162;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2018;13760;0.1
6163;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2019;14825;0.11
6164;Total male and female;10000;Dutch background;A09 Digestives, incl. enzymes;2020;15670;0.12
6165;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2006;9815;0.07
6166;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2007;9645;0.07
6167;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2008;9520;0.07
6168;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2009;9940;0.07
6169;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2010;10050;0.08
6170;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2011;10335;0.08
6171;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2012;10935;0.08
6172;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2013;11985;0.09
6173;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2014;11775;0.09
6174;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2015;12095;0.09
6175;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2016;12575;0.09
6176;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2017;13065;0.1
6177;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2018;13760;0.1
6178;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2019;14825;0.11
6179;Total male and female;10000;Dutch background;A09A Digestives, incl. enzymes;2020;15670;0.12
6180;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2006;495685;3.71
6181;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2007;514105;3.85
6182;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2008;534180;4.0
6183;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2009;556460;4.16
6184;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2010;576745;4.31
6185;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2011;592175;4.42
6186;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2012;602730;4.5
6187;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2013;608110;4.54
6188;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2014;610440;4.56
6189;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2015;611910;4.57
6190;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2016;612595;4.58
6191;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2017;612275;4.58
6192;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2018;611245;4.58
6193;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2019;609210;4.56
6194;Total male and female;10000;Dutch background;A10 Drugs used in diabetes;2020;607160;4.55
6195;Total male and female;10000;Dutch background;A10A Insulins and analogues;2006;169230;1.27
6196;Total male and female;10000;Dutch background;A10A Insulins and analogues;2007;176905;1.32
6197;Total male and female;10000;Dutch background;A10A Insulins and analogues;2008;185560;1.39
6198;Total male and female;10000;Dutch background;A10A Insulins and analogues;2009;192780;1.44
6199;Total male and female;10000;Dutch background;A10A Insulins and analogues;2010;198200;1.48
6200;Total male and female;10000;Dutch background;A10A Insulins and analogues;2011;202125;1.51
6201;Total male and female;10000;Dutch background;A10A Insulins and analogues;2012;205450;1.53
6202;Total male and female;10000;Dutch background;A10A Insulins and analogues;2013;208480;1.56
6203;Total male and female;10000;Dutch background;A10A Insulins and analogues;2014;211650;1.58
6204;Total male and female;10000;Dutch background;A10A Insulins and analogues;2015;213985;1.6
6205;Total male and female;10000;Dutch background;A10A Insulins and analogues;2016;215450;1.61
6206;Total male and female;10000;Dutch background;A10A Insulins and analogues;2017;216360;1.62
6207;Total male and female;10000;Dutch background;A10A Insulins and analogues;2018;215280;1.61
6208;Total male and female;10000;Dutch background;A10A Insulins and analogues;2019;213730;1.6
6209;Total male and female;10000;Dutch background;A10A Insulins and analogues;2020;212025;1.59
6210;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2006;402620;3.01
6211;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2007;420925;3.15
6212;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2008;440390;3.3
6213;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2009;464630;3.48
6214;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2010;486515;3.63
6215;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2011;502435;3.75
6216;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2012;512900;3.83
6217;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2013;518270;3.87
6218;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2014;520400;3.89
6219;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2015;522115;3.9
6220;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2016;523265;3.91
6221;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2017;523635;3.92
6222;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2018;523535;3.92
6223;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2019;523365;3.92
6224;Total male and female;10000;Dutch background;A10B Blood glucose lowering drugs, excl.;2020;521995;3.91
6225;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2006;0;0.0
6226;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2007;0;0.0
6227;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2008;0;0.0
6228;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2009;0;0.0
6229;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2010;0;0.0
6230;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2011;0;0.0
6231;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2012;0;0.0
6232;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2013;0;0.0
6233;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2014;0;0.0
6234;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2015;0;0.0
6235;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2016;0;0.0
6236;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2017;0;0.0
6237;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2018;0;0.0
6238;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2019;0;0.0
6239;Total male and female;10000;Dutch background;A10X Other drugs used in diabetes;2020;0;0.0
6240;Total male and female;10000;Dutch background;A11 Vitamins;2006;29355;0.22
6241;Total male and female;10000;Dutch background;A11 Vitamins;2007;31960;0.24
6242;Total male and female;10000;Dutch background;A11 Vitamins;2008;36470;0.27
6243;Total male and female;10000;Dutch background;A11 Vitamins;2009;43975;0.33
6244;Total male and female;10000;Dutch background;A11 Vitamins;2010;64645;0.48
6245;Total male and female;10000;Dutch background;A11 Vitamins;2011;99165;0.74
6246;Total male and female;10000;Dutch background;A11 Vitamins;2012;139635;1.04
6247;Total male and female;10000;Dutch background;A11 Vitamins;2013;265700;1.98
6248;Total male and female;10000;Dutch background;A11 Vitamins;2014;399565;2.98
6249;Total male and female;10000;Dutch background;A11 Vitamins;2015;494900;3.7
6250;Total male and female;10000;Dutch background;A11 Vitamins;2016;577700;4.32
6251;Total male and female;10000;Dutch background;A11 Vitamins;2017;650255;4.86
6252;Total male and female;10000;Dutch background;A11 Vitamins;2018;707985;5.3
6253;Total male and female;10000;Dutch background;A11 Vitamins;2019;592400;4.44
6254;Total male and female;10000;Dutch background;A11 Vitamins;2020;575415;4.31
6255;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2006;0;0.0
6256;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2007;0;0.0
6257;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2008;0;0.0
6258;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2009;0;0.0
6259;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2010;0;0.0
6260;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2011;0;0.0
6261;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2012;10;0.0
6262;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2013;0;0.0
6263;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2014;5;0.0
6264;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2015;5;0.0
6265;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2016;0;0.0
6266;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2017;0;0.0
6267;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2018;0;0.0
6268;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2019;0;0.0
6269;Total male and female;10000;Dutch background;A11A Multivitamins, combinations;2020;0;0.0
6270;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2006;5;0.0
6271;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2007;0;0.0
6272;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2008;0;0.0
6273;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2009;0;0.0
6274;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2010;0;0.0
6275;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2011;0;0.0
6276;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2012;0;0.0
6277;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2013;0;0.0
6278;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2014;0;0.0
6279;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2015;0;0.0
6280;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2016;0;0.0
6281;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2017;0;0.0
6282;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2018;0;0.0
6283;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2019;0;0.0
6284;Total male and female;10000;Dutch background;A11B Multivitamins, plain;2020;0;0.0
6285;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2006;26605;0.2
6286;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2007;29935;0.22
6287;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2008;34965;0.26
6288;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2009;42695;0.32
6289;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2010;63345;0.47
6290;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2011;97745;0.73
6291;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2012;138240;1.03
6292;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2013;264520;1.98
6293;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2014;398415;2.97
6294;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2015;494095;3.69
6295;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2016;576865;4.31
6296;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2017;649535;4.86
6297;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2018;707080;5.29
6298;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2019;591595;4.43
6299;Total male and female;10000;Dutch background;A11C Vit A and D, incl.combin.of the two;2020;574480;4.31
6300;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2006;605;0.0
6301;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2007;505;0.0
6302;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2008;495;0.0
6303;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2009;445;0.0
6304;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2010;605;0.0
6305;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2011;915;0.01
6306;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2012;1035;0.01
6307;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2013;975;0.01
6308;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2014;1185;0.01
6309;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2015;875;0.01
6310;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2016;990;0.01
6311;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2017;895;0.01
6312;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2018;1210;0.01
6313;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2019;1055;0.01
6314;Total male and female;10000;Dutch background;A11D Vitamin B1,and with vit. B6 and B12;2020;1190;0.01
6315;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2006;25;0.0
6316;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2007;20;0.0
6317;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2008;10;0.0
6318;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2009;5;0.0
6319;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2010;15;0.0
6320;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2011;25;0.0
6321;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2012;20;0.0
6322;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2013;20;0.0
6323;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2014;10;0.0
6324;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2015;10;0.0
6325;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2016;0;0.0
6326;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2017;0;0.0
6327;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2018;0;0.0
6328;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2019;0;0.0
6329;Total male and female;10000;Dutch background;A11E Vitamin B-complex, incl. combinat.;2020;5;0.0
6330;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2006;1015;0.01
6331;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2007;805;0.01
6332;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2008;620;0.0
6333;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2009;570;0.0
6334;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2010;455;0.0
6335;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2011;360;0.0
6336;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2012;265;0.0
6337;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2013;125;0.0
6338;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2014;85;0.0
6339;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2015;85;0.0
6340;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2016;65;0.0
6341;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2017;60;0.0
6342;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2018;50;0.0
6343;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2019;45;0.0
6344;Total male and female;10000;Dutch background;A11G Ascorbic acid (vitamin C) + combin.;2020;45;0.0
6345;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2006;1510;0.01
6346;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2007;870;0.01
6347;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2008;535;0.0
6348;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2009;355;0.0
6349;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2010;325;0.0
6350;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2011;330;0.0
6351;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2012;295;0.0
6352;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2013;390;0.0
6353;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2014;240;0.0
6354;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2015;70;0.0
6355;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2016;40;0.0
6356;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2017;35;0.0
6357;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2018;25;0.0
6358;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2019;30;0.0
6359;Total male and female;10000;Dutch background;A11H Other plain vitamin preparations;2020;15;0.0
6360;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2006;5;0.0
6361;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2007;5;0.0
6362;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2008;0;0.0
6363;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2009;0;0.0
6364;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2010;0;0.0
6365;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2011;0;0.0
6366;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2012;0;0.0
6367;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2013;0;0.0
6368;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2014;0;0.0
6369;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2015;0;0.0
6370;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2016;0;0.0
6371;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2017;0;0.0
6372;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2018;0;0.0
6373;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2019;0;0.0
6374;Total male and female;10000;Dutch background;A11J Other vitamin products + combinat.;2020;0;0.0
6375;Total male and female;10000;Dutch background;A12 Mineral supplements;2006;224455;1.68
6376;Total male and female;10000;Dutch background;A12 Mineral supplements;2007;245645;1.84
6377;Total male and female;10000;Dutch background;A12 Mineral supplements;2008;262390;1.96
6378;Total male and female;10000;Dutch background;A12 Mineral supplements;2009;284305;2.13
6379;Total male and female;10000;Dutch background;A12 Mineral supplements;2010;315210;2.35
6380;Total male and female;10000;Dutch background;A12 Mineral supplements;2011;351410;2.62
6381;Total male and female;10000;Dutch background;A12 Mineral supplements;2012;385685;2.88
6382;Total male and female;10000;Dutch background;A12 Mineral supplements;2013;400990;2.99
6383;Total male and female;10000;Dutch background;A12 Mineral supplements;2014;413335;3.09
6384;Total male and female;10000;Dutch background;A12 Mineral supplements;2015;424530;3.17
6385;Total male and female;10000;Dutch background;A12 Mineral supplements;2016;437885;3.27
6386;Total male and female;10000;Dutch background;A12 Mineral supplements;2017;448910;3.36
6387;Total male and female;10000;Dutch background;A12 Mineral supplements;2018;462460;3.46
6388;Total male and female;10000;Dutch background;A12 Mineral supplements;2019;466725;3.5
6389;Total male and female;10000;Dutch background;A12 Mineral supplements;2020;467870;3.51
6390;Total male and female;10000;Dutch background;A12A Calcium;2006;198565;1.49
6391;Total male and female;10000;Dutch background;A12A Calcium;2007;219875;1.65
6392;Total male and female;10000;Dutch background;A12A Calcium;2008;235655;1.76
6393;Total male and female;10000;Dutch background;A12A Calcium;2009;258850;1.94
6394;Total male and female;10000;Dutch background;A12A Calcium;2010;290910;2.17
6395;Total male and female;10000;Dutch background;A12A Calcium;2011;327350;2.44
6396;Total male and female;10000;Dutch background;A12A Calcium;2012;362300;2.7
6397;Total male and female;10000;Dutch background;A12A Calcium;2013;378510;2.83
6398;Total male and female;10000;Dutch background;A12A Calcium;2014;391910;2.93
6399;Total male and female;10000;Dutch background;A12A Calcium;2015;403515;3.01
6400;Total male and female;10000;Dutch background;A12A Calcium;2016;417200;3.12
6401;Total male and female;10000;Dutch background;A12A Calcium;2017;427870;3.2
6402;Total male and female;10000;Dutch background;A12A Calcium;2018;440830;3.3
6403;Total male and female;10000;Dutch background;A12A Calcium;2019;444550;3.33
6404;Total male and female;10000;Dutch background;A12A Calcium;2020;445440;3.34
6405;Total male and female;10000;Dutch background;A12B Potassium;2006;28540;0.21
6406;Total male and female;10000;Dutch background;A12B Potassium;2007;29110;0.22
6407;Total male and female;10000;Dutch background;A12B Potassium;2008;30405;0.23
6408;Total male and female;10000;Dutch background;A12B Potassium;2009;29545;0.22
6409;Total male and female;10000;Dutch background;A12B Potassium;2010;28705;0.21
6410;Total male and female;10000;Dutch background;A12B Potassium;2011;28765;0.21
6411;Total male and female;10000;Dutch background;A12B Potassium;2012;28320;0.21
6412;Total male and female;10000;Dutch background;A12B Potassium;2013;27250;0.2
6413;Total male and female;10000;Dutch background;A12B Potassium;2014;25575;0.19
6414;Total male and female;10000;Dutch background;A12B Potassium;2015;24985;0.19
6415;Total male and female;10000;Dutch background;A12B Potassium;2016;24635;0.18
6416;Total male and female;10000;Dutch background;A12B Potassium;2017;24345;0.18
6417;Total male and female;10000;Dutch background;A12B Potassium;2018;24615;0.18
6418;Total male and female;10000;Dutch background;A12B Potassium;2019;24560;0.18
6419;Total male and female;10000;Dutch background;A12B Potassium;2020;24390;0.18
6420;Total male and female;10000;Dutch background;A12C Other mineral supplements;2006;1190;0.01
6421;Total male and female;10000;Dutch background;A12C Other mineral supplements;2007;815;0.01
6422;Total male and female;10000;Dutch background;A12C Other mineral supplements;2008;845;0.01
6423;Total male and female;10000;Dutch background;A12C Other mineral supplements;2009;600;0.0
6424;Total male and female;10000;Dutch background;A12C Other mineral supplements;2010;550;0.0
6425;Total male and female;10000;Dutch background;A12C Other mineral supplements;2011;535;0.0
6426;Total male and female;10000;Dutch background;A12C Other mineral supplements;2012;605;0.0
6427;Total male and female;10000;Dutch background;A12C Other mineral supplements;2013;1035;0.01
6428;Total male and female;10000;Dutch background;A12C Other mineral supplements;2014;1630;0.01
6429;Total male and female;10000;Dutch background;A12C Other mineral supplements;2015;1755;0.01
6430;Total male and female;10000;Dutch background;A12C Other mineral supplements;2016;1720;0.01
6431;Total male and female;10000;Dutch background;A12C Other mineral supplements;2017;2565;0.02
6432;Total male and female;10000;Dutch background;A12C Other mineral supplements;2018;3600;0.03
6433;Total male and female;10000;Dutch background;A12C Other mineral supplements;2019;4490;0.03
6434;Total male and female;10000;Dutch background;A12C Other mineral supplements;2020;5290;0.04
6435;Total male and female;10000;Dutch background;A13 Tonics;2006;0;0.0
6436;Total male and female;10000;Dutch background;A13 Tonics;2007;0;0.0
6437;Total male and female;10000;Dutch background;A13 Tonics;2008;0;0.0
6438;Total male and female;10000;Dutch background;A13 Tonics;2009;0;0.0
6439;Total male and female;10000;Dutch background;A13 Tonics;2010;0;0.0
6440;Total male and female;10000;Dutch background;A13 Tonics;2011;0;0.0
6441;Total male and female;10000;Dutch background;A13 Tonics;2012;0;0.0
6442;Total male and female;10000;Dutch background;A13 Tonics;2013;0;0.0
6443;Total male and female;10000;Dutch background;A13 Tonics;2014;0;0.0
6444;Total male and female;10000;Dutch background;A13 Tonics;2015;0;0.0
6445;Total male and female;10000;Dutch background;A13 Tonics;2016;0;0.0
6446;Total male and female;10000;Dutch background;A13 Tonics;2017;0;0.0
6447;Total male and female;10000;Dutch background;A13 Tonics;2018;0;0.0
6448;Total male and female;10000;Dutch background;A13 Tonics;2019;0;0.0
6449;Total male and female;10000;Dutch background;A13 Tonics;2020;0;0.0
6450;Total male and female;10000;Dutch background;A13A Tonics;2006;0;0.0
6451;Total male and female;10000;Dutch background;A13A Tonics;2007;0;0.0
6452;Total male and female;10000;Dutch background;A13A Tonics;2008;0;0.0
6453;Total male and female;10000;Dutch background;A13A Tonics;2009;0;0.0
6454;Total male and female;10000;Dutch background;A13A Tonics;2010;0;0.0
6455;Total male and female;10000;Dutch background;A13A Tonics;2011;0;0.0
6456;Total male and female;10000;Dutch background;A13A Tonics;2012;0;0.0
6457;Total male and female;10000;Dutch background;A13A Tonics;2013;0;0.0
6458;Total male and female;10000;Dutch background;A13A Tonics;2014;0;0.0
6459;Total male and female;10000;Dutch background;A13A Tonics;2015;0;0.0
6460;Total male and female;10000;Dutch background;A13A Tonics;2016;0;0.0
6461;Total male and female;10000;Dutch background;A13A Tonics;2017;0;0.0
6462;Total male and female;10000;Dutch background;A13A Tonics;2018;0;0.0
6463;Total male and female;10000;Dutch background;A13A Tonics;2019;0;0.0
6464;Total male and female;10000;Dutch background;A13A Tonics;2020;0;0.0
6465;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2006;740;0.01
6466;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2007;615;0.0
6467;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2008;500;0.0
6468;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2009;420;0.0
6469;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2010;420;0.0
6470;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2011;370;0.0
6471;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2012;335;0.0
6472;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2013;335;0.0
6473;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2014;490;0.0
6474;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2015;435;0.0
6475;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2016;425;0.0
6476;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2017;395;0.0
6477;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2018;350;0.0
6478;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2019;380;0.0
6479;Total male and female;10000;Dutch background;A14 Anabolic agents for systemic use;2020;345;0.0
6480;Total male and female;10000;Dutch background;A14A Anabolic steroids;2006;740;0.01
6481;Total male and female;10000;Dutch background;A14A Anabolic steroids;2007;615;0.0
6482;Total male and female;10000;Dutch background;A14A Anabolic steroids;2008;500;0.0
6483;Total male and female;10000;Dutch background;A14A Anabolic steroids;2009;420;0.0
6484;Total male and female;10000;Dutch background;A14A Anabolic steroids;2010;420;0.0
6485;Total male and female;10000;Dutch background;A14A Anabolic steroids;2011;370;0.0
6486;Total male and female;10000;Dutch background;A14A Anabolic steroids;2012;335;0.0
6487;Total male and female;10000;Dutch background;A14A Anabolic steroids;2013;335;0.0
6488;Total male and female;10000;Dutch background;A14A Anabolic steroids;2014;490;0.0
6489;Total male and female;10000;Dutch background;A14A Anabolic steroids;2015;435;0.0
6490;Total male and female;10000;Dutch background;A14A Anabolic steroids;2016;425;0.0
6491;Total male and female;10000;Dutch background;A14A Anabolic steroids;2017;395;0.0
6492;Total male and female;10000;Dutch background;A14A Anabolic steroids;2018;350;0.0
6493;Total male and female;10000;Dutch background;A14A Anabolic steroids;2019;380;0.0
6494;Total male and female;10000;Dutch background;A14A Anabolic steroids;2020;345;0.0
6495;Total male and female;10000;Dutch background;A14B Other anabolic agents;2006;0;0.0
6496;Total male and female;10000;Dutch background;A14B Other anabolic agents;2007;0;0.0
6497;Total male and female;10000;Dutch background;A14B Other anabolic agents;2008;0;0.0
6498;Total male and female;10000;Dutch background;A14B Other anabolic agents;2009;0;0.0
6499;Total male and female;10000;Dutch background;A14B Other anabolic agents;2010;0;0.0
6500;Total male and female;10000;Dutch background;A14B Other anabolic agents;2011;0;0.0
6501;Total male and female;10000;Dutch background;A14B Other anabolic agents;2012;0;0.0
6502;Total male and female;10000;Dutch background;A14B Other anabolic agents;2013;0;0.0
6503;Total male and female;10000;Dutch background;A14B Other anabolic agents;2014;0;0.0
6504;Total male and female;10000;Dutch background;A14B Other anabolic agents;2015;0;0.0
6505;Total male and female;10000;Dutch background;A14B Other anabolic agents;2016;0;0.0
6506;Total male and female;10000;Dutch background;A14B Other anabolic agents;2017;0;0.0
6507;Total male and female;10000;Dutch background;A14B Other anabolic agents;2018;0;0.0
6508;Total male and female;10000;Dutch background;A14B Other anabolic agents;2019;0;0.0
6509;Total male and female;10000;Dutch background;A14B Other anabolic agents;2020;0;0.0
6510;Total male and female;10000;Dutch background;A15 Appetite stimulants;2006;0;0.0
6511;Total male and female;10000;Dutch background;A15 Appetite stimulants;2007;0;0.0
6512;Total male and female;10000;Dutch background;A15 Appetite stimulants;2008;0;0.0
6513;Total male and female;10000;Dutch background;A15 Appetite stimulants;2009;0;0.0
6514;Total male and female;10000;Dutch background;A15 Appetite stimulants;2010;0;0.0
6515;Total male and female;10000;Dutch background;A15 Appetite stimulants;2011;0;0.0
6516;Total male and female;10000;Dutch background;A15 Appetite stimulants;2012;0;0.0
6517;Total male and female;10000;Dutch background;A15 Appetite stimulants;2013;0;0.0
6518;Total male and female;10000;Dutch background;A15 Appetite stimulants;2014;0;0.0
6519;Total male and female;10000;Dutch background;A15 Appetite stimulants;2015;0;0.0
6520;Total male and female;10000;Dutch background;A15 Appetite stimulants;2016;0;0.0
6521;Total male and female;10000;Dutch background;A15 Appetite stimulants;2017;0;0.0
6522;Total male and female;10000;Dutch background;A15 Appetite stimulants;2018;0;0.0
6523;Total male and female;10000;Dutch background;A15 Appetite stimulants;2019;0;0.0
6524;Total male and female;10000;Dutch background;A15 Appetite stimulants;2020;0;0.0
6525;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2006;4950;0.04
6526;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2007;4960;0.04
6527;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2008;4840;0.04
6528;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2009;4800;0.04
6529;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2010;4900;0.04
6530;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2011;4610;0.03
6531;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2012;4495;0.03
6532;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2013;3640;0.03
6533;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2014;3295;0.02
6534;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2015;3045;0.02
6535;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2016;2905;0.02
6536;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2017;2815;0.02
6537;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2018;2715;0.02
6538;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2019;2650;0.02
6539;Total male and female;10000;Dutch background;A16 Other aliment.tract/metabol.products;2020;2530;0.02
6540;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2006;4950;0.04
6541;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2007;4960;0.04
6542;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2008;4840;0.04
6543;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2009;4800;0.04
6544;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2010;4900;0.04
6545;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2011;4610;0.03
6546;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2012;4495;0.03
6547;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2013;3640;0.03
6548;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2014;3295;0.02
6549;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2015;3045;0.02
6550;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2016;2905;0.02
6551;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2017;2815;0.02
6552;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2018;2715;0.02
6553;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2019;2650;0.02
6554;Total male and female;10000;Dutch background;A16A Oth.aliment.tract and metabol.prod.;2020;2530;0.02
6555;Total male and female;10000;Dutch background;B Blood and blood forming organs;2006;1467815;10.99
6556;Total male and female;10000;Dutch background;B Blood and blood forming organs;2007;1512810;11.33
6557;Total male and female;10000;Dutch background;B Blood and blood forming organs;2008;1553480;11.63
6558;Total male and female;10000;Dutch background;B Blood and blood forming organs;2009;1599905;11.97
6559;Total male and female;10000;Dutch background;B Blood and blood forming organs;2010;1641530;12.26
6560;Total male and female;10000;Dutch background;B Blood and blood forming organs;2011;1680315;12.54
6561;Total male and female;10000;Dutch background;B Blood and blood forming organs;2012;1703360;12.71
6562;Total male and female;10000;Dutch background;B Blood and blood forming organs;2013;1719790;12.84
6563;Total male and female;10000;Dutch background;B Blood and blood forming organs;2014;1746585;13.04
6564;Total male and female;10000;Dutch background;B Blood and blood forming organs;2015;1772820;13.24
6565;Total male and female;10000;Dutch background;B Blood and blood forming organs;2016;1812355;13.54
6566;Total male and female;10000;Dutch background;B Blood and blood forming organs;2017;1839320;13.75
6567;Total male and female;10000;Dutch background;B Blood and blood forming organs;2018;1866130;13.97
6568;Total male and female;10000;Dutch background;B Blood and blood forming organs;2019;1885450;14.13
6569;Total male and female;10000;Dutch background;B Blood and blood forming organs;2020;1869705;14.02
6570;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2006;1205915;9.03
6571;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2007;1250805;9.37
6572;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2008;1288490;9.64
6573;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2009;1330925;9.96
6574;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2010;1372105;10.25
6575;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2011;1406420;10.5
6576;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2012;1432265;10.69
6577;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2013;1451750;10.84
6578;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2014;1474595;11.01
6579;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2015;1495340;11.17
6580;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2016;1520180;11.36
6581;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2017;1539940;11.52
6582;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2018;1558845;11.67
6583;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2019;1577825;11.82
6584;Total male and female;10000;Dutch background;B01 Antithrombotic agents;2020;1574310;11.8
6585;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2006;1205915;9.03
6586;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2007;1250805;9.37
6587;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2008;1288490;9.64
6588;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2009;1330925;9.96
6589;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2010;1372105;10.25
6590;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2011;1406420;10.5
6591;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2012;1432265;10.69
6592;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2013;1451750;10.84
6593;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2014;1474595;11.01
6594;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2015;1495340;11.17
6595;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2016;1520180;11.36
6596;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2017;1539940;11.52
6597;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2018;1558845;11.67
6598;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2019;1577825;11.82
6599;Total male and female;10000;Dutch background;B01A Antithrombotic agents;2020;1574310;11.8
6600;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2006;25655;0.19
6601;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2007;27225;0.2
6602;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2008;27515;0.21
6603;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2009;27230;0.2
6604;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2010;25050;0.19
6605;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2011;24930;0.19
6606;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2012;25665;0.19
6607;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2013;27310;0.2
6608;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2014;34555;0.26
6609;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2015;38610;0.29
6610;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2016;35180;0.26
6611;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2017;34325;0.26
6612;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2018;36165;0.27
6613;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2019;33360;0.25
6614;Total male and female;10000;Dutch background;B02 Antihemorrhagics;2020;32820;0.25
6615;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2006;10350;0.08
6616;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2007;10765;0.08
6617;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2008;10970;0.08
6618;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2009;11175;0.08
6619;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2010;11350;0.08
6620;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2011;11785;0.09
6621;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2012;11655;0.09
6622;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2013;11670;0.09
6623;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2014;11760;0.09
6624;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2015;12195;0.09
6625;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2016;13280;0.1
6626;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2017;14310;0.11
6627;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2018;16265;0.12
6628;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2019;17640;0.13
6629;Total male and female;10000;Dutch background;B02A Antifibrinolytics;2020;19130;0.14
6630;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2006;15380;0.12
6631;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2007;16530;0.12
6632;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2008;16630;0.12
6633;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2009;16135;0.12
6634;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2010;13775;0.1
6635;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2011;13215;0.1
6636;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2012;14080;0.11
6637;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2013;15740;0.12
6638;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2014;22915;0.17
6639;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2015;26540;0.2
6640;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2016;22050;0.16
6641;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2017;20205;0.15
6642;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2018;20090;0.15
6643;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2019;15890;0.12
6644;Total male and female;10000;Dutch background;B02B Vitamin k and other hemostatics;2020;13920;0.1
6645;Total male and female;10000;Dutch background;B03 Antianemic preparations;2006;352205;2.64
6646;Total male and female;10000;Dutch background;B03 Antianemic preparations;2007;355680;2.66
6647;Total male and female;10000;Dutch background;B03 Antianemic preparations;2008;363150;2.72
6648;Total male and female;10000;Dutch background;B03 Antianemic preparations;2009;372820;2.79
6649;Total male and female;10000;Dutch background;B03 Antianemic preparations;2010;374680;2.8
6650;Total male and female;10000;Dutch background;B03 Antianemic preparations;2011;383575;2.86
6651;Total male and female;10000;Dutch background;B03 Antianemic preparations;2012;382945;2.86
6652;Total male and female;10000;Dutch background;B03 Antianemic preparations;2013;379415;2.83
6653;Total male and female;10000;Dutch background;B03 Antianemic preparations;2014;384745;2.87
6654;Total male and female;10000;Dutch background;B03 Antianemic preparations;2015;392790;2.93
6655;Total male and female;10000;Dutch background;B03 Antianemic preparations;2016;410620;3.07
6656;Total male and female;10000;Dutch background;B03 Antianemic preparations;2017;419320;3.14
6657;Total male and female;10000;Dutch background;B03 Antianemic preparations;2018;427825;3.2
6658;Total male and female;10000;Dutch background;B03 Antianemic preparations;2019;427335;3.2
6659;Total male and female;10000;Dutch background;B03 Antianemic preparations;2020;410530;3.08
6660;Total male and female;10000;Dutch background;B03A Iron preparations;2006;195860;1.47
6661;Total male and female;10000;Dutch background;B03A Iron preparations;2007;193155;1.45
6662;Total male and female;10000;Dutch background;B03A Iron preparations;2008;193540;1.45
6663;Total male and female;10000;Dutch background;B03A Iron preparations;2009;192160;1.44
6664;Total male and female;10000;Dutch background;B03A Iron preparations;2010;186540;1.39
6665;Total male and female;10000;Dutch background;B03A Iron preparations;2011;185705;1.39
6666;Total male and female;10000;Dutch background;B03A Iron preparations;2012;175325;1.31
6667;Total male and female;10000;Dutch background;B03A Iron preparations;2013;165530;1.24
6668;Total male and female;10000;Dutch background;B03A Iron preparations;2014;160075;1.2
6669;Total male and female;10000;Dutch background;B03A Iron preparations;2015;159855;1.19
6670;Total male and female;10000;Dutch background;B03A Iron preparations;2016;163390;1.22
6671;Total male and female;10000;Dutch background;B03A Iron preparations;2017;168015;1.26
6672;Total male and female;10000;Dutch background;B03A Iron preparations;2018;173045;1.3
6673;Total male and female;10000;Dutch background;B03A Iron preparations;2019;178050;1.33
6674;Total male and female;10000;Dutch background;B03A Iron preparations;2020;173895;1.3
6675;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2006;170855;1.28
6676;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2007;175620;1.31
6677;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2008;182900;1.37
6678;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2009;194730;1.46
6679;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2010;202030;1.51
6680;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2011;211450;1.58
6681;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2012;220285;1.64
6682;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2013;225500;1.68
6683;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2014;236830;1.77
6684;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2015;246115;1.84
6685;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2016;262500;1.96
6686;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2017;267505;2.0
6687;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2018;271260;2.03
6688;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2019;264685;1.98
6689;Total male and female;10000;Dutch background;B03B Vitamin B12 and folic acid;2020;250795;1.88
6690;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2006;18940;0.14
6691;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2007;21025;0.16
6692;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2008;21210;0.16
6693;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2009;21315;0.16
6694;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2010;20330;0.15
6695;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2011;19805;0.15
6696;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2012;19010;0.14
6697;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2013;17565;0.13
6698;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2014;16245;0.12
6699;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2015;14730;0.11
6700;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2016;13345;0.1
6701;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2017;12505;0.09
6702;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2018;12215;0.09
6703;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2019;12130;0.09
6704;Total male and female;10000;Dutch background;B03X Other antianemic preparations;2020;11755;0.09
6705;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2006;33125;0.25
6706;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2007;32530;0.24
6707;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2008;30635;0.23
6708;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2009;30530;0.23
6709;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2010;34155;0.26
6710;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2011;34905;0.26
6711;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2012;32620;0.24
6712;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2013;32975;0.25
6713;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2014;33035;0.25
6714;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2015;32970;0.25
6715;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2016;34390;0.26
6716;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2017;35485;0.27
6717;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2018;36125;0.27
6718;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2019;37360;0.28
6719;Total male and female;10000;Dutch background;B05 Blood substitutes / perfus.solutions;2020;38690;0.29
6720;Total male and female;10000;Dutch background;B05A Blood and related products;2006;10;0.0
6721;Total male and female;10000;Dutch background;B05A Blood and related products;2007;10;0.0
6722;Total male and female;10000;Dutch background;B05A Blood and related products;2008;10;0.0
6723;Total male and female;10000;Dutch background;B05A Blood and related products;2009;15;0.0
6724;Total male and female;10000;Dutch background;B05A Blood and related products;2010;15;0.0
6725;Total male and female;10000;Dutch background;B05A Blood and related products;2011;10;0.0
6726;Total male and female;10000;Dutch background;B05A Blood and related products;2012;10;0.0
6727;Total male and female;10000;Dutch background;B05A Blood and related products;2013;10;0.0
6728;Total male and female;10000;Dutch background;B05A Blood and related products;2014;5;0.0
6729;Total male and female;10000;Dutch background;B05A Blood and related products;2015;5;0.0
6730;Total male and female;10000;Dutch background;B05A Blood and related products;2016;5;0.0
6731;Total male and female;10000;Dutch background;B05A Blood and related products;2017;10;0.0
6732;Total male and female;10000;Dutch background;B05A Blood and related products;2018;10;0.0
6733;Total male and female;10000;Dutch background;B05A Blood and related products;2019;10;0.0
6734;Total male and female;10000;Dutch background;B05A Blood and related products;2020;15;0.0
6735;Total male and female;10000;Dutch background;B05B Intravenous solutions;2006;26305;0.2
6736;Total male and female;10000;Dutch background;B05B Intravenous solutions;2007;27840;0.21
6737;Total male and female;10000;Dutch background;B05B Intravenous solutions;2008;28250;0.21
6738;Total male and female;10000;Dutch background;B05B Intravenous solutions;2009;28665;0.21
6739;Total male and female;10000;Dutch background;B05B Intravenous solutions;2010;32175;0.24
6740;Total male and female;10000;Dutch background;B05B Intravenous solutions;2011;33470;0.25
6741;Total male and female;10000;Dutch background;B05B Intravenous solutions;2012;32195;0.24
6742;Total male and female;10000;Dutch background;B05B Intravenous solutions;2013;32545;0.24
6743;Total male and female;10000;Dutch background;B05B Intravenous solutions;2014;32615;0.24
6744;Total male and female;10000;Dutch background;B05B Intravenous solutions;2015;32830;0.25
6745;Total male and female;10000;Dutch background;B05B Intravenous solutions;2016;34255;0.26
6746;Total male and female;10000;Dutch background;B05B Intravenous solutions;2017;35350;0.26
6747;Total male and female;10000;Dutch background;B05B Intravenous solutions;2018;35340;0.26
6748;Total male and female;10000;Dutch background;B05B Intravenous solutions;2019;36230;0.27
6749;Total male and female;10000;Dutch background;B05B Intravenous solutions;2020;37525;0.28
6750;Total male and female;10000;Dutch background;B05C Irrigating solutions;2006;7545;0.06
6751;Total male and female;10000;Dutch background;B05C Irrigating solutions;2007;5175;0.04
6752;Total male and female;10000;Dutch background;B05C Irrigating solutions;2008;2640;0.02
6753;Total male and female;10000;Dutch background;B05C Irrigating solutions;2009;2095;0.02
6754;Total male and female;10000;Dutch background;B05C Irrigating solutions;2010;2220;0.02
6755;Total male and female;10000;Dutch background;B05C Irrigating solutions;2011;1605;0.01
6756;Total male and female;10000;Dutch background;B05C Irrigating solutions;2012;465;0.0
6757;Total male and female;10000;Dutch background;B05C Irrigating solutions;2013;430;0.0
6758;Total male and female;10000;Dutch background;B05C Irrigating solutions;2014;420;0.0
6759;Total male and female;10000;Dutch background;B05C Irrigating solutions;2015;85;0.0
6760;Total male and female;10000;Dutch background;B05C Irrigating solutions;2016;75;0.0
6761;Total male and female;10000;Dutch background;B05C Irrigating solutions;2017;80;0.0
6762;Total male and female;10000;Dutch background;B05C Irrigating solutions;2018;50;0.0
6763;Total male and female;10000;Dutch background;B05C Irrigating solutions;2019;45;0.0
6764;Total male and female;10000;Dutch background;B05C Irrigating solutions;2020;40;0.0
6765;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2006;0;0.0
6766;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2007;0;0.0
6767;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2008;0;0.0
6768;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2009;0;0.0
6769;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2010;0;0.0
6770;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2011;0;0.0
6771;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2012;0;0.0
6772;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2013;0;0.0
6773;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2014;0;0.0
6774;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2015;0;0.0
6775;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2016;0;0.0
6776;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2017;0;0.0
6777;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2018;0;0.0
6778;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2019;0;0.0
6779;Total male and female;10000;Dutch background;B05D Peritoneal dialytics;2020;0;0.0
6780;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2006;235;0.0
6781;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2007;205;0.0
6782;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2008;195;0.0
6783;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2009;265;0.0
6784;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2010;300;0.0
6785;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2011;325;0.0
6786;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2012;320;0.0
6787;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2013;370;0.0
6788;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2014;360;0.0
6789;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2015;370;0.0
6790;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2016;390;0.0
6791;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2017;395;0.0
6792;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2018;1285;0.01
6793;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2019;1740;0.01
6794;Total male and female;10000;Dutch background;B05X Intravenous solution additives;2020;1765;0.01
6795;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2006;0;0.0
6796;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2007;0;0.0
6797;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2008;0;0.0
6798;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2009;0;0.0
6799;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2010;0;0.0
6800;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2011;0;0.0
6801;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2012;0;0.0
6802;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2013;0;0.0
6803;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2014;0;0.0
6804;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2015;0;0.0
6805;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2016;0;0.0
6806;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2017;0;0.0
6807;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2018;0;0.0
6808;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2019;0;0.0
6809;Total male and female;10000;Dutch background;B05Z Hemodialytics and hemofiltrates;2020;0;0.0
6810;Total male and female;10000;Dutch background;B06 Other hematological agents;2006;10;0.0
6811;Total male and female;10000;Dutch background;B06 Other hematological agents;2007;10;0.0
6812;Total male and female;10000;Dutch background;B06 Other hematological agents;2008;5;0.0
6813;Total male and female;10000;Dutch background;B06 Other hematological agents;2009;5;0.0
6814;Total male and female;10000;Dutch background;B06 Other hematological agents;2010;5;0.0
6815;Total male and female;10000;Dutch background;B06 Other hematological agents;2011;5;0.0
6816;Total male and female;10000;Dutch background;B06 Other hematological agents;2012;85;0.0
6817;Total male and female;10000;Dutch background;B06 Other hematological agents;2013;80;0.0
6818;Total male and female;10000;Dutch background;B06 Other hematological agents;2014;85;0.0
6819;Total male and female;10000;Dutch background;B06 Other hematological agents;2015;90;0.0
6820;Total male and female;10000;Dutch background;B06 Other hematological agents;2016;105;0.0
6821;Total male and female;10000;Dutch background;B06 Other hematological agents;2017;115;0.0
6822;Total male and female;10000;Dutch background;B06 Other hematological agents;2018;135;0.0
6823;Total male and female;10000;Dutch background;B06 Other hematological agents;2019;145;0.0
6824;Total male and female;10000;Dutch background;B06 Other hematological agents;2020;160;0.0
6825;Total male and female;10000;Dutch background;B06A Other hematological agents;2006;10;0.0
6826;Total male and female;10000;Dutch background;B06A Other hematological agents;2007;10;0.0
6827;Total male and female;10000;Dutch background;B06A Other hematological agents;2008;5;0.0
6828;Total male and female;10000;Dutch background;B06A Other hematological agents;2009;5;0.0
6829;Total male and female;10000;Dutch background;B06A Other hematological agents;2010;5;0.0
6830;Total male and female;10000;Dutch background;B06A Other hematological agents;2011;5;0.0
6831;Total male and female;10000;Dutch background;B06A Other hematological agents;2012;85;0.0
6832;Total male and female;10000;Dutch background;B06A Other hematological agents;2013;80;0.0
6833;Total male and female;10000;Dutch background;B06A Other hematological agents;2014;85;0.0
6834;Total male and female;10000;Dutch background;B06A Other hematological agents;2015;85;0.0
6835;Total male and female;10000;Dutch background;B06A Other hematological agents;2016;100;0.0
6836;Total male and female;10000;Dutch background;B06A Other hematological agents;2017;105;0.0
6837;Total male and female;10000;Dutch background;B06A Other hematological agents;2018;120;0.0
6838;Total male and female;10000;Dutch background;B06A Other hematological agents;2019;130;0.0
6839;Total male and female;10000;Dutch background;B06A Other hematological agents;2020;145;0.0
6840;Total male and female;10000;Dutch background;C Cardiovascular system;2006;2693550;20.17
6841;Total male and female;10000;Dutch background;C Cardiovascular system;2007;2776310;20.79
6842;Total male and female;10000;Dutch background;C Cardiovascular system;2008;2849950;21.33
6843;Total male and female;10000;Dutch background;C Cardiovascular system;2009;2926820;21.89
6844;Total male and female;10000;Dutch background;C Cardiovascular system;2010;2993610;22.37
6845;Total male and female;10000;Dutch background;C Cardiovascular system;2011;3061190;22.85
6846;Total male and female;10000;Dutch background;C Cardiovascular system;2012;3103325;23.17
6847;Total male and female;10000;Dutch background;C Cardiovascular system;2013;3108415;23.21
6848;Total male and female;10000;Dutch background;C Cardiovascular system;2014;3075215;22.96
6849;Total male and female;10000;Dutch background;C Cardiovascular system;2015;3083525;23.03
6850;Total male and female;10000;Dutch background;C Cardiovascular system;2016;3099650;23.16
6851;Total male and female;10000;Dutch background;C Cardiovascular system;2017;3116765;23.31
6852;Total male and female;10000;Dutch background;C Cardiovascular system;2018;3118425;23.34
6853;Total male and female;10000;Dutch background;C Cardiovascular system;2019;3122850;23.4
6854;Total male and female;10000;Dutch background;C Cardiovascular system;2020;3091295;23.18
6855;Total male and female;10000;Dutch background;C01 Cardiac therapy;2006;416605;3.12
6856;Total male and female;10000;Dutch background;C01 Cardiac therapy;2007;413625;3.1
6857;Total male and female;10000;Dutch background;C01 Cardiac therapy;2008;406905;3.05
6858;Total male and female;10000;Dutch background;C01 Cardiac therapy;2009;409115;3.06
6859;Total male and female;10000;Dutch background;C01 Cardiac therapy;2010;407880;3.05
6860;Total male and female;10000;Dutch background;C01 Cardiac therapy;2011;412575;3.08
6861;Total male and female;10000;Dutch background;C01 Cardiac therapy;2012;396605;2.96
6862;Total male and female;10000;Dutch background;C01 Cardiac therapy;2013;391935;2.93
6863;Total male and female;10000;Dutch background;C01 Cardiac therapy;2014;386025;2.88
6864;Total male and female;10000;Dutch background;C01 Cardiac therapy;2015;378810;2.83
6865;Total male and female;10000;Dutch background;C01 Cardiac therapy;2016;376760;2.82
6866;Total male and female;10000;Dutch background;C01 Cardiac therapy;2017;378890;2.83
6867;Total male and female;10000;Dutch background;C01 Cardiac therapy;2018;380965;2.85
6868;Total male and female;10000;Dutch background;C01 Cardiac therapy;2019;367035;2.75
6869;Total male and female;10000;Dutch background;C01 Cardiac therapy;2020;363985;2.73
6870;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2006;100970;0.76
6871;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2007;98055;0.73
6872;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2008;95775;0.72
6873;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2009;93590;0.7
6874;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2010;91750;0.69
6875;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2011;89935;0.67
6876;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2012;88125;0.66
6877;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2013;85190;0.64
6878;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2014;82365;0.61
6879;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2015;80535;0.6
6880;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2016;78090;0.58
6881;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2017;76330;0.57
6882;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2018;75030;0.56
6883;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2019;73345;0.55
6884;Total male and female;10000;Dutch background;C01A Cardiac glycosides;2020;71410;0.54
6885;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2006;59280;0.44
6886;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2007;61180;0.46
6887;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2008;62595;0.47
6888;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2009;63780;0.48
6889;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2010;65005;0.49
6890;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2011;65720;0.49
6891;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2012;65750;0.49
6892;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2013;65245;0.49
6893;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2014;65415;0.49
6894;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2015;65450;0.49
6895;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2016;64660;0.48
6896;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2017;64250;0.48
6897;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2018;63550;0.48
6898;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2019;62685;0.47
6899;Total male and female;10000;Dutch background;C01B Antiarrhythmics, class I and III;2020;61065;0.46
6900;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2006;17850;0.13
6901;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2007;19870;0.15
6902;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2008;22130;0.17
6903;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2009;25895;0.19
6904;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2010;24065;0.18
6905;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2011;30110;0.22
6906;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2012;28375;0.21
6907;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2013;30885;0.23
6908;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2014;31080;0.23
6909;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2015;34625;0.26
6910;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2016;33545;0.25
6911;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2017;39580;0.3
6912;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2018;42045;0.31
6913;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2019;41965;0.31
6914;Total male and female;10000;Dutch background;C01C Cardiac stimulants excl. glycosides;2020;41820;0.31
6915;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2006;276885;2.07
6916;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2007;271145;2.03
6917;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2008;260740;1.95
6918;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2009;258515;1.93
6919;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2010;258000;1.93
6920;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2011;256235;1.91
6921;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2012;240835;1.8
6922;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2013;235255;1.76
6923;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2014;229435;1.71
6924;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2015;218405;1.63
6925;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2016;218915;1.64
6926;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2017;215995;1.62
6927;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2018;216750;1.62
6928;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2019;203865;1.53
6929;Total male and female;10000;Dutch background;C01D Vasodilators used in card. diseases;2020;203190;1.52
6930;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2006;70;0.0
6931;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2007;415;0.0
6932;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2008;1460;0.01
6933;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2009;2330;0.02
6934;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2010;3735;0.03
6935;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2011;5000;0.04
6936;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2012;5780;0.04
6937;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2013;6360;0.05
6938;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2014;7290;0.05
6939;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2015;7680;0.06
6940;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2016;8210;0.06
6941;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2017;8490;0.06
6942;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2018;8805;0.07
6943;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2019;8955;0.07
6944;Total male and female;10000;Dutch background;C01E Other cardiac preparations;2020;9430;0.07
6945;Total male and female;10000;Dutch background;C02 Antihypertensives;2006;49105;0.37
6946;Total male and female;10000;Dutch background;C02 Antihypertensives;2007;49870;0.37
6947;Total male and female;10000;Dutch background;C02 Antihypertensives;2008;49520;0.37
6948;Total male and female;10000;Dutch background;C02 Antihypertensives;2009;49170;0.37
6949;Total male and female;10000;Dutch background;C02 Antihypertensives;2010;49160;0.37
6950;Total male and female;10000;Dutch background;C02 Antihypertensives;2011;49250;0.37
6951;Total male and female;10000;Dutch background;C02 Antihypertensives;2012;49060;0.37
6952;Total male and female;10000;Dutch background;C02 Antihypertensives;2013;47355;0.35
6953;Total male and female;10000;Dutch background;C02 Antihypertensives;2014;46410;0.35
6954;Total male and female;10000;Dutch background;C02 Antihypertensives;2015;45375;0.34
6955;Total male and female;10000;Dutch background;C02 Antihypertensives;2016;44820;0.33
6956;Total male and female;10000;Dutch background;C02 Antihypertensives;2017;44380;0.33
6957;Total male and female;10000;Dutch background;C02 Antihypertensives;2018;43780;0.33
6958;Total male and female;10000;Dutch background;C02 Antihypertensives;2019;44965;0.34
6959;Total male and female;10000;Dutch background;C02 Antihypertensives;2020;44485;0.33
6960;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2006;11315;0.08
6961;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2007;11225;0.08
6962;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2008;11245;0.08
6963;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2009;11055;0.08
6964;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2010;10735;0.08
6965;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2011;10300;0.08
6966;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2012;9685;0.07
6967;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2013;8745;0.07
6968;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2014;8365;0.06
6969;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2015;7645;0.06
6970;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2016;7475;0.06
6971;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2017;7305;0.05
6972;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2018;7375;0.06
6973;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2019;7975;0.06
6974;Total male and female;10000;Dutch background;C02A Antiadren.agents, centrally acting;2020;8075;0.06
6975;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2006;0;0.0
6976;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2007;0;0.0
6977;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2008;0;0.0
6978;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2009;0;0.0
6979;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2010;0;0.0
6980;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2011;0;0.0
6981;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2012;0;0.0
6982;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2013;0;0.0
6983;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2014;0;0.0
6984;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2015;0;0.0
6985;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2016;0;0.0
6986;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2017;0;0.0
6987;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2018;0;0.0
6988;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2019;0;0.0
6989;Total male and female;10000;Dutch background;C02B Antiadren.agents, ganglion-blocking;2020;0;0.0
6990;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2006;33170;0.25
6991;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2007;34125;0.26
6992;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2008;33840;0.25
6993;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2009;33870;0.25
6994;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2010;34245;0.26
6995;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2011;35040;0.26
6996;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2012;35735;0.27
6997;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2013;35220;0.26
6998;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2014;34765;0.26
6999;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2015;34585;0.26
7000;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2016;34300;0.26
7001;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2017;34105;0.26
7002;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2018;33665;0.25
7003;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2019;34495;0.26
7004;Total male and female;10000;Dutch background;C02C Antiadren.agents, peripher. acting;2020;34000;0.25
7005;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2006;1095;0.01
7006;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2007;1105;0.01
7007;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2008;1090;0.01
7008;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2009;1065;0.01
7009;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2010;1085;0.01
7010;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2011;1100;0.01
7011;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2012;1005;0.01
7012;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2013;1050;0.01
7013;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2014;1110;0.01
7014;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2015;1100;0.01
7015;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2016;1080;0.01
7016;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2017;1055;0.01
7017;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2018;975;0.01
7018;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2019;745;0.01
7019;Total male and female;10000;Dutch background;C02D Arteriolar smooth muscle agents;2020;730;0.01
7020;Total male and female;10000;Dutch background;C02K Other antihypertensives;2006;4400;0.03
7021;Total male and female;10000;Dutch background;C02K Other antihypertensives;2007;4270;0.03
7022;Total male and female;10000;Dutch background;C02K Other antihypertensives;2008;4165;0.03
7023;Total male and female;10000;Dutch background;C02K Other antihypertensives;2009;3950;0.03
7024;Total male and female;10000;Dutch background;C02K Other antihypertensives;2010;3840;0.03
7025;Total male and female;10000;Dutch background;C02K Other antihypertensives;2011;3600;0.03
7026;Total male and female;10000;Dutch background;C02K Other antihypertensives;2012;3400;0.03
7027;Total male and female;10000;Dutch background;C02K Other antihypertensives;2013;3085;0.02
7028;Total male and female;10000;Dutch background;C02K Other antihypertensives;2014;2920;0.02
7029;Total male and female;10000;Dutch background;C02K Other antihypertensives;2015;2770;0.02
7030;Total male and female;10000;Dutch background;C02K Other antihypertensives;2016;2650;0.02
7031;Total male and female;10000;Dutch background;C02K Other antihypertensives;2017;2545;0.02
7032;Total male and female;10000;Dutch background;C02K Other antihypertensives;2018;2400;0.02
7033;Total male and female;10000;Dutch background;C02K Other antihypertensives;2019;2350;0.02
7034;Total male and female;10000;Dutch background;C02K Other antihypertensives;2020;2275;0.02
7035;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2006;0;0.0
7036;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2007;0;0.0
7037;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2008;0;0.0
7038;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2009;0;0.0
7039;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2010;0;0.0
7040;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2011;0;0.0
7041;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2012;0;0.0
7042;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2013;0;0.0
7043;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2014;0;0.0
7044;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2015;0;0.0
7045;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2016;0;0.0
7046;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2017;0;0.0
7047;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2018;0;0.0
7048;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2019;0;0.0
7049;Total male and female;10000;Dutch background;C02L Antihypertensives/diuretics combin.;2020;0;0.0
7050;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2006;0;0.0
7051;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2007;0;0.0
7052;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2008;0;0.0
7053;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2009;0;0.0
7054;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2010;0;0.0
7055;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2011;0;0.0
7056;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2012;0;0.0
7057;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2013;0;0.0
7058;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2014;0;0.0
7059;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2015;0;0.0
7060;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2016;0;0.0
7061;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2017;0;0.0
7062;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2018;0;0.0
7063;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2019;0;0.0
7064;Total male and female;10000;Dutch background;C02N Combinations of antihypertensives..;2020;0;0.0
7065;Total male and female;10000;Dutch background;C03 Diuretics;2006;907370;6.79
7066;Total male and female;10000;Dutch background;C03 Diuretics;2007;918540;6.88
7067;Total male and female;10000;Dutch background;C03 Diuretics;2008;943815;7.06
7068;Total male and female;10000;Dutch background;C03 Diuretics;2009;960925;7.19
7069;Total male and female;10000;Dutch background;C03 Diuretics;2010;980635;7.33
7070;Total male and female;10000;Dutch background;C03 Diuretics;2011;993175;7.41
7071;Total male and female;10000;Dutch background;C03 Diuretics;2012;998045;7.45
7072;Total male and female;10000;Dutch background;C03 Diuretics;2013;983410;7.34
7073;Total male and female;10000;Dutch background;C03 Diuretics;2014;977245;7.3
7074;Total male and female;10000;Dutch background;C03 Diuretics;2015;971355;7.25
7075;Total male and female;10000;Dutch background;C03 Diuretics;2016;967410;7.23
7076;Total male and female;10000;Dutch background;C03 Diuretics;2017;958545;7.17
7077;Total male and female;10000;Dutch background;C03 Diuretics;2018;967980;7.25
7078;Total male and female;10000;Dutch background;C03 Diuretics;2019;977070;7.32
7079;Total male and female;10000;Dutch background;C03 Diuretics;2020;918990;6.89
7080;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2006;364760;2.73
7081;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2007;394105;2.95
7082;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2008;430050;3.22
7083;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2009;458625;3.43
7084;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2010;484690;3.62
7085;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2011;505625;3.77
7086;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2012;520055;3.88
7087;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2013;518950;3.87
7088;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2014;522285;3.9
7089;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2015;523760;3.91
7090;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2016;528545;3.95
7091;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2017;544405;4.07
7092;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2018;551170;4.13
7093;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2019;560350;4.2
7094;Total male and female;10000;Dutch background;C03A Low-ceiling diuretics, thiazides;2020;508180;3.81
7095;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2006;86545;0.65
7096;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2007;80010;0.6
7097;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2008;74360;0.56
7098;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2009;68845;0.51
7099;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2010;69820;0.52
7100;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2011;69610;0.52
7101;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2012;68065;0.51
7102;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2013;65855;0.49
7103;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2014;65065;0.49
7104;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2015;63165;0.47
7105;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2016;61140;0.46
7106;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2017;59025;0.44
7107;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2018;59380;0.44
7108;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2019;61895;0.46
7109;Total male and female;10000;Dutch background;C03B Low-ceiling diuret.,excl. thiazides;2020;57500;0.43
7110;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2006;359030;2.69
7111;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2007;353680;2.65
7112;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2008;356875;2.67
7113;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2009;357685;2.68
7114;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2010;357455;2.67
7115;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2011;353495;2.64
7116;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2012;348445;2.6
7117;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2013;339825;2.54
7118;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2014;335695;2.51
7119;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2015;331425;2.48
7120;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2016;325965;2.44
7121;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2017;320090;2.39
7122;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2018;316350;2.37
7123;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2019;310200;2.32
7124;Total male and female;10000;Dutch background;C03C High-ceiling diuretics;2020;303085;2.27
7125;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2006;104180;0.78
7126;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2007;106775;0.8
7127;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2008;109110;0.82
7128;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2009;110910;0.83
7129;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2010;112990;0.84
7130;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2011;115450;0.86
7131;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2012;117745;0.88
7132;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2013;120375;0.9
7133;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2014;127895;0.95
7134;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2015;130890;0.98
7135;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2016;134195;1.0
7136;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2017;152985;1.14
7137;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2018;146065;1.09
7138;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2019;146450;1.1
7139;Total male and female;10000;Dutch background;C03D Potassium-sparing agents;2020;150115;1.13
7140;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2006;124975;0.94
7141;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2007;114800;0.86
7142;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2008;105865;0.79
7143;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2009;96710;0.72
7144;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2010;87975;0.66
7145;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2011;79910;0.6
7146;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2012;72880;0.54
7147;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2013;65785;0.49
7148;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2014;58785;0.44
7149;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2015;51570;0.39
7150;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2016;46625;0.35
7151;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2017;40990;0.31
7152;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2018;35555;0.27
7153;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2019;31350;0.23
7154;Total male and female;10000;Dutch background;C03E Diuretics/potassium-sparing agents;2020;27855;0.21
7155;Total male and female;10000;Dutch background;C03X Other diuretics;2006;0;0.0
7156;Total male and female;10000;Dutch background;C03X Other diuretics;2007;0;0.0
7157;Total male and female;10000;Dutch background;C03X Other diuretics;2008;0;0.0
7158;Total male and female;10000;Dutch background;C03X Other diuretics;2009;0;0.0
7159;Total male and female;10000;Dutch background;C03X Other diuretics;2010;0;0.0
7160;Total male and female;10000;Dutch background;C03X Other diuretics;2011;0;0.0
7161;Total male and female;10000;Dutch background;C03X Other diuretics;2012;0;0.0
7162;Total male and female;10000;Dutch background;C03X Other diuretics;2013;0;0.0
7163;Total male and female;10000;Dutch background;C03X Other diuretics;2014;0;0.0
7164;Total male and female;10000;Dutch background;C03X Other diuretics;2015;0;0.0
7165;Total male and female;10000;Dutch background;C03X Other diuretics;2016;0;0.0
7166;Total male and female;10000;Dutch background;C03X Other diuretics;2017;0;0.0
7167;Total male and female;10000;Dutch background;C03X Other diuretics;2018;0;0.0
7168;Total male and female;10000;Dutch background;C03X Other diuretics;2019;145;0.0
7169;Total male and female;10000;Dutch background;C03X Other diuretics;2020;145;0.0
7170;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2006;4735;0.04
7171;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2007;4055;0.03
7172;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2008;3570;0.03
7173;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2009;3090;0.02
7174;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2010;2840;0.02
7175;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2011;2515;0.02
7176;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2012;1785;0.01
7177;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2013;1535;0.01
7178;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2014;1315;0.01
7179;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2015;1125;0.01
7180;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2016;1330;0.01
7181;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2017;1370;0.01
7182;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2018;1160;0.01
7183;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2019;1120;0.01
7184;Total male and female;10000;Dutch background;C04 Peripheral vasodilators;2020;990;0.01
7185;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2006;4735;0.04
7186;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2007;4055;0.03
7187;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2008;3570;0.03
7188;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2009;3090;0.02
7189;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2010;2840;0.02
7190;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2011;2515;0.02
7191;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2012;1785;0.01
7192;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2013;1535;0.01
7193;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2014;1315;0.01
7194;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2015;1125;0.01
7195;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2016;1330;0.01
7196;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2017;1370;0.01
7197;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2018;1160;0.01
7198;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2019;1120;0.01
7199;Total male and female;10000;Dutch background;C04A Peripheral vasodilators;2020;990;0.01
7200;Total male and female;10000;Dutch background;C05 Vasoprotectives;2006;103470;0.77
7201;Total male and female;10000;Dutch background;C05 Vasoprotectives;2007;111685;0.84
7202;Total male and female;10000;Dutch background;C05 Vasoprotectives;2008;130825;0.98
7203;Total male and female;10000;Dutch background;C05 Vasoprotectives;2009;134920;1.01
7204;Total male and female;10000;Dutch background;C05 Vasoprotectives;2010;137225;1.03
7205;Total male and female;10000;Dutch background;C05 Vasoprotectives;2011;142010;1.06
7206;Total male and female;10000;Dutch background;C05 Vasoprotectives;2012;138675;1.04
7207;Total male and female;10000;Dutch background;C05 Vasoprotectives;2013;131205;0.98
7208;Total male and female;10000;Dutch background;C05 Vasoprotectives;2014;56120;0.42
7209;Total male and female;10000;Dutch background;C05 Vasoprotectives;2015;39640;0.3
7210;Total male and female;10000;Dutch background;C05 Vasoprotectives;2016;37060;0.28
7211;Total male and female;10000;Dutch background;C05 Vasoprotectives;2017;36115;0.27
7212;Total male and female;10000;Dutch background;C05 Vasoprotectives;2018;34695;0.26
7213;Total male and female;10000;Dutch background;C05 Vasoprotectives;2019;36030;0.27
7214;Total male and female;10000;Dutch background;C05 Vasoprotectives;2020;32565;0.24
7215;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2006;102995;0.77
7216;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2007;111405;0.83
7217;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2008;130775;0.98
7218;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2009;134885;1.01
7219;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2010;137195;1.02
7220;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2011;141960;1.06
7221;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2012;138670;1.04
7222;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2013;131185;0.98
7223;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2014;56110;0.42
7224;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2015;39640;0.3
7225;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2016;37060;0.28
7226;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2017;36115;0.27
7227;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2018;34695;0.26
7228;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2019;36030;0.27
7229;Total male and female;10000;Dutch background;C05A Topic agents hemorrh./anal fissures;2020;32565;0.24
7230;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2006;355;0.0
7231;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2007;200;0.0
7232;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2008;35;0.0
7233;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2009;25;0.0
7234;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2010;30;0.0
7235;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2011;40;0.0
7236;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2012;5;0.0
7237;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2013;15;0.0
7238;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2014;5;0.0
7239;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2015;0;0.0
7240;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2016;0;0.0
7241;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2017;0;0.0
7242;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2018;0;0.0
7243;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2019;0;0.0
7244;Total male and female;10000;Dutch background;C05B Antivaricose therapy;2020;0;0.0
7245;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2006;155;0.0
7246;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2007;100;0.0
7247;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2008;15;0.0
7248;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2009;15;0.0
7249;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2010;5;0.0
7250;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2011;10;0.0
7251;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2012;5;0.0
7252;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2013;10;0.0
7253;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2014;5;0.0
7254;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2015;0;0.0
7255;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2016;0;0.0
7256;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2017;0;0.0
7257;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2018;0;0.0
7258;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2019;0;0.0
7259;Total male and female;10000;Dutch background;C05C Capillary stabilizing agents;2020;0;0.0
7260;Total male and female;10000;Dutch background;C07 Beta blocking agents;2006;1239255;9.28
7261;Total male and female;10000;Dutch background;C07 Beta blocking agents;2007;1287535;9.64
7262;Total male and female;10000;Dutch background;C07 Beta blocking agents;2008;1330185;9.96
7263;Total male and female;10000;Dutch background;C07 Beta blocking agents;2009;1369705;10.25
7264;Total male and female;10000;Dutch background;C07 Beta blocking agents;2010;1403040;10.48
7265;Total male and female;10000;Dutch background;C07 Beta blocking agents;2011;1429125;10.67
7266;Total male and female;10000;Dutch background;C07 Beta blocking agents;2012;1431075;10.68
7267;Total male and female;10000;Dutch background;C07 Beta blocking agents;2013;1413395;10.55
7268;Total male and female;10000;Dutch background;C07 Beta blocking agents;2014;1400510;10.46
7269;Total male and female;10000;Dutch background;C07 Beta blocking agents;2015;1386060;10.35
7270;Total male and female;10000;Dutch background;C07 Beta blocking agents;2016;1374135;10.27
7271;Total male and female;10000;Dutch background;C07 Beta blocking agents;2017;1361325;10.18
7272;Total male and female;10000;Dutch background;C07 Beta blocking agents;2018;1342525;10.05
7273;Total male and female;10000;Dutch background;C07 Beta blocking agents;2019;1328050;9.95
7274;Total male and female;10000;Dutch background;C07 Beta blocking agents;2020;1297030;9.73
7275;Total male and female;10000;Dutch background;C07A Beta blocking agents;2006;1185315;8.87
7276;Total male and female;10000;Dutch background;C07A Beta blocking agents;2007;1234580;9.24
7277;Total male and female;10000;Dutch background;C07A Beta blocking agents;2008;1277625;9.56
7278;Total male and female;10000;Dutch background;C07A Beta blocking agents;2009;1317600;9.86
7279;Total male and female;10000;Dutch background;C07A Beta blocking agents;2010;1352315;10.1
7280;Total male and female;10000;Dutch background;C07A Beta blocking agents;2011;1380205;10.3
7281;Total male and female;10000;Dutch background;C07A Beta blocking agents;2012;1384575;10.34
7282;Total male and female;10000;Dutch background;C07A Beta blocking agents;2013;1370115;10.23
7283;Total male and female;10000;Dutch background;C07A Beta blocking agents;2014;1360515;10.16
7284;Total male and female;10000;Dutch background;C07A Beta blocking agents;2015;1349280;10.08
7285;Total male and female;10000;Dutch background;C07A Beta blocking agents;2016;1340405;10.02
7286;Total male and female;10000;Dutch background;C07A Beta blocking agents;2017;1330345;9.95
7287;Total male and female;10000;Dutch background;C07A Beta blocking agents;2018;1314335;9.84
7288;Total male and female;10000;Dutch background;C07A Beta blocking agents;2019;1303285;9.76
7289;Total male and female;10000;Dutch background;C07A Beta blocking agents;2020;1276370;9.57
7290;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2006;33655;0.25
7291;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2007;36150;0.27
7292;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2008;35970;0.27
7293;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2009;37035;0.28
7294;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2010;37390;0.28
7295;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2011;37195;0.28
7296;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2012;35795;0.27
7297;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2013;33515;0.25
7298;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2014;31445;0.23
7299;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2015;29500;0.22
7300;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2016;27680;0.21
7301;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2017;25820;0.19
7302;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2018;23860;0.18
7303;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2019;21735;0.16
7304;Total male and female;10000;Dutch background;C07B Beta blocking agents and thiazides;2020;19395;0.15
7305;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2006;33655;0.25
7306;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2007;30550;0.23
7307;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2008;27685;0.21
7308;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2009;24960;0.19
7309;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2010;22490;0.17
7310;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2011;20090;0.15
7311;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2012;17845;0.13
7312;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2013;15945;0.12
7313;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2014;14005;0.1
7314;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2015;12425;0.09
7315;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2016;11055;0.08
7316;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2017;9705;0.07
7317;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2018;8490;0.06
7318;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2019;7445;0.06
7319;Total male and female;10000;Dutch background;C07C Beta block.agents / other diuretics;2020;6425;0.05
7320;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2006;0;0.0
7321;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2007;0;0.0
7322;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2008;0;0.0
7323;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2009;0;0.0
7324;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2010;0;0.0
7325;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2011;0;0.0
7326;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2012;0;0.0
7327;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2013;0;0.0
7328;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2014;0;0.0
7329;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2015;0;0.0
7330;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2016;0;0.0
7331;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2017;0;0.0
7332;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2018;0;0.0
7333;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2019;0;0.0
7334;Total male and female;10000;Dutch background;C07D Beta block./thiazides/other diuret.;2020;0;0.0
7335;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2006;0;0.0
7336;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2007;0;0.0
7337;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2008;0;0.0
7338;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2009;0;0.0
7339;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2010;0;0.0
7340;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2011;0;0.0
7341;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2012;0;0.0
7342;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2013;0;0.0
7343;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2014;0;0.0
7344;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2015;0;0.0
7345;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2016;0;0.0
7346;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2017;0;0.0
7347;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2018;0;0.0
7348;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2019;0;0.0
7349;Total male and female;10000;Dutch background;C07E Beta blocking agents / vasodilators;2020;0;0.0
7350;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2006;0;0.0
7351;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2007;0;0.0
7352;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2008;0;0.0
7353;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2009;0;0.0
7354;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2010;0;0.0
7355;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2011;0;0.0
7356;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2012;0;0.0
7357;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2013;0;0.0
7358;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2014;0;0.0
7359;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2015;0;0.0
7360;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2016;0;0.0
7361;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2017;0;0.0
7362;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2018;0;0.0
7363;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2019;0;0.0
7364;Total male and female;10000;Dutch background;C07F Beta block./other antihypertensives;2020;0;0.0
7365;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2006;519005;3.89
7366;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2007;537930;4.03
7367;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2008;558045;4.18
7368;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2009;579415;4.33
7369;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2010;600340;4.49
7370;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2011;621385;4.64
7371;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2012;650760;4.86
7372;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2013;669095;5.0
7373;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2014;688295;5.14
7374;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2015;711535;5.31
7375;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2016;737000;5.51
7376;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2017;759395;5.68
7377;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2018;781760;5.85
7378;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2019;817070;6.12
7379;Total male and female;10000;Dutch background;C08 Calcium channel blockers;2020;834365;6.26
7380;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2006;407825;3.05
7381;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2007;430685;3.22
7382;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2008;454460;3.4
7383;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2009;478870;3.58
7384;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2010;501930;3.75
7385;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2011;525860;3.93
7386;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2012;557540;4.16
7387;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2013;578755;4.32
7388;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2014;599285;4.47
7389;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2015;623185;4.65
7390;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2016;649165;4.85
7391;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2017;672190;5.03
7392;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2018;694570;5.2
7393;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2019;729175;5.46
7394;Total male and female;10000;Dutch background;C08C Sel.calcium ch.block.mnly.vascular;2020;746660;5.6
7395;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2006;117350;0.88
7396;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2007;113065;0.85
7397;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2008;109415;0.82
7398;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2009;106330;0.8
7399;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2010;103995;0.78
7400;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2011;101185;0.76
7401;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2012;98775;0.74
7402;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2013;95890;0.72
7403;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2014;94520;0.71
7404;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2015;93860;0.7
7405;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2016;93450;0.7
7406;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2017;92740;0.69
7407;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2018;93130;0.7
7408;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2019;94315;0.71
7409;Total male and female;10000;Dutch background;C08D Sel.calcium ch.block.direct cardiac;2020;94550;0.71
7410;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2006;0;0.0
7411;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2007;0;0.0
7412;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2008;0;0.0
7413;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2009;0;0.0
7414;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2010;0;0.0
7415;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2011;0;0.0
7416;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2012;0;0.0
7417;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2013;0;0.0
7418;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2014;0;0.0
7419;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2015;0;0.0
7420;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2016;0;0.0
7421;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2017;0;0.0
7422;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2018;0;0.0
7423;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2019;0;0.0
7424;Total male and female;10000;Dutch background;C08E Non-sel. calcium channel blockers;2020;0;0.0
7425;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2006;0;0.0
7426;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2007;0;0.0
7427;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2008;0;0.0
7428;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2009;0;0.0
7429;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2010;0;0.0
7430;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2011;0;0.0
7431;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2012;0;0.0
7432;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2013;0;0.0
7433;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2014;65;0.0
7434;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2015;170;0.0
7435;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2016;250;0.0
7436;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2017;300;0.0
7437;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2018;335;0.0
7438;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2019;400;0.0
7439;Total male and female;10000;Dutch background;C08G Calcium channel blockers/diuretics;2020;380;0.0
7440;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2006;1227550;9.19
7441;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2007;1316520;9.86
7442;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2008;1393995;10.43
7443;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2009;1462175;10.94
7444;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2010;1522295;11.37
7445;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2011;1578510;11.78
7446;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2012;1622340;12.11
7447;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2013;1636060;12.22
7448;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2014;1649535;12.32
7449;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2015;1661095;12.41
7450;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2016;1671990;12.49
7451;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2017;1677970;12.55
7452;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2018;1678340;12.56
7453;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2019;1682235;12.6
7454;Total male and female;10000;Dutch background;C09 Agents on renin-angiotensin system;2020;1671070;12.53
7455;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2006;659060;4.93
7456;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2007;687460;5.15
7457;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2008;713815;5.34
7458;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2009;734150;5.49
7459;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2010;756980;5.66
7460;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2011;780095;5.82
7461;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2012;803415;6.0
7462;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2013;810795;6.05
7463;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2014;824115;6.15
7464;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2015;836790;6.25
7465;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2016;847565;6.33
7466;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2017;854695;6.39
7467;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2018;866280;6.48
7468;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2019;887535;6.65
7469;Total male and female;10000;Dutch background;C09A Ace inhibitors, plain;2020;882690;6.62
7470;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2006;115255;0.86
7471;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2007;122295;0.92
7472;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2008;128245;0.96
7473;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2009;131570;0.98
7474;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2010;133630;1.0
7475;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2011;134945;1.01
7476;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2012;134470;1.0
7477;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2013;130305;0.97
7478;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2014;127835;0.95
7479;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2015;123990;0.93
7480;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2016;119640;0.89
7481;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2017;115625;0.86
7482;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2018;110575;0.83
7483;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2019;104455;0.78
7484;Total male and female;10000;Dutch background;C09B Ace inhibitors, combinations;2020;93175;0.7
7485;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2006;410715;3.07
7486;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2007;442800;3.32
7487;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2008;470530;3.52
7488;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2009;491640;3.68
7489;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2010;508320;3.8
7490;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2011;525235;3.92
7491;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2012;539140;4.02
7492;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2013;543435;4.06
7493;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2014;547770;4.09
7494;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2015;549875;4.11
7495;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2016;555900;4.15
7496;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2017;562530;4.21
7497;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2018;585350;4.38
7498;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2019;618155;4.63
7499;Total male and female;10000;Dutch background;C09C Angiotensin II antagonists, plain;2020;589895;4.42
7500;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2006;173560;1.3
7501;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2007;199895;1.5
7502;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2008;221970;1.66
7503;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2009;239945;1.79
7504;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2010;252650;1.89
7505;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2011;262205;1.96
7506;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2012;265285;1.98
7507;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2013;257540;1.92
7508;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2014;252415;1.88
7509;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2015;244225;1.82
7510;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2016;236880;1.77
7511;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2017;232215;1.74
7512;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2018;226770;1.7
7513;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2019;199650;1.5
7514;Total male and female;10000;Dutch background;C09D Angiotensin II antagonists, combin.;2020;184040;1.38
7515;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2006;0;0.0
7516;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2007;0;0.0
7517;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2008;1880;0.01
7518;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2009;6305;0.05
7519;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2010;11150;0.08
7520;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2011;15015;0.11
7521;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2012;13445;0.1
7522;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2013;10790;0.08
7523;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2014;9325;0.07
7524;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2015;8310;0.06
7525;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2016;7580;0.06
7526;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2017;6885;0.05
7527;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2018;6280;0.05
7528;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2019;5760;0.04
7529;Total male and female;10000;Dutch background;C09X Other renin angiotensin syst.agents;2020;5265;0.04
7530;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2006;1160135;8.69
7531;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2007;1238850;9.28
7532;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2008;1264310;9.46
7533;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2009;1330325;9.95
7534;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2010;1394170;10.42
7535;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2011;1461460;10.91
7536;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2012;1529380;11.42
7537;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2013;1564715;11.68
7538;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2014;1601000;11.95
7539;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2015;1630300;12.18
7540;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2016;1657470;12.39
7541;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2017;1685465;12.6
7542;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2018;1695725;12.69
7543;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2019;1693860;12.69
7544;Total male and female;10000;Dutch background;C10 Lipid modifying agents;2020;1660415;12.45
7545;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2006;1150805;8.62
7546;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2007;1221385;9.15
7547;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2008;1240100;9.28
7548;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2009;1304070;9.75
7549;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2010;1365655;10.2
7550;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2011;1431365;10.69
7551;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2012;1497650;11.18
7552;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2013;1532715;11.44
7553;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2014;1570340;11.72
7554;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2015;1601280;11.96
7555;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2016;1628915;12.17
7556;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2017;1658915;12.41
7557;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2018;1669645;12.5
7558;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2019;1669750;12.51
7559;Total male and female;10000;Dutch background;C10A Lipid modifying agents, plain;2020;1640265;12.3
7560;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2006;19190;0.14
7561;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2007;30005;0.22
7562;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2008;32995;0.25
7563;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2009;33330;0.25
7564;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2010;34795;0.26
7565;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2011;36595;0.27
7566;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2012;38540;0.29
7567;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2013;38545;0.29
7568;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2014;36640;0.27
7569;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2015;34865;0.26
7570;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2016;34780;0.26
7571;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2017;35340;0.26
7572;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2018;34155;0.26
7573;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2019;32340;0.24
7574;Total male and female;10000;Dutch background;C10B Lipid modifying agents,combinations;2020;25005;0.19
7575;Total male and female;10000;Dutch background;D Dermatologicals;2006;2620225;19.62
7576;Total male and female;10000;Dutch background;D Dermatologicals;2007;2688095;20.13
7577;Total male and female;10000;Dutch background;D Dermatologicals;2008;2690520;20.14
7578;Total male and female;10000;Dutch background;D Dermatologicals;2009;2725950;20.39
7579;Total male and female;10000;Dutch background;D Dermatologicals;2010;2794580;20.88
7580;Total male and female;10000;Dutch background;D Dermatologicals;2011;2785845;20.8
7581;Total male and female;10000;Dutch background;D Dermatologicals;2012;2749080;20.52
7582;Total male and female;10000;Dutch background;D Dermatologicals;2013;2702960;20.18
7583;Total male and female;10000;Dutch background;D Dermatologicals;2014;2719450;20.3
7584;Total male and female;10000;Dutch background;D Dermatologicals;2015;2641130;19.72
7585;Total male and female;10000;Dutch background;D Dermatologicals;2016;2632025;19.67
7586;Total male and female;10000;Dutch background;D Dermatologicals;2017;2586840;19.34
7587;Total male and female;10000;Dutch background;D Dermatologicals;2018;2617855;19.59
7588;Total male and female;10000;Dutch background;D Dermatologicals;2019;2578660;19.32
7589;Total male and female;10000;Dutch background;D Dermatologicals;2020;2409835;18.07
7590;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2006;384975;2.88
7591;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2007;382640;2.86
7592;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2008;369680;2.77
7593;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2009;376105;2.81
7594;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2010;394345;2.95
7595;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2011;401745;3.0
7596;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2012;399805;2.98
7597;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2013;374745;2.8
7598;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2014;417230;3.12
7599;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2015;397350;2.97
7600;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2016;379120;2.83
7601;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2017;408075;3.05
7602;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2018;667975;5.0
7603;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2019;640395;4.8
7604;Total male and female;10000;Dutch background;D01 Antifungals for dermatological use;2020;578920;4.34
7605;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2006;313125;2.34
7606;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2007;316075;2.37
7607;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2008;304910;2.28
7608;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2009;312170;2.33
7609;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2010;332795;2.49
7610;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2011;340475;2.54
7611;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2012;339405;2.53
7612;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2013;317750;2.37
7613;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2014;363040;2.71
7614;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2015;342795;2.56
7615;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2016;325260;2.43
7616;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2017;356350;2.66
7617;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2018;620385;4.64
7618;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2019;594255;4.45
7619;Total male and female;10000;Dutch background;D01A Antifungals for topical use;2020;539730;4.05
7620;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2006;81845;0.61
7621;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2007;75920;0.57
7622;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2008;73965;0.55
7623;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2009;73155;0.55
7624;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2010;71030;0.53
7625;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2011;70865;0.53
7626;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2012;69705;0.52
7627;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2013;65765;0.49
7628;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2014;64095;0.48
7629;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2015;64335;0.48
7630;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2016;62955;0.47
7631;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2017;61430;0.46
7632;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2018;61260;0.46
7633;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2019;58970;0.44
7634;Total male and female;10000;Dutch background;D01B Antifungals for systemic use;2020;49970;0.37
7635;Total male and female;10000;Dutch background;D02 Emollients and protectives;2006;518250;3.88
7636;Total male and female;10000;Dutch background;D02 Emollients and protectives;2007;531200;3.98
7637;Total male and female;10000;Dutch background;D02 Emollients and protectives;2008;564760;4.23
7638;Total male and female;10000;Dutch background;D02 Emollients and protectives;2009;575255;4.3
7639;Total male and female;10000;Dutch background;D02 Emollients and protectives;2010;662465;4.95
7640;Total male and female;10000;Dutch background;D02 Emollients and protectives;2011;693560;5.18
7641;Total male and female;10000;Dutch background;D02 Emollients and protectives;2012;719070;5.37
7642;Total male and female;10000;Dutch background;D02 Emollients and protectives;2013;744820;5.56
7643;Total male and female;10000;Dutch background;D02 Emollients and protectives;2014;734480;5.48
7644;Total male and female;10000;Dutch background;D02 Emollients and protectives;2015;705960;5.27
7645;Total male and female;10000;Dutch background;D02 Emollients and protectives;2016;702295;5.25
7646;Total male and female;10000;Dutch background;D02 Emollients and protectives;2017;687555;5.14
7647;Total male and female;10000;Dutch background;D02 Emollients and protectives;2018;733290;5.49
7648;Total male and female;10000;Dutch background;D02 Emollients and protectives;2019;739350;5.54
7649;Total male and female;10000;Dutch background;D02 Emollients and protectives;2020;737485;5.53
7650;Total male and female;10000;Dutch background;D02A Emollients and protectives;2006;482095;3.61
7651;Total male and female;10000;Dutch background;D02A Emollients and protectives;2007;500450;3.75
7652;Total male and female;10000;Dutch background;D02A Emollients and protectives;2008;531720;3.98
7653;Total male and female;10000;Dutch background;D02A Emollients and protectives;2009;545665;4.08
7654;Total male and female;10000;Dutch background;D02A Emollients and protectives;2010;635350;4.75
7655;Total male and female;10000;Dutch background;D02A Emollients and protectives;2011;670715;5.01
7656;Total male and female;10000;Dutch background;D02A Emollients and protectives;2012;697330;5.21
7657;Total male and female;10000;Dutch background;D02A Emollients and protectives;2013;725870;5.42
7658;Total male and female;10000;Dutch background;D02A Emollients and protectives;2014;718370;5.36
7659;Total male and female;10000;Dutch background;D02A Emollients and protectives;2015;705960;5.27
7660;Total male and female;10000;Dutch background;D02A Emollients and protectives;2016;702295;5.25
7661;Total male and female;10000;Dutch background;D02A Emollients and protectives;2017;687555;5.14
7662;Total male and female;10000;Dutch background;D02A Emollients and protectives;2018;733290;5.49
7663;Total male and female;10000;Dutch background;D02A Emollients and protectives;2019;739350;5.54
7664;Total male and female;10000;Dutch background;D02A Emollients and protectives;2020;737485;5.53
7665;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2006;41570;0.31
7666;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2007;35635;0.27
7667;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2008;38485;0.29
7668;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2009;34565;0.26
7669;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2010;32770;0.24
7670;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2011;28010;0.21
7671;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2012;26820;0.2
7672;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2013;23635;0.18
7673;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2014;20265;0.15
7674;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2015;5;0.0
7675;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2016;0;0.0
7676;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2017;0;0.0
7677;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2018;0;0.0
7678;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2019;0;0.0
7679;Total male and female;10000;Dutch background;D02B Protectives against uv-radiation;2020;0;0.0
7680;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2006;27965;0.21
7681;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2007;25530;0.19
7682;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2008;2455;0.02
7683;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2009;1845;0.01
7684;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2010;1810;0.01
7685;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2011;1640;0.01
7686;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2012;1355;0.01
7687;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2013;1705;0.01
7688;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2014;1840;0.01
7689;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2015;1900;0.01
7690;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2016;1775;0.01
7691;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2017;1785;0.01
7692;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2018;1750;0.01
7693;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2019;1535;0.01
7694;Total male and female;10000;Dutch background;D03 Means for wounds & ulcers treatment;2020;1460;0.01
7695;Total male and female;10000;Dutch background;D03A Cicatrizants;2006;25775;0.19
7696;Total male and female;10000;Dutch background;D03A Cicatrizants;2007;23500;0.18
7697;Total male and female;10000;Dutch background;D03A Cicatrizants;2008;730;0.01
7698;Total male and female;10000;Dutch background;D03A Cicatrizants;2009;180;0.0
7699;Total male and female;10000;Dutch background;D03A Cicatrizants;2010;110;0.0
7700;Total male and female;10000;Dutch background;D03A Cicatrizants;2011;40;0.0
7701;Total male and female;10000;Dutch background;D03A Cicatrizants;2012;5;0.0
7702;Total male and female;10000;Dutch background;D03A Cicatrizants;2013;5;0.0
7703;Total male and female;10000;Dutch background;D03A Cicatrizants;2014;5;0.0
7704;Total male and female;10000;Dutch background;D03A Cicatrizants;2015;5;0.0
7705;Total male and female;10000;Dutch background;D03A Cicatrizants;2016;0;0.0
7706;Total male and female;10000;Dutch background;D03A Cicatrizants;2017;0;0.0
7707;Total male and female;10000;Dutch background;D03A Cicatrizants;2018;0;0.0
7708;Total male and female;10000;Dutch background;D03A Cicatrizants;2019;0;0.0
7709;Total male and female;10000;Dutch background;D03A Cicatrizants;2020;0;0.0
7710;Total male and female;10000;Dutch background;D03B Enzymes;2006;2195;0.02
7711;Total male and female;10000;Dutch background;D03B Enzymes;2007;2040;0.02
7712;Total male and female;10000;Dutch background;D03B Enzymes;2008;1730;0.01
7713;Total male and female;10000;Dutch background;D03B Enzymes;2009;1675;0.01
7714;Total male and female;10000;Dutch background;D03B Enzymes;2010;1700;0.01
7715;Total male and female;10000;Dutch background;D03B Enzymes;2011;1600;0.01
7716;Total male and female;10000;Dutch background;D03B Enzymes;2012;1355;0.01
7717;Total male and female;10000;Dutch background;D03B Enzymes;2013;1270;0.01
7718;Total male and female;10000;Dutch background;D03B Enzymes;2014;1260;0.01
7719;Total male and female;10000;Dutch background;D03B Enzymes;2015;1315;0.01
7720;Total male and female;10000;Dutch background;D03B Enzymes;2016;1145;0.01
7721;Total male and female;10000;Dutch background;D03B Enzymes;2017;1070;0.01
7722;Total male and female;10000;Dutch background;D03B Enzymes;2018;1075;0.01
7723;Total male and female;10000;Dutch background;D03B Enzymes;2019;740;0.01
7724;Total male and female;10000;Dutch background;D03B Enzymes;2020;710;0.01
7725;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2006;25940;0.19
7726;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2007;23880;0.18
7727;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2008;23740;0.18
7728;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2009;24595;0.18
7729;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2010;32460;0.24
7730;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2011;25635;0.19
7731;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2012;19845;0.15
7732;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2013;17100;0.13
7733;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2014;220;0.0
7734;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2015;75;0.0
7735;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2016;40;0.0
7736;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2017;25;0.0
7737;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2018;10;0.0
7738;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2019;10;0.0
7739;Total male and female;10000;Dutch background;D04 Antipruritics,incl antesthetics ....;2020;10;0.0
7740;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2006;25940;0.19
7741;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2007;23880;0.18
7742;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2008;23740;0.18
7743;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2009;24595;0.18
7744;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2010;32460;0.24
7745;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2011;25635;0.19
7746;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2012;19845;0.15
7747;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2013;17100;0.13
7748;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2014;220;0.0
7749;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2015;75;0.0
7750;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2016;40;0.0
7751;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2017;25;0.0
7752;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2018;10;0.0
7753;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2019;10;0.0
7754;Total male and female;10000;Dutch background;D04A Antipruritics, incl antihistam. etc;2020;10;0.0
7755;Total male and female;10000;Dutch background;D05 Antipsoriatics;2006;55805;0.42
7756;Total male and female;10000;Dutch background;D05 Antipsoriatics;2007;57155;0.43
7757;Total male and female;10000;Dutch background;D05 Antipsoriatics;2008;57780;0.43
7758;Total male and female;10000;Dutch background;D05 Antipsoriatics;2009;61665;0.46
7759;Total male and female;10000;Dutch background;D05 Antipsoriatics;2010;68475;0.51
7760;Total male and female;10000;Dutch background;D05 Antipsoriatics;2011;72830;0.54
7761;Total male and female;10000;Dutch background;D05 Antipsoriatics;2012;70955;0.53
7762;Total male and female;10000;Dutch background;D05 Antipsoriatics;2013;70260;0.52
7763;Total male and female;10000;Dutch background;D05 Antipsoriatics;2014;69735;0.52
7764;Total male and female;10000;Dutch background;D05 Antipsoriatics;2015;67325;0.5
7765;Total male and female;10000;Dutch background;D05 Antipsoriatics;2016;67490;0.5
7766;Total male and female;10000;Dutch background;D05 Antipsoriatics;2017;70320;0.53
7767;Total male and female;10000;Dutch background;D05 Antipsoriatics;2018;68750;0.51
7768;Total male and female;10000;Dutch background;D05 Antipsoriatics;2019;70715;0.53
7769;Total male and female;10000;Dutch background;D05 Antipsoriatics;2020;67825;0.51
7770;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2006;53040;0.4
7771;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2007;54225;0.41
7772;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2008;54700;0.41
7773;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2009;58485;0.44
7774;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2010;64465;0.48
7775;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2011;68225;0.51
7776;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2012;66190;0.49
7777;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2013;65235;0.49
7778;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2014;63560;0.47
7779;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2015;60875;0.45
7780;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2016;60940;0.46
7781;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2017;64295;0.48
7782;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2018;62905;0.47
7783;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2019;65195;0.49
7784;Total male and female;10000;Dutch background;D05A Antipsoriatics for topical use;2020;62775;0.47
7785;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2006;3935;0.03
7786;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2007;4090;0.03
7787;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2008;4260;0.03
7788;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2009;4375;0.03
7789;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2010;5545;0.04
7790;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2011;6505;0.05
7791;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2012;6945;0.05
7792;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2013;7340;0.05
7793;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2014;9005;0.07
7794;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2015;9365;0.07
7795;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2016;9350;0.07
7796;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2017;9160;0.07
7797;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2018;8850;0.07
7798;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2019;8510;0.06
7799;Total male and female;10000;Dutch background;D05B Antipsoriatics for systemic use;2020;7440;0.06
7800;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2006;571785;4.28
7801;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2007;571105;4.28
7802;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2008;583055;4.36
7803;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2009;601355;4.5
7804;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2010;613930;4.59
7805;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2011;617165;4.61
7806;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2012;609750;4.55
7807;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2013;604180;4.51
7808;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2014;610575;4.56
7809;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2015;608025;4.54
7810;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2016;627180;4.69
7811;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2017;621880;4.65
7812;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2018;639225;4.78
7813;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2019;622365;4.66
7814;Total male and female;10000;Dutch background;D06 Antibiotics.. for dermatological use;2020;540180;4.05
7815;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2006;470695;3.52
7816;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2007;461495;3.46
7817;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2008;464815;3.48
7818;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2009;477635;3.57
7819;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2010;486705;3.64
7820;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2011;486235;3.63
7821;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2012;480690;3.59
7822;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2013;475770;3.55
7823;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2014;474345;3.54
7824;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2015;476715;3.56
7825;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2016;497240;3.72
7826;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2017;497790;3.72
7827;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2018;522000;3.91
7828;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2019;508530;3.81
7829;Total male and female;10000;Dutch background;D06A Antibiotics for topical use;2020;443480;3.33
7830;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2006;111995;0.84
7831;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2007;121315;0.91
7832;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2008;131265;0.98
7833;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2009;137110;1.03
7834;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2010;141175;1.05
7835;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2011;145180;1.08
7836;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2012;142685;1.07
7837;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2013;142255;1.06
7838;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2014;151015;1.13
7839;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2015;145490;1.09
7840;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2016;144155;1.08
7841;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2017;137725;1.03
7842;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2018;130390;0.98
7843;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2019;126125;0.94
7844;Total male and female;10000;Dutch background;D06B Chemotherapeutics for topical use;2020;106130;0.8
7845;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2006;0;0.0
7846;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2007;0;0.0
7847;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2008;0;0.0
7848;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2009;0;0.0
7849;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2010;0;0.0
7850;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2011;0;0.0
7851;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2012;0;0.0
7852;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2013;0;0.0
7853;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2014;0;0.0
7854;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2015;0;0.0
7855;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2016;0;0.0
7856;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2017;0;0.0
7857;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2018;0;0.0
7858;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2019;0;0.0
7859;Total male and female;10000;Dutch background;D06C Antibiotics/chemotherapeutics, comb;2020;0;0.0
7860;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2006;1598150;11.97
7861;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2007;1658530;12.42
7862;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2008;1672215;12.51
7863;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2009;1690540;12.65
7864;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2010;1709445;12.77
7865;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2011;1694550;12.65
7866;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2012;1663205;12.42
7867;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2013;1634000;12.2
7868;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2014;1664195;12.42
7869;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2015;1655785;12.37
7870;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2016;1658095;12.39
7871;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2017;1611135;12.05
7872;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2018;1384415;10.36
7873;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2019;1367850;10.25
7874;Total male and female;10000;Dutch background;D07 Dermatological corticosteroids;2020;1297030;9.73
7875;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2006;1253385;9.38
7876;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2007;1298925;9.73
7877;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2008;1316430;9.85
7878;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2009;1328955;9.94
7879;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2010;1357100;10.14
7880;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2011;1346575;10.05
7881;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2012;1330490;9.93
7882;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2013;1319455;9.85
7883;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2014;1325325;9.89
7884;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2015;1353735;10.11
7885;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2016;1380455;10.32
7886;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2017;1373695;10.27
7887;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2018;1365950;10.22
7888;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2019;1350855;10.12
7889;Total male and female;10000;Dutch background;D07A Corticosteroids, plain;2020;1281200;9.61
7890;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2006;1895;0.01
7891;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2007;505;0.0
7892;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2008;25;0.0
7893;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2009;0;0.0
7894;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2010;0;0.0
7895;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2011;0;0.0
7896;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2012;0;0.0
7897;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2013;0;0.0
7898;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2014;0;0.0
7899;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2015;0;0.0
7900;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2016;0;0.0
7901;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2017;0;0.0
7902;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2018;0;0.0
7903;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2019;0;0.0
7904;Total male and female;10000;Dutch background;D07B Corticosteroids with antiseptics;2020;0;0.0
7905;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2006;6975;0.05
7906;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2007;1610;0.01
7907;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2008;40;0.0
7908;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2009;5;0.0
7909;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2010;0;0.0
7910;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2011;0;0.0
7911;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2012;0;0.0
7912;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2013;495;0.0
7913;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2014;44975;0.34
7914;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2015;26875;0.2
7915;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2016;670;0.01
7916;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2017;0;0.0
7917;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2018;5;0.0
7918;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2019;0;0.0
7919;Total male and female;10000;Dutch background;D07C Corticosteroids with antibiotics;2020;0;0.0
7920;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2006;458435;3.43
7921;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2007;485260;3.63
7922;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2008;483590;3.62
7923;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2009;490760;3.67
7924;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2010;480190;3.59
7925;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2011;473250;3.53
7926;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2012;451505;3.37
7927;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2013;426500;3.18
7928;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2014;430010;3.21
7929;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2015;399865;2.99
7930;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2016;388260;2.9
7931;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2017;338415;2.53
7932;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2018;34130;0.26
7933;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2019;32435;0.24
7934;Total male and female;10000;Dutch background;D07X Corticosteroids, other combinations;2020;28935;0.22
7935;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2006;14485;0.11
7936;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2007;13720;0.1
7937;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2008;12095;0.09
7938;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2009;10835;0.08
7939;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2010;10135;0.08
7940;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2011;8670;0.06
7941;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2012;6165;0.05
7942;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2013;3430;0.03
7943;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2014;1920;0.01
7944;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2015;1925;0.01
7945;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2016;2000;0.01
7946;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2017;1900;0.01
7947;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2018;1500;0.01
7948;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2019;1400;0.01
7949;Total male and female;10000;Dutch background;D08 Antiseptics and disinfectants;2020;1310;0.01
7950;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2006;14485;0.11
7951;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2007;13720;0.1
7952;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2008;12095;0.09
7953;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2009;10835;0.08
7954;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2010;10135;0.08
7955;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2011;8670;0.06
7956;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2012;6165;0.05
7957;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2013;3430;0.03
7958;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2014;1920;0.01
7959;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2015;1925;0.01
7960;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2016;2000;0.01
7961;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2017;1900;0.01
7962;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2018;1500;0.01
7963;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2019;1400;0.01
7964;Total male and female;10000;Dutch background;D08A Antiseptics and disinfectants;2020;1310;0.01
7965;Total male and female;10000;Dutch background;D09 Medicated dressings;2006;5715;0.04
7966;Total male and female;10000;Dutch background;D09 Medicated dressings;2007;5190;0.04
7967;Total male and female;10000;Dutch background;D09 Medicated dressings;2008;4525;0.03
7968;Total male and female;10000;Dutch background;D09 Medicated dressings;2009;4655;0.03
7969;Total male and female;10000;Dutch background;D09 Medicated dressings;2010;4720;0.04
7970;Total male and female;10000;Dutch background;D09 Medicated dressings;2011;4055;0.03
7971;Total male and female;10000;Dutch background;D09 Medicated dressings;2012;3310;0.02
7972;Total male and female;10000;Dutch background;D09 Medicated dressings;2013;2955;0.02
7973;Total male and female;10000;Dutch background;D09 Medicated dressings;2014;2790;0.02
7974;Total male and female;10000;Dutch background;D09 Medicated dressings;2015;2340;0.02
7975;Total male and female;10000;Dutch background;D09 Medicated dressings;2016;2280;0.02
7976;Total male and female;10000;Dutch background;D09 Medicated dressings;2017;2130;0.02
7977;Total male and female;10000;Dutch background;D09 Medicated dressings;2018;1975;0.01
7978;Total male and female;10000;Dutch background;D09 Medicated dressings;2019;1540;0.01
7979;Total male and female;10000;Dutch background;D09 Medicated dressings;2020;180;0.0
7980;Total male and female;10000;Dutch background;D09A Medicated dressings;2006;5715;0.04
7981;Total male and female;10000;Dutch background;D09A Medicated dressings;2007;5190;0.04
7982;Total male and female;10000;Dutch background;D09A Medicated dressings;2008;4525;0.03
7983;Total male and female;10000;Dutch background;D09A Medicated dressings;2009;4655;0.03
7984;Total male and female;10000;Dutch background;D09A Medicated dressings;2010;4720;0.04
7985;Total male and female;10000;Dutch background;D09A Medicated dressings;2011;4055;0.03
7986;Total male and female;10000;Dutch background;D09A Medicated dressings;2012;3310;0.02
7987;Total male and female;10000;Dutch background;D09A Medicated dressings;2013;2955;0.02
7988;Total male and female;10000;Dutch background;D09A Medicated dressings;2014;2790;0.02
7989;Total male and female;10000;Dutch background;D09A Medicated dressings;2015;2340;0.02
7990;Total male and female;10000;Dutch background;D09A Medicated dressings;2016;2280;0.02
7991;Total male and female;10000;Dutch background;D09A Medicated dressings;2017;2130;0.02
7992;Total male and female;10000;Dutch background;D09A Medicated dressings;2018;1975;0.01
7993;Total male and female;10000;Dutch background;D09A Medicated dressings;2019;1540;0.01
7994;Total male and female;10000;Dutch background;D09A Medicated dressings;2020;180;0.0
7995;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2006;127805;0.96
7996;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2007;136190;1.02
7997;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2008;136290;1.02
7998;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2009;139330;1.04
7999;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2010;139975;1.05
8000;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2011;140150;1.05
8001;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2012;142100;1.06
8002;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2013;142435;1.06
8003;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2014;143095;1.07
8004;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2015;129315;0.97
8005;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2016;123680;0.92
8006;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2017;124270;0.93
8007;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2018;123260;0.92
8008;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2019;119645;0.9
8009;Total male and female;10000;Dutch background;D10 Anti-acne preparations;2020;112370;0.84
8010;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2006;121900;0.91
8011;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2007;129670;0.97
8012;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2008;129510;0.97
8013;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2009;131715;0.99
8014;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2010;131560;0.98
8015;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2011;132235;0.99
8016;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2012;133845;1.0
8017;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2013;133945;1.0
8018;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2014;133340;1.0
8019;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2015;118910;0.89
8020;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2016;112855;0.84
8021;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2017;113015;0.85
8022;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2018;111045;0.83
8023;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2019;106430;0.8
8024;Total male and female;10000;Dutch background;D10A Anti-acne preparations, topical use;2020;99275;0.74
8025;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2006;9475;0.07
8026;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2007;10475;0.08
8027;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2008;10905;0.08
8028;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2009;12290;0.09
8029;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2010;13075;0.1
8030;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2011;12175;0.09
8031;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2012;12590;0.09
8032;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2013;13125;0.1
8033;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2014;14825;0.11
8034;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2015;15125;0.11
8035;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2016;15390;0.12
8036;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2017;16270;0.12
8037;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2018;17505;0.13
8038;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2019;18390;0.14
8039;Total male and female;10000;Dutch background;D10B Anti-acne preparations,systemic use;2020;18315;0.14
8040;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2006;109970;0.82
8041;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2007;118335;0.89
8042;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2008;112585;0.84
8043;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2009;112335;0.84
8044;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2010;115100;0.86
8045;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2011;109430;0.82
8046;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2012;99110;0.74
8047;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2013;95695;0.71
8048;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2014;96925;0.72
8049;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2015;88315;0.66
8050;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2016;86710;0.65
8051;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2017;83225;0.62
8052;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2018;93465;0.7
8053;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2019;101780;0.76
8054;Total male and female;10000;Dutch background;D11 Other dermatological preparations;2020;102650;0.77
8055;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2006;109970;0.82
8056;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2007;118335;0.89
8057;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2008;112585;0.84
8058;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2009;112335;0.84
8059;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2010;115100;0.86
8060;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2011;109430;0.82
8061;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2012;99110;0.74
8062;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2013;95695;0.71
8063;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2014;96925;0.72
8064;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2015;88315;0.66
8065;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2016;86710;0.65
8066;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2017;83225;0.62
8067;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2018;93465;0.7
8068;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2019;101780;0.76
8069;Total male and female;10000;Dutch background;D11A Other dermatological preparations;2020;102650;0.77
8070;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2006;1672885;12.52
8071;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2007;1262330;9.45
8072;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2008;2157605;16.15
8073;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2009;2163035;16.18
8074;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2010;2170940;16.22
8075;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2011;1381820;10.32
8076;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2012;1348835;10.07
8077;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2013;1149725;8.58
8078;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2014;1076485;8.04
8079;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2015;1052790;7.86
8080;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2016;1007625;7.53
8081;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2017;1018105;7.61
8082;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2018;1025870;7.68
8083;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2019;1034820;7.75
8084;Total male and female;10000;Dutch background;G Genito urinary system and sex hormones;2020;983960;7.38
8085;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2006;274200;2.05
8086;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2007;283260;2.12
8087;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2008;285530;2.14
8088;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2009;289555;2.17
8089;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2010;288715;2.16
8090;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2011;290055;2.17
8091;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2012;272550;2.03
8092;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2013;224800;1.68
8093;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2014;205750;1.54
8094;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2015;192270;1.44
8095;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2016;143380;1.07
8096;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2017;153100;1.14
8097;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2018;150575;1.13
8098;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2019;144985;1.09
8099;Total male and female;10000;Dutch background;G01 Gynecological antiseptics/infectives;2020;134485;1.01
8100;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2006;274200;2.05
8101;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2007;283260;2.12
8102;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2008;285530;2.14
8103;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2009;289555;2.17
8104;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2010;288715;2.16
8105;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2011;290055;2.17
8106;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2012;272550;2.03
8107;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2013;224800;1.68
8108;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2014;205750;1.54
8109;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2015;192270;1.44
8110;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2016;143380;1.07
8111;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2017;153100;1.14
8112;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2018;150575;1.13
8113;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2019;144985;1.09
8114;Total male and female;10000;Dutch background;G01A Antiinfectives/antisept.exc.cortico;2020;134485;1.01
8115;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2006;0;0.0
8116;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2007;0;0.0
8117;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2008;0;0.0
8118;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2009;0;0.0
8119;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2010;0;0.0
8120;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2011;0;0.0
8121;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2012;0;0.0
8122;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2013;0;0.0
8123;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2014;0;0.0
8124;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2015;0;0.0
8125;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2016;0;0.0
8126;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2017;0;0.0
8127;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2018;0;0.0
8128;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2019;0;0.0
8129;Total male and female;10000;Dutch background;G01B Antiinfectives/antisept.inc.cortico;2020;0;0.0
8130;Total male and female;10000;Dutch background;G02 Other gynecologicals;2006;61735;0.46
8131;Total male and female;10000;Dutch background;G02 Other gynecologicals;2007;24775;0.19
8132;Total male and female;10000;Dutch background;G02 Other gynecologicals;2008;115325;0.86
8133;Total male and female;10000;Dutch background;G02 Other gynecologicals;2009;121395;0.91
8134;Total male and female;10000;Dutch background;G02 Other gynecologicals;2010;132140;0.99
8135;Total male and female;10000;Dutch background;G02 Other gynecologicals;2011;35685;0.27
8136;Total male and female;10000;Dutch background;G02 Other gynecologicals;2012;31190;0.23
8137;Total male and female;10000;Dutch background;G02 Other gynecologicals;2013;16400;0.12
8138;Total male and female;10000;Dutch background;G02 Other gynecologicals;2014;14470;0.11
8139;Total male and female;10000;Dutch background;G02 Other gynecologicals;2015;14810;0.11
8140;Total male and female;10000;Dutch background;G02 Other gynecologicals;2016;15200;0.11
8141;Total male and female;10000;Dutch background;G02 Other gynecologicals;2017;16030;0.12
8142;Total male and female;10000;Dutch background;G02 Other gynecologicals;2018;17420;0.13
8143;Total male and female;10000;Dutch background;G02 Other gynecologicals;2019;17870;0.13
8144;Total male and female;10000;Dutch background;G02 Other gynecologicals;2020;18650;0.14
8145;Total male and female;10000;Dutch background;G02A Oxytocics;2006;1075;0.01
8146;Total male and female;10000;Dutch background;G02A Oxytocics;2007;210;0.0
8147;Total male and female;10000;Dutch background;G02A Oxytocics;2008;60;0.0
8148;Total male and female;10000;Dutch background;G02A Oxytocics;2009;30;0.0
8149;Total male and female;10000;Dutch background;G02A Oxytocics;2010;15;0.0
8150;Total male and female;10000;Dutch background;G02A Oxytocics;2011;15;0.0
8151;Total male and female;10000;Dutch background;G02A Oxytocics;2012;5;0.0
8152;Total male and female;10000;Dutch background;G02A Oxytocics;2013;10;0.0
8153;Total male and female;10000;Dutch background;G02A Oxytocics;2014;20;0.0
8154;Total male and female;10000;Dutch background;G02A Oxytocics;2015;30;0.0
8155;Total male and female;10000;Dutch background;G02A Oxytocics;2016;35;0.0
8156;Total male and female;10000;Dutch background;G02A Oxytocics;2017;45;0.0
8157;Total male and female;10000;Dutch background;G02A Oxytocics;2018;35;0.0
8158;Total male and female;10000;Dutch background;G02A Oxytocics;2019;45;0.0
8159;Total male and female;10000;Dutch background;G02A Oxytocics;2020;60;0.0
8160;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2006;52815;0.4
8161;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2007;16455;0.12
8162;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2008;108045;0.81
8163;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2009;114355;0.86
8164;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2010;125080;0.93
8165;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2011;28485;0.21
8166;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2012;24570;0.18
8167;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2013;10175;0.08
8168;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2014;8455;0.06
8169;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2015;9045;0.07
8170;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2016;9585;0.07
8171;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2017;10545;0.08
8172;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2018;12010;0.09
8173;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2019;12460;0.09
8174;Total male and female;10000;Dutch background;G02B Contraceptives for topical use;2020;13445;0.1
8175;Total male and female;10000;Dutch background;G02C Other gynecologicals;2006;8270;0.06
8176;Total male and female;10000;Dutch background;G02C Other gynecologicals;2007;8185;0.06
8177;Total male and female;10000;Dutch background;G02C Other gynecologicals;2008;7830;0.06
8178;Total male and female;10000;Dutch background;G02C Other gynecologicals;2009;7605;0.06
8179;Total male and female;10000;Dutch background;G02C Other gynecologicals;2010;7680;0.06
8180;Total male and female;10000;Dutch background;G02C Other gynecologicals;2011;7285;0.05
8181;Total male and female;10000;Dutch background;G02C Other gynecologicals;2012;6700;0.05
8182;Total male and female;10000;Dutch background;G02C Other gynecologicals;2013;6225;0.05
8183;Total male and female;10000;Dutch background;G02C Other gynecologicals;2014;6000;0.04
8184;Total male and female;10000;Dutch background;G02C Other gynecologicals;2015;5740;0.04
8185;Total male and female;10000;Dutch background;G02C Other gynecologicals;2016;5585;0.04
8186;Total male and female;10000;Dutch background;G02C Other gynecologicals;2017;5440;0.04
8187;Total male and female;10000;Dutch background;G02C Other gynecologicals;2018;5380;0.04
8188;Total male and female;10000;Dutch background;G02C Other gynecologicals;2019;5370;0.04
8189;Total male and female;10000;Dutch background;G02C Other gynecologicals;2020;5150;0.04
8190;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2006;1211655;9.07
8191;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2007;756270;5.66
8192;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2008;1654940;12.39
8193;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2009;1645920;12.31
8194;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2010;1631465;12.19
8195;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2011;812120;6.06
8196;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2012;785770;5.87
8197;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2013;617915;4.61
8198;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2014;547840;4.09
8199;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2015;528490;3.95
8200;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2016;521825;3.9
8201;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2017;521370;3.9
8202;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2018;527250;3.95
8203;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2019;533585;4.0
8204;Total male and female;10000;Dutch background;G03 Sex hormones, modulators genit.syst.;2020;493190;3.7
8205;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2006;829875;6.21
8206;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2007;362050;2.71
8207;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2008;1307245;9.78
8208;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2009;1311190;9.81
8209;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2010;1306560;9.76
8210;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2011;465625;3.48
8211;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2012;449500;3.36
8212;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2013;330140;2.46
8213;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2014;327555;2.45
8214;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2015;323530;2.42
8215;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2016;316690;2.37
8216;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2017;314345;2.35
8217;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2018;313580;2.35
8218;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2019;315395;2.36
8219;Total male and female;10000;Dutch background;G03A Hormonal contraceptives system. use;2020;296585;2.22
8220;Total male and female;10000;Dutch background;G03B Androgens;2006;7515;0.06
8221;Total male and female;10000;Dutch background;G03B Androgens;2007;8045;0.06
8222;Total male and female;10000;Dutch background;G03B Androgens;2008;8615;0.06
8223;Total male and female;10000;Dutch background;G03B Androgens;2009;9145;0.07
8224;Total male and female;10000;Dutch background;G03B Androgens;2010;9595;0.07
8225;Total male and female;10000;Dutch background;G03B Androgens;2011;10270;0.08
8226;Total male and female;10000;Dutch background;G03B Androgens;2012;11065;0.08
8227;Total male and female;10000;Dutch background;G03B Androgens;2013;11860;0.09
8228;Total male and female;10000;Dutch background;G03B Androgens;2014;12185;0.09
8229;Total male and female;10000;Dutch background;G03B Androgens;2015;12730;0.1
8230;Total male and female;10000;Dutch background;G03B Androgens;2016;13505;0.1
8231;Total male and female;10000;Dutch background;G03B Androgens;2017;14495;0.11
8232;Total male and female;10000;Dutch background;G03B Androgens;2018;15410;0.12
8233;Total male and female;10000;Dutch background;G03B Androgens;2019;16385;0.12
8234;Total male and female;10000;Dutch background;G03B Androgens;2020;17065;0.13
8235;Total male and female;10000;Dutch background;G03C Estrogens;2006;139510;1.04
8236;Total male and female;10000;Dutch background;G03C Estrogens;2007;134690;1.01
8237;Total male and female;10000;Dutch background;G03C Estrogens;2008;128240;0.96
8238;Total male and female;10000;Dutch background;G03C Estrogens;2009;123670;0.93
8239;Total male and female;10000;Dutch background;G03C Estrogens;2010;120990;0.9
8240;Total male and female;10000;Dutch background;G03C Estrogens;2011;120195;0.9
8241;Total male and female;10000;Dutch background;G03C Estrogens;2012;116950;0.87
8242;Total male and female;10000;Dutch background;G03C Estrogens;2013;111320;0.83
8243;Total male and female;10000;Dutch background;G03C Estrogens;2014;108645;0.81
8244;Total male and female;10000;Dutch background;G03C Estrogens;2015;103805;0.78
8245;Total male and female;10000;Dutch background;G03C Estrogens;2016;103535;0.77
8246;Total male and female;10000;Dutch background;G03C Estrogens;2017;103805;0.78
8247;Total male and female;10000;Dutch background;G03C Estrogens;2018;106335;0.8
8248;Total male and female;10000;Dutch background;G03C Estrogens;2019;109465;0.82
8249;Total male and female;10000;Dutch background;G03C Estrogens;2020;106185;0.8
8250;Total male and female;10000;Dutch background;G03D Progestogens;2006;92495;0.69
8251;Total male and female;10000;Dutch background;G03D Progestogens;2007;93700;0.7
8252;Total male and female;10000;Dutch background;G03D Progestogens;2008;90840;0.68
8253;Total male and female;10000;Dutch background;G03D Progestogens;2009;87895;0.66
8254;Total male and female;10000;Dutch background;G03D Progestogens;2010;86115;0.64
8255;Total male and female;10000;Dutch background;G03D Progestogens;2011;85045;0.63
8256;Total male and female;10000;Dutch background;G03D Progestogens;2012;82970;0.62
8257;Total male and female;10000;Dutch background;G03D Progestogens;2013;79875;0.6
8258;Total male and female;10000;Dutch background;G03D Progestogens;2014;78730;0.59
8259;Total male and female;10000;Dutch background;G03D Progestogens;2015;77335;0.58
8260;Total male and female;10000;Dutch background;G03D Progestogens;2016;76390;0.57
8261;Total male and female;10000;Dutch background;G03D Progestogens;2017;75980;0.57
8262;Total male and female;10000;Dutch background;G03D Progestogens;2018;77860;0.58
8263;Total male and female;10000;Dutch background;G03D Progestogens;2019;77765;0.58
8264;Total male and female;10000;Dutch background;G03D Progestogens;2020;58540;0.44
8265;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2006;0;0.0
8266;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2007;0;0.0
8267;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2008;0;0.0
8268;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2009;0;0.0
8269;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2010;0;0.0
8270;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2011;0;0.0
8271;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2012;0;0.0
8272;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2013;0;0.0
8273;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2014;0;0.0
8274;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2015;0;0.0
8275;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2016;0;0.0
8276;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2017;0;0.0
8277;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2018;0;0.0
8278;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2019;0;0.0
8279;Total male and female;10000;Dutch background;G03E Androgens / female sex hormon.comb.;2020;0;0.0
8280;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2006;22645;0.17
8281;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2007;20615;0.15
8282;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2008;19570;0.15
8283;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2009;18995;0.14
8284;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2010;18175;0.14
8285;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2011;17980;0.13
8286;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2012;17270;0.13
8287;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2013;17475;0.13
8288;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2014;17985;0.13
8289;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2015;17380;0.13
8290;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2016;18035;0.13
8291;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2017;20165;0.15
8292;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2018;24310;0.18
8293;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2019;27065;0.2
8294;Total male and female;10000;Dutch background;G03F Progestogens / estrogens combinat.;2020;27740;0.21
8295;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2006;12105;0.09
8296;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2007;17780;0.13
8297;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2008;21315;0.16
8298;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2009;22885;0.17
8299;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2010;23360;0.17
8300;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2011;23580;0.18
8301;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2012;23530;0.18
8302;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2013;22940;0.17
8303;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2014;20;0.0
8304;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2015;5;0.0
8305;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2016;5;0.0
8306;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2017;10;0.0
8307;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2018;5;0.0
8308;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2019;5;0.0
8309;Total male and female;10000;Dutch background;G03G Gonadotropins/oth.ovulation stimul.;2020;5;0.0
8310;Total male and female;10000;Dutch background;G03H Antiandrogens;2006;154950;1.16
8311;Total male and female;10000;Dutch background;G03H Antiandrogens;2007;151900;1.14
8312;Total male and female;10000;Dutch background;G03H Antiandrogens;2008;146855;1.1
8313;Total male and female;10000;Dutch background;G03H Antiandrogens;2009;139890;1.05
8314;Total male and female;10000;Dutch background;G03H Antiandrogens;2010;133890;1.0
8315;Total male and female;10000;Dutch background;G03H Antiandrogens;2011;127790;0.95
8316;Total male and female;10000;Dutch background;G03H Antiandrogens;2012;122720;0.92
8317;Total male and female;10000;Dutch background;G03H Antiandrogens;2013;81200;0.61
8318;Total male and female;10000;Dutch background;G03H Antiandrogens;2014;13980;0.1
8319;Total male and female;10000;Dutch background;G03H Antiandrogens;2015;4115;0.03
8320;Total male and female;10000;Dutch background;G03H Antiandrogens;2016;4025;0.03
8321;Total male and female;10000;Dutch background;G03H Antiandrogens;2017;3995;0.03
8322;Total male and female;10000;Dutch background;G03H Antiandrogens;2018;3980;0.03
8323;Total male and female;10000;Dutch background;G03H Antiandrogens;2019;3965;0.03
8324;Total male and female;10000;Dutch background;G03H Antiandrogens;2020;3730;0.03
8325;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2006;3955;0.03
8326;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2007;3460;0.03
8327;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2008;3065;0.02
8328;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2009;2695;0.02
8329;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2010;2405;0.02
8330;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2011;2065;0.02
8331;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2012;1805;0.01
8332;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2013;1565;0.01
8333;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2014;1915;0.01
8334;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2015;2135;0.02
8335;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2016;2475;0.02
8336;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2017;2720;0.02
8337;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2018;1400;0.01
8338;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2019;1105;0.01
8339;Total male and female;10000;Dutch background;G03X Oth.sex horm./modulat.genital syst.;2020;780;0.01
8340;Total male and female;10000;Dutch background;G04 Urologicals;2006;253515;1.9
8341;Total male and female;10000;Dutch background;G04 Urologicals;2007;275610;2.06
8342;Total male and female;10000;Dutch background;G04 Urologicals;2008;290260;2.17
8343;Total male and female;10000;Dutch background;G04 Urologicals;2009;298600;2.23
8344;Total male and female;10000;Dutch background;G04 Urologicals;2010;316415;2.36
8345;Total male and female;10000;Dutch background;G04 Urologicals;2011;335160;2.5
8346;Total male and female;10000;Dutch background;G04 Urologicals;2012;344775;2.57
8347;Total male and female;10000;Dutch background;G04 Urologicals;2013;349880;2.61
8348;Total male and female;10000;Dutch background;G04 Urologicals;2014;358700;2.68
8349;Total male and female;10000;Dutch background;G04 Urologicals;2015;363610;2.72
8350;Total male and female;10000;Dutch background;G04 Urologicals;2016;365880;2.73
8351;Total male and female;10000;Dutch background;G04 Urologicals;2017;368005;2.75
8352;Total male and female;10000;Dutch background;G04 Urologicals;2018;372580;2.79
8353;Total male and female;10000;Dutch background;G04 Urologicals;2019;379795;2.85
8354;Total male and female;10000;Dutch background;G04 Urologicals;2020;377265;2.83
8355;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2006;84270;0.63
8356;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2007;90710;0.68
8357;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2008;93050;0.7
8358;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2009;91830;0.69
8359;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2010;99160;0.74
8360;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2011;106530;0.8
8361;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2012;108230;0.81
8362;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2013;107915;0.81
8363;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2014;112335;0.84
8364;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2015;114305;0.85
8365;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2016;115960;0.87
8366;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2017;120075;0.9
8367;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2018;121910;0.91
8368;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2019;125465;0.94
8369;Total male and female;10000;Dutch background;G04B Oth.urologicals, inc.antispasmodics;2020;122170;0.92
8370;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2006;181125;1.36
8371;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2007;199175;1.49
8372;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2008;212630;1.59
8373;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2009;222980;1.67
8374;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2010;235510;1.76
8375;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2011;248640;1.86
8376;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2012;257225;1.92
8377;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2013;263210;1.97
8378;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2014;268440;2.0
8379;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2015;272330;2.03
8380;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2016;273245;2.04
8381;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2017;272385;2.04
8382;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2018;275515;2.06
8383;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2019;280505;2.1
8384;Total male and female;10000;Dutch background;G04C Benign prostatic hypertrophy drugs;2020;280675;2.1
8385;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2006;792765;5.94
8386;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2007;829780;6.21
8387;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2008;856220;6.41
8388;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2009;890295;6.66
8389;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2010;917010;6.85
8390;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2011;949040;7.09
8391;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2012;973380;7.27
8392;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2013;996470;7.44
8393;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2014;1020040;7.62
8394;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2015;1063315;7.94
8395;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2016;1075805;8.04
8396;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2017;1088665;8.14
8397;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2018;1110525;8.31
8398;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2019;1126590;8.44
8399;Total male and female;10000;Dutch background;H Systemic hormonal prep,ex.sex hormones;2020;1032315;7.74
8400;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2006;30510;0.23
8401;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2007;32180;0.24
8402;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2008;31380;0.23
8403;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2009;31630;0.24
8404;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2010;31390;0.23
8405;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2011;31655;0.24
8406;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2012;30725;0.23
8407;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2013;25940;0.19
8408;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2014;21965;0.16
8409;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2015;22045;0.16
8410;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2016;21945;0.16
8411;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2017;21620;0.16
8412;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2018;21000;0.16
8413;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2019;20755;0.16
8414;Total male and female;10000;Dutch background;H01 Pituitary, hypothalamic hormones.;2020;17940;0.13
8415;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2006;3465;0.03
8416;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2007;3685;0.03
8417;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2008;3895;0.03
8418;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2009;4190;0.03
8419;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2010;4405;0.03
8420;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2011;4590;0.03
8421;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2012;4650;0.03
8422;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2013;315;0.0
8423;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2014;285;0.0
8424;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2015;310;0.0
8425;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2016;305;0.0
8426;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2017;290;0.0
8427;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2018;300;0.0
8428;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2019;300;0.0
8429;Total male and female;10000;Dutch background;H01A Anterior pituitary lobe hormones.;2020;310;0.0
8430;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2006;24830;0.19
8431;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2007;25725;0.19
8432;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2008;24290;0.18
8433;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2009;23995;0.18
8434;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2010;23125;0.17
8435;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2011;22980;0.17
8436;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2012;21845;0.16
8437;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2013;20855;0.16
8438;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2014;19065;0.14
8439;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2015;19090;0.14
8440;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2016;18805;0.14
8441;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2017;18405;0.14
8442;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2018;17660;0.13
8443;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2019;17340;0.13
8444;Total male and female;10000;Dutch background;H01B Posterior pituitary lobe hormones;2020;14505;0.11
8445;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2006;2740;0.02
8446;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2007;3360;0.03
8447;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2008;3850;0.03
8448;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2009;4140;0.03
8449;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2010;4570;0.03
8450;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2011;4845;0.04
8451;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2012;5005;0.04
8452;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2013;5010;0.04
8453;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2014;2845;0.02
8454;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2015;2890;0.02
8455;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2016;3075;0.02
8456;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2017;3155;0.02
8457;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2018;3260;0.02
8458;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2019;3355;0.03
8459;Total male and female;10000;Dutch background;H01C Hypothalamic hormones;2020;3365;0.03
8460;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2006;510025;3.82
8461;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2007;532295;3.99
8462;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2008;548650;4.11
8463;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2009;570880;4.27
8464;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2010;586920;4.38
8465;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2011;605415;4.52
8466;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2012;617555;4.61
8467;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2013;634485;4.74
8468;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2014;655255;4.89
8469;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2015;692230;5.17
8470;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2016;696450;5.2
8471;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2017;704545;5.27
8472;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2018;721855;5.4
8473;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2019;731620;5.48
8474;Total male and female;10000;Dutch background;H02 Corticosteroids for systemic use;2020;634325;4.76
8475;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2006;493715;3.7
8476;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2007;515810;3.86
8477;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2008;533520;3.99
8478;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2009;556740;4.16
8479;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2010;571645;4.27
8480;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2011;590195;4.41
8481;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2012;603245;4.5
8482;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2013;620770;4.63
8483;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2014;641810;4.79
8484;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2015;679700;5.08
8485;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2016;685540;5.12
8486;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2017;695010;5.2
8487;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2018;713180;5.34
8488;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2019;723560;5.42
8489;Total male and female;10000;Dutch background;H02A Corticosteroids system.use, plain;2020;627525;4.71
8490;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2006;18950;0.14
8491;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2007;19200;0.14
8492;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2008;18200;0.14
8493;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2009;16910;0.13
8494;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2010;18095;0.14
8495;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2011;18180;0.14
8496;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2012;17245;0.13
8497;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2013;16645;0.12
8498;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2014;16380;0.12
8499;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2015;15465;0.12
8500;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2016;13700;0.1
8501;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2017;12065;0.09
8502;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2018;11100;0.08
8503;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2019;10395;0.08
8504;Total male and female;10000;Dutch background;H02B Corticosteroids system.use, combi.;2020;8560;0.06
8505;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2006;0;0.0
8506;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2007;0;0.0
8507;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2008;0;0.0
8508;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2009;0;0.0
8509;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2010;0;0.0
8510;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2011;0;0.0
8511;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2012;0;0.0
8512;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2013;0;0.0
8513;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2014;0;0.0
8514;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2015;0;0.0
8515;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2016;0;0.0
8516;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2017;0;0.0
8517;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2018;0;0.0
8518;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2019;0;0.0
8519;Total male and female;10000;Dutch background;H02C Antiadrenal preparations;2020;0;0.0
8520;Total male and female;10000;Dutch background;H03 Thyroid therapy;2006;269710;2.02
8521;Total male and female;10000;Dutch background;H03 Thyroid therapy;2007;284390;2.13
8522;Total male and female;10000;Dutch background;H03 Thyroid therapy;2008;297165;2.22
8523;Total male and female;10000;Dutch background;H03 Thyroid therapy;2009;310635;2.32
8524;Total male and female;10000;Dutch background;H03 Thyroid therapy;2010;324270;2.42
8525;Total male and female;10000;Dutch background;H03 Thyroid therapy;2011;339950;2.54
8526;Total male and female;10000;Dutch background;H03 Thyroid therapy;2012;354905;2.65
8527;Total male and female;10000;Dutch background;H03 Thyroid therapy;2013;367700;2.75
8528;Total male and female;10000;Dutch background;H03 Thyroid therapy;2014;376980;2.81
8529;Total male and female;10000;Dutch background;H03 Thyroid therapy;2015;385995;2.88
8530;Total male and female;10000;Dutch background;H03 Thyroid therapy;2016;395795;2.96
8531;Total male and female;10000;Dutch background;H03 Thyroid therapy;2017;403800;3.02
8532;Total male and female;10000;Dutch background;H03 Thyroid therapy;2018;410235;3.07
8533;Total male and female;10000;Dutch background;H03 Thyroid therapy;2019;416180;3.12
8534;Total male and female;10000;Dutch background;H03 Thyroid therapy;2020;418560;3.14
8535;Total male and female;10000;Dutch background;H03A Thyroid preparations;2006;257840;1.93
8536;Total male and female;10000;Dutch background;H03A Thyroid preparations;2007;273160;2.05
8537;Total male and female;10000;Dutch background;H03A Thyroid preparations;2008;286250;2.14
8538;Total male and female;10000;Dutch background;H03A Thyroid preparations;2009;300080;2.24
8539;Total male and female;10000;Dutch background;H03A Thyroid preparations;2010;314240;2.35
8540;Total male and female;10000;Dutch background;H03A Thyroid preparations;2011;330355;2.47
8541;Total male and female;10000;Dutch background;H03A Thyroid preparations;2012;345435;2.58
8542;Total male and female;10000;Dutch background;H03A Thyroid preparations;2013;358530;2.68
8543;Total male and female;10000;Dutch background;H03A Thyroid preparations;2014;368085;2.75
8544;Total male and female;10000;Dutch background;H03A Thyroid preparations;2015;377595;2.82
8545;Total male and female;10000;Dutch background;H03A Thyroid preparations;2016;387535;2.9
8546;Total male and female;10000;Dutch background;H03A Thyroid preparations;2017;395245;2.96
8547;Total male and female;10000;Dutch background;H03A Thyroid preparations;2018;401260;3.0
8548;Total male and female;10000;Dutch background;H03A Thyroid preparations;2019;407085;3.05
8549;Total male and female;10000;Dutch background;H03A Thyroid preparations;2020;409150;3.07
8550;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2006;24265;0.18
8551;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2007;23415;0.18
8552;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2008;22655;0.17
8553;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2009;21830;0.16
8554;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2010;20900;0.16
8555;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2011;19970;0.15
8556;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2012;19685;0.15
8557;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2013;19005;0.14
8558;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2014;18110;0.14
8559;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2015;17470;0.13
8560;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2016;17240;0.13
8561;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2017;17405;0.13
8562;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2018;17500;0.13
8563;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2019;17205;0.13
8564;Total male and female;10000;Dutch background;H03B Antithyroid preparations;2020;17080;0.13
8565;Total male and female;10000;Dutch background;H03C Iodine therapy;2006;145;0.0
8566;Total male and female;10000;Dutch background;H03C Iodine therapy;2007;125;0.0
8567;Total male and female;10000;Dutch background;H03C Iodine therapy;2008;90;0.0
8568;Total male and female;10000;Dutch background;H03C Iodine therapy;2009;105;0.0
8569;Total male and female;10000;Dutch background;H03C Iodine therapy;2010;150;0.0
8570;Total male and female;10000;Dutch background;H03C Iodine therapy;2011;140;0.0
8571;Total male and female;10000;Dutch background;H03C Iodine therapy;2012;120;0.0
8572;Total male and female;10000;Dutch background;H03C Iodine therapy;2013;165;0.0
8573;Total male and female;10000;Dutch background;H03C Iodine therapy;2014;195;0.0
8574;Total male and female;10000;Dutch background;H03C Iodine therapy;2015;45;0.0
8575;Total male and female;10000;Dutch background;H03C Iodine therapy;2016;0;0.0
8576;Total male and female;10000;Dutch background;H03C Iodine therapy;2017;0;0.0
8577;Total male and female;10000;Dutch background;H03C Iodine therapy;2018;0;0.0
8578;Total male and female;10000;Dutch background;H03C Iodine therapy;2019;0;0.0
8579;Total male and female;10000;Dutch background;H03C Iodine therapy;2020;0;0.0
8580;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2006;16095;0.12
8581;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2007;17070;0.13
8582;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2008;17310;0.13
8583;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2009;17655;0.13
8584;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2010;17470;0.13
8585;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2011;17590;0.13
8586;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2012;18335;0.14
8587;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2013;17235;0.13
8588;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2014;16905;0.13
8589;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2015;17495;0.13
8590;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2016;17665;0.13
8591;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2017;16220;0.12
8592;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2018;17095;0.13
8593;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2019;19150;0.14
8594;Total male and female;10000;Dutch background;H04 Pancreatic hormones;2020;15375;0.12
8595;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2006;16095;0.12
8596;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2007;17070;0.13
8597;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2008;17310;0.13
8598;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2009;17655;0.13
8599;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2010;17470;0.13
8600;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2011;17590;0.13
8601;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2012;18335;0.14
8602;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2013;17235;0.13
8603;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2014;16905;0.13
8604;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2015;17495;0.13
8605;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2016;17665;0.13
8606;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2017;16220;0.12
8607;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2018;17095;0.13
8608;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2019;19150;0.14
8609;Total male and female;10000;Dutch background;H04A Glycogenolytic hormones;2020;15375;0.12
8610;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2006;1680;0.01
8611;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2007;2165;0.02
8612;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2008;2745;0.02
8613;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2009;3300;0.02
8614;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2010;3740;0.03
8615;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2011;4220;0.03
8616;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2012;4510;0.03
8617;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2013;4685;0.03
8618;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2014;4810;0.04
8619;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2015;5070;0.04
8620;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2016;5340;0.04
8621;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2017;5545;0.04
8622;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2018;5925;0.04
8623;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2019;6420;0.05
8624;Total male and female;10000;Dutch background;H05 Calcium homeostasis;2020;6615;0.05
8625;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2006;725;0.01
8626;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2007;885;0.01
8627;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2008;1145;0.01
8628;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2009;1265;0.01
8629;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2010;1370;0.01
8630;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2011;1440;0.01
8631;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2012;1365;0.01
8632;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2013;1325;0.01
8633;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2014;1320;0.01
8634;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2015;1325;0.01
8635;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2016;1310;0.01
8636;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2017;1410;0.01
8637;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2018;1670;0.01
8638;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2019;2015;0.02
8639;Total male and female;10000;Dutch background;H05A Parathyroid hormones and analogues;2020;2130;0.02
8640;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2006;960;0.01
8641;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2007;1280;0.01
8642;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2008;1600;0.01
8643;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2009;2040;0.02
8644;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2010;2375;0.02
8645;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2011;2785;0.02
8646;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2012;3150;0.02
8647;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2013;3360;0.03
8648;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2014;3495;0.03
8649;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2015;3745;0.03
8650;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2016;4035;0.03
8651;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2017;4135;0.03
8652;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2018;4255;0.03
8653;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2019;4405;0.03
8654;Total male and female;10000;Dutch background;H05B Anti-parathyroid agents;2020;4480;0.03
8655;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2006;3297970;24.69
8656;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2007;3393495;25.41
8657;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2008;3396155;25.42
8658;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2009;3406790;25.48
8659;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2010;3332640;24.9
8660;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2011;3343810;24.96
8661;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2012;3259400;24.33
8662;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2013;3140395;23.45
8663;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2014;3031335;22.63
8664;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2015;3079380;23.0
8665;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2016;2999075;22.41
8666;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2017;2901565;21.7
8667;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2018;2917560;21.84
8668;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2019;2827200;21.18
8669;Total male and female;10000;Dutch background;J General antiinfectives for system.use;2020;2416000;18.12
8670;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2006;3097830;23.19
8671;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2007;3194155;23.92
8672;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2008;3201430;23.96
8673;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2009;3215825;24.05
8674;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2010;3146175;23.51
8675;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2011;3156880;23.57
8676;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2012;3074105;22.95
8677;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2013;2961030;22.11
8678;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2014;2847270;21.26
8679;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2015;2899775;21.66
8680;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2016;2809480;20.99
8681;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2017;2713385;20.29
8682;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2018;2722325;20.38
8683;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2019;2630600;19.71
8684;Total male and female;10000;Dutch background;J01 Antibacterials for systemic use;2020;2223970;16.68
8685;Total male and female;10000;Dutch background;J01A Tetracyclines;2006;750815;5.62
8686;Total male and female;10000;Dutch background;J01A Tetracyclines;2007;825570;6.18
8687;Total male and female;10000;Dutch background;J01A Tetracyclines;2008;841925;6.3
8688;Total male and female;10000;Dutch background;J01A Tetracyclines;2009;837945;6.27
8689;Total male and female;10000;Dutch background;J01A Tetracyclines;2010;812615;6.07
8690;Total male and female;10000;Dutch background;J01A Tetracyclines;2011;764160;5.71
8691;Total male and female;10000;Dutch background;J01A Tetracyclines;2012;710875;5.31
8692;Total male and female;10000;Dutch background;J01A Tetracyclines;2013;641915;4.79
8693;Total male and female;10000;Dutch background;J01A Tetracyclines;2014;577820;4.31
8694;Total male and female;10000;Dutch background;J01A Tetracyclines;2015;593175;4.43
8695;Total male and female;10000;Dutch background;J01A Tetracyclines;2016;527200;3.94
8696;Total male and female;10000;Dutch background;J01A Tetracyclines;2017;493375;3.69
8697;Total male and female;10000;Dutch background;J01A Tetracyclines;2018;473105;3.54
8698;Total male and female;10000;Dutch background;J01A Tetracyclines;2019;427770;3.21
8699;Total male and female;10000;Dutch background;J01A Tetracyclines;2020;299130;2.24
8700;Total male and female;10000;Dutch background;J01B Amphenicols;2006;125;0.0
8701;Total male and female;10000;Dutch background;J01B Amphenicols;2007;5;0.0
8702;Total male and female;10000;Dutch background;J01B Amphenicols;2008;10;0.0
8703;Total male and female;10000;Dutch background;J01B Amphenicols;2009;5;0.0
8704;Total male and female;10000;Dutch background;J01B Amphenicols;2010;5;0.0
8705;Total male and female;10000;Dutch background;J01B Amphenicols;2011;5;0.0
8706;Total male and female;10000;Dutch background;J01B Amphenicols;2012;35;0.0
8707;Total male and female;10000;Dutch background;J01B Amphenicols;2013;70;0.0
8708;Total male and female;10000;Dutch background;J01B Amphenicols;2014;30;0.0
8709;Total male and female;10000;Dutch background;J01B Amphenicols;2015;0;0.0
8710;Total male and female;10000;Dutch background;J01B Amphenicols;2016;20;0.0
8711;Total male and female;10000;Dutch background;J01B Amphenicols;2017;5;0.0
8712;Total male and female;10000;Dutch background;J01B Amphenicols;2018;0;0.0
8713;Total male and female;10000;Dutch background;J01B Amphenicols;2019;0;0.0
8714;Total male and female;10000;Dutch background;J01B Amphenicols;2020;0;0.0
8715;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2006;1649175;12.35
8716;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2007;1687695;12.64
8717;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2008;1691190;12.66
8718;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2009;1713175;12.81
8719;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2010;1671530;12.49
8720;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2011;1710170;12.77
8721;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2012;1677610;12.52
8722;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2013;1633475;12.2
8723;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2014;1556950;11.62
8724;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2015;1606250;12.0
8725;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2016;1570340;11.73
8726;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2017;1501550;11.23
8727;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2018;1505040;11.27
8728;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2019;1474245;11.05
8729;Total male and female;10000;Dutch background;J01C Beta-lactam antibact., penicillins;2020;1207070;9.05
8730;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2006;12665;0.09
8731;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2007;11890;0.09
8732;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2008;10975;0.08
8733;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2009;10790;0.08
8734;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2010;10735;0.08
8735;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2011;11560;0.09
8736;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2012;10635;0.08
8737;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2013;10405;0.08
8738;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2014;10170;0.08
8739;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2015;10715;0.08
8740;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2016;9980;0.07
8741;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2017;9910;0.07
8742;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2018;9725;0.07
8743;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2019;10740;0.08
8744;Total male and female;10000;Dutch background;J01D Other beta-lactam antibacterials;2020;9760;0.07
8745;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2006;289590;2.17
8746;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2007;267985;2.01
8747;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2008;253750;1.9
8748;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2009;240440;1.8
8749;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2010;232925;1.74
8750;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2011;222700;1.66
8751;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2012;206655;1.54
8752;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2013;179150;1.34
8753;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2014;150500;1.12
8754;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2015;141930;1.06
8755;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2016;137150;1.02
8756;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2017;131245;0.98
8757;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2018;130665;0.98
8758;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2019;134220;1.01
8759;Total male and female;10000;Dutch background;J01E Sulfonamides and trimethoprim;2020;126010;0.94
8760;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2006;587730;4.4
8761;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2007;592690;4.44
8762;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2008;568215;4.25
8763;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2009;553000;4.14
8764;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2010;529230;3.95
8765;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2011;537950;4.02
8766;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2012;524625;3.92
8767;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2013;469670;3.51
8768;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2014;436200;3.26
8769;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2015;439210;3.28
8770;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2016;409745;3.06
8771;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2017;390810;2.92
8772;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2018;402605;3.01
8773;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2019;381205;2.86
8774;Total male and female;10000;Dutch background;J01F Macrolides,lincosamides,streptogr.;2020;292015;2.19
8775;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2006;1075;0.01
8776;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2007;945;0.01
8777;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2008;985;0.01
8778;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2009;920;0.01
8779;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2010;985;0.01
8780;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2011;1185;0.01
8781;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2012;1245;0.01
8782;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2013;1215;0.01
8783;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2014;1095;0.01
8784;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2015;1090;0.01
8785;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2016;1020;0.01
8786;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2017;1000;0.01
8787;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2018;940;0.01
8788;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2019;1050;0.01
8789;Total male and female;10000;Dutch background;J01G Aminoglycoside antibacterials;2020;1000;0.01
8790;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2006;327310;2.45
8791;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2007;342665;2.57
8792;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2008;335000;2.51
8793;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2009;333110;2.49
8794;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2010;328775;2.46
8795;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2011;316510;2.36
8796;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2012;302860;2.26
8797;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2013;290765;2.17
8798;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2014;297535;2.22
8799;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2015;292650;2.19
8800;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2016;282855;2.11
8801;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2017;280190;2.1
8802;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2018;277335;2.08
8803;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2019;254295;1.91
8804;Total male and female;10000;Dutch background;J01M Quinolone antibacterials;2020;232185;1.74
8805;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2006;0;0.0
8806;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2007;0;0.0
8807;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2008;0;0.0
8808;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2009;0;0.0
8809;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2010;0;0.0
8810;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2011;0;0.0
8811;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2012;0;0.0
8812;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2013;0;0.0
8813;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2014;0;0.0
8814;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2015;0;0.0
8815;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2016;0;0.0
8816;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2017;0;0.0
8817;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2018;0;0.0
8818;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2019;0;0.0
8819;Total male and female;10000;Dutch background;J01R Combinations of antibacterials;2020;0;0.0
8820;Total male and female;10000;Dutch background;J01X Other antibacterials;2006;398660;2.98
8821;Total male and female;10000;Dutch background;J01X Other antibacterials;2007;437345;3.27
8822;Total male and female;10000;Dutch background;J01X Other antibacterials;2008;471690;3.53
8823;Total male and female;10000;Dutch background;J01X Other antibacterials;2009;499155;3.73
8824;Total male and female;10000;Dutch background;J01X Other antibacterials;2010;519265;3.88
8825;Total male and female;10000;Dutch background;J01X Other antibacterials;2011;551475;4.12
8826;Total male and female;10000;Dutch background;J01X Other antibacterials;2012;574695;4.29
8827;Total male and female;10000;Dutch background;J01X Other antibacterials;2013;592470;4.42
8828;Total male and female;10000;Dutch background;J01X Other antibacterials;2014;621835;4.64
8829;Total male and female;10000;Dutch background;J01X Other antibacterials;2015;633540;4.73
8830;Total male and female;10000;Dutch background;J01X Other antibacterials;2016;638845;4.77
8831;Total male and female;10000;Dutch background;J01X Other antibacterials;2017;648715;4.85
8832;Total male and female;10000;Dutch background;J01X Other antibacterials;2018;661000;4.95
8833;Total male and female;10000;Dutch background;J01X Other antibacterials;2019;649180;4.86
8834;Total male and female;10000;Dutch background;J01X Other antibacterials;2020;626140;4.69
8835;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2006;181855;1.36
8836;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2007;182170;1.36
8837;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2008;178815;1.34
8838;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2009;177805;1.33
8839;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2010;173825;1.3
8840;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2011;173285;1.29
8841;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2012;170155;1.27
8842;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2013;156630;1.17
8843;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2014;151510;1.13
8844;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2015;140095;1.05
8845;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2016;142295;1.06
8846;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2017;131950;0.99
8847;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2018;130175;0.97
8848;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2019;123325;0.92
8849;Total male and female;10000;Dutch background;J02 Antimycotics for systemic use;2020;108380;0.81
8850;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2006;181855;1.36
8851;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2007;182170;1.36
8852;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2008;178815;1.34
8853;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2009;177805;1.33
8854;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2010;173825;1.3
8855;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2011;173285;1.29
8856;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2012;170155;1.27
8857;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2013;156630;1.17
8858;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2014;151510;1.13
8859;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2015;140095;1.05
8860;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2016;142295;1.06
8861;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2017;131950;0.99
8862;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2018;130175;0.97
8863;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2019;123325;0.92
8864;Total male and female;10000;Dutch background;J02A Antimycotics for systemic use;2020;108380;0.81
8865;Total male and female;10000;Dutch background;J04 Antimycobacterials;2006;5460;0.04
8866;Total male and female;10000;Dutch background;J04 Antimycobacterials;2007;5455;0.04
8867;Total male and female;10000;Dutch background;J04 Antimycobacterials;2008;5530;0.04
8868;Total male and female;10000;Dutch background;J04 Antimycobacterials;2009;5270;0.04
8869;Total male and female;10000;Dutch background;J04 Antimycobacterials;2010;5160;0.04
8870;Total male and female;10000;Dutch background;J04 Antimycobacterials;2011;5130;0.04
8871;Total male and female;10000;Dutch background;J04 Antimycobacterials;2012;5250;0.04
8872;Total male and female;10000;Dutch background;J04 Antimycobacterials;2013;5165;0.04
8873;Total male and female;10000;Dutch background;J04 Antimycobacterials;2014;5070;0.04
8874;Total male and female;10000;Dutch background;J04 Antimycobacterials;2015;5320;0.04
8875;Total male and female;10000;Dutch background;J04 Antimycobacterials;2016;5425;0.04
8876;Total male and female;10000;Dutch background;J04 Antimycobacterials;2017;5595;0.04
8877;Total male and female;10000;Dutch background;J04 Antimycobacterials;2018;5655;0.04
8878;Total male and female;10000;Dutch background;J04 Antimycobacterials;2019;5500;0.04
8879;Total male and female;10000;Dutch background;J04 Antimycobacterials;2020;4795;0.04
8880;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2006;4350;0.03
8881;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2007;4390;0.03
8882;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2008;4430;0.03
8883;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2009;4195;0.03
8884;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2010;4125;0.03
8885;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2011;4125;0.03
8886;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2012;4240;0.03
8887;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2013;4170;0.03
8888;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2014;4080;0.03
8889;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2015;4345;0.03
8890;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2016;4470;0.03
8891;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2017;4650;0.03
8892;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2018;4675;0.03
8893;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2019;4545;0.03
8894;Total male and female;10000;Dutch background;J04A Drugs for treatment of tuberculosis;2020;3890;0.03
8895;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2006;1115;0.01
8896;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2007;1075;0.01
8897;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2008;1110;0.01
8898;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2009;1090;0.01
8899;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2010;1050;0.01
8900;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2011;1015;0.01
8901;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2012;1015;0.01
8902;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2013;1005;0.01
8903;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2014;995;0.01
8904;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2015;980;0.01
8905;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2016;960;0.01
8906;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2017;945;0.01
8907;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2018;990;0.01
8908;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2019;965;0.01
8909;Total male and female;10000;Dutch background;J04B Drugs for treatment of lepra;2020;915;0.01
8910;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2006;56540;0.42
8911;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2007;60865;0.46
8912;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2008;62065;0.46
8913;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2009;65720;0.49
8914;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2010;68510;0.51
8915;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2011;70440;0.53
8916;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2012;71255;0.53
8917;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2013;70920;0.53
8918;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2014;72475;0.54
8919;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2015;76040;0.57
8920;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2016;77745;0.58
8921;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2017;79445;0.59
8922;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2018;81865;0.61
8923;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2019;83060;0.62
8924;Total male and female;10000;Dutch background;J05 Antivirals for systemic use;2020;79335;0.59
8925;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2006;56540;0.42
8926;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2007;60865;0.46
8927;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2008;62065;0.46
8928;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2009;65720;0.49
8929;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2010;68510;0.51
8930;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2011;70440;0.53
8931;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2012;71255;0.53
8932;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2013;70920;0.53
8933;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2014;72475;0.54
8934;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2015;76040;0.57
8935;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2016;77745;0.58
8936;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2017;79445;0.59
8937;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2018;81865;0.61
8938;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2019;83060;0.62
8939;Total male and female;10000;Dutch background;J05A Direct acting antivirals;2020;79335;0.59
8940;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2006;7250;0.05
8941;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2007;7770;0.06
8942;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2008;5395;0.04
8943;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2009;4815;0.04
8944;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2010;4385;0.03
8945;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2011;4335;0.03
8946;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2012;4440;0.03
8947;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2013;4345;0.03
8948;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2014;4430;0.03
8949;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2015;4395;0.03
8950;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2016;4235;0.03
8951;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2017;4120;0.03
8952;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2018;4220;0.03
8953;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2019;4965;0.04
8954;Total male and female;10000;Dutch background;J06 Immune sera and immunoglobulins;2020;8580;0.06
8955;Total male and female;10000;Dutch background;J06A Immune sera;2006;0;0.0
8956;Total male and female;10000;Dutch background;J06A Immune sera;2007;0;0.0
8957;Total male and female;10000;Dutch background;J06A Immune sera;2008;0;0.0
8958;Total male and female;10000;Dutch background;J06A Immune sera;2009;0;0.0
8959;Total male and female;10000;Dutch background;J06A Immune sera;2010;0;0.0
8960;Total male and female;10000;Dutch background;J06A Immune sera;2011;0;0.0
8961;Total male and female;10000;Dutch background;J06A Immune sera;2012;0;0.0
8962;Total male and female;10000;Dutch background;J06A Immune sera;2013;0;0.0
8963;Total male and female;10000;Dutch background;J06A Immune sera;2014;0;0.0
8964;Total male and female;10000;Dutch background;J06A Immune sera;2015;0;0.0
8965;Total male and female;10000;Dutch background;J06A Immune sera;2016;0;0.0
8966;Total male and female;10000;Dutch background;J06A Immune sera;2017;0;0.0
8967;Total male and female;10000;Dutch background;J06A Immune sera;2018;0;0.0
8968;Total male and female;10000;Dutch background;J06A Immune sera;2019;0;0.0
8969;Total male and female;10000;Dutch background;J06A Immune sera;2020;0;0.0
8970;Total male and female;10000;Dutch background;J06B Immunoglobulins;2006;7250;0.05
8971;Total male and female;10000;Dutch background;J06B Immunoglobulins;2007;7770;0.06
8972;Total male and female;10000;Dutch background;J06B Immunoglobulins;2008;5395;0.04
8973;Total male and female;10000;Dutch background;J06B Immunoglobulins;2009;4815;0.04
8974;Total male and female;10000;Dutch background;J06B Immunoglobulins;2010;4385;0.03
8975;Total male and female;10000;Dutch background;J06B Immunoglobulins;2011;4335;0.03
8976;Total male and female;10000;Dutch background;J06B Immunoglobulins;2012;4440;0.03
8977;Total male and female;10000;Dutch background;J06B Immunoglobulins;2013;4345;0.03
8978;Total male and female;10000;Dutch background;J06B Immunoglobulins;2014;4430;0.03
8979;Total male and female;10000;Dutch background;J06B Immunoglobulins;2015;4395;0.03
8980;Total male and female;10000;Dutch background;J06B Immunoglobulins;2016;4235;0.03
8981;Total male and female;10000;Dutch background;J06B Immunoglobulins;2017;4120;0.03
8982;Total male and female;10000;Dutch background;J06B Immunoglobulins;2018;4220;0.03
8983;Total male and female;10000;Dutch background;J06B Immunoglobulins;2019;4965;0.04
8984;Total male and female;10000;Dutch background;J06B Immunoglobulins;2020;8580;0.06
8985;Total male and female;10000;Dutch background;J07 Vaccines;2006;107810;0.81
8986;Total male and female;10000;Dutch background;J07 Vaccines;2007;109295;0.82
8987;Total male and female;10000;Dutch background;J07 Vaccines;2008;109560;0.82
8988;Total male and female;10000;Dutch background;J07 Vaccines;2009;103695;0.78
8989;Total male and female;10000;Dutch background;J07 Vaccines;2010;98370;0.73
8990;Total male and female;10000;Dutch background;J07 Vaccines;2011;99030;0.74
8991;Total male and female;10000;Dutch background;J07 Vaccines;2012;96145;0.72
8992;Total male and female;10000;Dutch background;J07 Vaccines;2013;97045;0.72
8993;Total male and female;10000;Dutch background;J07 Vaccines;2014;103480;0.77
8994;Total male and female;10000;Dutch background;J07 Vaccines;2015;105800;0.79
8995;Total male and female;10000;Dutch background;J07 Vaccines;2016;113195;0.85
8996;Total male and female;10000;Dutch background;J07 Vaccines;2017;116580;0.87
8997;Total male and female;10000;Dutch background;J07 Vaccines;2018;127905;0.96
8998;Total male and female;10000;Dutch background;J07 Vaccines;2019;133330;1.0
8999;Total male and female;10000;Dutch background;J07 Vaccines;2020;130780;0.98
9000;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2006;79905;0.6
9001;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2007;84540;0.63
9002;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2008;86055;0.64
9003;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2009;89835;0.67
9004;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2010;86770;0.65
9005;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2011;89175;0.67
9006;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2012;88200;0.66
9007;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2013;91105;0.68
9008;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2014;98320;0.73
9009;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2015;101530;0.76
9010;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2016;109370;0.82
9011;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2017;113120;0.85
9012;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2018;122725;0.92
9013;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2019;127345;0.95
9014;Total male and female;10000;Dutch background;J07A Bacterial vaccines;2020;127800;0.96
9015;Total male and female;10000;Dutch background;J07B Viral vaccines;2006;25515;0.19
9016;Total male and female;10000;Dutch background;J07B Viral vaccines;2007;21655;0.16
9017;Total male and female;10000;Dutch background;J07B Viral vaccines;2008;21455;0.16
9018;Total male and female;10000;Dutch background;J07B Viral vaccines;2009;12790;0.1
9019;Total male and female;10000;Dutch background;J07B Viral vaccines;2010;10645;0.08
9020;Total male and female;10000;Dutch background;J07B Viral vaccines;2011;9045;0.07
9021;Total male and female;10000;Dutch background;J07B Viral vaccines;2012;7205;0.05
9022;Total male and female;10000;Dutch background;J07B Viral vaccines;2013;5265;0.04
9023;Total male and female;10000;Dutch background;J07B Viral vaccines;2014;4625;0.03
9024;Total male and female;10000;Dutch background;J07B Viral vaccines;2015;3850;0.03
9025;Total male and female;10000;Dutch background;J07B Viral vaccines;2016;3775;0.03
9026;Total male and female;10000;Dutch background;J07B Viral vaccines;2017;3200;0.02
9027;Total male and female;10000;Dutch background;J07B Viral vaccines;2018;3065;0.02
9028;Total male and female;10000;Dutch background;J07B Viral vaccines;2019;3535;0.03
9029;Total male and female;10000;Dutch background;J07B Viral vaccines;2020;2680;0.02
9030;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2006;8685;0.07
9031;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2007;6630;0.05
9032;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2008;5965;0.04
9033;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2009;3410;0.03
9034;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2010;2655;0.02
9035;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2011;2105;0.02
9036;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2012;1740;0.01
9037;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2013;1380;0.01
9038;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2014;1225;0.01
9039;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2015;920;0.01
9040;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2016;325;0.0
9041;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2017;475;0.0
9042;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2018;2340;0.02
9043;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2019;2795;0.02
9044;Total male and female;10000;Dutch background;J07C Bacterial and viral vaccines,combi.;2020;545;0.0
9045;Total male and female;10000;Dutch background;J07X Other vaccines;2006;0;0.0
9046;Total male and female;10000;Dutch background;J07X Other vaccines;2007;0;0.0
9047;Total male and female;10000;Dutch background;J07X Other vaccines;2008;0;0.0
9048;Total male and female;10000;Dutch background;J07X Other vaccines;2009;0;0.0
9049;Total male and female;10000;Dutch background;J07X Other vaccines;2010;0;0.0
9050;Total male and female;10000;Dutch background;J07X Other vaccines;2011;0;0.0
9051;Total male and female;10000;Dutch background;J07X Other vaccines;2012;0;0.0
9052;Total male and female;10000;Dutch background;J07X Other vaccines;2013;0;0.0
9053;Total male and female;10000;Dutch background;J07X Other vaccines;2014;0;0.0
9054;Total male and female;10000;Dutch background;J07X Other vaccines;2015;0;0.0
9055;Total male and female;10000;Dutch background;J07X Other vaccines;2016;0;0.0
9056;Total male and female;10000;Dutch background;J07X Other vaccines;2017;0;0.0
9057;Total male and female;10000;Dutch background;J07X Other vaccines;2018;0;0.0
9058;Total male and female;10000;Dutch background;J07X Other vaccines;2019;0;0.0
9059;Total male and female;10000;Dutch background;J07X Other vaccines;2020;0;0.0
9060;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2006;173680;1.3
9061;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2007;189290;1.42
9062;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2008;203640;1.52
9063;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2009;219755;1.64
9064;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2010;234840;1.75
9065;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2011;248025;1.85
9066;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2012;245305;1.83
9067;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2013;247265;1.85
9068;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2014;249280;1.86
9069;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2015;237605;1.77
9070;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2016;247660;1.85
9071;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2017;253060;1.89
9072;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2018;261970;1.96
9073;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2019;276560;2.07
9074;Total male and female;10000;Dutch background;L Antineoplastic and immunomodul. agents;2020;282920;2.12
9075;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2006;35325;0.26
9076;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2007;40895;0.31
9077;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2008;45300;0.34
9078;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2009;53470;0.4
9079;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2010;62260;0.47
9080;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2011;68050;0.51
9081;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2012;71340;0.53
9082;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2013;70515;0.53
9083;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2014;77050;0.58
9084;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2015;62065;0.46
9085;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2016;70950;0.53
9086;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2017;55660;0.42
9087;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2018;61380;0.46
9088;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2019;70070;0.53
9089;Total male and female;10000;Dutch background;L01 Antineoplastic agents;2020;75180;0.56
9090;Total male and female;10000;Dutch background;L01A Alkylating agents;2006;4705;0.04
9091;Total male and female;10000;Dutch background;L01A Alkylating agents;2007;4765;0.04
9092;Total male and female;10000;Dutch background;L01A Alkylating agents;2008;4650;0.03
9093;Total male and female;10000;Dutch background;L01A Alkylating agents;2009;4625;0.03
9094;Total male and female;10000;Dutch background;L01A Alkylating agents;2010;4730;0.04
9095;Total male and female;10000;Dutch background;L01A Alkylating agents;2011;4715;0.04
9096;Total male and female;10000;Dutch background;L01A Alkylating agents;2012;4735;0.04
9097;Total male and female;10000;Dutch background;L01A Alkylating agents;2013;4505;0.03
9098;Total male and female;10000;Dutch background;L01A Alkylating agents;2014;4745;0.04
9099;Total male and female;10000;Dutch background;L01A Alkylating agents;2015;0;0.0
9100;Total male and female;10000;Dutch background;L01A Alkylating agents;2016;0;0.0
9101;Total male and female;10000;Dutch background;L01A Alkylating agents;2017;0;0.0
9102;Total male and female;10000;Dutch background;L01A Alkylating agents;2018;0;0.0
9103;Total male and female;10000;Dutch background;L01A Alkylating agents;2019;0;0.0
9104;Total male and female;10000;Dutch background;L01A Alkylating agents;2020;0;0.0
9105;Total male and female;10000;Dutch background;L01B Antimetabolites;2006;26260;0.2
9106;Total male and female;10000;Dutch background;L01B Antimetabolites;2007;30680;0.23
9107;Total male and female;10000;Dutch background;L01B Antimetabolites;2008;34670;0.26
9108;Total male and female;10000;Dutch background;L01B Antimetabolites;2009;42440;0.32
9109;Total male and female;10000;Dutch background;L01B Antimetabolites;2010;50765;0.38
9110;Total male and female;10000;Dutch background;L01B Antimetabolites;2011;55935;0.42
9111;Total male and female;10000;Dutch background;L01B Antimetabolites;2012;59095;0.44
9112;Total male and female;10000;Dutch background;L01B Antimetabolites;2013;61795;0.46
9113;Total male and female;10000;Dutch background;L01B Antimetabolites;2014;67625;0.5
9114;Total male and female;10000;Dutch background;L01B Antimetabolites;2015;61985;0.46
9115;Total male and female;10000;Dutch background;L01B Antimetabolites;2016;70655;0.53
9116;Total male and female;10000;Dutch background;L01B Antimetabolites;2017;55280;0.41
9117;Total male and female;10000;Dutch background;L01B Antimetabolites;2018;60935;0.46
9118;Total male and female;10000;Dutch background;L01B Antimetabolites;2019;69545;0.52
9119;Total male and female;10000;Dutch background;L01B Antimetabolites;2020;74580;0.56
9120;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2006;585;0.0
9121;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2007;520;0.0
9122;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2008;595;0.0
9123;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2009;535;0.0
9124;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2010;590;0.0
9125;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2011;590;0.0
9126;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2012;520;0.0
9127;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2013;535;0.0
9128;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2014;560;0.0
9129;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2015;0;0.0
9130;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2016;0;0.0
9131;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2017;0;0.0
9132;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2018;0;0.0
9133;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2019;0;0.0
9134;Total male and female;10000;Dutch background;L01C Plant alkaloids/oth.natural product;2020;0;0.0
9135;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2006;20;0.0
9136;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2007;15;0.0
9137;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2008;5;0.0
9138;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2009;10;0.0
9139;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2010;15;0.0
9140;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2011;5;0.0
9141;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2012;10;0.0
9142;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2013;20;0.0
9143;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2014;5;0.0
9144;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2015;0;0.0
9145;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2016;0;0.0
9146;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2017;0;0.0
9147;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2018;0;0.0
9148;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2019;0;0.0
9149;Total male and female;10000;Dutch background;L01D Cytoox.antibiotics/related substan;2020;0;0.0
9150;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2006;4450;0.03
9151;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2007;5735;0.04
9152;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2008;6270;0.05
9153;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2009;6795;0.05
9154;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2010;7215;0.05
9155;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2011;7880;0.06
9156;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2012;8105;0.06
9157;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2013;4570;0.03
9158;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2014;5110;0.04
9159;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2015;75;0.0
9160;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2016;295;0.0
9161;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2017;385;0.0
9162;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2018;455;0.0
9163;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2019;535;0.0
9164;Total male and female;10000;Dutch background;L01X Other antineoplastic agents;2020;610;0.0
9165;Total male and female;10000;Dutch background;L02 Endocrine therapy;2006;62570;0.47
9166;Total male and female;10000;Dutch background;L02 Endocrine therapy;2007;66615;0.5
9167;Total male and female;10000;Dutch background;L02 Endocrine therapy;2008;69580;0.52
9168;Total male and female;10000;Dutch background;L02 Endocrine therapy;2009;72815;0.54
9169;Total male and female;10000;Dutch background;L02 Endocrine therapy;2010;76115;0.57
9170;Total male and female;10000;Dutch background;L02 Endocrine therapy;2011;78950;0.59
9171;Total male and female;10000;Dutch background;L02 Endocrine therapy;2012;81310;0.61
9172;Total male and female;10000;Dutch background;L02 Endocrine therapy;2013;81495;0.61
9173;Total male and female;10000;Dutch background;L02 Endocrine therapy;2014;74745;0.56
9174;Total male and female;10000;Dutch background;L02 Endocrine therapy;2015;74545;0.56
9175;Total male and female;10000;Dutch background;L02 Endocrine therapy;2016;75820;0.57
9176;Total male and female;10000;Dutch background;L02 Endocrine therapy;2017;76580;0.57
9177;Total male and female;10000;Dutch background;L02 Endocrine therapy;2018;77215;0.58
9178;Total male and female;10000;Dutch background;L02 Endocrine therapy;2019;78305;0.59
9179;Total male and female;10000;Dutch background;L02 Endocrine therapy;2020;78945;0.59
9180;Total male and female;10000;Dutch background;L02A Hormones and related agents;2006;27435;0.21
9181;Total male and female;10000;Dutch background;L02A Hormones and related agents;2007;29780;0.22
9182;Total male and female;10000;Dutch background;L02A Hormones and related agents;2008;31275;0.23
9183;Total male and female;10000;Dutch background;L02A Hormones and related agents;2009;32215;0.24
9184;Total male and female;10000;Dutch background;L02A Hormones and related agents;2010;32830;0.25
9185;Total male and female;10000;Dutch background;L02A Hormones and related agents;2011;33055;0.25
9186;Total male and female;10000;Dutch background;L02A Hormones and related agents;2012;33145;0.25
9187;Total male and female;10000;Dutch background;L02A Hormones and related agents;2013;32115;0.24
9188;Total male and female;10000;Dutch background;L02A Hormones and related agents;2014;24190;0.18
9189;Total male and female;10000;Dutch background;L02A Hormones and related agents;2015;23535;0.18
9190;Total male and female;10000;Dutch background;L02A Hormones and related agents;2016;24220;0.18
9191;Total male and female;10000;Dutch background;L02A Hormones and related agents;2017;24845;0.19
9192;Total male and female;10000;Dutch background;L02A Hormones and related agents;2018;26095;0.2
9193;Total male and female;10000;Dutch background;L02A Hormones and related agents;2019;27535;0.21
9194;Total male and female;10000;Dutch background;L02A Hormones and related agents;2020;28975;0.22
9195;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2006;43930;0.33
9196;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2007;45845;0.34
9197;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2008;47455;0.36
9198;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2009;50260;0.38
9199;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2010;53165;0.4
9200;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2011;55660;0.42
9201;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2012;58225;0.43
9202;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2013;58850;0.44
9203;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2014;59660;0.45
9204;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2015;59875;0.45
9205;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2016;60345;0.45
9206;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2017;60315;0.45
9207;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2018;59510;0.45
9208;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2019;59305;0.44
9209;Total male and female;10000;Dutch background;L02B Hormone antagonists/related agents;2020;58345;0.44
9210;Total male and female;10000;Dutch background;L03 Immunostimulants;2006;10805;0.08
9211;Total male and female;10000;Dutch background;L03 Immunostimulants;2007;11570;0.09
9212;Total male and female;10000;Dutch background;L03 Immunostimulants;2008;12505;0.09
9213;Total male and female;10000;Dutch background;L03 Immunostimulants;2009;13215;0.1
9214;Total male and female;10000;Dutch background;L03 Immunostimulants;2010;13540;0.1
9215;Total male and female;10000;Dutch background;L03 Immunostimulants;2011;13935;0.1
9216;Total male and female;10000;Dutch background;L03 Immunostimulants;2012;14520;0.11
9217;Total male and female;10000;Dutch background;L03 Immunostimulants;2013;14380;0.11
9218;Total male and female;10000;Dutch background;L03 Immunostimulants;2014;13445;0.1
9219;Total male and female;10000;Dutch background;L03 Immunostimulants;2015;12235;0.09
9220;Total male and female;10000;Dutch background;L03 Immunostimulants;2016;11020;0.08
9221;Total male and female;10000;Dutch background;L03 Immunostimulants;2017;10270;0.08
9222;Total male and female;10000;Dutch background;L03 Immunostimulants;2018;10620;0.08
9223;Total male and female;10000;Dutch background;L03 Immunostimulants;2019;11005;0.08
9224;Total male and female;10000;Dutch background;L03 Immunostimulants;2020;10695;0.08
9225;Total male and female;10000;Dutch background;L03A Immunostimulants;2006;10805;0.08
9226;Total male and female;10000;Dutch background;L03A Immunostimulants;2007;11570;0.09
9227;Total male and female;10000;Dutch background;L03A Immunostimulants;2008;12505;0.09
9228;Total male and female;10000;Dutch background;L03A Immunostimulants;2009;13215;0.1
9229;Total male and female;10000;Dutch background;L03A Immunostimulants;2010;13540;0.1
9230;Total male and female;10000;Dutch background;L03A Immunostimulants;2011;13935;0.1
9231;Total male and female;10000;Dutch background;L03A Immunostimulants;2012;14520;0.11
9232;Total male and female;10000;Dutch background;L03A Immunostimulants;2013;14380;0.11
9233;Total male and female;10000;Dutch background;L03A Immunostimulants;2014;13445;0.1
9234;Total male and female;10000;Dutch background;L03A Immunostimulants;2015;12235;0.09
9235;Total male and female;10000;Dutch background;L03A Immunostimulants;2016;11020;0.08
9236;Total male and female;10000;Dutch background;L03A Immunostimulants;2017;10270;0.08
9237;Total male and female;10000;Dutch background;L03A Immunostimulants;2018;10620;0.08
9238;Total male and female;10000;Dutch background;L03A Immunostimulants;2019;11005;0.08
9239;Total male and female;10000;Dutch background;L03A Immunostimulants;2020;10695;0.08
9240;Total male and female;10000;Dutch background;L04 Immunosuppressants;2006;70360;0.53
9241;Total male and female;10000;Dutch background;L04 Immunosuppressants;2007;76470;0.57
9242;Total male and female;10000;Dutch background;L04 Immunosuppressants;2008;83420;0.62
9243;Total male and female;10000;Dutch background;L04 Immunosuppressants;2009;90145;0.67
9244;Total male and female;10000;Dutch background;L04 Immunosuppressants;2010;96555;0.72
9245;Total male and female;10000;Dutch background;L04 Immunosuppressants;2011;101770;0.76
9246;Total male and female;10000;Dutch background;L04 Immunosuppressants;2012;90055;0.67
9247;Total male and female;10000;Dutch background;L04 Immunosuppressants;2013;92105;0.69
9248;Total male and female;10000;Dutch background;L04 Immunosuppressants;2014;95715;0.71
9249;Total male and female;10000;Dutch background;L04 Immunosuppressants;2015;98435;0.74
9250;Total male and female;10000;Dutch background;L04 Immunosuppressants;2016;100150;0.75
9251;Total male and female;10000;Dutch background;L04 Immunosuppressants;2017;116710;0.87
9252;Total male and female;10000;Dutch background;L04 Immunosuppressants;2018;119245;0.89
9253;Total male and female;10000;Dutch background;L04 Immunosuppressants;2019;124470;0.93
9254;Total male and female;10000;Dutch background;L04 Immunosuppressants;2020;125630;0.94
9255;Total male and female;10000;Dutch background;L04A Immunosuppressants;2006;70360;0.53
9256;Total male and female;10000;Dutch background;L04A Immunosuppressants;2007;76470;0.57
9257;Total male and female;10000;Dutch background;L04A Immunosuppressants;2008;83420;0.62
9258;Total male and female;10000;Dutch background;L04A Immunosuppressants;2009;90145;0.67
9259;Total male and female;10000;Dutch background;L04A Immunosuppressants;2010;96555;0.72
9260;Total male and female;10000;Dutch background;L04A Immunosuppressants;2011;101770;0.76
9261;Total male and female;10000;Dutch background;L04A Immunosuppressants;2012;90055;0.67
9262;Total male and female;10000;Dutch background;L04A Immunosuppressants;2013;92105;0.69
9263;Total male and female;10000;Dutch background;L04A Immunosuppressants;2014;95715;0.71
9264;Total male and female;10000;Dutch background;L04A Immunosuppressants;2015;98435;0.74
9265;Total male and female;10000;Dutch background;L04A Immunosuppressants;2016;100150;0.75
9266;Total male and female;10000;Dutch background;L04A Immunosuppressants;2017;116710;0.87
9267;Total male and female;10000;Dutch background;L04A Immunosuppressants;2018;119245;0.89
9268;Total male and female;10000;Dutch background;L04A Immunosuppressants;2019;124470;0.93
9269;Total male and female;10000;Dutch background;L04A Immunosuppressants;2020;125630;0.94
9270;Total male and female;10000;Dutch background;M Musculo-skeletal system;2006;2424335;18.15
9271;Total male and female;10000;Dutch background;M Musculo-skeletal system;2007;2479400;18.56
9272;Total male and female;10000;Dutch background;M Musculo-skeletal system;2008;2481890;18.57
9273;Total male and female;10000;Dutch background;M Musculo-skeletal system;2009;2484250;18.58
9274;Total male and female;10000;Dutch background;M Musculo-skeletal system;2010;2486405;18.58
9275;Total male and female;10000;Dutch background;M Musculo-skeletal system;2011;2493810;18.62
9276;Total male and female;10000;Dutch background;M Musculo-skeletal system;2012;2412630;18.01
9277;Total male and female;10000;Dutch background;M Musculo-skeletal system;2013;2297400;17.15
9278;Total male and female;10000;Dutch background;M Musculo-skeletal system;2014;2239665;16.72
9279;Total male and female;10000;Dutch background;M Musculo-skeletal system;2015;2179735;16.28
9280;Total male and female;10000;Dutch background;M Musculo-skeletal system;2016;2122980;15.86
9281;Total male and female;10000;Dutch background;M Musculo-skeletal system;2017;2062920;15.43
9282;Total male and female;10000;Dutch background;M Musculo-skeletal system;2018;2013100;15.07
9283;Total male and female;10000;Dutch background;M Musculo-skeletal system;2019;1948260;14.6
9284;Total male and female;10000;Dutch background;M Musculo-skeletal system;2020;1764840;13.23
9285;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2006;2240245;16.77
9286;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2007;2277705;17.05
9287;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2008;2266790;16.96
9288;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2009;2255380;16.87
9289;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2010;2242890;16.76
9290;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2011;2243365;16.75
9291;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2012;2153245;16.07
9292;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2013;2031655;15.17
9293;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2014;1969965;14.71
9294;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2015;1907995;14.25
9295;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2016;1847435;13.81
9296;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2017;1785670;13.35
9297;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2018;1733560;12.98
9298;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2019;1664640;12.47
9299;Total male and female;10000;Dutch background;M01 Antiinflammatory/antirheumatic prod.;2020;1476925;11.07
9300;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2006;2240020;16.77
9301;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2007;2277520;17.05
9302;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2008;2266650;16.96
9303;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2009;2255265;16.87
9304;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2010;2242780;16.76
9305;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2011;2243270;16.75
9306;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2012;2153145;16.07
9307;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2013;2031575;15.17
9308;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2014;1969885;14.71
9309;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2015;1907920;14.25
9310;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2016;1847365;13.8
9311;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2017;1785590;13.35
9312;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2018;1733505;12.98
9313;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2019;1664580;12.47
9314;Total male and female;10000;Dutch background;M01A Anti-inflammatory/-rheumatic prod.;2020;1476900;11.07
9315;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2006;0;0.0
9316;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2007;0;0.0
9317;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2008;0;0.0
9318;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2009;0;0.0
9319;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2010;0;0.0
9320;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2011;0;0.0
9321;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2012;0;0.0
9322;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2013;0;0.0
9323;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2014;0;0.0
9324;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2015;0;0.0
9325;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2016;0;0.0
9326;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2017;0;0.0
9327;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2018;0;0.0
9328;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2019;0;0.0
9329;Total male and female;10000;Dutch background;M01B Anti-inflammatory/-rheumatic comb.;2020;0;0.0
9330;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2006;675;0.01
9331;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2007;530;0.0
9332;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2008;395;0.0
9333;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2009;285;0.0
9334;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2010;245;0.0
9335;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2011;220;0.0
9336;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2012;200;0.0
9337;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2013;165;0.0
9338;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2014;150;0.0
9339;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2015;145;0.0
9340;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2016;120;0.0
9341;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2017;130;0.0
9342;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2018;95;0.0
9343;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2019;85;0.0
9344;Total male and female;10000;Dutch background;M01C Specific antirheumatic agents;2020;40;0.0
9345;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2006;4840;0.04
9346;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2007;4935;0.04
9347;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2008;4410;0.03
9348;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2009;4515;0.03
9349;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2010;5785;0.04
9350;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2011;2620;0.02
9351;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2012;105;0.0
9352;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2013;130;0.0
9353;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2014;40;0.0
9354;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2015;30;0.0
9355;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2016;10;0.0
9356;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2017;15;0.0
9357;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2018;10;0.0
9358;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2019;10;0.0
9359;Total male and female;10000;Dutch background;M02 Topical joint/muscular pain products;2020;5;0.0
9360;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2006;4840;0.04
9361;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2007;4935;0.04
9362;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2008;4410;0.03
9363;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2009;4515;0.03
9364;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2010;5785;0.04
9365;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2011;2620;0.02
9366;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2012;105;0.0
9367;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2013;130;0.0
9368;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2014;40;0.0
9369;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2015;30;0.0
9370;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2016;10;0.0
9371;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2017;15;0.0
9372;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2018;10;0.0
9373;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2019;10;0.0
9374;Total male and female;10000;Dutch background;M02A Joint and muscular pain top. prod.;2020;5;0.0
9375;Total male and female;10000;Dutch background;M03 Muscle relaxants;2006;14330;0.11
9376;Total male and female;10000;Dutch background;M03 Muscle relaxants;2007;14825;0.11
9377;Total male and female;10000;Dutch background;M03 Muscle relaxants;2008;15220;0.11
9378;Total male and female;10000;Dutch background;M03 Muscle relaxants;2009;16055;0.12
9379;Total male and female;10000;Dutch background;M03 Muscle relaxants;2010;17580;0.13
9380;Total male and female;10000;Dutch background;M03 Muscle relaxants;2011;18730;0.14
9381;Total male and female;10000;Dutch background;M03 Muscle relaxants;2012;19345;0.14
9382;Total male and female;10000;Dutch background;M03 Muscle relaxants;2013;20645;0.15
9383;Total male and female;10000;Dutch background;M03 Muscle relaxants;2014;21895;0.16
9384;Total male and female;10000;Dutch background;M03 Muscle relaxants;2015;22030;0.16
9385;Total male and female;10000;Dutch background;M03 Muscle relaxants;2016;22625;0.17
9386;Total male and female;10000;Dutch background;M03 Muscle relaxants;2017;22920;0.17
9387;Total male and female;10000;Dutch background;M03 Muscle relaxants;2018;22370;0.17
9388;Total male and female;10000;Dutch background;M03 Muscle relaxants;2019;22340;0.17
9389;Total male and female;10000;Dutch background;M03 Muscle relaxants;2020;22790;0.17
9390;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2006;1055;0.01
9391;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2007;1230;0.01
9392;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2008;1275;0.01
9393;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2009;1470;0.01
9394;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2010;1745;0.01
9395;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2011;1915;0.01
9396;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2012;2195;0.02
9397;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2013;2715;0.02
9398;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2014;3265;0.02
9399;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2015;3395;0.03
9400;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2016;3975;0.03
9401;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2017;4295;0.03
9402;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2018;4080;0.03
9403;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2019;4205;0.03
9404;Total male and female;10000;Dutch background;M03A Muscle relaxants, peripheral.acting;2020;4830;0.04
9405;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2006;12940;0.1
9406;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2007;13260;0.1
9407;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2008;13620;0.1
9408;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2009;14275;0.11
9409;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2010;15525;0.12
9410;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2011;16510;0.12
9411;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2012;16840;0.13
9412;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2013;17630;0.13
9413;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2014;18375;0.14
9414;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2015;18420;0.14
9415;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2016;18460;0.14
9416;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2017;18455;0.14
9417;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2018;18140;0.14
9418;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2019;18015;0.13
9419;Total male and female;10000;Dutch background;M03B Muscle relaxants, centrally acting;2020;17865;0.13
9420;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2006;685;0.01
9421;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2007;680;0.01
9422;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2008;665;0.0
9423;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2009;655;0.0
9424;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2010;665;0.0
9425;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2011;665;0.0
9426;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2012;640;0.0
9427;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2013;635;0.0
9428;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2014;595;0.0
9429;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2015;555;0.0
9430;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2016;540;0.0
9431;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2017;490;0.0
9432;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2018;455;0.0
9433;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2019;430;0.0
9434;Total male and female;10000;Dutch background;M03C Muscle relaxants, directly acting;2020;370;0.0
9435;Total male and female;10000;Dutch background;M04 Antigout preparations;2006;89125;0.67
9436;Total male and female;10000;Dutch background;M04 Antigout preparations;2007;94415;0.71
9437;Total male and female;10000;Dutch background;M04 Antigout preparations;2008;102125;0.76
9438;Total male and female;10000;Dutch background;M04 Antigout preparations;2009;109850;0.82
9439;Total male and female;10000;Dutch background;M04 Antigout preparations;2010;117080;0.87
9440;Total male and female;10000;Dutch background;M04 Antigout preparations;2011;123475;0.92
9441;Total male and female;10000;Dutch background;M04 Antigout preparations;2012;130315;0.97
9442;Total male and female;10000;Dutch background;M04 Antigout preparations;2013;137180;1.02
9443;Total male and female;10000;Dutch background;M04 Antigout preparations;2014;144050;1.08
9444;Total male and female;10000;Dutch background;M04 Antigout preparations;2015;149485;1.12
9445;Total male and female;10000;Dutch background;M04 Antigout preparations;2016;155485;1.16
9446;Total male and female;10000;Dutch background;M04 Antigout preparations;2017;159265;1.19
9447;Total male and female;10000;Dutch background;M04 Antigout preparations;2018;164030;1.23
9448;Total male and female;10000;Dutch background;M04 Antigout preparations;2019;166685;1.25
9449;Total male and female;10000;Dutch background;M04 Antigout preparations;2020;167350;1.25
9450;Total male and female;10000;Dutch background;M04A Antigout preparations;2006;89125;0.67
9451;Total male and female;10000;Dutch background;M04A Antigout preparations;2007;94415;0.71
9452;Total male and female;10000;Dutch background;M04A Antigout preparations;2008;102125;0.76
9453;Total male and female;10000;Dutch background;M04A Antigout preparations;2009;109850;0.82
9454;Total male and female;10000;Dutch background;M04A Antigout preparations;2010;117080;0.87
9455;Total male and female;10000;Dutch background;M04A Antigout preparations;2011;123475;0.92
9456;Total male and female;10000;Dutch background;M04A Antigout preparations;2012;130315;0.97
9457;Total male and female;10000;Dutch background;M04A Antigout preparations;2013;137180;1.02
9458;Total male and female;10000;Dutch background;M04A Antigout preparations;2014;144050;1.08
9459;Total male and female;10000;Dutch background;M04A Antigout preparations;2015;149485;1.12
9460;Total male and female;10000;Dutch background;M04A Antigout preparations;2016;155485;1.16
9461;Total male and female;10000;Dutch background;M04A Antigout preparations;2017;159265;1.19
9462;Total male and female;10000;Dutch background;M04A Antigout preparations;2018;164030;1.23
9463;Total male and female;10000;Dutch background;M04A Antigout preparations;2019;166685;1.25
9464;Total male and female;10000;Dutch background;M04A Antigout preparations;2020;167350;1.25
9465;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2006;200960;1.5
9466;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2007;216500;1.62
9467;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2008;224125;1.68
9468;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2009;231670;1.73
9469;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2010;236195;1.76
9470;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2011;235610;1.76
9471;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2012;233655;1.74
9472;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2013;225560;1.68
9473;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2014;216330;1.62
9474;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2015;208450;1.56
9475;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2016;201855;1.51
9476;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2017;196250;1.47
9477;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2018;191645;1.43
9478;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2019;191035;1.43
9479;Total male and female;10000;Dutch background;M05 Drugs for treatment of bone diseases;2020;186460;1.4
9480;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2006;200960;1.5
9481;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2007;216500;1.62
9482;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2008;224125;1.68
9483;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2009;231670;1.73
9484;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2010;236195;1.76
9485;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2011;235610;1.76
9486;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2012;233655;1.74
9487;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2013;225560;1.68
9488;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2014;216330;1.62
9489;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2015;208450;1.56
9490;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2016;201855;1.51
9491;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2017;196250;1.47
9492;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2018;191645;1.43
9493;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2019;191035;1.43
9494;Total male and female;10000;Dutch background;M05B Bone structure and mineralization .;2020;186460;1.4
9495;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2006;505;0.0
9496;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2007;340;0.0
9497;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2008;50;0.0
9498;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2009;20;0.0
9499;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2010;20;0.0
9500;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2011;10;0.0
9501;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2012;5;0.0
9502;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2013;20;0.0
9503;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2014;0;0.0
9504;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2015;5;0.0
9505;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2016;5;0.0
9506;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2017;0;0.0
9507;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2018;0;0.0
9508;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2019;0;0.0
9509;Total male and female;10000;Dutch background;M09 Oth.drugs for musculo-skelet.disord.;2020;0;0.0
9510;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2006;505;0.0
9511;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2007;340;0.0
9512;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2008;50;0.0
9513;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2009;20;0.0
9514;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2010;20;0.0
9515;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2011;10;0.0
9516;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2012;5;0.0
9517;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2013;20;0.0
9518;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2014;0;0.0
9519;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2015;5;0.0
9520;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2016;5;0.0
9521;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2017;0;0.0
9522;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2018;0;0.0
9523;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2019;0;0.0
9524;Total male and female;10000;Dutch background;M09A Oth.disord.musculoskelet.syst.drugs;2020;0;0.0
9525;Total male and female;10000;Dutch background;N Nervous system;2006;2636715;19.74
9526;Total male and female;10000;Dutch background;N Nervous system;2007;2744615;20.55
9527;Total male and female;10000;Dutch background;N Nervous system;2008;2778940;20.8
9528;Total male and female;10000;Dutch background;N Nervous system;2009;2141575;16.02
9529;Total male and female;10000;Dutch background;N Nervous system;2010;2203980;16.47
9530;Total male and female;10000;Dutch background;N Nervous system;2011;2307505;17.23
9531;Total male and female;10000;Dutch background;N Nervous system;2012;2324255;17.35
9532;Total male and female;10000;Dutch background;N Nervous system;2013;2210245;16.5
9533;Total male and female;10000;Dutch background;N Nervous system;2014;2267545;16.93
9534;Total male and female;10000;Dutch background;N Nervous system;2015;2311965;17.27
9535;Total male and female;10000;Dutch background;N Nervous system;2016;2353245;17.58
9536;Total male and female;10000;Dutch background;N Nervous system;2017;2372405;17.74
9537;Total male and female;10000;Dutch background;N Nervous system;2018;2383830;17.84
9538;Total male and female;10000;Dutch background;N Nervous system;2019;2297710;17.22
9539;Total male and female;10000;Dutch background;N Nervous system;2020;2259970;16.95
9540;Total male and female;10000;Dutch background;N01 Anesthetics;2006;137610;1.03
9541;Total male and female;10000;Dutch background;N01 Anesthetics;2007;159440;1.19
9542;Total male and female;10000;Dutch background;N01 Anesthetics;2008;151255;1.13
9543;Total male and female;10000;Dutch background;N01 Anesthetics;2009;137395;1.03
9544;Total male and female;10000;Dutch background;N01 Anesthetics;2010;142740;1.07
9545;Total male and female;10000;Dutch background;N01 Anesthetics;2011;145425;1.09
9546;Total male and female;10000;Dutch background;N01 Anesthetics;2012;148225;1.11
9547;Total male and female;10000;Dutch background;N01 Anesthetics;2013;144715;1.08
9548;Total male and female;10000;Dutch background;N01 Anesthetics;2014;161460;1.21
9549;Total male and female;10000;Dutch background;N01 Anesthetics;2015;161165;1.2
9550;Total male and female;10000;Dutch background;N01 Anesthetics;2016;158710;1.19
9551;Total male and female;10000;Dutch background;N01 Anesthetics;2017;138640;1.04
9552;Total male and female;10000;Dutch background;N01 Anesthetics;2018;142580;1.07
9553;Total male and female;10000;Dutch background;N01 Anesthetics;2019;148145;1.11
9554;Total male and female;10000;Dutch background;N01 Anesthetics;2020;137685;1.03
9555;Total male and female;10000;Dutch background;N01A Anesthetics, general;2006;2240;0.02
9556;Total male and female;10000;Dutch background;N01A Anesthetics, general;2007;2235;0.02
9557;Total male and female;10000;Dutch background;N01A Anesthetics, general;2008;2305;0.02
9558;Total male and female;10000;Dutch background;N01A Anesthetics, general;2009;2190;0.02
9559;Total male and female;10000;Dutch background;N01A Anesthetics, general;2010;2435;0.02
9560;Total male and female;10000;Dutch background;N01A Anesthetics, general;2011;1670;0.01
9561;Total male and female;10000;Dutch background;N01A Anesthetics, general;2012;1615;0.01
9562;Total male and female;10000;Dutch background;N01A Anesthetics, general;2013;1985;0.01
9563;Total male and female;10000;Dutch background;N01A Anesthetics, general;2014;1980;0.01
9564;Total male and female;10000;Dutch background;N01A Anesthetics, general;2015;1985;0.01
9565;Total male and female;10000;Dutch background;N01A Anesthetics, general;2016;2560;0.02
9566;Total male and female;10000;Dutch background;N01A Anesthetics, general;2017;3730;0.03
9567;Total male and female;10000;Dutch background;N01A Anesthetics, general;2018;4165;0.03
9568;Total male and female;10000;Dutch background;N01A Anesthetics, general;2019;4710;0.04
9569;Total male and female;10000;Dutch background;N01A Anesthetics, general;2020;5075;0.04
9570;Total male and female;10000;Dutch background;N01B Anesthetics, local;2006;135820;1.02
9571;Total male and female;10000;Dutch background;N01B Anesthetics, local;2007;157380;1.18
9572;Total male and female;10000;Dutch background;N01B Anesthetics, local;2008;149225;1.12
9573;Total male and female;10000;Dutch background;N01B Anesthetics, local;2009;135410;1.01
9574;Total male and female;10000;Dutch background;N01B Anesthetics, local;2010;140520;1.05
9575;Total male and female;10000;Dutch background;N01B Anesthetics, local;2011;143875;1.07
9576;Total male and female;10000;Dutch background;N01B Anesthetics, local;2012;146800;1.1
9577;Total male and female;10000;Dutch background;N01B Anesthetics, local;2013;143300;1.07
9578;Total male and female;10000;Dutch background;N01B Anesthetics, local;2014;160180;1.2
9579;Total male and female;10000;Dutch background;N01B Anesthetics, local;2015;159845;1.19
9580;Total male and female;10000;Dutch background;N01B Anesthetics, local;2016;157395;1.18
9581;Total male and female;10000;Dutch background;N01B Anesthetics, local;2017;137190;1.03
9582;Total male and female;10000;Dutch background;N01B Anesthetics, local;2018;141085;1.06
9583;Total male and female;10000;Dutch background;N01B Anesthetics, local;2019;146670;1.1
9584;Total male and female;10000;Dutch background;N01B Anesthetics, local;2020;136465;1.02
9585;Total male and female;10000;Dutch background;N02 Analgesics;2006;821650;6.15
9586;Total male and female;10000;Dutch background;N02 Analgesics;2007;880180;6.59
9587;Total male and female;10000;Dutch background;N02 Analgesics;2008;919090;6.88
9588;Total male and female;10000;Dutch background;N02 Analgesics;2009;961530;7.19
9589;Total male and female;10000;Dutch background;N02 Analgesics;2010;1012950;7.57
9590;Total male and female;10000;Dutch background;N02 Analgesics;2011;1072240;8.01
9591;Total male and female;10000;Dutch background;N02 Analgesics;2012;1100870;8.22
9592;Total male and female;10000;Dutch background;N02 Analgesics;2013;919840;6.87
9593;Total male and female;10000;Dutch background;N02 Analgesics;2014;959080;7.16
9594;Total male and female;10000;Dutch background;N02 Analgesics;2015;1001465;7.48
9595;Total male and female;10000;Dutch background;N02 Analgesics;2016;1046260;7.82
9596;Total male and female;10000;Dutch background;N02 Analgesics;2017;1088390;8.14
9597;Total male and female;10000;Dutch background;N02 Analgesics;2018;1098855;8.22
9598;Total male and female;10000;Dutch background;N02 Analgesics;2019;953080;7.14
9599;Total male and female;10000;Dutch background;N02 Analgesics;2020;918300;6.89
9600;Total male and female;10000;Dutch background;N02A Opioids;2006;478660;3.58
9601;Total male and female;10000;Dutch background;N02A Opioids;2007;522860;3.91
9602;Total male and female;10000;Dutch background;N02A Opioids;2008;558355;4.18
9603;Total male and female;10000;Dutch background;N02A Opioids;2009;594720;4.45
9604;Total male and female;10000;Dutch background;N02A Opioids;2010;643560;4.81
9605;Total male and female;10000;Dutch background;N02A Opioids;2011;686900;5.13
9606;Total male and female;10000;Dutch background;N02A Opioids;2012;715305;5.34
9607;Total male and female;10000;Dutch background;N02A Opioids;2013;655530;4.89
9608;Total male and female;10000;Dutch background;N02A Opioids;2014;693620;5.18
9609;Total male and female;10000;Dutch background;N02A Opioids;2015;739185;5.52
9610;Total male and female;10000;Dutch background;N02A Opioids;2016;780690;5.83
9611;Total male and female;10000;Dutch background;N02A Opioids;2017;819215;6.13
9612;Total male and female;10000;Dutch background;N02A Opioids;2018;818175;6.12
9613;Total male and female;10000;Dutch background;N02A Opioids;2019;789905;5.92
9614;Total male and female;10000;Dutch background;N02A Opioids;2020;760120;5.7
9615;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2006;230155;1.72
9616;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2007;243270;1.82
9617;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2008;250325;1.87
9618;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2009;262145;1.96
9619;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2010;269990;2.02
9620;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2011;293895;2.19
9621;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2012;306640;2.29
9622;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2013;147070;1.1
9623;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2014;162750;1.22
9624;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2015;180250;1.35
9625;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2016;199155;1.49
9626;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2017;215700;1.61
9627;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2018;239580;1.79
9628;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2019;3050;0.02
9629;Total male and female;10000;Dutch background;N02B Other analgesics and antipyretics;2020;2705;0.02
9630;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2006;184165;1.38
9631;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2007;191910;1.44
9632;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2008;193075;1.44
9633;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2009;195595;1.46
9634;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2010;202130;1.51
9635;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2011;208125;1.55
9636;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2012;204950;1.53
9637;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2013;200225;1.49
9638;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2014;197515;1.47
9639;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2015;190615;1.42
9640;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2016;187395;1.4
9641;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2017;185180;1.38
9642;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2018;183935;1.38
9643;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2019;184530;1.38
9644;Total male and female;10000;Dutch background;N02C Antimigraine preparations;2020;178730;1.34
9645;Total male and female;10000;Dutch background;N03 Antiepileptics;2006;207465;1.55
9646;Total male and female;10000;Dutch background;N03 Antiepileptics;2007;217695;1.63
9647;Total male and female;10000;Dutch background;N03 Antiepileptics;2008;226280;1.69
9648;Total male and female;10000;Dutch background;N03 Antiepileptics;2009;224010;1.68
9649;Total male and female;10000;Dutch background;N03 Antiepileptics;2010;224585;1.68
9650;Total male and female;10000;Dutch background;N03 Antiepileptics;2011;235300;1.76
9651;Total male and female;10000;Dutch background;N03 Antiepileptics;2012;246090;1.84
9652;Total male and female;10000;Dutch background;N03 Antiepileptics;2013;254400;1.9
9653;Total male and female;10000;Dutch background;N03 Antiepileptics;2014;265620;1.98
9654;Total male and female;10000;Dutch background;N03 Antiepileptics;2015;276145;2.06
9655;Total male and female;10000;Dutch background;N03 Antiepileptics;2016;283735;2.12
9656;Total male and female;10000;Dutch background;N03 Antiepileptics;2017;285885;2.14
9657;Total male and female;10000;Dutch background;N03 Antiepileptics;2018;286105;2.14
9658;Total male and female;10000;Dutch background;N03 Antiepileptics;2019;289120;2.17
9659;Total male and female;10000;Dutch background;N03 Antiepileptics;2020;286460;2.15
9660;Total male and female;10000;Dutch background;N03A Antiepileptics;2006;207465;1.55
9661;Total male and female;10000;Dutch background;N03A Antiepileptics;2007;217695;1.63
9662;Total male and female;10000;Dutch background;N03A Antiepileptics;2008;226280;1.69
9663;Total male and female;10000;Dutch background;N03A Antiepileptics;2009;224010;1.68
9664;Total male and female;10000;Dutch background;N03A Antiepileptics;2010;224585;1.68
9665;Total male and female;10000;Dutch background;N03A Antiepileptics;2011;235300;1.76
9666;Total male and female;10000;Dutch background;N03A Antiepileptics;2012;246090;1.84
9667;Total male and female;10000;Dutch background;N03A Antiepileptics;2013;254400;1.9
9668;Total male and female;10000;Dutch background;N03A Antiepileptics;2014;265620;1.98
9669;Total male and female;10000;Dutch background;N03A Antiepileptics;2015;276145;2.06
9670;Total male and female;10000;Dutch background;N03A Antiepileptics;2016;283735;2.12
9671;Total male and female;10000;Dutch background;N03A Antiepileptics;2017;285885;2.14
9672;Total male and female;10000;Dutch background;N03A Antiepileptics;2018;286105;2.14
9673;Total male and female;10000;Dutch background;N03A Antiepileptics;2019;289120;2.17
9674;Total male and female;10000;Dutch background;N03A Antiepileptics;2020;286460;2.15
9675;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2006;53210;0.4
9676;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2007;62930;0.47
9677;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2008;70070;0.52
9678;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2009;75105;0.56
9679;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2010;73625;0.55
9680;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2011;75115;0.56
9681;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2012;75055;0.56
9682;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2013;74850;0.56
9683;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2014;75875;0.57
9684;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2015;76770;0.57
9685;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2016;77810;0.58
9686;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2017;78135;0.58
9687;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2018;78755;0.59
9688;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2019;79100;0.59
9689;Total male and female;10000;Dutch background;N04 Anti-parkinson drugs;2020;79085;0.59
9690;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2006;13925;0.1
9691;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2007;13490;0.1
9692;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2008;12845;0.1
9693;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2009;12205;0.09
9694;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2010;11860;0.09
9695;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2011;11630;0.09
9696;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2012;11395;0.09
9697;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2013;10905;0.08
9698;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2014;10585;0.08
9699;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2015;10345;0.08
9700;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2016;9970;0.07
9701;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2017;9610;0.07
9702;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2018;9360;0.07
9703;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2019;8790;0.07
9704;Total male and female;10000;Dutch background;N04A Anticholinergic agents;2020;8525;0.06
9705;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2006;40585;0.3
9706;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2007;50735;0.38
9707;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2008;58475;0.44
9708;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2009;64030;0.48
9709;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2010;62815;0.47
9710;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2011;64460;0.48
9711;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2012;64560;0.48
9712;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2013;64775;0.48
9713;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2014;66100;0.49
9714;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2015;67235;0.5
9715;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2016;68605;0.51
9716;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2017;69240;0.52
9717;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2018;70135;0.52
9718;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2019;70955;0.53
9719;Total male and female;10000;Dutch background;N04B Dopaminergic agents;2020;71170;0.53
9720;Total male and female;10000;Dutch background;N05 Psycholeptics;2006;1541790;11.54
9721;Total male and female;10000;Dutch background;N05 Psycholeptics;2007;1572610;11.77
9722;Total male and female;10000;Dutch background;N05 Psycholeptics;2008;1564315;11.71
9723;Total male and female;10000;Dutch background;N05 Psycholeptics;2009;434120;3.25
9724;Total male and female;10000;Dutch background;N05 Psycholeptics;2010;446895;3.34
9725;Total male and female;10000;Dutch background;N05 Psycholeptics;2011;470245;3.51
9726;Total male and female;10000;Dutch background;N05 Psycholeptics;2012;472705;3.53
9727;Total male and female;10000;Dutch background;N05 Psycholeptics;2013;465080;3.47
9728;Total male and female;10000;Dutch background;N05 Psycholeptics;2014;479260;3.58
9729;Total male and female;10000;Dutch background;N05 Psycholeptics;2015;492040;3.67
9730;Total male and female;10000;Dutch background;N05 Psycholeptics;2016;504045;3.77
9731;Total male and female;10000;Dutch background;N05 Psycholeptics;2017;516045;3.86
9732;Total male and female;10000;Dutch background;N05 Psycholeptics;2018;527830;3.95
9733;Total male and female;10000;Dutch background;N05 Psycholeptics;2019;532380;3.99
9734;Total male and female;10000;Dutch background;N05 Psycholeptics;2020;534740;4.01
9735;Total male and female;10000;Dutch background;N05A Antipsychotics;2006;183520;1.37
9736;Total male and female;10000;Dutch background;N05A Antipsychotics;2007;192275;1.44
9737;Total male and female;10000;Dutch background;N05A Antipsychotics;2008;196400;1.47
9738;Total male and female;10000;Dutch background;N05A Antipsychotics;2009;199525;1.49
9739;Total male and female;10000;Dutch background;N05A Antipsychotics;2010;206240;1.54
9740;Total male and female;10000;Dutch background;N05A Antipsychotics;2011;213310;1.59
9741;Total male and female;10000;Dutch background;N05A Antipsychotics;2012;217490;1.62
9742;Total male and female;10000;Dutch background;N05A Antipsychotics;2013;222085;1.66
9743;Total male and female;10000;Dutch background;N05A Antipsychotics;2014;231120;1.73
9744;Total male and female;10000;Dutch background;N05A Antipsychotics;2015;238225;1.78
9745;Total male and female;10000;Dutch background;N05A Antipsychotics;2016;242245;1.81
9746;Total male and female;10000;Dutch background;N05A Antipsychotics;2017;246235;1.84
9747;Total male and female;10000;Dutch background;N05A Antipsychotics;2018;253330;1.9
9748;Total male and female;10000;Dutch background;N05A Antipsychotics;2019;256475;1.92
9749;Total male and female;10000;Dutch background;N05A Antipsychotics;2020;264435;1.98
9750;Total male and female;10000;Dutch background;N05B Anxiolytics;2006;966515;7.24
9751;Total male and female;10000;Dutch background;N05B Anxiolytics;2007;981795;7.35
9752;Total male and female;10000;Dutch background;N05B Anxiolytics;2008;971525;7.27
9753;Total male and female;10000;Dutch background;N05B Anxiolytics;2009;217005;1.62
9754;Total male and female;10000;Dutch background;N05B Anxiolytics;2010;227810;1.7
9755;Total male and female;10000;Dutch background;N05B Anxiolytics;2011;242370;1.81
9756;Total male and female;10000;Dutch background;N05B Anxiolytics;2012;240845;1.8
9757;Total male and female;10000;Dutch background;N05B Anxiolytics;2013;232830;1.74
9758;Total male and female;10000;Dutch background;N05B Anxiolytics;2014;235450;1.76
9759;Total male and female;10000;Dutch background;N05B Anxiolytics;2015;237495;1.77
9760;Total male and female;10000;Dutch background;N05B Anxiolytics;2016;241710;1.81
9761;Total male and female;10000;Dutch background;N05B Anxiolytics;2017;246715;1.84
9762;Total male and female;10000;Dutch background;N05B Anxiolytics;2018;247415;1.85
9763;Total male and female;10000;Dutch background;N05B Anxiolytics;2019;245305;1.84
9764;Total male and female;10000;Dutch background;N05B Anxiolytics;2020;239860;1.8
9765;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2006;710690;5.32
9766;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2007;725830;5.43
9767;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2008;722110;5.4
9768;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2009;130860;0.98
9769;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2010;133670;1.0
9770;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2011;144300;1.08
9771;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2012;147035;1.1
9772;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2013;143950;1.07
9773;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2014;152800;1.14
9774;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2015;161655;1.21
9775;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2016;170880;1.28
9776;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2017;178590;1.34
9777;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2018;185315;1.39
9778;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2019;186730;1.4
9779;Total male and female;10000;Dutch background;N05C Hypnotics and sedatives;2020;188090;1.41
9780;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2006;782705;5.86
9781;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2007;829625;6.21
9782;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2008;853235;6.39
9783;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2009;872030;6.52
9784;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2010;896700;6.7
9785;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2011;937865;7.0
9786;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2012;953810;7.12
9787;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2013;978635;7.31
9788;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2014;1000745;7.47
9789;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2015;1018090;7.6
9790;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2016;1022375;7.64
9791;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2017;1019550;7.62
9792;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2018;1028000;7.69
9793;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2019;1037895;7.78
9794;Total male and female;10000;Dutch background;N06 Psychoanaleptics;2020;1029455;7.72
9795;Total male and female;10000;Dutch background;N06A Antidepressants;2006;703610;5.27
9796;Total male and female;10000;Dutch background;N06A Antidepressants;2007;736080;5.51
9797;Total male and female;10000;Dutch background;N06A Antidepressants;2008;743985;5.57
9798;Total male and female;10000;Dutch background;N06A Antidepressants;2009;746565;5.58
9799;Total male and female;10000;Dutch background;N06A Antidepressants;2010;753290;5.63
9800;Total male and female;10000;Dutch background;N06A Antidepressants;2011;779095;5.82
9801;Total male and female;10000;Dutch background;N06A Antidepressants;2012;783905;5.85
9802;Total male and female;10000;Dutch background;N06A Antidepressants;2013;801525;5.98
9803;Total male and female;10000;Dutch background;N06A Antidepressants;2014;814620;6.08
9804;Total male and female;10000;Dutch background;N06A Antidepressants;2015;829255;6.19
9805;Total male and female;10000;Dutch background;N06A Antidepressants;2016;832990;6.22
9806;Total male and female;10000;Dutch background;N06A Antidepressants;2017;833225;6.23
9807;Total male and female;10000;Dutch background;N06A Antidepressants;2018;843480;6.31
9808;Total male and female;10000;Dutch background;N06A Antidepressants;2019;850310;6.37
9809;Total male and female;10000;Dutch background;N06A Antidepressants;2020;840675;6.3
9810;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2006;68790;0.52
9811;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2007;83865;0.63
9812;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2008;98455;0.74
9813;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2009;113985;0.85
9814;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2010;132875;0.99
9815;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2011;149565;1.12
9816;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2012;161840;1.21
9817;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2013;172175;1.29
9818;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2014;184610;1.38
9819;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2015;190135;1.42
9820;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2016;193570;1.45
9821;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2017;193670;1.45
9822;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2018;194735;1.46
9823;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2019;200320;1.5
9824;Total male and female;10000;Dutch background;N06B Psychostimul.,adhd agents,nootropic;2020;202835;1.52
9825;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2006;0;0.0
9826;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2007;0;0.0
9827;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2008;0;0.0
9828;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2009;0;0.0
9829;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2010;0;0.0
9830;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2011;0;0.0
9831;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2012;0;0.0
9832;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2013;0;0.0
9833;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2014;0;0.0
9834;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2015;0;0.0
9835;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2016;0;0.0
9836;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2017;0;0.0
9837;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2018;0;0.0
9838;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2019;0;0.0
9839;Total male and female;10000;Dutch background;N06C Psycholeptics, -analeptics combin.;2020;0;0.0
9840;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2006;22110;0.17
9841;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2007;24360;0.18
9842;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2008;28085;0.21
9843;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2009;30985;0.23
9844;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2010;32875;0.25
9845;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2011;33715;0.25
9846;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2012;33590;0.25
9847;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2013;31885;0.24
9848;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2014;29865;0.22
9849;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2015;28055;0.21
9850;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2016;25800;0.19
9851;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2017;21670;0.16
9852;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2018;18895;0.14
9853;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2019;17820;0.13
9854;Total male and female;10000;Dutch background;N06D Anti-dementia drugs;2020;16960;0.13
9855;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2006;125530;0.94
9856;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2007;127010;0.95
9857;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2008;124205;0.93
9858;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2009;122455;0.92
9859;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2010;121970;0.91
9860;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2011;147725;1.1
9861;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2012;115730;0.86
9862;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2013;133270;1.0
9863;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2014;124720;0.93
9864;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2015;124075;0.93
9865;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2016;128915;0.96
9866;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2017;127780;0.96
9867;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2018;110615;0.83
9868;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2019;105705;0.79
9869;Total male and female;10000;Dutch background;N07 Other nervous system drugs;2020;112160;0.84
9870;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2006;7760;0.06
9871;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2007;7520;0.06
9872;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2008;6960;0.05
9873;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2009;6795;0.05
9874;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2010;6430;0.05
9875;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2011;6225;0.05
9876;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2012;5735;0.04
9877;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2013;5285;0.04
9878;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2014;5520;0.04
9879;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2015;5210;0.04
9880;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2016;4735;0.04
9881;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2017;4530;0.03
9882;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2018;4455;0.03
9883;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2019;5005;0.04
9884;Total male and female;10000;Dutch background;N07A Parasympathomimetics;2020;4965;0.04
9885;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2006;17690;0.13
9886;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2007;19090;0.14
9887;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2008;19665;0.15
9888;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2009;20175;0.15
9889;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2010;20710;0.15
9890;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2011;47960;0.36
9891;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2012;20800;0.16
9892;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2013;44580;0.33
9893;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2014;38650;0.29
9894;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2015;41245;0.31
9895;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2016;48275;0.36
9896;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2017;51500;0.39
9897;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2018;39570;0.3
9898;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2019;40365;0.3
9899;Total male and female;10000;Dutch background;N07B Drugs used in addictive disorders;2020;50965;0.38
9900;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2006;99685;0.75
9901;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2007;99855;0.75
9902;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2008;96940;0.73
9903;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2009;94765;0.71
9904;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2010;93985;0.7
9905;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2011;92870;0.69
9906;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2012;88160;0.66
9907;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2013;82525;0.62
9908;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2014;78760;0.59
9909;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2015;75025;0.56
9910;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2016;71630;0.54
9911;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2017;66695;0.5
9912;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2018;61490;0.46
9913;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2019;56770;0.43
9914;Total male and female;10000;Dutch background;N07C Antivertigo preparations;2020;51965;0.39
9915;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2006;840;0.01
9916;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2007;960;0.01
9917;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2008;1030;0.01
9918;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2009;1105;0.01
9919;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2010;1230;0.01
9920;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2011;1335;0.01
9921;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2012;1355;0.01
9922;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2013;1455;0.01
9923;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2014;2310;0.02
9924;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2015;3115;0.02
9925;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2016;4860;0.04
9926;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2017;5635;0.04
9927;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2018;5585;0.04
9928;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2019;4045;0.03
9929;Total male and female;10000;Dutch background;N07X Other nervous system drugs;2020;4860;0.04
9930;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2006;131450;0.98
9931;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2007;131020;0.98
9932;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2008;134305;1.01
9933;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2009;137695;1.03
9934;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2010;142260;1.06
9935;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2011;147290;1.1
9936;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2012;149540;1.12
9937;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2013;149710;1.12
9938;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2014;153035;1.14
9939;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2015;147630;1.1
9940;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2016;144800;1.08
9941;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2017;143175;1.07
9942;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2018;141330;1.06
9943;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2019;138435;1.04
9944;Total male and female;10000;Dutch background;P Antiparasitics,insecticides,repellents;2020;127690;0.96
9945;Total male and female;10000;Dutch background;P01 Antiprotozoals;2006;125735;0.94
9946;Total male and female;10000;Dutch background;P01 Antiprotozoals;2007;124225;0.93
9947;Total male and female;10000;Dutch background;P01 Antiprotozoals;2008;130110;0.97
9948;Total male and female;10000;Dutch background;P01 Antiprotozoals;2009;132675;0.99
9949;Total male and female;10000;Dutch background;P01 Antiprotozoals;2010;136255;1.02
9950;Total male and female;10000;Dutch background;P01 Antiprotozoals;2011;140440;1.05
9951;Total male and female;10000;Dutch background;P01 Antiprotozoals;2012;142600;1.06
9952;Total male and female;10000;Dutch background;P01 Antiprotozoals;2013;141480;1.06
9953;Total male and female;10000;Dutch background;P01 Antiprotozoals;2014;142700;1.07
9954;Total male and female;10000;Dutch background;P01 Antiprotozoals;2015;135125;1.01
9955;Total male and female;10000;Dutch background;P01 Antiprotozoals;2016;129700;0.97
9956;Total male and female;10000;Dutch background;P01 Antiprotozoals;2017;124660;0.93
9957;Total male and female;10000;Dutch background;P01 Antiprotozoals;2018;122235;0.91
9958;Total male and female;10000;Dutch background;P01 Antiprotozoals;2019;119520;0.9
9959;Total male and female;10000;Dutch background;P01 Antiprotozoals;2020;106850;0.8
9960;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2006;96695;0.72
9961;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2007;102115;0.76
9962;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2008;104875;0.78
9963;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2009;107175;0.8
9964;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2010;108970;0.81
9965;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2011;110755;0.83
9966;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2012;111485;0.83
9967;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2013;108235;0.81
9968;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2014;107175;0.8
9969;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2015;98500;0.74
9970;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2016;92350;0.69
9971;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2017;86635;0.65
9972;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2018;84235;0.63
9973;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2019;80175;0.6
9974;Total male and female;10000;Dutch background;P01A Amoebiasis / other protozoal dis.;2020;69855;0.52
9975;Total male and female;10000;Dutch background;P01B Antimalarials;2006;29330;0.22
9976;Total male and female;10000;Dutch background;P01B Antimalarials;2007;22275;0.17
9977;Total male and female;10000;Dutch background;P01B Antimalarials;2008;25450;0.19
9978;Total male and female;10000;Dutch background;P01B Antimalarials;2009;25705;0.19
9979;Total male and female;10000;Dutch background;P01B Antimalarials;2010;27540;0.21
9980;Total male and female;10000;Dutch background;P01B Antimalarials;2011;29935;0.22
9981;Total male and female;10000;Dutch background;P01B Antimalarials;2012;31310;0.23
9982;Total male and female;10000;Dutch background;P01B Antimalarials;2013;33490;0.25
9983;Total male and female;10000;Dutch background;P01B Antimalarials;2014;35760;0.27
9984;Total male and female;10000;Dutch background;P01B Antimalarials;2015;36795;0.27
9985;Total male and female;10000;Dutch background;P01B Antimalarials;2016;37540;0.28
9986;Total male and female;10000;Dutch background;P01B Antimalarials;2017;38235;0.29
9987;Total male and female;10000;Dutch background;P01B Antimalarials;2018;38280;0.29
9988;Total male and female;10000;Dutch background;P01B Antimalarials;2019;39600;0.3
9989;Total male and female;10000;Dutch background;P01B Antimalarials;2020;37235;0.28
9990;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2006;75;0.0
9991;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2007;105;0.0
9992;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2008;105;0.0
9993;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2009;130;0.0
9994;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2010;150;0.0
9995;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2011;150;0.0
9996;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2012;160;0.0
9997;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2013;155;0.0
9998;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2014;160;0.0
9999;Total male and female;10000;Dutch background;P01C Leishmaniasis and trypanosomiasis;2015;185;0.0
